Gene,Gene synonym,Ensembl,Gene description,Uniprot,Chromosome,Position,Protein class,Biological process,Molecular function,Disease involvement,Evidence,HPA evidence,UniProt evidence,NeXtProt evidence,MS evidence,RNA tissue specificity,RNA tissue distribution,RNA tissue specificity score,RNA tissue specific NX,RNA single cell type specificity,RNA single cell type distribution,RNA single cell type specificity score,RNA single cell type specific NX,RNA cancer specificity,RNA cancer distribution,RNA cancer specificity score,RNA cancer specific FPKM,RNA brain regional specificity,RNA brain regional distribution,RNA brain regional specificity score,RNA brain regional specific NX,RNA blood cell specificity,RNA blood cell distribution,RNA blood cell specificity score,RNA blood cell specific NX,RNA blood lineage specificity,RNA blood lineage distribution,RNA blood lineage specificity score,RNA blood lineage specific NX,RNA cell line specificity,RNA cell line distribution,RNA cell line specificity score,RNA cell line specific NX,RNA mouse brain regional specificity,RNA mouse brain regional distribution,RNA mouse brain regional specificity score,RNA mouse brain regional specific pTPM,RNA pig brain regional specificity,RNA pig brain regional distribution,RNA pig brain regional specificity score,RNA pig brain regional specific pTPM,Antibody,Reliability (IH),Reliability (Mouse Brain),Reliability (IF),Subcellular location,Secretome location,CCD Protein,CCD Transcript,Blood concentration - Conc. blood IM [pg/L],Blood concentration - Conc. blood MS [pg/L],Subcellular main location,Subcellular additional location,Antibody RRID,Pathology prognostics - Breast cancer,Pathology prognostics - Cervical cancer,Pathology prognostics - Colorectal cancer,Pathology prognostics - Endometrial cancer,Pathology prognostics - Glioma,Pathology prognostics - Head and neck cancer,Pathology prognostics - Liver cancer,Pathology prognostics - Lung cancer,Pathology prognostics - Melanoma,Pathology prognostics - Ovarian cancer,Pathology prognostics - Pancreatic cancer,Pathology prognostics - Prostate cancer,Pathology prognostics - Renal cancer,Pathology prognostics - Stomach cancer,Pathology prognostics - Testis cancer,Pathology prognostics - Thyroid cancer,Pathology prognostics - Urothelial cancer,Tissue RNA - adipose tissue [NX],Tissue RNA - adrenal gland [NX],Tissue RNA - amygdala [NX],Tissue RNA - appendix [NX],Tissue RNA - basal ganglia [NX],Tissue RNA - bone marrow [NX],Tissue RNA - breast [NX],Tissue RNA - cerebellum [NX],Tissue RNA - cerebral cortex [NX],"Tissue RNA - cervix, uterine [NX]",Tissue RNA - colon [NX],Tissue RNA - corpus callosum [NX],Tissue RNA - ductus deferens [NX],Tissue RNA - duodenum [NX],Tissue RNA - endometrium 1 [NX],Tissue RNA - epididymis [NX],Tissue RNA - esophagus [NX],Tissue RNA - fallopian tube [NX],Tissue RNA - gallbladder [NX],Tissue RNA - heart muscle [NX],Tissue RNA - hippocampal formation [NX],Tissue RNA - hypothalamus [NX],Tissue RNA - kidney [NX],Tissue RNA - liver [NX],Tissue RNA - lung [NX],Tissue RNA - lymph node [NX],Tissue RNA - midbrain [NX],Tissue RNA - olfactory region [NX],Tissue RNA - ovary [NX],Tissue RNA - pancreas [NX],Tissue RNA - parathyroid gland [NX],Tissue RNA - pituitary gland [NX],Tissue RNA - placenta [NX],Tissue RNA - pons and medulla [NX],Tissue RNA - prostate [NX],Tissue RNA - rectum [NX],Tissue RNA - retina [NX],Tissue RNA - salivary gland [NX],Tissue RNA - seminal vesicle [NX],Tissue RNA - skeletal muscle [NX],Tissue RNA - skin 1 [NX],Tissue RNA - small intestine [NX],Tissue RNA - smooth muscle [NX],Tissue RNA - spinal cord [NX],Tissue RNA - spleen [NX],Tissue RNA - stomach 1 [NX],Tissue RNA - testis [NX],Tissue RNA - thalamus [NX],Tissue RNA - thymus [NX],Tissue RNA - thyroid gland [NX],Tissue RNA - tongue [NX],Tissue RNA - tonsil [NX],Tissue RNA - urinary bladder [NX],Tissue RNA - vagina [NX],Tissue RNA - B-cells [NX],Tissue RNA - dendritic cells [NX],Tissue RNA - granulocytes [NX],Tissue RNA - monocytes [NX],Tissue RNA - NK-cells [NX],Tissue RNA - T-cells [NX],Tissue RNA - total PBMC [NX],Cell RNA - A-431 [NX],Cell RNA - A549 [NX],Cell RNA - AF22 [NX],Cell RNA - AN3-CA [NX],Cell RNA - ASC diff [NX],Cell RNA - ASC TERT1 [NX],Cell RNA - BEWO [NX],Cell RNA - BJ [NX],Cell RNA - BJ hTERT+ [NX],Cell RNA - BJ hTERT+ SV40 Large T+ [NX],Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX],Cell RNA - CACO-2 [NX],Cell RNA - CAPAN-2 [NX],Cell RNA - Daudi [NX],Cell RNA - EFO-21 [NX],Cell RNA - fHDF/TERT166 [NX],Cell RNA - GAMG [NX],Cell RNA - HaCaT [NX],Cell RNA - HAP1 [NX],Cell RNA - HBEC3-KT [NX],Cell RNA - HBF TERT88 [NX],Cell RNA - HDLM-2 [NX],Cell RNA - HEK 293 [NX],Cell RNA - HEL [NX],Cell RNA - HeLa [NX],Cell RNA - Hep G2 [NX],Cell RNA - HHSteC [NX],Cell RNA - HL-60 [NX],Cell RNA - HMC-1 [NX],Cell RNA - HSkMC [NX],Cell RNA - hTCEpi [NX],Cell RNA - hTEC/SVTERT24-B [NX],Cell RNA - hTERT-HME1 [NX],Cell RNA - hTERT-RPE1 [NX],Cell RNA - HUVEC TERT2 [NX],Cell RNA - JURKAT [NX],Cell RNA - K-562 [NX],Cell RNA - Karpas-707 [NX],Cell RNA - LHCN-M2 [NX],Cell RNA - MCF7 [NX],Cell RNA - MOLT-4 [NX],Cell RNA - NB-4 [NX],Cell RNA - NTERA-2 [NX],Cell RNA - OE19 [NX],Cell RNA - PC-3 [NX],Cell RNA - REH [NX],Cell RNA - RH-30 [NX],Cell RNA - RPMI-8226 [NX],Cell RNA - RPTEC TERT1 [NX],Cell RNA - RT4 [NX],Cell RNA - SCLC-21H [NX],Cell RNA - SH-SY5Y [NX],Cell RNA - SiHa [NX],Cell RNA - SK-BR-3 [NX],Cell RNA - SK-MEL-30 [NX],Cell RNA - SuSa [NX],Cell RNA - T-47d [NX],Cell RNA - THP-1 [NX],Cell RNA - TIME [NX],Cell RNA - U-138 MG [NX],Cell RNA - U-2 OS [NX],Cell RNA - U-2197 [NX],Cell RNA - U-251 MG [NX],Cell RNA - U-266/70 [NX],Cell RNA - U-266/84 [NX],Cell RNA - U-698 [NX],Cell RNA - U-87 MG [NX],Cell RNA - U-937 [NX],Cell RNA - WM-115 [NX],Blood RNA - basophil [NX],Blood RNA - classical monocyte [NX],Blood RNA - eosinophil [NX],Blood RNA - gdT-cell [NX],Blood RNA - intermediate monocyte [NX],Blood RNA - MAIT T-cell [NX],Blood RNA - memory B-cell [NX],Blood RNA - memory CD4 T-cell [NX],Blood RNA - memory CD8 T-cell [NX],Blood RNA - myeloid DC [NX],Blood RNA - naive B-cell [NX],Blood RNA - naive CD4 T-cell [NX],Blood RNA - naive CD8 T-cell [NX],Blood RNA - neutrophil [NX],Blood RNA - NK-cell [NX],Blood RNA - non-classical monocyte [NX],Blood RNA - plasmacytoid DC [NX],Blood RNA - T-reg [NX],Blood RNA - total PBMC [NX],Brain RNA - amygdala [NX],Brain RNA - basal ganglia [NX],Brain RNA - cerebellum [NX],Brain RNA - cerebral cortex [NX],Brain RNA - hippocampal formation [NX],Brain RNA - hypothalamus [NX],Brain RNA - midbrain [NX],Brain RNA - olfactory region [NX],Brain RNA - pons and medulla [NX],Brain RNA - thalamus [NX],Single Cell Type RNA - Alveolar cells type 1 [NX],Single Cell Type RNA - Alveolar cells type 2 [NX],Single Cell Type RNA - B-cells [NX],Single Cell Type RNA - Basal glandular cells [NX],Single Cell Type RNA - Basal keratinocytes [NX],Single Cell Type RNA - Bipolar cells [NX],Single Cell Type RNA - Cardiomyocytes [NX],Single Cell Type RNA - Cholangiocytes [NX],Single Cell Type RNA - Ciliated cells [NX],Single Cell Type RNA - Club cells [NX],Single Cell Type RNA - Collecting duct cells [NX],Single Cell Type RNA - Cone photoreceptor cells [NX],Single Cell Type RNA - Cytotrophoblasts [NX],Single Cell Type RNA - Distal tubular cells [NX],Single Cell Type RNA - Ductal cells [NX],Single Cell Type RNA - Early spermatids [NX],Single Cell Type RNA - Endothelial cells [NX],Single Cell Type RNA - Enterocytes [NX],Single Cell Type RNA - Erythroid cells [NX],Single Cell Type RNA - Exocrine glandular cells [NX],Single Cell Type RNA - Extravillous trophoblasts [NX],Single Cell Type RNA - Fibroblasts [NX],Single Cell Type RNA - Glandular cells [NX],Single Cell Type RNA - granulocytes [NX],Single Cell Type RNA - Hepatocytes [NX],Single Cell Type RNA - Hofbauer cells [NX],Single Cell Type RNA - Horizontal cells [NX],Single Cell Type RNA - Intestinal endocrine cells [NX],Single Cell Type RNA - Ito cells [NX],Single Cell Type RNA - Kupffer cells [NX],Single Cell Type RNA - Late spermatids [NX],Single Cell Type RNA - Leydig cells [NX],Single Cell Type RNA - Macrophages [NX],Single Cell Type RNA - Melanocytes [NX],Single Cell Type RNA - monocytes [NX],Single Cell Type RNA - Mucus-secreting cells [NX],Single Cell Type RNA - Muller glia cells [NX],Single Cell Type RNA - Pancreatic endocrine cells [NX],Single Cell Type RNA - Paneth cells [NX],Single Cell Type RNA - Peritubular cells [NX],Single Cell Type RNA - Proximal tubular cells [NX],Single Cell Type RNA - Rod photoreceptor cells [NX],Single Cell Type RNA - Sertoli cells [NX],Single Cell Type RNA - Smooth muscle cells [NX],Single Cell Type RNA - Spermatocytes [NX],Single Cell Type RNA - Spermatogonia [NX],Single Cell Type RNA - Suprabasal keratinocytes [NX],Single Cell Type RNA - Syncytiotrophoblasts [NX],Single Cell Type RNA - T-cells [NX],Single Cell Type RNA - Undifferentiated cells [NX],Single Cell Type RNA - Urothelial cells [NX]
ABCC4,"EST170205, MOAT-B, MOATB, MRP4",ENSG00000125257,ATP binding cassette subfamily C member 4,O15439,13,95019829-95301475,"Plasma proteins, Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,prostate: 35.0,Cell type enhanced,Detected in many,7,Glandular cells: 38.5;granulocytes: 53.1;Proximal tubular cells: 32.7,Cancer enriched,Detected in all,8,prostate cancer: 90.8,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Group enriched,Detected in many,4,HEL: 61.8;HMC-1: 67.7;RPTEC TERT1: 18.2,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,HPA002476,Enhanced,NA,Approved,"Nucleoli,Golgi apparatus,Plasma membrane",NA,NA,NA,NA,NA,"Nucleoli, Plasma membrane",Golgi apparatus,HPA002476: AB_1844434,unprognostic (8.77e-2),unprognostic (1.94e-2),unprognostic (1.48e-1),prognostic unfavorable (9.89e-4),unprognostic (2.83e-2),unprognostic (1.23e-1),unprognostic (7.45e-3),unprognostic (2.40e-2),unprognostic (9.96e-2),unprognostic (2.60e-2),unprognostic (1.28e-1),unprognostic (2.55e-2),prognostic favorable (2.25e-10),unprognostic (7.44e-3),unprognostic (1.67e-1),unprognostic (5.55e-2),unprognostic (2.35e-2),3.2,1.7,3.8,11.8,4.7,2.9,6.2,1,4.6,4.4,11.6,10.3,3.9,4.1,5.8,16.4,3,8.6,10.3,3.5,5.7,3.9,19.6,1.9,13.8,7.4,6.6,2.2,7.2,3.5,7,2.8,1.8,7.4,35,7.3,6,3.3,5.2,7.6,4.5,7.4,11.1,6.5,3.8,8.2,3.8,7,3.4,6.6,3.1,5.8,25.6,13.4,3.6,4.1,1,4.8,4.1,3.6,3.4,4.5,8,1.3,2.4,2.5,3.3,0.3,3.6,3.7,3.3,2.8,11.1,3.4,2.5,2.4,4.9,2.4,6.2,2,1.8,4.1,7.5,3.1,61.8,2.5,2.2,5.1,7,67.7,2.5,0.8,2.3,4.8,4.7,4.2,2.8,6.4,0.1,4.4,1.4,1.3,1.1,1.5,5.5,1.9,1.9,3.7,6.6,18.2,10.3,3.3,2.4,1.2,0.2,2.5,1.5,0,3.8,6.9,3.5,2.2,2.9,4.3,0,0,1,6.6,4,1.7,0.6,1.2,0.4,3.2,1.2,2.7,3.6,2.6,3.6,4.1,2.7,1.6,3.5,1,4.1,4.8,0.7,3.3,3.4,3.8,4.7,1,4.6,5.7,3.9,6.6,2.2,7.4,7,8.9,28.3,3.7,6.2,3.8,0,3.1,5.1,6.7,11.4,22.7,21.6,0.1,0,5.2,3.2,11.3,1.4,0,2.6,0.4,3.9,38.5,53.1,0,3.8,0,0,2.5,1,1.7,6.4,6.3,1.7,19,3.2,0.3,4.1,9.3,1.8,32.7,0.7,0,3.9,0.6,9.1,6.6,0.2,2.2,7.8,3.7
ABCC5,"EST277145, MOAT-C, MRP5, SMRP",ENSG00000114770,ATP binding cassette subfamily C member 5,O15440,3,183919934-184018015,"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,Cancer-related genes,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,10,Cone photoreceptor cells: 184.6;Rod photoreceptor cells: 122.3,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in all,NA,RT4: 48.0,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA044067, HPA052295",Uncertain,NA,Approved,"Nucleoplasm,Plasma membrane,Cell Junctions",NA,NA,NA,NA,NA,"Plasma membrane, Cell Junctions",Nucleoplasm,"HPA044067: AB_2678797, HPA052295: AB_2681789",unprognostic (9.39e-2),unprognostic (6.23e-3),unprognostic (3.83e-2),unprognostic (1.10e-3),unprognostic (2.28e-2),unprognostic (2.07e-1),prognostic unfavorable (6.78e-8),unprognostic (4.46e-2),unprognostic (6.07e-3),unprognostic (1.02e-1),unprognostic (5.91e-3),prognostic unfavorable (3.40e-4),unprognostic (1.10e-1),unprognostic (9.05e-3),unprognostic (1.64e-1),unprognostic (3.33e-2),unprognostic (1.24e-2),7.9,11.2,24.7,9.6,26.2,12,6.7,42.8,28.6,7.7,11.4,12,13.4,6.8,14.1,7,17.1,6.1,11.6,16,19.1,13.7,12.8,3.6,9.4,7.3,20.5,18.5,11.8,4.9,22.4,20.5,10.8,21.7,10.6,14.4,31.1,7.4,9.3,41,14.5,8.5,10.5,12.9,16.3,48.5,9.4,20.9,9.3,5.5,7.3,7.4,18.1,12.7,4.2,3.5,15.8,4.5,5,7,4.5,7.3,4.1,9.4,11.2,9.4,10.7,14.6,6,4.7,5.4,5.9,6.3,5.7,8,14.1,5.7,8.2,29.9,11.6,6.6,7.1,8.7,11.2,16.9,10.3,5.7,3.9,5.1,13.2,17,6.7,5.8,3.8,11.1,6.3,23.7,15.7,11.1,9.2,19.5,14.1,5.9,9.7,13.4,7.9,9.8,3.1,4.7,19.6,48,17.2,10.2,6.1,33.9,10.1,12.7,20.5,1.6,7.2,6.3,6.2,8,8.2,4.3,8.3,7.4,4.6,10.3,6.4,10.7,4.5,7.7,7,2.1,4.5,3.2,4,3.1,3.5,4.2,4.6,6.3,15.8,5,3.5,1.3,5,4.5,24.7,26.2,42.8,28.6,19.1,13.7,20.5,18.5,21.7,20.9,8.9,4,1.9,12.9,7.9,34.3,31.9,2.5,56.2,46.6,41.8,184.6,2.7,6.6,5,4.8,6.7,9.5,0,4,3.9,8,10.9,4.7,2.4,39.9,31.8,56.9,5.5,27.9,2.2,7.5,11.2,11.8,6.4,6.3,9.4,6.1,9.3,7.4,2.7,122.3,0,8.6,3.1,14.7,10.7,3.8,5,7.2,50.3
GCM1,"GCMA, hGCMa",ENSG00000137270,Glial cells missing homolog 1,Q9NP62,6,53126964-53148829,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation","Developmental protein, DNA-binding",NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,22,placenta: 102.4,Group enriched,Detected in some,7,Extravillous trophoblasts: 166.4;Syncytiotrophoblasts: 222.5,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell type enhanced,Detected in some,NA,neutrophil: 4.5,Group enriched,Detected in many,8,B-cells: 1.8;granulocytes: 4.5,Cell line enriched,Detected in some,5,BEWO: 30.1,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA011343, HPA073469",Enhanced,NA,Approved,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,"HPA011343: AB_2668489, HPA073469:",unprognostic (2.81e-2),unprognostic (4.09e-2),unprognostic (1.89e-2),unprognostic (1.53e-1),unprognostic (3.17e-1),unprognostic (7.68e-2),unprognostic (8.47e-3),unprognostic (2.83e-2),unprognostic (2.81e-1),unprognostic (4.04e-2),unprognostic (1.42e-1),unprognostic (5.98e-2),unprognostic (1.29e-4),unprognostic (1.86e-1),unprognostic (7.42e-2),NA,unprognostic (2.96e-2),0.3,0.3,0.1,0.1,0.1,0.3,0.5,0.1,0.1,0.1,0.1,0.1,0.7,0,0.1,0.2,0.2,0.2,0.1,0.1,0.1,0,1.5,0.1,0.7,0.1,0.1,0.1,0.1,0.1,0,0.2,102.4,0.1,0.2,0,0.1,0.1,0.1,3.1,0,0.4,0.1,0.1,2.2,0,2.7,0.1,0.1,0.1,0.1,0.1,0.1,0.1,1.8,0.2,4.5,0.3,0.4,0.3,0.1,0.1,0.1,0.1,0.2,0,0,30.1,0,0,0,0,1.3,0.1,0,0,0,0,0,0,0,0.1,0.1,0.1,0,0.2,0.3,0,0,0.3,0,0,0,0,0,0,0.1,0,0.2,0,0,0.1,0.2,0.1,0,0,0,0,0.2,0.1,0,0.1,0.2,0,0.1,0,6.6,0.1,0.1,0,0.1,0.1,0.1,0.1,0.3,0.2,0.1,0,0.1,0.1,0.6,0.3,2.2,0.2,0.1,0.2,0.7,0.1,0.1,0.2,1.8,0.2,0.2,4.5,0.4,0.3,0.2,0.3,0.1,0.1,0.1,0.1,0.1,0.1,0,0.1,0.1,0.1,0.1,0,0,0,0.1,0,0,0.3,0,0,0,0,0,27.5,0,0.3,1.9,0,0,0,0.2,166.4,0,0.1,0,0,6.3,0,0,0,0,0.4,0,0,0,0,0,0,0.2,0,0,5.7,0,0,0.2,0,0,0,222.5,0,0,0
GCM2,"GCMB, hGCMb",ENSG00000124827,Glial cells missing homolog 2,O75603,6,10873223-10881941,"Disease related genes, Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation","Developmental protein, DNA-binding",Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,NA,Tissue enriched,Detected in some,24,parathyroid gland: 110.5,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,HL-60: 1.2;HMC-1: 1.0,Not detected,Not detected,NA,NA,Low region specificity,Detected in many,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (1.55e-1),NA,NA,NA,NA,unprognostic (4.94e-1),NA,NA,NA,unprognostic (2.18e-2),unprognostic (7.17e-2),unprognostic (2.63e-3),NA,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,110.5,0,0,0,0.9,0,0,0,0,0,0,0,0,0,0,0,2,0,0,4.6,0,0,0,0,0,0.5,0,0,0,0.3,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0.3,0,0,0,0,1.2,1,0,0,0,0,0,0,0.3,0.4,0,0,0,0.3,0.1,0.1,0,0,0.2,0.1,0,0,0,0.1,0.3,0,0,0,0.2,0,0,0,0,0.2,0,0,0.5,0,0.1,0,0,0.4,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0.5,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0.2,0,0,0,0,0
NANOS3,"NANOS1L, NOS3, ZC2HC12C",ENSG00000187556,Nanos C2HC-type zinc finger 3,P60323,19,13862063-13880757,Predicted intracellular proteins,"Differentiation, Oogenesis, Spermatogenesis, Translation regulation","Developmental protein, RNA-binding",NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,NA,brain: 5.1;testis: 9.4,Cell type enhanced,Detected in many,5,Alveolar cells type 2: 3.7;monocytes: 4.6;Spermatogonia: 4.5,Cancer enriched,Detected in many,34,testis cancer: 132.0,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,HDLM-2: 2.0;MCF7: 3.2;MOLT-4: 1.8;REH: 2.9;RPMI-8226: 2.2;SH-SY5Y: 2.7,Low region specificity,Detected in some,NA,NA,Low region specificity,Detected in all,NA,NA,HPA062989,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA062989: AB_2684916,unprognostic (9.42e-3),unprognostic (3.17e-2),unprognostic (1.58e-1),unprognostic (8.58e-2),unprognostic (2.69e-1),unprognostic (6.89e-3),unprognostic (3.23e-3),unprognostic (4.97e-3),unprognostic (1.65e-1),unprognostic (1.39e-1),unprognostic (5.29e-3),unprognostic (5.17e-2),unprognostic (4.60e-2),unprognostic (3.12e-1),unprognostic (1.73e-1),unprognostic (2.16e-1),unprognostic (2.06e-1),0.3,0,1.7,0.3,0.4,0,0.3,5.1,4.4,0.3,0.3,0.3,0.3,2.2,0.3,0.3,0.3,0,0.3,0.3,1.3,1.7,0.3,0.3,1.1,0.3,0.8,0.3,0.3,0.5,0,0.4,0.4,0.3,0.3,0,0.3,0.3,0.4,0.3,0.4,1.3,0.3,0.3,0.4,0.5,9.4,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0,0,0,0,0,0.6,0,0.1,0.9,0,0,0,0,0,1,0.4,0,0,0,0.3,0,0.3,0,0,1.5,0,0,0,2,0.7,0,0.8,0,0,0,0.3,0,0,0,0,1.5,0,0.2,0,0,0,3.2,1.8,1.5,0.3,0,0,2.9,0,2.2,0,0,0.4,2.7,0,0,0,0.8,0,0,0,0,1.8,1.2,0,0.3,0,0,1,0,0.7,0,0,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.7,0.4,5.1,4.4,1.3,1.7,0.8,0.3,0.3,0.3,0,3.7,0,0.6,1.5,0.8,0.4,0,0,0,1.8,0,0,0,1.6,0.8,0.2,0,0,1,0.2,0.7,1.7,1.1,0,0.4,0,1.2,0,1,1.4,0,0.4,3.3,4.6,0.7,1.2,2.2,0,0.7,0,0.5,0,1.9,0.2,4.5,1.1,0.1,0,0.4,0.8
NANOS1,"NOS1, ZC2HC12A",ENSG00000188613,Nanos C2HC-type zinc finger 1,Q8WY41,10,119029716-119033732,"Disease related genes, Predicted intracellular proteins",Translation regulation,"Repressor, RNA-binding",Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,skeletal muscle: 40.7,Cell type enhanced,Detected in many,7,Cardiomyocytes: 10.9;Cone photoreceptor cells: 9.8;Muller glia cells: 8.5,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in some,NA,basophil: 3.2,Lineage enriched,Detected in single,5,granulocytes: 3.2,Cell line enhanced,Detected in many,NA,SH-SY5Y: 39.6;SK-BR-3: 22.7;SK-MEL-30: 17.2,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,CAB012219,Approved,NA,Approved,"Nucleoplasm,Cytosol",NA,NA,NA,NA,NA,"Nucleoplasm, Cytosol",NA,CAB012219:,prognostic unfavorable (1.52e-4),unprognostic (1.17e-1),unprognostic (1.50e-3),unprognostic (1.59e-3),unprognostic (7.07e-3),unprognostic (2.01e-1),unprognostic (2.19e-2),unprognostic (4.76e-3),unprognostic (1.97e-1),unprognostic (2.70e-1),unprognostic (8.22e-3),unprognostic (8.79e-2),unprognostic (2.64e-4),unprognostic (7.89e-2),unprognostic (6.99e-2),unprognostic (2.78e-2),unprognostic (2.52e-3),8.5,10.5,8.1,1,7.1,1,6.4,6.5,4.8,4.9,2.1,4.5,1.3,1.2,2.1,4.4,2.1,1.5,1,16.7,5,6.7,3.5,1,1.3,1.1,3.4,2.4,0.9,3.3,0.9,2.2,8.2,6,3.5,1.2,8.8,1.5,2.5,40.7,1.7,1.4,3.4,6.7,0.9,3.1,2.9,3,0.1,9.3,0.3,1,3.3,9.8,0.6,0.5,3.2,0.3,0.6,0.3,0.1,7.6,0.6,1.1,0.2,3.7,0.5,4.7,0.1,0.2,0.2,0.1,0.9,2.7,4.1,1,0,0,2.8,1.3,1.3,0.3,1.2,3.2,0.1,1.9,0.8,1.7,0.4,0,0.7,5.7,0,0.8,1.2,0.2,1.4,0.7,0.5,0.2,1.1,1,1.3,3.5,1.6,0.6,0,1.3,2.7,1.5,0.6,3,39.6,2.2,22.7,17.2,6.2,3.6,2.2,0.2,0,1.7,0,0.3,1.2,3.9,1.4,0.3,1,0,3.2,0.3,0.4,0.2,0.1,0.1,0.2,0.2,0.2,0,0.6,0.3,0.2,1.3,0.6,0.2,0.5,0.1,0.1,8.1,7.1,6.5,4.8,5,6.7,3.4,2.4,6,3,6,0.6,0,3.5,0.7,3.3,10.9,0,0,1.2,1.8,9.8,5.3,0,0.5,0.1,0.6,0.4,0,0.2,0.2,4.1,3.2,0,0,0.5,1.6,2.9,0.6,0,0,1.7,0,0,0,1,8.5,0.2,0,0.7,0.2,1.7,0,0.5,0.2,0.7,1.1,0.8,0,0.6,0.9
NANOS2,"NOS2, ZC2HC12B",ENSG00000188425,Nanos C2HC-type zinc finger 2,P60321,19,45913214-45914870,Predicted intracellular proteins,"Differentiation, Spermatogenesis, Translation regulation","Developmental protein, RNA-binding",NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,26,testis: 8.5,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in single,6,BEWO: 4.1,Low region specificity,Detected in some,NA,NA,Low region specificity,Detected in many,NA,NA,HPA014190,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA014190: AB_2668950,NA,NA,NA,NA,unprognostic (2.65e-1),NA,NA,NA,NA,unprognostic (1.01e-1),NA,NA,NA,NA,unprognostic (3.69e-1),NA,NA,0,0,0.1,0,0.3,0,0,0.1,0.2,0,0,0,0,0,0,0,0,0,0,0,0.1,0.3,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0.1,0,0,8.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0.3,0,0,4.1,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.3,0.1,0.2,0.1,0.3,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0
SIX1,DFNA23,ENSG00000126778,SIX homeobox 1,Q15475,14,60643415-60658259,"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors","Apoptosis, Transcription, Transcription regulation","Activator, Developmental protein, DNA-binding, Repressor","Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0,Cell type enhanced,Detected in some,19,Basal glandular cells: 23.3;Ciliated cells: 65.6;Club cells: 33.0;Glandular cells: 24.0;Urothelial cells: 14.9,Low cancer specificity,Detected in many,NA,NA,Group enriched,Detected in some,5,olfactory region: 1.2;pons and medulla: 4.5,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in many,NA,hTERT-RPE1: 14.3;LHCN-M2: 53.4;RH-30: 29.2,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,"HPA001893, CAB058690",Enhanced,NA,Supported,"Nucleoplasm,Nucleoli",NA,No,No,NA,NA,Nucleoplasm,Nucleoli,"CAB058690: AB_2665581, HPA001893: AB_1079991",unprognostic (3.62e-1),unprognostic (5.44e-2),unprognostic (5.09e-2),prognostic unfavorable (8.92e-6),unprognostic (1.33e-2),unprognostic (1.44e-2),unprognostic (2.04e-3),prognostic favorable (3.94e-4),unprognostic (1.40e-1),unprognostic (9.15e-2),unprognostic (6.45e-2),unprognostic (1.89e-1),unprognostic (3.06e-8),unprognostic (8.61e-2),unprognostic (2.13e-1),unprognostic (1.94e-1),unprognostic (3.86e-1),7.1,0.4,0.3,0.1,0.5,0.1,4.7,0.3,0.6,7.4,0.2,0.2,0,0.1,0.2,2.1,1.3,0.5,0.4,0.4,0.3,0.3,0.3,0.2,1.8,0.3,0.4,1.2,0.3,0.3,16.8,39.1,0.1,4.5,8.7,0.1,2,55.1,0.2,59,0.4,0.2,0.7,0.5,0.2,0.5,1.6,0,6.5,2.4,22.5,3,1.4,9.7,0.6,0,0,0,0,0,0,8.3,1.9,0.2,11.9,6.9,8.1,0.1,2,4.5,2.3,2,0,3.8,0,1.1,0.4,1.1,2.7,3.9,3.6,0.8,0,9.5,0.9,0.8,2.7,0,0,0.1,6,1.8,1.6,0.3,14.3,0.1,0.7,2.6,0,53.4,1.3,0,0.2,0,0,4.8,0,29.2,0,2.3,6.5,1.1,0.1,2.3,0.1,2.4,0.2,1.4,0.2,6.8,3.2,3.2,3.7,3,0.2,0,0,0.8,0,1.3,0,0,0,0,0,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0.5,0.3,0.5,0.3,0.3,0.4,1.2,4.5,0,3,1,0,23.3,0.1,0,0.8,0,65.6,33,1.8,0,0,1.7,0,0.2,0,0,0,0.7,0.4,0.8,24,0,0,0.1,0,0,0,0,0.4,0,0,0,0,0,0.8,0.2,0,1.1,0,0.3,0,0.2,0,2.5,0.1,0.2,0,0,14.9
SIX6,"OPTX2, Six9",ENSG00000184302,SIX homeobox 6,O95475,14,60508951-60512850,"Disease related genes, Predicted intracellular proteins, Transcription factors",NA,"Developmental protein, DNA-binding","Cataract, Disease mutation, Microphthalmia",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,4,pituitary gland: 43.3,Cell type enhanced,Detected in some,33,Cone photoreceptor cells: 27.5;Horizontal cells: 46.1;Muller glia cells: 158.1,Cancer enriched,Detected in single,8,glioma: 1.0,Region enriched,Detected in single,8,hypothalamus: 2.7,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,11,JURKAT: 9.3;MOLT-4: 29.4,Not detected,Not detected,NA,NA,Region enriched,Detected in single,12,hypothalamus: 2.5,HPA001403,Approved,NA,Approved,Nucleoplasm,NA,NA,NA,NA,NA,Nucleoplasm,NA,HPA001403: AB_1079993,NA,NA,NA,NA,unprognostic (2.76e-1),NA,NA,NA,unprognostic (6.14e-2),NA,NA,unprognostic (8.18e-2),NA,NA,unprognostic (5.75e-2),NA,NA,0.1,0,0.3,0,0.3,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.7,0,0,0,0,0,0,0,0,0,43.3,0,0,0.4,0,10.6,0.3,0,2.2,0,0,0,0,0.1,0,0.9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.3,0,0,0,0,29.4,0,1.7,0,0,0,0,0,0,0,0.2,1.4,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0.3,0,0,0,2.7,0,0,0,0,0,0,0,0.2,0,3.8,0.8,0,0,0,0,27.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,46.1,0,0,0,0,0,0,0,0,0,158.1,0,0,0,0,7.4,0,0,0,0,0,0,0,0,0
C14orf39,SIX6OS1,ENSG00000179008,Chromosome 14 open reading frame 39,Q8N1H7,14,60396469-60515543,"Plasma proteins, Predicted intracellular proteins","DNA recombination, Meiosis",Developmental protein,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,NA,pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9,Cell type enriched,Detected in some,6,Spermatocytes: 70.5,Low cancer specificity,Detected in single,NA,NA,Region enhanced,Detected in single,NA,hypothalamus: 1.4,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,HEL: 4.7;JURKAT: 21.7;MOLT-4: 17.6;RH-30: 4.8;U-2 OS: 9.9,Low region specificity,Detected in some,NA,NA,Not detected,Not detected,NA,NA,HPA059518,Uncertain,NA,Approved,"Nucleoplasm,Nucleoli",NA,Yes,No,NA,NA,"Nucleoplasm, Nucleoli",NA,HPA059518: AB_2684049,unprognostic (6.17e-2),unprognostic (1.73e-3),NA,unprognostic (3.00e-6),unprognostic (2.78e-1),unprognostic (6.97e-2),NA,unprognostic (7.55e-4),unprognostic (2.12e-1),unprognostic (1.71e-1),unprognostic (2.17e-1),unprognostic (1.78e-1),NA,unprognostic (7.46e-2),unprognostic (4.35e-1),unprognostic (1.50e-1),unprognostic (2.09e-1),1,2.7,0,0.6,0.2,0,0.1,0,0.5,0.5,0.8,0,0,0.3,0.6,0,0.7,0,0,0,0,1.4,0,0,0,0,0.1,0.4,1.7,0,0.6,16.9,0,0.2,1.6,0,1.6,6.7,0.1,3.8,0,0.3,0.1,0.5,0,0.6,14.9,0,0,0.4,1,0,0.5,0.2,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0.1,0.1,0.1,0,0,0,0,0,0,0,1,0,0,0,0.6,4.7,0,0,0,0,0.3,3.6,0,0.6,0,0.1,0,21.7,0,0,1.6,0,17.6,0.2,2.3,0,1.1,0,4.8,0,0.3,1.2,0,2,0,0,0,0.4,0,0.1,0,0,9.9,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0.5,0,1.4,0.1,0.4,0.2,0,0,0,0,0.8,0,0.3,0.6,0,1.4,5.7,0,0,0,0,0,7.6,0,0,0,0,0,0,0.7,1.1,0,0,3.2,0,0,0,5.1,0.3,0,0,0,0,11.8,0,0,0.7,0,1,0,0,70.5,6.1,0,0,0,0,0.1
SLC10A1,NTCP,ENSG00000100652,Solute carrier family 10 member 1,Q14973,14,69775417-69797289,"Predicted membrane proteins, Transporters","Host-virus interaction, Ion transport, Sodium transport, Symport, Transport","Host cell receptor for virus entry, Receptor",NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,44,liver: 121.2,Cell type enriched,Detected in some,13,Hepatocytes: 130.2,Cancer enriched,Detected in some,79,liver cancer: 65.2,Not detected,Not detected,NA,NA,Cell type enhanced,Detected in some,NA,neutrophil: 2.7,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in some,NA,CACO-2: 4.3,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,HPA042727,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA042727: AB_10960691,unprognostic (3.42e-1),unprognostic (9.39e-2),unprognostic (1.51e-2),unprognostic (2.11e-2),unprognostic (1.93e-2),unprognostic (6.51e-3),prognostic favorable (9.53e-6),unprognostic (6.07e-3),unprognostic (8.95e-2),unprognostic (2.17e-1),unprognostic (5.75e-3),unprognostic (1.22e-1),unprognostic (1.71e-2),unprognostic (1.05e-1),unprognostic (3.21e-1),unprognostic (2.45e-1),unprognostic (5.69e-2),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,121.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,1,0.3,2.7,0.5,0.1,0.6,0,0.2,0,0.2,0.4,0,0,0.4,0,0,0.1,0,4.3,0.1,0.6,0,0,0.1,0.4,0,0,0,0.2,0.5,0.6,0.3,0.6,0,0.8,0.5,0,0,0,0,0,0,0.1,0.1,0,0,0,0.2,0,0.1,0.1,0.1,0.1,0.3,0,0,0.9,0.1,0.1,0.8,0.5,0,0.1,0.4,0.5,1.1,0.1,0.6,0,0.3,0,0.1,0.9,0.1,0.6,0.1,0,0.3,1.7,0.5,0.3,0.4,0.8,0.5,0.2,0.3,1,0.6,0.4,2.7,0.1,0.5,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.6,0.4,10.2,0,0,0,0,0.1,0,0,1.2,0,0,0,0,0,0,0.1,0,130.2,0.1,0,0,1.8,2.7,3.6,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0
SLC10A2,"ASBT, ISBT",ENSG00000125255,Solute carrier family 10 member 2,Q12908,13,103043998-103066846,"Disease related genes, Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Symport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,NA,Tissue enriched,Detected in some,4,intestine: 40.9,Group enriched,Detected in some,29,Enterocytes: 5.1;Proximal tubular cells: 6.4,Cancer enriched,Detected in single,11,renal cancer: 4.3,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,AF22: 1.2;HAP1: 2.5;NB-4: 1.2;U-2197: 1.2,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,HPA004795,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA004795: AB_1856953,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (2.82e-2),NA,prognostic favorable (5.78e-5),unprognostic (1.64e-2),unprognostic (1.29e-1),NA,NA,0,0,0,0,0,0.1,0,0,0,0,1.5,0,0,13.6,0,0,0,0,0.9,0,0,0,9.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40.9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,1.2,0,0,0,0.6,0,0,0,0,0.1,0,0.6,0,0,0,0,2.5,0.9,0,0,0,0.1,0,0,0,0.1,0,0,0,0,0,0,0,0.1,0,0,0,0,0,1.2,0.1,0,0,0,0,0.2,0.3,0,0,0.1,0,0,0.1,0,0,0,0.2,0,0,1.2,0,0,0,0.2,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,5.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.4,0,0,0,0,0,0,0,0,0,0
SLC10A3,"DXS253E, P3",ENSG00000126903,Solute carrier family 10 member 3,P09131,X,154487306-154490690,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,6,Syncytiotrophoblasts: 86.2,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enriched,Detected in all,9,basophil: 51.2,Lineage enriched,Detected in all,13,granulocytes: 51.2,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA021656,Approved,NA,Approved,Intermediate filaments,NA,NA,NA,NA,NA,Intermediate filaments,NA,HPA021656: AB_1856955,unprognostic (1.60e-1),prognostic favorable (4.53e-4),prognostic unfavorable (4.15e-5),unprognostic (8.00e-3),prognostic unfavorable (9.97e-4),unprognostic (5.47e-2),unprognostic (2.28e-3),unprognostic (9.76e-2),unprognostic (1.63e-1),unprognostic (1.05e-1),prognostic unfavorable (7.22e-4),unprognostic (3.42e-1),unprognostic (2.52e-3),unprognostic (6.23e-2),unprognostic (2.99e-1),unprognostic (7.29e-2),unprognostic (2.99e-2),14.5,14.6,3.6,11.6,5.1,22.5,13.4,5,8.1,21.5,15.3,8.1,16.3,10.6,25,36.1,22.8,15.4,21.1,19.5,6,4.6,17.7,6.7,16.3,14,5.8,6.2,32.3,25.7,6.1,12.7,40.1,7.6,23.7,6.4,12.4,11.7,13.3,13.7,26.2,13.6,20.1,5.3,13.1,12.6,11.6,4.7,12.6,15.7,23.3,18.6,23.3,18.3,1.6,2.7,51.2,1.7,2.2,3.8,1.8,24.9,10.7,2.9,14.6,10.1,11,19,18.6,11.4,12.6,12.7,9.5,12.1,19,35.4,17.8,16.8,21.5,9.4,9.5,3.4,12.3,4.4,5.9,14.1,7.5,18.6,7,9.6,13.7,10.9,11.7,6.3,11.3,8.6,3.3,6.6,18.7,8.2,33.1,3.8,6.3,2.2,12.2,20.8,6.1,7.7,14.4,9.5,9.3,2.6,4.7,11.7,21.3,4.9,3.5,6.8,5.6,11.3,15,9.4,34.8,23.5,13.4,12.9,19.6,16,14.7,7.7,51.2,1.3,5.6,3.8,1.7,2.9,1.6,2.6,2.8,1.1,1.6,1.9,1.8,1.7,2.2,1.5,2.7,1.8,1.8,3.6,5.1,5,8.1,6,4.6,5.8,6.2,7.6,4.7,3,6.5,11.7,23.8,20,2,3.6,7.6,4,3.4,17.4,5.9,42.9,6.6,15.3,2.4,14.3,14.4,0,17,52.6,23.3,12.1,12.7,1.6,17.2,3.2,9.8,18.4,7.8,1,25,10.5,3.3,16.2,14,2.3,15.9,15.3,12.4,7.7,1.6,6.5,22.6,1.2,2.7,24.3,86.2,17.5,10.6,24.7
SLC10A4,MGC29802,ENSG00000145248,Solute carrier family 10 member 4,Q96EP9,4,48483343-48489196,"Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,adrenal gland: 12.3;brain: 19.0,Cell type enhanced,Detected in some,13,Alveolar cells type 2: 2.7;Cone photoreceptor cells: 2.0;Early spermatids: 1.4,Cancer enhanced,Detected in many,NA,glioma: 5.9,Group enriched,Detected in many,7,basal ganglia: 7.3;cerebral cortex: 6.3;hypothalamus: 6.3;midbrain: 19.0;pons and medulla: 15.3,Cell type enhanced,Detected in single,NA,naive CD4 T-cell: 1.0,Lineage enriched,Detected in single,11,T-cells: 1.0,Cell line enhanced,Detected in some,NA,HAP1: 10.6;HEL: 4.6;K-562: 10.6;SH-SY5Y: 28.2;THP-1: 4.6,NA,NA,NA,NA,Group enriched,Detected in many,5,basal ganglia: 19.0;midbrain: 63.0;pons and medulla: 27.5,HPA028835,Uncertain,Supported,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA028835: AB_10603025,unprognostic (4.06e-1),unprognostic (1.19e-1),unprognostic (1.06e-1),unprognostic (3.05e-3),unprognostic (2.49e-1),unprognostic (3.46e-2),unprognostic (5.41e-2),unprognostic (3.67e-1),unprognostic (1.86e-1),unprognostic (4.08e-3),unprognostic (9.98e-3),unprognostic (1.46e-1),unprognostic (3.50e-1),unprognostic (5.14e-2),unprognostic (1.94e-1),unprognostic (1.72e-1),unprognostic (8.73e-2),0.4,12.3,1.4,2.7,7.3,3.4,0.5,0.5,6.4,2.9,1.6,0.7,0,0.8,0.4,0.2,0.4,0.4,0.6,0.6,1.2,6.3,0.3,0.2,1.1,0.3,19,0.8,0.3,0.3,0.4,7.5,0.4,15.3,0.4,1.5,4,4.9,0.9,0.9,0.4,1.3,0.6,1.1,0.4,0.8,1.2,0.7,0,1.5,0,0.3,0.4,0.7,0,0,0,0,0,1,0,0,2.6,1.2,0,0,0,0,0,0,0,0.2,0.1,0,0,0.1,0,2.1,0,10.6,0,0.1,0,2.3,4.6,0.1,0.1,0,0,2.1,0,0,0,0,0,0,0,10.6,0,0,0.1,0,0.2,3.1,0,0.4,0,0,0,0,0.5,0.7,28.2,0.5,0,0.1,0.6,0,4.6,0,0,0.9,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0.3,0,0,0,1,0,0,0,0,0,0,0,1.4,7.3,0.5,6.3,1.2,6.3,19,0.8,15.3,0.7,0,2.7,0,0.1,0.3,0.1,0.4,0,0,0,0,2,0,0,0,1.4,0,0,0,0,0.2,0,0.2,0,0,0.1,0,0,0,0,0.9,0.3,0,0,0,0,0,0,0,0.4,0,0.4,0,0,0.5,0.2,0,0.2,0,0,0
SLC10A5,NA,ENSG00000253598,Solute carrier family 10 member 5,Q5PT55,8,81693607-81696174,"Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enhanced,Detected in some,NA,brain: 5.1;liver: 10.3,Cell type enhanced,Detected in some,11,Ciliated cells: 6.7;Enterocytes: 5.2;Intestinal endocrine cells: 3.5,Low cancer specificity,Detected in some,NA,NA,NA,NA,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in many,NA,OE19: 6.5,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,HPA025966,Uncertain,NA,Approved,Plasma membrane,NA,NA,NA,NA,NA,Plasma membrane,NA,HPA025966: AB_1856959,unprognostic (6.42e-2),unprognostic (3.89e-1),unprognostic (1.25e-2),unprognostic (2.34e-2),unprognostic (8.13e-3),unprognostic (1.91e-1),unprognostic (5.71e-2),unprognostic (5.63e-2),unprognostic (3.67e-1),unprognostic (2.41e-1),unprognostic (1.37e-1),unprognostic (3.22e-1),unprognostic (8.95e-2),unprognostic (2.51e-1),unprognostic (2.24e-1),unprognostic (1.67e-1),unprognostic (2.82e-7),0,0.3,0.9,0.1,2.3,0,0.2,5.1,1.8,0.3,2.5,NA,NA,2.9,0.3,0.9,0.2,0.3,1.4,0.1,0.9,2.1,1.8,10.3,0.3,0,0.8,NA,0.4,1,0.3,1.9,0,NA,0.5,3.5,NA,0.3,0.2,0.1,0.4,3.5,0.2,0.3,0.3,3.4,0,NA,NA,0.8,NA,0,0.3,0.1,0,0.5,0,0,0.3,0.4,0,0.7,0.3,0.9,0.9,0.7,1.4,0.7,0.9,0.4,0.3,0.5,0.4,0.5,0.9,1.3,0.2,0.2,0.9,1.1,0.8,1.3,0.7,2.4,1.8,2.6,1.4,0.4,0.1,0.3,0.4,2.2,0.7,1.7,1.5,0.4,0.6,1.6,1.2,1.3,0.7,0.5,1.2,0.4,6.5,0.5,0.3,0.3,0.6,1.2,3.1,2.1,0.9,0.7,0.6,0.3,0.5,1.6,0.6,0.9,1.1,1.5,1.4,1.4,1.5,2.2,0.1,1.1,0.1,1.1,0,0,0,0,0,0.4,0,0,0,0,0,0,0.4,0,0.3,0,0.5,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0.4,0.2,0,6.7,0,0,0,0,1.7,0.3,0,0,5.2,0,1,0.1,0,0.2,0,2.1,0,0,3.5,0.6,0.3,0,0,0,0,0,1.7,0.2,0.5,1.7,0,1.8,0.3,0,0.2,0,0,0.1,0,0,2,0.4
SLC10A6,SOAT,ENSG00000145283,Solute carrier family 10 member 6,Q3KNW5,4,86823468-86849263,Predicted membrane proteins,"Ion transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,NA,Tissue enhanced,Detected in many,NA,adipose tissue: 20.3;breast: 15.2;skin 1: 17.7,Group enriched,Detected in some,5,Early spermatids: 62.9;Late spermatids: 160.4,Group enriched,Detected in many,5,cervical cancer: 3.5;head and neck cancer: 6.2,Low region specificity,Detected in some,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,ASC diff: 2.0;BJ: 4.9;BJ hTERT+: 4.0;HaCaT: 3.7;HBEC3-KT: 1.6;U-266/84: 2.1,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,HPA016662,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA016662: AB_1669899,unprognostic (2.79e-2),unprognostic (1.86e-1),unprognostic (1.05e-1),unprognostic (8.31e-3),unprognostic (5.88e-2),unprognostic (8.87e-3),unprognostic (1.32e-2),unprognostic (1.31e-1),unprognostic (1.07e-1),unprognostic (7.51e-2),unprognostic (1.08e-1),unprognostic (1.73e-1),unprognostic (3.84e-4),unprognostic (1.54e-1),unprognostic (2.06e-1),unprognostic (9.22e-2),unprognostic (5.89e-4),20.3,0.5,0.6,0.9,0.7,0,15.2,0.1,0.6,3.7,1.6,0,2.1,0.1,2,0.8,12.5,0.8,1.4,1.2,0.4,0.2,0.2,0.2,1.2,0.1,2.7,0,0.4,1.1,0.9,3.7,0.3,0.9,0.9,0.4,0,2,0.5,2.3,17.7,0.4,2.4,1.6,0.3,0.5,4.9,1.1,0,1.4,11.2,2.9,4.6,5.3,0,0,0,0,0,0.2,0.2,0.1,0,0,0,2,0.1,0.2,4.9,4,0,0,0,0.2,0,0.2,0.1,0,3.7,0.2,1.6,0.2,0,0,0,0.1,0,0,0.2,0,0.3,0.3,0,0.1,0,0,0,0,0.1,0,0,0,0,0.1,0.1,0,0,0,0,0.1,0,0,0,0.2,0.1,0.1,0,0,0,0,0,0.1,0,0,0.3,2.1,0.2,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0.2,0.6,0.7,0.1,0.6,0.4,0.2,2.7,0,0.9,1.1,0,0,0,0,12.2,0,0,0,0,0,0,0,0,0,0,62.9,0.1,0,0,0,0,0.2,0,0,0,0,0,0,0,0,160.4,1.4,0,0,0,0,0,0.1,0,0.4,0,0,0,0,0.9,0.4,21.8,0,0,0,0.1
SLC10A7,"C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043",ENSG00000120519,Solute carrier family 10 member 7,Q0GE19,4,146253975-146521964,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Symport, Transport",NA,"Amelogenesis imperfecta, Disease mutation, Dwarfism",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,4,Erythroid cells: 23.3;granulocytes: 23.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA039996,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA039996: AB_10673266,unprognostic (9.44e-2),unprognostic (4.03e-1),unprognostic (3.39e-3),unprognostic (5.07e-2),unprognostic (1.01e-1),unprognostic (9.02e-2),unprognostic (7.96e-2),unprognostic (2.54e-1),unprognostic (3.55e-1),unprognostic (8.53e-2),unprognostic (2.68e-3),unprognostic (1.24e-1),unprognostic (1.43e-2),unprognostic (8.99e-2),unprognostic (2.79e-1),unprognostic (6.69e-2),unprognostic (9.57e-2),12,10.7,8,8.1,14.3,8.8,11.3,17,10.5,13.5,11.8,10,17.4,7.8,13.2,21.4,14.9,9.2,9.7,8.3,8.6,6.4,8.6,17.2,16,13.9,10.9,6.9,12,14.5,7.9,22.2,15,11.2,11.1,16.2,7.8,15.5,16,8.8,9.4,10.3,10.3,19.3,11,16.3,6.6,11.7,16.8,12.3,9.2,12.8,10.2,12.7,6.7,6.4,11.5,7.7,7.5,7.8,3.7,3.8,1.3,9.5,4,7.1,8.5,4.7,4.9,6.4,4.5,4.6,3.6,16.7,7.4,3.4,5.3,2.8,4,5.5,6.7,5.4,8.4,2.6,8.9,3.2,6.4,4.5,15.5,14.2,4.1,5.6,5.3,6.8,2.7,8,7.7,9.9,19.5,3.2,2.7,11.6,3.7,1.8,8.8,6.4,6.4,6.9,10.1,3.2,2.9,2.9,2.6,3.3,10,4,5.3,5.9,6.2,4.4,4,4.2,6.1,3.3,16.4,17.9,10.1,5.5,6.5,5.7,11.5,5.1,6.8,6.4,7.7,6.6,6.7,6.5,5.8,6.4,4.5,6,5.9,0.5,7.5,5.9,4.4,7.8,3.7,8,14.3,17,10.5,8.6,6.4,10.9,6.9,11.2,11.7,3,3.8,3.7,2.8,3,5.6,1.6,12.7,9.4,2.3,1.8,3.9,5.7,1.7,3.3,1.4,3.6,4.9,23.3,4.4,11.7,4.9,5.4,23,9,5.2,7.9,4.6,8.6,6.3,0.7,6.9,3.6,0,2.8,11.3,4.3,3,2.9,4.6,1.7,11.3,0,5.1,5.4,4.1,4.3,5.1,4.8,5.6,3.5
SLC11A1,"LSH, NRAMP, NRAMP1",ENSG00000018280,Solute carrier family 11 member 1,P49279,2,218382029-218396894,"Predicted membrane proteins, Transporters","Ion transport, Iron transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,lung: 37.6;lymphoid tissue: 23.8,Group enriched,Detected in many,5,Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in many,NA,NA,Group enriched,Detected in some,9,classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0,Group enriched,Detected in many,11,dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9,Cell line enhanced,Detected in some,NA,HEL: 3.8;HMC-1: 3.7;NB-4: 3.1,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,"HPA029590, HPA050378, HPA068540",Uncertain,NA,Approved,"Nucleoli,Mitochondria",NA,NA,NA,NA,NA,Mitochondria,Nucleoli,"HPA029590: AB_10794613, HPA050378: , HPA068540:",unprognostic (2.64e-1),unprognostic (3.05e-2),unprognostic (1.46e-2),unprognostic (2.34e-2),unprognostic (1.99e-2),unprognostic (3.83e-2),unprognostic (1.04e-3),unprognostic (2.06e-1),unprognostic (1.14e-1),unprognostic (1.58e-2),unprognostic (7.29e-3),unprognostic (2.49e-1),prognostic unfavorable (2.58e-8),unprognostic (9.55e-2),unprognostic (3.50e-2),unprognostic (1.78e-2),unprognostic (1.08e-2),13.5,4.7,4.3,14.9,13.3,11.6,2.6,0.6,9.3,1.7,1.8,4.6,0,1.3,1.3,2.1,1.4,4.1,3,6.5,15,2.6,2.1,3.2,37.6,19.9,17.1,0.7,2.4,3.3,1.2,1.9,6.2,11.3,1.7,1,1.7,2,1.2,2,1,1.2,4.6,18.1,23.8,1.7,2.4,10.3,0,1.8,0.2,1,7.1,1.3,0.4,2.4,6,7.9,0.2,0.4,2.6,0.3,0.7,0,0.4,0.1,0.1,0.9,0,0,0.1,0.2,1,2.1,0.2,0.2,0,0.3,0.8,0,0,0,0.7,0.1,3.8,0.6,0.7,0.1,0,3.7,0.3,0.1,0,0.2,0.3,0,1.2,1,0.7,0.1,1.3,0.2,3.1,0,0.6,0.2,0.2,0.6,0.4,0.1,0.3,0.8,0.2,0.5,0.4,0.4,0.2,0.3,1.1,0.3,0.7,0.4,0.2,0,0.3,0.3,0.7,0.2,0.4,0.4,0.3,7.9,0.6,0.4,5.8,0.3,0.1,0.2,0.2,2.4,0.4,0.4,0.3,6,0.2,7,0.2,0.2,2.6,4.3,13.3,0.6,9.3,15,2.6,17.1,0.7,11.3,10.3,20.8,52.4,3,3.9,0.8,3.6,6.3,5.1,17.4,22.7,8.7,0,1.6,8.3,0.8,1.2,4.7,1.2,0,1.8,7.2,2.4,5.7,24.3,4.7,110.2,1.6,1.2,8.6,163.4,0.4,2,201.4,1.7,1,4,7.6,0.6,0.9,0.7,6.8,3,19.4,5,0.5,1.7,0.9,6.8,1.7,2.2,2.7
SLC11A2,"DCT1, DMT1, NRAMP2",ENSG00000110911,Solute carrier family 11 member 2,P49281,12,50979401-51028566,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Iron transport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA032139, HPA032140",Uncertain,NA,Supported,Mitochondria,NA,No,No,NA,NA,Mitochondria,NA,"HPA032139: AB_10964213, HPA032140: AB_10962932",unprognostic (4.40e-3),unprognostic (1.41e-2),unprognostic (1.50e-1),unprognostic (2.07e-3),unprognostic (2.35e-1),unprognostic (1.92e-1),unprognostic (2.09e-1),prognostic favorable (3.07e-6),unprognostic (1.06e-2),unprognostic (1.99e-2),unprognostic (1.15e-1),unprognostic (7.28e-2),unprognostic (2.29e-1),unprognostic (3.20e-2),unprognostic (2.61e-1),unprognostic (2.32e-2),unprognostic (2.24e-1),11.3,15.1,12.8,9.6,26.2,9.6,20.8,14.7,22.1,20.8,11.3,38.2,8.4,35.3,12.3,12.7,17.3,15.4,12.1,12.9,14.5,14.2,16.1,18,18.6,7.9,40,15.4,10.4,20.6,29.8,21.7,16.4,29.7,18,11.8,18.7,26.9,14.8,17.6,15.6,11.6,11,33.1,9.5,12.5,8.7,31,15.8,29.9,8.7,16.5,12.9,13.9,4.1,9.8,3,9.5,8.3,7.1,4.6,7.7,10,13.2,12.1,14.7,12.5,44.4,8.4,30.5,8,9.4,12.6,14.6,4.8,16.6,9.4,15.3,10.7,11.9,7.9,9.4,6.9,7.2,11.4,12.1,14.3,15.6,7.7,23,13.7,9.9,14.9,15.2,19.6,9.5,9.8,9.8,2.4,9.3,8.9,9.1,5.2,19.6,8.2,6.9,5.9,12.1,8.5,9.7,11.6,9.1,8.1,6.4,19.5,8.5,16,21.9,5.1,11.4,8.2,6.9,9.2,4.4,6,8.1,2,23.1,4.2,3.4,0.7,6.6,2.4,6.4,9.5,5.8,3.6,5,6.3,9.8,4.1,7.1,6.6,3,8.3,6,4.1,3.8,4.6,12.8,26.2,14.7,22.1,14.5,14.2,40,15.4,29.7,31,35.7,40.3,11.5,22.2,13.7,23.8,12,28.1,45.5,43.3,54.1,17.7,20.6,3.3,25.3,0.8,14.3,8.6,70,24.8,18.3,17.5,32.8,67.2,38.4,29.8,27,15.7,9.8,13.3,1.5,8.9,25.8,25.3,9,13.5,27.5,20.6,14.7,8.1,8.8,16.5,6.5,12.4,5.5,12.8,11.7,16.2,7.9,16.1,19
SLC40A1,"FPN1, HFE4, IREG1, MTP1, SLC11A3",ENSG00000138449,Solute carrier family 40 member 1,Q9NP59,2,189560579-189583758,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Iron transport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,adrenal gland: 126.4;lymphoid tissue: 170.2,Group enriched,Detected in many,5,Kupffer cells: 1044.2;Syncytiotrophoblasts: 2060.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,NA,neutrophil: 64.7,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,ASC diff: 93.2;CACO-2: 21.3;HEL: 75.5;HMC-1: 19.9;T-47d: 36.8,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA065634,Approved,NA,Approved,"Nucleoplasm,Plasma membrane,Cytosol",NA,NA,NA,NA,NA,"Plasma membrane, Cytosol",Nucleoplasm,HPA065634: AB_2685524,unprognostic (1.28e-2),unprognostic (1.73e-2),unprognostic (9.41e-2),unprognostic (1.83e-2),unprognostic (8.00e-3),unprognostic (1.36e-2),unprognostic (1.66e-1),unprognostic (6.22e-2),unprognostic (6.65e-2),unprognostic (1.84e-1),unprognostic (6.43e-2),unprognostic (6.44e-2),prognostic favorable (8.55e-5),unprognostic (4.66e-1),unprognostic (1.61e-1),unprognostic (8.96e-2),unprognostic (4.11e-2),18.2,126.4,3.9,10.1,5.5,3.9,47.4,1.8,3.5,20,25.7,3.7,13.9,34.4,24.7,24.3,6.3,25.9,25.2,37.1,4.1,4.3,14.4,42.1,45.9,170.2,5.1,1.9,50.9,24,4.6,9.8,51.3,6.4,18.4,15.8,11.6,10.2,16.6,12.3,4.9,44.7,13.6,5.8,76.4,11.3,16.2,3.5,17,20.8,6.4,8.8,11.1,20.4,0.1,22.7,64.7,20.8,0.8,17.3,20.1,0,1.3,0.1,0,93.2,0.6,4.5,0,1.1,0.3,0.5,21.3,0,0,0.1,0,0.2,0,0.4,0,0.2,0,0.3,75.5,0.3,7.8,0.3,0.2,19.9,6.5,0,0.2,0,2.1,2.2,2.9,7.7,0.2,1.1,0,3.1,4.9,0.2,16,0.3,0,0.8,0.4,0.9,3.1,0.1,0.9,0.1,6.2,0,7.4,36.8,1.1,0,0.1,2.1,0.1,0,0.1,0,0,0,0,0,20.3,20.8,32.9,0.4,4.7,0.6,0,11.3,1,22.7,0.1,17.3,3.7,64.7,0.8,0.4,3.7,1,20.1,3.9,5.5,1.8,3.5,4.1,4.3,5.1,1.9,6.4,3.5,116.1,32.3,28.1,45.3,8.1,3.7,37.5,142.7,53.5,39.8,31.4,3.9,335.3,41.4,23.9,6.9,30.8,119.4,70,64.9,10.7,46.3,32.2,9.2,223.5,72.3,6.4,17.9,211.8,1044.2,4.7,112.2,26.2,8.5,1.8,50.3,9.6,51.2,77.2,55.2,100.1,43.2,64.7,18.1,5,0.9,7,2060.1,8.4,30.8,19.7
SLC15A2,PEPT2,ENSG00000163406,Solute carrier family 15 member 2,Q16348,3,121894089-121944102,"Predicted membrane proteins, Transporters","Peptide transport, Protein transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,"cervix, uterine: 35.2;ductus deferens: 35.8",Cell type enhanced,Detected in many,14,Alveolar cells type 1: 92.3;Club cells: 31.8;Muller glia cells: 64.9,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,NB-4: 8.4;U-937: 7.1,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (4.72e-2),prognostic favorable (2.37e-4),unprognostic (3.50e-2),prognostic favorable (6.96e-4),unprognostic (1.80e-2),unprognostic (1.78e-1),unprognostic (8.03e-3),prognostic favorable (6.74e-4),unprognostic (3.21e-1),unprognostic (1.28e-1),unprognostic (9.92e-2),unprognostic (1.43e-1),unprognostic (5.53e-3),unprognostic (1.63e-1),unprognostic (2.58e-1),unprognostic (2.67e-2),unprognostic (4.60e-2),1,1.2,13.8,1.9,15,3.3,3.2,4,15.3,35.2,1.8,7.6,35.8,1.5,1.5,26.2,3.6,7.4,4.2,2,14.6,5.3,7.4,1.1,12.9,3.6,5.3,12.9,1,3.6,2.4,3.6,1.6,6.8,26.5,2.1,15.1,14.6,25.1,0.8,0.7,2.2,0.9,4,6.1,1.1,3.9,6.7,0,4.6,0.5,3.8,3.6,2.6,4.2,1.6,2.4,2.5,0.3,0.3,0.3,1.9,0.9,1.1,0.4,1.3,0.7,1.4,0.2,0.1,0.5,0.6,1.8,3.2,3.5,0.2,0.1,0.6,2.1,0.8,1.9,0.6,2.8,0.6,5,1.3,0.8,0.2,5.3,5,1.1,5.5,0.6,0.4,0.6,0.3,1,0.8,1.5,0.6,1.4,1,8.4,5.8,2.1,0.5,1.2,0.5,1,1.3,1.2,0.4,0.4,0.5,0.3,0.1,1.7,0.3,4.7,0.1,0.4,0.3,0.4,0.4,1.9,0.5,5,0.6,7.1,0.5,2.4,1.1,0.4,0.3,0.4,0.3,3.3,0.3,0.2,0.3,4.2,0.3,0.3,0.6,0.3,2.5,1.6,0.2,0.3,13.8,15,4,11,14.6,5.3,5.3,12.9,6.8,6.7,92.3,21.4,4.4,2.1,0.5,1,1.9,7.6,12,31.8,10.4,0,2.1,3.3,0.3,0.3,0.8,0.2,0,7.5,0.6,0.6,22.7,3.5,0,2.1,0,0,1.3,10,0.6,6.1,3.8,0,1,1,64.9,2.6,0,4.9,1.1,2.4,0,0.1,0.5,0.1,0.5,1.1,0,0.6,8.2
SLC15A1,"HPECT1, HPEPT1, PEPT1",ENSG00000088386,Solute carrier family 15 member 1,P46059,13,98683801-98752654,"Predicted membrane proteins, Transporters","Peptide transport, Protein transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,8,intestine: 134.9,Cell type enhanced,Detected in many,16,Cholangiocytes: 30.6;Enterocytes: 51.2;Hepatocytes: 29.9,Low cancer specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Low cell type specificity,Detected in some,NA,NA,Low lineage specificity,Detected in many,NA,NA,Group enriched,Detected in some,4,CAPAN-2: 30.1;SK-BR-3: 29.9,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,HPA002827,Uncertain,NA,Approved,"Nucleoplasm,Cytosol",NA,NA,NA,NA,NA,"Nucleoplasm, Cytosol",NA,HPA002827: AB_1856974,unprognostic (8.76e-2),unprognostic (1.87e-1),unprognostic (4.72e-2),unprognostic (1.49e-1),unprognostic (6.76e-3),unprognostic (6.26e-2),unprognostic (7.83e-2),unprognostic (5.47e-2),unprognostic (1.92e-1),unprognostic (2.37e-1),unprognostic (6.79e-2),unprognostic (6.88e-4),unprognostic (2.11e-2),unprognostic (2.84e-1),unprognostic (2.64e-1),unprognostic (9.01e-2),unprognostic (3.87e-2),0.1,0.1,0.1,0.2,0.1,0,0.1,0.1,0.1,1.1,51.7,0.2,0.3,42.7,1.9,2.2,0.9,0.1,16.6,0.1,0.1,0.1,6.3,8.2,0.2,0.1,0.1,0.1,0.2,7.1,4.3,0.3,1,0.3,0.9,0.5,0.2,0.3,0.3,0.1,9.9,134.9,0.1,0.1,0.1,0.2,0.2,0.1,0.3,0.2,0.7,0.4,0.5,1.9,1.1,1.1,2.3,0.7,1.2,0.9,0.4,0,0,0,0.1,0,0,0.2,0,0,0,0,4.9,30.1,0,1.3,0,0,0.1,0,0,0,0.1,0.1,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0.1,0,0,0,0.2,0.3,6.8,0,0,0,1.7,1.7,0.6,0.1,0.3,0,29.9,0,1.5,0.1,0,0,0.2,0,0.1,0.1,0,0,0,0,0,0,2.3,0.7,0.7,0.9,0.3,0.8,0.8,0.7,0.7,0.2,1.1,0.9,0.8,2.2,1.2,0.4,1.1,0.6,0.4,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.3,0.1,3,0,0,0.1,0.1,0,0.4,30.6,1.4,2.3,1.8,0,0,1.7,9.1,0,0,51.2,0,0.7,0,0,0.8,0,29.9,0.1,0,3.5,0.6,0.3,0,0,0,1.7,0,1.7,0,2.9,5.8,0,9.8,0,0,0.2,0,0.2,0.6,0.1,0,1.7,0.3
SLC15A3,"hPTR3, PHT2",ENSG00000110446,Solute carrier family 15 member 3,Q8IY34,11,60937084-60952530,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Peptide transport, Protein transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,16,Hofbauer cells: 82.1;monocytes: 92.8;Muller glia cells: 202.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,BJ hTERT+ SV40 Large T+: 36.4;BJ hTERT+ SV40 Large T+ RasG12V: 44.2;HHSteC: 21.4,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA047880, HPA057642",Approved,NA,Supported,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,"HPA047880: AB_10959455, HPA057642: AB_2683487",unprognostic (5.61e-2),prognostic favorable (4.07e-5),unprognostic (8.79e-2),unprognostic (1.67e-2),unprognostic (8.48e-2),unprognostic (9.33e-3),unprognostic (1.49e-1),unprognostic (2.10e-1),unprognostic (1.10e-1),unprognostic (1.39e-1),unprognostic (1.60e-1),unprognostic (1.46e-1),unprognostic (9.78e-3),unprognostic (6.47e-2),unprognostic (4.42e-2),unprognostic (1.34e-1),unprognostic (1.02e-1),27.2,7.5,7.7,23.5,8.3,36.8,9.3,2,7,11,16.3,10.6,8.1,9,10.3,7.4,12,8.6,15.4,11.1,8.2,5.4,8.9,9.1,30.1,24.2,12.2,5.9,16.1,6.6,1.9,5,26.6,9.8,10.2,6.7,13.2,5.8,5.5,4,4.2,14,9.7,12.6,40,9.8,5,8.3,8.6,5.6,6.5,19.3,11.4,9.3,5,10.8,15,12.5,0.1,1.4,2.2,3.4,0.1,1.3,0,7.7,5.5,13.4,0.8,13.5,36.4,44.2,0,1.7,5.6,0.1,5.9,9.3,1.1,0,0.4,1.3,5.6,0,0.1,0.1,0.2,21.4,0.2,0.5,3.9,0.1,9.8,0,0.1,2.1,0,0,1.1,2.3,0.2,0,0.8,6.4,0,0.2,2.4,0.1,1.7,0,0.8,0,0,1.7,6.8,0.6,0.3,2.8,4.3,0,0.2,1.1,0.8,0.1,0,0,3.5,2.3,0.1,9.7,0,9.5,0.9,0.1,12.5,0.1,5,0,0,6,2.4,1.3,1.4,15,0.1,6.4,10.8,0,2.2,7.7,8.3,2,7,8.2,5.4,12.2,5.9,9.8,8.3,8.9,19.9,9.3,0.2,1.4,1.3,1.7,0,0,2.3,0,0,3.1,0,0.3,5.5,10.1,0,0,1.9,10.4,4.1,0.2,15,2.4,82.1,4.8,0,16,47,2.9,7.5,37,1.7,92.8,0.9,202.1,1.2,0.9,4.6,0,4.2,12.9,3.5,0.5,0.7,1.3,2.2,0,0.9,0.3
SLC15A4,"PHT1, PTR4",ENSG00000139370,Solute carrier family 15 member 4,Q8N697,12,128793191-128823983,"Predicted membrane proteins, Transporters","Peptide transport, Protein transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,6,Early spermatids: 67.3;Late spermatids: 84.4;Muller glia cells: 87.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,NA,plasmacytoid DC: 20.1,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA016713,Approved,NA,Approved,Nucleoplasm,NA,NA,NA,NA,NA,Nucleoplasm,NA,HPA016713: AB_1856978,unprognostic (3.12e-1),unprognostic (1.00e-1),unprognostic (3.63e-2),unprognostic (1.10e-1),unprognostic (1.46e-1),prognostic unfavorable (8.45e-4),prognostic unfavorable (6.78e-4),unprognostic (5.14e-3),unprognostic (6.39e-2),unprognostic (1.50e-1),unprognostic (2.26e-1),unprognostic (2.06e-2),prognostic unfavorable (7.56e-6),unprognostic (1.28e-1),unprognostic (2.06e-1),unprognostic (2.34e-2),unprognostic (2.57e-1),12.7,7,6.6,11.4,7.3,17.6,10.7,8.7,10.2,11.6,8.8,16,4.2,5.4,17.2,5.7,9.1,12.3,10,9.8,8.4,5,8.1,20.4,10.9,14.8,13.8,6.6,10.4,8.2,8.4,6.2,8.8,9.7,7.4,5.4,16.1,8.4,8.8,35.1,9.7,8.2,12.2,10.2,12.2,7.9,27.8,10.1,29.7,9.1,7.3,17.8,11.9,10.5,2,20.1,12.1,2.4,4.2,5,1.7,6.2,10.3,2.6,5.7,23.4,15.2,9.7,10.9,9.2,7.9,9,4.6,9.1,22.8,5.7,9.5,7.9,7.1,7.2,6.7,8.6,11.1,6.6,3.1,6.2,8.2,24.4,10.5,3.3,9.8,12.4,6.5,17.2,23.5,5.4,4.6,5.1,14.4,16,4.3,5.4,2.7,9.3,6.8,6,4.6,5.7,8.8,15.2,8,4.7,3.9,4.4,8.4,11.6,7.4,11.3,2.9,8.1,8.7,4.9,4.3,6.6,4.8,10.6,10.5,11.7,7.4,0.1,0,1.8,4.4,5,2.4,2.5,1.9,0.9,2.9,1.1,2,1,2.5,12.1,4.2,1,20.1,0.4,1.7,6.6,7.3,8.7,10.2,8.4,5,13.8,6.6,9.7,10.1,17.9,10.1,9.7,6.1,9.2,10.3,8.3,5.1,0,6.8,21,11.8,4.5,1.7,21,67.3,4.8,5.5,0,9.4,4.8,9.8,7.2,11.5,16.3,18.7,14.3,10.4,13.5,21.5,84.4,11.5,18.6,23.6,19,4.3,87.4,19.6,4.9,12.7,3.7,15.6,6.5,9.2,8,10.6,8,3.3,19.2,6.1,6
SLC15A5,NA,ENSG00000188991,Solute carrier family 15 member 5,A6NIM6,12,16188485-16277685,"Predicted membrane proteins, Transporters","Peptide transport, Protein transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,NA,Group enriched,Detected in some,12,adipose tissue: 1.9;brain: 1.6;breast: 1.2;testis: 1.4,Cell type enhanced,Detected in single,35,Early spermatids: 2.2,Not detected,Not detected,NA,NA,NA,NA,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,HPA041638,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA041638: AB_2677590,unprognostic (3.68e-3),NA,NA,NA,unprognostic (1.64e-1),NA,NA,NA,NA,NA,NA,NA,unprognostic (4.89e-6),NA,unprognostic (1.34e-1),unprognostic (1.72e-3),NA,1.9,0,1.1,0,0.7,0,1.2,0.3,1.3,0,0,NA,NA,0,0,0,0,0,0,0,0.7,0.9,0,0.1,0,0,1.6,NA,0,0,0,0,0,NA,0,0,NA,0,0,0,0,0,0,0.2,0,0,1.4,NA,NA,0,NA,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0.6,0.4,0,0,0,0.2,0,0,0,0.2,0,0,0,0,0,0,0,0.2,0,0,0.3,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0.1,0,0,0,0.4,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.7,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
SLC1A5,"AAAT, ASCT2, M7V1, RDRC",ENSG00000105281,Solute carrier family 1 member 5,Q15758,19,46774883-46788594,"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Host-virus interaction, Symport, Transport","Host cell receptor for virus entry, Receptor",FDA approved drug targets,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,NA,NA,Cell type enhanced,Detected in many,5,Basal glandular cells: 134.3,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in many,NA,NA,Cell type enhanced,Detected in many,NA,plasmacytoid DC: 34.6,Group enriched,Detected in many,4,dendritic cells: 34.6;monocytes: 22.4,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in single,NA,NA,Low region specificity,Detected in many,NA,NA,"HPA035239, HPA035240",Enhanced,NA,Enhanced,Plasma membrane,NA,NA,NA,NA,NA,Plasma membrane,NA,"HPA035239: AB_10670587, HPA035240: AB_10604092",unprognostic (8.26e-3),unprognostic (6.38e-2),unprognostic (7.24e-2),unprognostic (7.94e-2),unprognostic (2.32e-1),unprognostic (1.24e-1),prognostic unfavorable (1.66e-8),unprognostic (2.08e-1),unprognostic (1.06e-2),unprognostic (9.82e-2),unprognostic (9.40e-3),unprognostic (9.57e-3),prognostic unfavorable (1.18e-7),unprognostic (1.28e-2),unprognostic (6.30e-2),unprognostic (1.06e-2),unprognostic (9.83e-2),39.3,5.7,3.4,16,5.4,16.2,45,0.9,3,20.7,15.8,5,50.4,4.9,14.3,33.7,33.9,18.1,31.2,10,4.5,2.2,23.7,4.1,23.4,17.7,8.2,0.9,33.3,24.6,0.2,9.1,25.8,4.9,35.2,13.8,5.2,99,55.7,6.9,18.6,12.1,23.1,5.3,19.8,17.9,21.7,6.1,14.9,6.5,28.4,25.9,48.3,44.9,7,34.6,0.9,22.4,6.9,5.6,7.4,23.8,44.1,10.6,16,27.7,23.6,25.1,34.1,39,25.6,37.2,40,27,26.2,16.7,84.6,14.7,38.5,30.9,40.5,19.1,17.3,28,43.4,16.9,37.5,71.7,30.2,25.6,38.3,101.3,30,76.2,8.6,13.6,35,45.8,69.4,13.6,40.6,13.8,81.3,18.5,85.5,19.4,15.7,12,37.2,14.3,52.2,16.4,12,16.8,46,36.5,8.6,26.5,39.9,10.1,15.4,24.7,12,27.7,43.1,41.6,21.8,29,37.7,37.7,0,11.5,0.9,5.3,19.9,4.4,7,3.1,3.7,17.8,2.5,0.7,2.3,0.3,6.9,22.4,34.6,5.6,7.4,3.4,5.4,0.9,3,4.5,2.2,8.2,0.9,4.9,6.1,0,15.9,11.9,134.3,51.3,0.1,19.9,20.4,4,7.9,0,0,80.4,3.3,26.8,14.6,17.1,22,93.5,55.3,97.4,44.3,44.4,28.8,0.5,33.9,0,10.3,26.4,16.8,10.3,17.5,27.3,18.6,10.8,88.4,0.6,35.9,74.6,18.4,23.9,0.8,6.5,22.6,4.4,4.3,24.7,20.4,20.8,50.3,96.8
SLC1A3,"EA6, EAAT1, GLAST",ENSG00000079215,Solute carrier family 1 member 3,P43003,5,36606355-36688334,"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters","Amino-acid transport, Symport, Transport",NA,"Cancer-related genes, Disease mutation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,11,brain: 188.6,Cell type enriched,Detected in many,9,Muller glia cells: 579.8,Cancer enriched,Detected in all,21,glioma: 168.1,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in some,12,classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4,Group enriched,Detected in many,39,dendritic cells: 3.4;monocytes: 4.3,Cell line enhanced,Detected in many,NA,AF22: 21.5;CACO-2: 34.7;HaCaT: 26.3,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"CAB002573, HPA037467, HPA037468",Enhanced,Supported,Approved,"Nucleoli,Mitochondria",NA,NA,NA,NA,NA,Mitochondria,Nucleoli,"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371",unprognostic (1.23e-1),unprognostic (2.15e-2),unprognostic (2.58e-3),unprognostic (1.74e-2),unprognostic (1.02e-1),unprognostic (7.70e-2),unprognostic (3.89e-3),unprognostic (2.36e-1),unprognostic (1.24e-1),unprognostic (2.84e-2),unprognostic (4.17e-3),unprognostic (3.28e-1),unprognostic (2.46e-1),unprognostic (1.06e-1),unprognostic (4.17e-2),unprognostic (1.03e-1),unprognostic (1.31e-2),17.3,10.3,76.1,5.9,70.6,3.1,6.3,45.8,188.6,6.9,3.2,26.3,0,2.1,2.8,2.3,7.2,5.4,5.9,12,57.9,27.3,3.1,3.6,4.7,8.6,32.7,39.6,8.6,4,2.6,3.7,12.7,28.5,3.3,2.6,1.9,3,4.4,7.6,5.5,2.3,4.1,29.4,5.8,2.9,2.7,33.6,0,2.6,0.7,4.5,4.8,1.2,0,3.4,0,4.3,0,0,0.8,0.4,0.1,21.5,1.9,2.2,6,13.8,0,0,0.8,1.9,34.7,1.7,0,10.5,0.3,0.3,26.3,6.3,2.8,0.9,0.3,12.9,0,0.1,0,0.4,0.4,0.1,11.1,13,5.3,2.2,0.4,0,0.4,0,0.1,3.6,0,0,0.1,2.5,0,2.2,0,0.1,0,0,1.4,1.8,0,2.1,6.3,0.3,10.5,0,1,0,1.9,3.2,0,7.6,0,0,0,8.8,14.5,4.9,0,4.3,0,0,2.1,0,0,0,0,3.4,0,0,0,0,0,0.1,0.2,0,0.8,76.1,70.6,45.8,57.8,57.9,27.3,32.7,39.6,28.5,33.6,3,0.3,0.5,10.4,9.5,7.7,33.9,0,5.3,1.2,0,2,25.3,0,0.4,0.6,1.1,0,0,0,13.5,11.8,3.2,0,0.2,38.2,3.2,0,1.3,63.4,1.9,4,11,6.8,3.6,0,579.8,0.3,0,0,0,11.3,6.5,4.7,0.2,0.1,6.1,7.7,0,0,3.3
SLC1A1,"EAAC1, EAAT3",ENSG00000106688,Solute carrier family 1 member 1,P43005,9,4490444-4587469,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Amino-acid transport, Symport, Transport",NA,"Disease mutation, Schizophrenia",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,intestine: 40.4;kidney: 31.2,Cell type enhanced,Detected in many,19,Alveolar cells type 1: 151.8;Cholangiocytes: 35.7;Enterocytes: 37.3;Hepatocytes: 62.7;Proximal tubular cells: 37.2,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in single,NA,T-reg: 2.9,Lineage enriched,Detected in single,30,T-cells: 2.9,Cell line enhanced,Detected in many,NA,ASC TERT1: 13.9;HDLM-2: 31.6;HUVEC TERT2: 14.9;RPTEC TERT1: 31.0,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA062356,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA062356:,unprognostic (1.28e-2),unprognostic (2.37e-2),unprognostic (6.83e-3),unprognostic (3.07e-3),unprognostic (2.04e-2),unprognostic (1.51e-1),unprognostic (1.07e-1),unprognostic (4.28e-2),unprognostic (1.58e-1),unprognostic (2.71e-1),unprognostic (1.35e-2),unprognostic (1.25e-2),prognostic favorable (2.86e-8),unprognostic (2.68e-1),unprognostic (9.49e-2),unprognostic (7.78e-2),unprognostic (2.64e-1),3.3,1.4,8.6,3.4,10.2,0.3,2.9,4.7,12.4,4,17.9,2.7,0.5,21,4,28.8,1.7,1.9,16.3,2,10,10.2,31.2,29.1,12.8,1.8,8.6,5.8,0.7,1.8,0.4,5.2,5.1,6.7,4.3,6.6,1.9,3.1,2.4,2.2,1.2,40.4,5.6,5.3,0.5,3.4,0.8,4.4,0,25,1.8,5,3.5,1.3,0,0,0,0,0,2.9,0,0,0.9,0.7,4.4,11.5,13.9,3.9,4.7,9.8,1.5,1.4,7.8,0.2,6.1,0.3,2.4,1.8,0,1.6,2.6,1.3,31.6,2.1,0,6.6,0,0.4,0.4,0,0.9,0.1,5.6,0,0.7,14.9,0.1,0,0,1,0.1,0,0.1,1.9,4.7,0.8,0,0,0,31,2.7,1,0.9,0.3,1.7,0,3.7,0.6,0.2,8,2.3,0.1,4.4,1.3,0,0,0,10.9,0,0.1,0,0,0,0,0,0,0,0.9,0,0,0,0,0,0,0,0,0,2.9,0,8.6,10.2,4.7,11.7,10,10.2,8.6,5.8,6.7,4.4,151.8,2.7,0.8,1,0,0.7,0.8,35.7,4,9.1,0,0,0,3.3,5.5,3.5,7,37.3,0,0.7,0,0.9,1.7,0,62.7,0.1,0,0,3.1,2.1,6.1,0.3,0.1,0,0,6.5,0.8,5.8,8.6,0,37.2,0.9,0,1.1,0,0.2,0.5,0.1,0.8,4.8,0.2
SLC1A2,"EAAT2, GLT-1",ENSG00000110436,Solute carrier family 1 member 2,P43004,11,35251205-35420063,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Symport, Transport",NA,"Disease mutation, Epilepsy",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,8,brain: 160.9,Cell type enhanced,Detected in many,14,Cone photoreceptor cells: 139.4;Early spermatids: 85.3;Rod photoreceptor cells: 160.3;Syncytiotrophoblasts: 225.3,Cancer enriched,Detected in some,5,glioma: 28.6,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in some,NA,basophil: 3.9,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in some,NA,ASC TERT1: 4.5;BJ hTERT+: 4.9;fHDF/TERT166: 3.4;Hep G2: 5.7;NTERA-2: 6.4;SCLC-21H: 3.3,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"CAB002574, HPA009172, HPA067499",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499:",unprognostic (8.00e-2),unprognostic (5.71e-3),unprognostic (1.39e-1),unprognostic (2.77e-2),unprognostic (1.33e-1),unprognostic (5.65e-3),unprognostic (1.39e-2),unprognostic (9.27e-3),unprognostic (1.55e-1),unprognostic (1.65e-2),unprognostic (1.79e-3),unprognostic (2.35e-1),unprognostic (8.33e-4),unprognostic (6.34e-2),unprognostic (8.06e-2),unprognostic (5.24e-2),unprognostic (3.49e-2),1.7,4.1,65.1,1.9,79.4,1.8,3.7,7.2,160.9,2,1.7,9.8,0,1.8,2.1,1.8,1.7,1.7,1.7,2.1,47.6,11.7,1.7,20.5,1.9,2.5,15.2,43.1,1.6,4.2,1.6,0.4,2.1,27.6,1.7,1.7,0,3.9,1.7,1.7,2.3,1.6,1.8,17.2,1.8,2.6,2.4,16.3,0,1.7,0,2.4,1.7,0.3,1.1,0.7,3.9,0.7,1.2,0.9,0.4,0,0.2,1.1,0.1,0.5,4.5,0,1.1,4.9,0.2,0.3,0.2,0,0.1,0.1,3.4,0.2,0.3,0,0,0.4,0,0,0.4,0.5,5.7,0.2,0.6,0.2,0.9,0,0.4,0,0,0,0,0,0.4,0.1,2.2,0,0,6.4,0,0,0,0.1,0,0,0.3,3.3,0.5,0,2.3,0,0.3,1.1,0,0.6,0.2,0.2,0.5,0.1,0.6,0,0,1.1,0,0.3,3.9,0.7,0.8,0.5,0.3,0.3,0.4,0.5,0.4,0.7,1.1,0.9,0.7,2.1,1.2,0.4,0.6,0.4,0.4,65.1,79.4,7.2,64.9,47.6,11.7,15.2,43.1,27.6,16.3,3,3.7,0,0,2.6,48.2,2.8,0,1.4,0,0,139.4,14.9,0,0.1,85.3,0.3,0,0,2.9,0.8,2.6,0.4,0,5.4,3.1,6.4,0,0,0,59.1,0,0.5,1.7,55.1,0,10.6,0.7,0,0,0,160.3,0,1,0.2,1.2,1,225.3,0,0,0.1
SLC1A4,"ASCT1, SATT",ENSG00000115902,Solute carrier family 1 member 4,P43007,2,64988477-65023865,"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters","Symport, Transport",NA,"Disease mutation, Epilepsy, Mental retardation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,9,Melanocytes: 81.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,SK-MEL-30: 72.7;U-266/70: 34.0,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA034963, HPA034964",Approved,NA,Enhanced,Centrosome,NA,NA,NA,NA,NA,Centrosome,NA,"HPA034963: AB_2797223, HPA034964: AB_2674386",unprognostic (7.61e-2),prognostic favorable (3.59e-4),unprognostic (2.49e-1),unprognostic (3.19e-3),unprognostic (1.26e-1),unprognostic (2.24e-2),prognostic unfavorable (4.23e-5),unprognostic (1.26e-2),unprognostic (2.10e-1),unprognostic (3.16e-2),unprognostic (2.28e-2),unprognostic (3.48e-1),prognostic unfavorable (4.87e-4),unprognostic (6.37e-3),unprognostic (4.14e-2),unprognostic (3.53e-2),unprognostic (1.98e-2),6,20.3,31.4,7.6,34.4,10.3,12.7,8.8,43.1,13.5,8.3,8.1,6.1,5.6,11.7,7.8,6.5,4.7,3.8,5.1,20.6,23.5,1.9,11.1,4.5,8.7,17.1,21.2,12.2,28.4,6.1,10.3,6,15.4,9.1,7.8,12.1,5.7,6.9,29.6,15.9,5.1,11.3,5.8,6.3,7,7.8,8.5,15.7,5.3,11.5,15.8,5.4,7.8,1.1,8.4,2,10.1,5.5,3.9,1.4,3.7,2.9,1.7,8.8,3.8,2.5,2.4,7.1,3.5,3,5.1,0.8,0.5,12.2,1.6,11.1,3.7,10.8,3.4,0.9,3.1,4.9,1.3,6.3,3.5,7.5,8.1,10.6,5.9,1.1,18.8,4,6.2,1,1.8,12.3,4.9,30.9,2.1,3.3,9,7,1.2,4.9,3.5,3.3,0.4,30.3,1.2,1.9,7.5,3.6,4.4,4,72.7,0.8,4.8,11.7,0.4,4.1,4.9,7.9,4.3,34,16.8,29.6,6,21.4,21.7,0,2.3,2,1,5.3,1.4,1.1,1.1,1.8,4.4,0.3,0,1,0,5.5,10.1,8.4,3.9,1.4,31.4,34.4,8.8,25.9,20.6,23.5,17.1,21.2,15.4,8.5,0,2.4,14.5,2,17.7,5.4,4.4,2.5,4,1.2,1.8,31.4,0.9,0,1.4,23.4,4.5,0.7,0,8.1,1.1,5.6,2.5,6.9,10.9,17.4,6.4,8.1,9.2,4.5,34,10.3,9.5,81,5.4,6.2,14.7,8.6,0,28,1.2,16.5,0,9,1.1,0.6,5.4,2.1,2.5,4.4,0.9
SLC1A6,EAAT4,ENSG00000105143,Solute carrier family 1 member 6,P48664,19,14950034-15022990,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,4,brain: 52.1;testis: 23.3,Cell type enhanced,Detected in some,11,Bipolar cells: 12.3;Early spermatids: 29.3;Horizontal cells: 22.3;Late spermatids: 27.3;Syncytiotrophoblasts: 33.4,Cancer enriched,Detected in some,7,urothelial cancer: 5.2,Region enriched,Detected in many,5,cerebellum: 52.1,Low cell type specificity,Detected in some,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in some,NA,HAP1: 6.6;NTERA-2: 5.4;U-698: 24.6,Region enriched,Detected in many,6,cerebellum: 152.9,Low region specificity,Detected in all,NA,NA,"HPA041505, HPA044066",Enhanced,Supported,Supported,"Plasma membrane,Intermediate filaments",NA,NA,NA,NA,NA,Plasma membrane,Intermediate filaments,"HPA041505: AB_2677520, HPA044066: AB_2678796",unprognostic (3.62e-2),unprognostic (1.35e-1),NA,unprognostic (4.41e-2),unprognostic (1.52e-1),unprognostic (1.12e-1),NA,unprognostic (5.94e-3),unprognostic (8.90e-2),unprognostic (6.52e-4),unprognostic (1.55e-1),unprognostic (5.40e-3),unprognostic (1.11e-2),unprognostic (9.92e-2),unprognostic (1.35e-1),unprognostic (5.57e-2),prognostic unfavorable (6.88e-6),0.4,0.5,3.2,0.5,9.6,1.2,0.8,52.1,12.8,0.4,0.5,0.6,0,0.6,0.8,4.2,0.4,0.5,0.5,0.4,4.8,4,0.4,0.5,0.5,0.5,1.6,3.4,0.6,0.9,0.6,0,4.3,3,0.9,0.6,0.1,0.7,0.9,0.5,9.2,0.5,0.5,1.4,0.7,0.5,23.3,0.9,0,0.6,0,0.6,0.4,0,2,0.7,2.2,0.7,0.5,0.6,0.1,0.1,0.1,0.3,0.3,0.2,0.2,0.8,0.1,0.1,0.1,0.1,0.2,0.2,0.1,0.1,0.2,0.1,1.2,6.6,0.1,0.1,0.2,0.1,0.2,0.3,0.2,0,0.1,0.1,0.1,0.2,0.1,0.1,0.2,0.1,0.2,0.1,0.6,0.1,0.5,0,0.3,5.4,0,0.1,0.1,0,0.1,0,0.2,0.4,0.2,0.2,2.6,0,1.1,0.3,0.1,0,0.3,1,0.2,0.1,0.4,0.1,24.6,0.1,0.3,0.1,1.6,0.7,0.5,0.6,0.4,0.4,1,0.5,0.3,0.3,2,0.6,0.6,2.2,0.5,0.4,0.7,0.3,0.1,3.2,9.6,52.1,6.5,4.8,4,1.6,3.4,3,0.9,0,0,0,0.6,2.9,12.3,1.6,0,0,0,1.8,0,0.5,0,0,29.3,0,0,0,0.3,8.5,1,0.2,0,0,0.4,22.3,0,0,0,27.3,0.6,0,0,0,0,0.4,0,0,0.7,0,0.7,0,0.3,1.7,1.5,5.9,33.4,0,0,0.1
SLC1A7,EAAT5,ENSG00000162383,Solute carrier family 1 member 7,O00341,1,53087179-53142632,"Predicted membrane proteins, Transporters","Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enriched,Detected in many,7,retina: 70.1,Group enriched,Detected in some,17,Bipolar cells: 228.0;Cone photoreceptor cells: 66.8;Rod photoreceptor cells: 66.6,Cancer enhanced,Detected in many,NA,lung cancer: 3.4,Low region specificity,Detected in many,NA,NA,Group enriched,Detected in some,12,gdT-cell: 5.7;memory CD8 T-cell: 2.2;naive CD8 T-cell: 2.6,Lineage enriched,Detected in single,58,T-cells: 5.7,Cell line enriched,Detected in some,9,HHSteC: 24.4,Not detected,Not detected,NA,NA,Low region specificity,Detected in single,NA,NA,HPA049124,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA049124: AB_2680643,unprognostic (2.33e-1),unprognostic (1.31e-1),unprognostic (1.09e-1),unprognostic (9.48e-4),unprognostic (2.31e-1),unprognostic (8.73e-2),unprognostic (1.52e-2),unprognostic (6.26e-3),unprognostic (4.35e-1),unprognostic (1.45e-2),unprognostic (1.59e-1),unprognostic (7.65e-2),unprognostic (1.19e-3),unprognostic (2.58e-3),unprognostic (5.43e-2),unprognostic (8.12e-2),unprognostic (4.70e-3),2,0.2,1.1,0.6,0.6,0,1.2,0.6,0.7,0.9,1,0.7,0.6,4.1,1.3,1.2,2.1,2.2,9.6,2.9,1.7,1.1,0.7,2.8,0.9,0.6,1.2,0.6,3.8,0.6,0,0.6,0.6,1.1,0.9,0,70.1,0.6,0.6,2.1,1.2,5.3,0.6,1.3,0.6,1.1,0.9,0.6,0.6,0.6,0.6,0.6,2.5,0.9,0,0,0,0,0,5.7,0.8,0,0.2,0,0,0,0,0.1,0.2,0.3,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,24.4,0,0.1,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0.1,0,0,0,0,0,0.1,0,0,0,0,0,0.2,0,0,0,0,0,2.6,0,0,0,0,0,0,0,0,0,0,5.7,0,0,0,0.1,2.2,0,0,0.2,2.6,0,0,0,0,0.1,0.8,1.1,0.6,0.6,0.7,1.7,1.1,1.2,0.6,1.1,0.6,0,0.6,0,0,0,228,0.4,0,0,0,0,66.8,0.1,0,0,0,0,7,0,1.3,0.1,0.2,0,0,0,0.2,0,0,0.6,0,0,1.1,0,0,0,0.7,5.2,0,2.9,1.1,0.2,66.6,0,0,0,0,0,0,0,0,0
SLC22A18,"BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5",ENSG00000110628,Solute carrier family 22 member 18,Q96BI1,11,2899721-2925246,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Ion transport, Symport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,intestine: 71.4;liver: 44.3,Cell type enhanced,Detected in many,11,Enterocytes: 511.8;Late spermatids: 354.1;Paneth cells: 245.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in many,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,CAPAN-2: 21.6;Karpas-707: 20.1,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,"HPA067812, HPA071461",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA067812: AB_2685902, HPA071461: AB_2686401",unprognostic (1.10e-1),unprognostic (1.14e-1),unprognostic (4.80e-1),unprognostic (7.75e-2),unprognostic (7.92e-3),unprognostic (2.67e-1),unprognostic (8.25e-2),unprognostic (4.21e-1),unprognostic (2.56e-2),unprognostic (3.48e-2),unprognostic (9.35e-2),unprognostic (8.60e-2),unprognostic (8.36e-2),unprognostic (9.51e-2),unprognostic (5.97e-3),unprognostic (1.55e-1),unprognostic (2.82e-1),3.5,1.6,0.5,11.4,1.2,1.4,3.2,0.1,2,2.6,36.6,0.8,2.9,36.7,3.1,15.2,6.1,4.7,21.9,8.5,0.9,1.1,18.2,44.3,8.7,8.3,1,1.7,2.9,3,4.1,1.5,4.9,1.3,4,3.7,4.2,8.6,4.3,1,6.5,71.4,3.7,1.2,4.7,8.1,2.8,0.8,3.1,8.1,7.6,5.4,4.5,4.4,2.1,8.9,21.7,15,2.7,4.6,6,1.4,8.7,0,4.9,0.9,1.4,3.6,2.9,5.2,1.7,3,5.1,21.6,0.6,9.2,3.9,3.7,4.7,0.2,0.4,0.4,4.3,0.7,0.1,2.1,4.6,9.6,0,4,4,0.9,1.4,0.3,1.5,0,3,0.1,20.1,0.9,4.4,0.1,0.6,0.5,7,1.9,1.5,0,2.7,0.8,3,0.1,1.6,1.1,12.6,10.4,0.1,2.4,2.5,0.2,1.3,2.8,4,0.2,3.6,0.8,0.2,5.3,2.7,5,15.3,15,12.6,3.5,14.3,2,2.1,2.8,2.5,8.9,1.3,1.5,2.2,21.7,2.7,10.8,6.4,4.6,6,0.5,1.2,0.1,2,0.9,1.1,1,1.7,1.3,0.8,6,8.1,3.9,17.1,6.5,1.2,8.6,71.4,16,9.1,26.2,0,70.1,6.6,24.6,135.4,3.2,511.8,0,7.7,17.5,12.2,13.4,16.1,138.4,40.5,0,19,6.2,27.6,354.1,9.8,18.7,18.6,14.4,72.1,5,15.7,245.4,7.1,76.4,1,0,11.3,1.9,2.4,7.8,151.6,15.3,106.9,17.1
SLC22A18AS,"BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS",ENSG00000254827,Solute carrier family 22 member 18 antisense,Q8N1D0,11,2887780-2903740,Predicted intracellular proteins,NA,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enhanced,Detected in many,NA,intestine: 20.1;kidney: 13.4;liver: 13.6,Cell type enhanced,Detected in many,11,Enterocytes: 89.5;Paneth cells: 107.4;Proximal tubular cells: 73.1;Syncytiotrophoblasts: 67.5,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in many,NA,NA,Cell type enhanced,Detected in many,NA,classical monocyte: 9.1,Group enriched,Detected in many,10,dendritic cells: 4.9;granulocytes: 5.2;monocytes: 9.1,Cell line enhanced,Detected in some,NA,A549: 7.1;CAPAN-2: 7.0;MCF7: 13.2;OE19: 6.7;SK-MEL-30: 24.5;WM-115: 11.0,NA,NA,NA,NA,NA,NA,NA,NA,HPA068288,Enhanced,NA,Approved,Nucleoplasm,NA,No,NA,NA,NA,Nucleoplasm,NA,HPA068288: AB_2685969,unprognostic (1.43e-1),unprognostic (9.21e-2),unprognostic (3.36e-1),unprognostic (8.05e-2),unprognostic (1.33e-3),unprognostic (3.16e-2),unprognostic (5.14e-3),unprognostic (9.76e-2),unprognostic (1.45e-1),unprognostic (2.73e-1),unprognostic (1.10e-2),unprognostic (1.48e-2),unprognostic (9.52e-2),unprognostic (1.77e-1),unprognostic (2.39e-1),unprognostic (1.05e-1),unprognostic (1.62e-1),1.4,0.3,0.2,6,0.7,0,0.6,0.2,2.2,0.5,13.7,0.6,0.2,12.8,0.8,1.2,1.1,0.4,4.9,0.3,0.2,0.3,13.4,13.6,0.6,0.2,1.3,1.5,0.4,0.2,0,0.3,2,1.6,0.7,9.8,0.2,4.2,0.2,0.4,1,20.1,0.6,1.6,0.8,1.4,0.6,0.4,0.2,0.3,1.6,0.3,0.5,0.9,0,4.9,5.2,9.1,0.5,0.6,2.7,0.8,7.1,0.1,0.3,0,0,0.7,0.4,0.3,0,0.2,1.6,7,0,0.6,0,0.4,0.4,0,0.2,0,0.3,0.1,0,0.6,4.1,0.5,0,0.1,0.1,0.2,0,0.4,0.2,0.2,0.4,0,0.7,0,13.2,0,0.3,0.1,6.7,0.3,0.2,0,0.6,0.6,0,0.1,0.2,0.3,0.3,24.5,0.1,0,0.7,1.4,0,0.5,0.2,0.1,0,0,0.1,0.2,1.9,11,5.2,9.1,1.6,0.3,5.1,0.1,0,0.1,0.3,4.9,0,0,0.1,2.2,0.5,3.5,0,0.6,2.7,0.2,0.7,0.2,2.2,0.2,0.3,1.3,1.5,1.6,0.4,0,0.3,1.3,1.1,0.5,0,0.1,2.5,0,0,7,0,16.4,8.3,0.8,0,0,89.5,0,0.7,8.2,0.8,1.4,1.1,18.4,15.6,0,8.7,1.8,4.1,0,0.3,5.4,3.3,3.6,25.4,0,1.5,107.4,0,73.1,0,0,0.6,0,0.2,1,67.5,0,23.7,2.3
SLC22A15,FLIPT1,ENSG00000163393,Solute carrier family 22 member 15,Q8IZD6,1,115976498-116070054,"Predicted membrane proteins, Transporters","Ion transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,bone marrow: 34.6;brain: 27.8,Cell type enhanced,Detected in many,5,Alveolar cells type 2: 10.7;Cone photoreceptor cells: 9.8;Kupffer cells: 8.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in some,NA,neutrophil: 3.9,Group enriched,Detected in many,7,granulocytes: 3.9;monocytes: 2.9,Cell line enhanced,Detected in many,NA,hTCEpi: 21.1;hTERT-HME1: 27.9;NB-4: 15.2;THP-1: 16.5,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA019785,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA019785: AB_1857011,unprognostic (3.81e-1),unprognostic (1.11e-2),unprognostic (7.65e-3),unprognostic (1.01e-3),unprognostic (5.62e-2),unprognostic (5.22e-2),unprognostic (5.85e-5),unprognostic (8.91e-3),unprognostic (1.81e-1),unprognostic (4.97e-2),unprognostic (5.15e-2),unprognostic (9.06e-2),unprognostic (7.29e-3),unprognostic (8.78e-3),unprognostic (3.44e-1),unprognostic (9.97e-4),unprognostic (1.30e-1),2.9,4.5,7,3.2,14.1,34.6,2.3,8.6,11.1,2.6,2.1,27.8,0.7,1.7,1.9,2.2,5.5,2.4,2.9,6.1,9.9,8,4.9,1.3,6.3,1.7,20,8.1,2,4.2,7.5,4.5,2.9,15.1,2.8,2.7,2.5,4.6,2.7,0.8,11.8,1.7,1.7,14.1,3.5,4.8,1.8,17.6,0,4,0.8,1.9,2.5,4.6,0.5,0.3,3.9,2.9,0.2,0,0.3,1.6,0.1,1.2,0,2.2,2.7,0.8,2.7,3.9,1.6,2.9,0,0.3,1.8,2.9,1.3,1.4,2.5,2,5.5,1.6,0,1.3,1.8,1.9,0.2,7.3,2.7,2.5,2.7,21.1,0,27.9,0.1,0,0,0.1,0,2.7,1.5,0,15.2,1.7,1.5,1.3,0,0,0,2.3,0.9,1.3,1.1,4.6,0.9,7.8,1.9,0.2,16.5,0,2.9,1.6,0.5,0.6,2.8,2.6,0.2,3.1,4.5,4.6,1,2.5,0.9,0,0.7,0,0.5,0,0,0.3,0.1,0,0,3.9,0.2,2.9,0,0,0.3,7,14.1,8.6,11.1,9.9,8,20,8.1,15.1,17.6,0,10.7,0.8,2.9,2.5,2.1,7.5,0,4,2.3,5.2,9.8,0.5,1.7,1.1,0.6,0,0,0,0.3,0.3,1.3,0.8,1.1,0,2.9,7.9,8.1,1.3,8.6,0,0.9,5.9,1.7,1,0.2,0.8,1.7,0.2,0.4,0.1,2,0,1,0.2,0.2,2.6,0,0.5,0.4,0.9
SLC22A23,"C6orf85, FLJ22174",ENSG00000137266,Solute carrier family 22 member 23,A1A5C7,6,3268962-3457022,"Predicted membrane proteins, Transporters","Ion transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,NA,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,13,Early spermatids: 73.9;Late spermatids: 171.9;Mucus-secreting cells: 52.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in some,NA,NA,Low lineage specificity,Detected in single,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA014697,Approved,NA,Approved,"Nucleoplasm,Vesicles,Cytosol",NA,NA,NA,NA,NA,"Nucleoplasm, Vesicles",Cytosol,HPA014697: AB_1844371,unprognostic (4.58e-2),unprognostic (2.48e-1),unprognostic (1.05e-1),prognostic favorable (6.57e-4),unprognostic (5.16e-3),unprognostic (3.25e-3),unprognostic (1.40e-1),unprognostic (4.53e-3),unprognostic (9.74e-2),unprognostic (2.87e-2),unprognostic (1.07e-2),unprognostic (2.62e-2),prognostic unfavorable (2.39e-4),unprognostic (8.91e-2),unprognostic (4.30e-1),unprognostic (4.06e-2),unprognostic (1.74e-1),7.4,2.2,9,4.6,16.2,8.1,9.3,8.4,14.8,5.6,17.4,30.8,3.4,19.6,3.6,11.8,16.8,11.3,7.5,2.2,11,8.1,6.9,12.6,8,3.9,28.6,8.7,3,14.9,14.8,6.5,8.3,17.8,14.2,14.4,5.7,10,2.8,5.9,14.9,20.3,3,17.5,4.6,26,7.2,21,5.2,4.1,9.8,9.9,3.8,9.9,0.1,0.7,0.8,0.3,0.3,1.4,1.9,2.4,5.6,12.5,13.9,4.4,5,16,0.4,0.1,0.7,0.3,12.5,0.4,0.6,1.4,2.7,11.1,3.6,2.5,6.6,0.2,2,7.7,5.8,2.1,11,0.6,0.3,0.4,1.2,13,12.1,0.6,2.6,0.4,3.2,5.2,3.3,0.4,2.9,0.5,1.4,4.3,13.7,2.3,1.3,0.8,9.9,0,15.3,1.4,0.2,3.3,4.8,4.1,13.3,18.5,0.1,3.1,7.3,2.3,9.4,1.5,7.5,0.1,0.2,12.8,0.4,4.4,0,0.3,0,0.4,0,0.2,0,1,0.4,0.2,0.1,1.4,0.9,0.8,0.3,0.2,0.7,0,1.9,9,16.2,8.4,14.8,11,8.1,28.6,8.7,17.8,21,6,13.7,0.5,4.2,10.3,7.9,2.4,10.2,33.5,17,5.2,7.9,12.2,0,2.5,73.9,8.4,29,23.3,7,0.9,1.4,19.2,0,10,9.8,0,4.1,6.7,8,171.9,1.7,2,3.3,10.8,52.1,9.1,5.7,14.4,0.7,2.4,3.4,0,0.9,2.1,1.1,11,7.7,1,22.6,3.9
SLC22A24,"MGC34821, NET46",ENSG00000197658,Solute carrier family 22 member 24,Q8N4F4,11,63079940-63144221,"Predicted membrane proteins, Transporters","Ion transport, Lipid metabolism, Steroid metabolism, Transport",NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enriched,Detected in some,5,kidney: 10.5,Cell type enriched,Detected in single,30,Proximal tubular cells: 8.4,Cancer enriched,Detected in single,11,renal cancer: 0.5,NA,NA,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA045015,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA045015: AB_2679183,NA,NA,NA,NA,NA,NA,unprognostic (5.72e-3),NA,NA,NA,NA,NA,unprognostic (1.80e-7),NA,NA,NA,NA,0,0,0,0,0.2,0,0,0,0,0,0,NA,NA,0,0,0,0,0,0,0,0,0,10.5,2.1,0,0,0,NA,0,0.1,0,0,0,NA,0,0,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,0,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.7,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.4,0,0,0,0,0,0,0,0,0,0
SLC22A1,1-Oct,ENSG00000175003,Solute carrier family 22 member 1,O15245,6,160121789-160158718,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,24,liver: 175.8,Cell type enriched,Detected in some,16,Hepatocytes: 709.2,Cancer enriched,Detected in some,81,liver cancer: 83.0,Not detected,Not detected,NA,NA,Cell type enriched,Detected in single,13,neutrophil: 7.3,Lineage enriched,Detected in single,13,granulocytes: 7.3,Low cell line specificity,Detected in many,NA,NA,Region enhanced,Detected in single,NA,cerebral cortex: 0.7,Not detected,Not detected,NA,NA,HPA029846,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA029846: AB_10603026,unprognostic (8.28e-2),unprognostic (2.10e-1),unprognostic (7.80e-2),unprognostic (2.68e-1),unprognostic (1.93e-1),unprognostic (2.10e-2),prognostic favorable (1.35e-5),unprognostic (2.28e-1),unprognostic (8.61e-2),unprognostic (3.35e-1),unprognostic (9.11e-2),unprognostic (9.94e-2),unprognostic (1.46e-7),unprognostic (1.58e-1),unprognostic (1.24e-1),unprognostic (4.72e-2),unprognostic (8.07e-4),0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0.1,0,0,0.2,0,0,0,0.1,175.8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0.3,0,0.1,0,0,0.1,0,0,0,0,0.3,0.2,7.3,0.3,0,0.5,0,0,0.9,0.9,1.8,1.6,0.6,0.7,0.4,0.2,0.5,0.5,1.4,0.4,0.5,1,0.1,3.1,0.3,0,1.8,0.7,1.5,0.9,0.6,0.6,2.4,0,1.5,1.1,0,2,0,1,0.3,0.1,0.9,0.5,0.3,0.3,0.2,0,1.1,0,0.3,0.7,0,1.8,1.5,0.2,0.9,0.6,0,2.5,0,1.6,1.5,0.3,0.1,0,0.6,0.7,1.7,1.2,1.4,2.8,0.9,0.2,1,0.3,0,0.3,0,0.5,0,0,0,0.1,0.4,0,0.3,0,0.1,7.3,0,0,0.2,0.2,0,0,0,0,0.1,0,0,0,0,0,0,0,2.2,0,0.1,0,0,0.3,43.3,0,0,0,2,0,0,0.5,0.1,0,0,0,0.2,0,0.2,0.3,0,709.2,0.1,0,0,14.1,12.6,0,0.3,0,0,0,0,1,0.1,0,0.7,1.1,0,0,0.2,0,0,0.3,0.1,2.9,0,0.1
SLC22A10,"hOAT5, OAT5",ENSG00000184999,Solute carrier family 22 member 10,Q63ZE4,11,63137867-63369718,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enriched,Detected in some,32,liver: 41.7,Cell type enriched,Detected in some,13,Hepatocytes: 15.5,Cancer enriched,Detected in single,14,liver cancer: 6.0,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (1.17e-2),NA,NA,NA,unprognostic (9.77e-2),NA,unprognostic (7.07e-3),unprognostic (7.46e-4),NA,NA,unprognostic (7.62e-3),unprognostic (2.87e-1),unprognostic (1.56e-1),unprognostic (6.52e-2),unprognostic (4.25e-1),NA,NA,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,41.7,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.5,0,0,0,0,0.5,0,0,0,0.9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,15.5,0,0,0,0,1.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
SLC22A11,OAT4,ENSG00000168065,Solute carrier family 22 member 11,Q9NSA0,11,64555626-64572875,"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters","Ion transport, Transport",NA,FDA approved drug targets,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,10,epididymis: 22.2;kidney: 47.6;placenta: 64.7,Group enriched,Detected in some,17,Cytotrophoblasts: 554.5;Syncytiotrophoblasts: 1271.5,Group enriched,Detected in some,14,liver cancer: 3.7;renal cancer: 15.2,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,BEWO: 4.8;CACO-2: 1.1;Hep G2: 3.4;SuSa: 1.9,NA,NA,NA,NA,Not detected,Not detected,NA,NA,HPA026076,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA026076: AB_1854756,unprognostic (8.21e-5),unprognostic (3.29e-2),unprognostic (3.57e-1),unprognostic (1.57e-1),unprognostic (3.20e-2),unprognostic (4.57e-3),unprognostic (3.48e-1),unprognostic (1.93e-1),unprognostic (4.86e-2),unprognostic (4.51e-2),unprognostic (7.56e-2),unprognostic (1.13e-1),prognostic favorable (3.68e-5),unprognostic (4.62e-2),unprognostic (6.52e-2),unprognostic (3.50e-2),unprognostic (8.24e-3),0.1,0.2,0.1,0,0.1,0,0.1,0.1,0.1,0.1,0.1,0,4.4,0,0.1,22.2,0.1,0.1,0,0.1,0.1,0.1,47.6,0.4,0.1,0,0.2,0,0.1,0.3,0,0.1,64.7,0,0.1,0,0,0.1,0,0.1,0.1,0.1,0,0.1,0.3,0.1,0.4,0,0,0.1,0,0,0.1,0.1,0,0,0,0,0,0,0,0,0.8,0,0,0,0.2,4.8,0,0,0,0,1.1,0,0,0,0,0,0,0,0,0,0,0,0,0,3.4,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0.3,0,0,0,0.3,0,0.7,0,0,0,0,0.2,0.4,0,0.2,0,1.9,0.1,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.1,0.1,0.1,0.1,0.1,0.2,0,0,0,0,0,0,0,0,0,0.8,0,0,0,0,0,554.5,5,0,1,0,0,0,0.3,13.6,0.6,0,0,0,44.6,0,0,0,0,1.3,0.3,0,0,0,0,0.4,0,0,0,54.2,0,0,0,0,0.1,0,1271.5,0,0,0
SLC22A12,"OAT4L, RST, URAT1",ENSG00000197891,Solute carrier family 22 member 12,Q96S37,11,64590641-64602353,"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters","Ion transport, Transport",NA,"Disease mutation, FDA approved drug targets",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,349,kidney: 70.1,Cell type enriched,Detected in some,18,Proximal tubular cells: 149.1,Group enriched,Detected in some,207,liver cancer: 4.0;renal cancer: 16.5,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Low region specificity,Detected in single,NA,NA,Not detected,Not detected,NA,NA,HPA024575,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA024575: AB_1858650,NA,NA,NA,NA,unprognostic (5.88e-2),NA,unprognostic (2.33e-1),NA,NA,NA,NA,NA,prognostic favorable (2.63e-4),unprognostic (6.19e-2),unprognostic (3.91e-2),NA,NA,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,70.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,1.8,0,0,8.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,149.1,0,0,0,0,0,0,0,0,0,0
SLC22A13,"OAT10, OCTL1, OCTL3, ORCTL3",ENSG00000172940,Solute carrier family 22 member 13,Q9Y226,3,38265812-38278315,"Predicted membrane proteins, Transporters",NA,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,7,kidney: 16.4,Cell type enriched,Detected in single,23,Proximal tubular cells: 6.5,Cancer enriched,Detected in single,7,renal cancer: 0.7,Not detected,Not detected,NA,NA,Cell type enriched,Detected in single,5,T-reg: 2.3,Lineage enriched,Detected in single,5,T-cells: 2.3,Cell line enhanced,Detected in some,NA,HeLa: 2.2,NA,NA,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA035603, HPA035962",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA035603: AB_10672869, HPA035962: AB_2674890",unprognostic (2.73e-2),unprognostic (6.70e-2),unprognostic (2.80e-1),unprognostic (5.68e-2),unprognostic (7.13e-3),unprognostic (3.50e-3),unprognostic (6.83e-2),unprognostic (1.49e-1),unprognostic (3.48e-1),unprognostic (2.09e-1),unprognostic (3.04e-1),unprognostic (1.92e-1),unprognostic (8.65e-5),unprognostic (3.39e-1),unprognostic (1.96e-2),unprognostic (5.24e-2),unprognostic (2.74e-1),0,0,0,0,0,0.1,0,0.6,0.1,0,0,0,0,0,0,0,0.4,0,0.1,0,0,0,16.4,0.1,0,0,0,0,0,0.1,0,0.7,0,0,0,0.1,0,1.3,0,0.2,0,0.3,0,0,0,0.1,0.5,0,0,0,0,0,0.2,0.2,0.4,0,0.1,0.3,0,2.3,0,0.2,0.5,0.1,0.7,0.4,0.5,0.1,0.3,0,0.2,0.3,0,0.5,0.9,0.2,0.1,0.6,0.8,0.5,0.7,0.1,0.4,0.1,0,2.2,0,0.1,0,0.8,0,0.5,0.1,1.5,0.8,0,0.9,0,0.1,1.1,0.1,0.1,0,0,0.2,0.5,0,0,0.2,0,1.2,0.1,0.1,0,0.5,0,0.4,0.1,0.1,0,0.3,0.7,1.2,0.3,0.3,0.4,0.4,0.9,0,0,0,0.2,0,0,0.3,0.3,0.4,0.1,0.3,0,0.3,0.3,0,0.1,0,0,0,2.3,0,0,0,0.6,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.5,0,0,0,0,0,0,0,0,0,0
SLC22A14,"OCTL2, ORCTL4",ENSG00000144671,Solute carrier family 22 member 14,Q9Y267,3,38282294-38318575,"Predicted membrane proteins, Transporters",NA,NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enriched,Detected in some,8,testis: 13.2,Group enriched,Detected in some,44,Early spermatids: 57.6;Late spermatids: 81.6,Not detected,Not detected,NA,NA,NA,NA,NA,NA,Group enriched,Detected in some,13,neutrophil: 1.4;plasmacytoid DC: 1.2,Group enriched,Detected in many,13,dendritic cells: 1.2;granulocytes: 1.4,Cell line enhanced,Detected in some,NA,hTCEpi: 2.9,Not detected,Not detected,NA,NA,Low region specificity,Detected in single,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (6.26e-2),unprognostic (6.10e-2),unprognostic (1.07e-1),unprognostic (1.17e-1),unprognostic (6.25e-2),unprognostic (4.78e-2),unprognostic (2.33e-1),unprognostic (1.52e-1),unprognostic (1.07e-1),unprognostic (4.97e-2),unprognostic (4.81e-2),unprognostic (1.69e-1),unprognostic (3.57e-4),unprognostic (2.19e-1),unprognostic (4.02e-2),unprognostic (1.69e-1),unprognostic (2.35e-1),0.1,0,0.2,0,0.3,0.5,0,1.6,0.9,0,0,NA,NA,0,0,0.3,0.3,0,0,0,0.2,0.3,1.1,0,0,0.1,0.2,NA,0,0.1,0,0.2,0,NA,0.1,0.1,NA,0.2,0.2,0.3,0.1,0.1,0,0,0,0.2,13.2,NA,NA,0,NA,0,0,0,0,1.2,1.4,0,0,0,0,0,0.2,0.5,1.7,0.7,1.3,0.2,0.1,0.6,0.4,1,1.6,0.1,0,0.4,0.9,0.5,0.8,0,0,0.1,1,0,0,0.6,0,0,0,0.3,1.9,2.9,0,0.8,1.1,0.1,1.1,0,0,0.7,0,0,0.3,0.2,0,0,0,0,0,0.1,1.9,0,0,0.4,0.7,0.1,1.4,0,0,1.9,0,1.1,0.6,0.3,0.3,0.3,0,0.7,0.1,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,1.4,0,0,1.2,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0.9,0.3,0,0,0,0,0,0,0,0.1,57.6,0,0,0,0,0,0,0.2,0,0,0.1,1.6,0,0,0,81.6,0.9,0,0,0,0,0,0.2,0,0,0.1,0,0,0,1.1,0.9,0,0,0,0,0.1
SLC22A16,"CT2, FLIPT2, OAT6, OKB1",ENSG00000004809,Solute carrier family 22 member 16,Q86VW1,6,110424687-110476641,Predicted membrane proteins,"Differentiation, Ion transport, Spermatogenesis, Transport",Developmental protein,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,NA,blood: 9.5;bone marrow: 16.0;parathyroid gland: 9.6;testis: 26.4,Group enriched,Detected in some,5,Early spermatids: 28.2;Erythroid cells: 23.3;Late spermatids: 23.1;Spermatocytes: 35.7,Cancer enriched,Detected in single,5,endometrial cancer: 0.8,Not detected,Not detected,NA,NA,Cell type enhanced,Detected in some,NA,classical monocyte: 9.5,Group enriched,Detected in many,66,dendritic cells: 5.1;granulocytes: 5.0;monocytes: 9.5,Group enriched,Detected in some,18,NB-4: 9.8;REH: 9.0;THP-1: 31.3;U-937: 18.4,NA,NA,NA,NA,Low region specificity,Detected in all,NA,NA,HPA036902,Uncertain,NA,Approved,"Plasma membrane,Cytosol",NA,NA,NA,NA,NA,"Plasma membrane, Cytosol",NA,HPA036902: AB_10672274,unprognostic (1.01e-1),unprognostic (1.88e-2),unprognostic (5.11e-3),unprognostic (2.19e-3),unprognostic (2.70e-4),unprognostic (1.45e-1),unprognostic (8.15e-2),unprognostic (6.93e-2),unprognostic (1.48e-2),unprognostic (4.98e-2),unprognostic (1.02e-3),unprognostic (2.49e-1),unprognostic (2.61e-6),unprognostic (5.78e-4),unprognostic (2.72e-2),unprognostic (2.74e-2),unprognostic (2.65e-2),3.5,0.2,0.2,0.4,0.2,16,0.2,0.1,0.2,0.1,0.7,0,0,0,4.9,0.8,0.1,0.3,0.7,0.1,0.2,0.1,1.1,0.3,1.6,0,0.2,0,0.9,0.1,9.6,0.1,0.3,0.2,0.2,0,0,0.6,0,0.2,0.3,0.1,1.6,0.2,0.8,0.2,26.4,0,2.2,0.1,0.8,0.1,0.1,0.1,0,5.1,5,9.5,0,0,1.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.9,0,0,0,0,0,0,0,0,0,0,0,0,0,9.8,0,0,0,9,0,0,0,0,0.3,0.1,0,0,0,0,0,31.3,0,0,0,0.4,0,0,0,0,0,18.4,0,5,9.5,1.6,0,2.1,0,0,0,0,5.1,0,0,0,0,0,0,0.6,0,1.7,0.2,0.2,0.1,0.2,0.2,0.1,0.2,0,0.2,0,0,0,0,0,0.2,0,0.3,0,5.3,0,0,0,0,0,0,28.2,0,0,23.3,0,0.1,0.2,0,0,0,2.3,0,0,0,2.2,23.1,1.4,1.8,0,0,0,0,0,0,0.4,0,0,0,0,35.7,0.2,0.4,0,0,0,0
SLC22A17,"BOCT, BOIT, NGALR",ENSG00000092096,Solute carrier family 22 member 17,Q8WUG5,14,23346306-23352912,"Predicted membrane proteins, Transporters","Ion transport, Iron transport, Transport",Receptor,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 112.4,Cell type enhanced,Detected in many,13,Horizontal cells: 190.7;Muller glia cells: 81.5;Rod photoreceptor cells: 64.5,Cancer enhanced,Detected in all,NA,glioma: 51.5,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in some,5,memory CD4 T-cell: 1.1;naive CD4 T-cell: 3.6;naive CD8 T-cell: 1.8,Lineage enriched,Detected in single,26,T-cells: 3.6,Cell line enhanced,Detected in many,NA,AN3-CA: 20.8;ASC diff: 17.3;SH-SY5Y: 24.2,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA002728,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA002728: AB_1079998,unprognostic (9.34e-2),unprognostic (2.34e-1),unprognostic (2.31e-2),unprognostic (6.23e-3),unprognostic (2.85e-2),unprognostic (1.07e-1),unprognostic (2.31e-2),unprognostic (1.26e-2),unprognostic (4.23e-2),unprognostic (3.22e-1),prognostic favorable (1.73e-4),unprognostic (1.78e-1),unprognostic (1.07e-1),prognostic unfavorable (5.95e-4),unprognostic (3.50e-2),unprognostic (1.23e-2),unprognostic (3.87e-2),6,24.2,32.9,4,63.4,1.6,7,40.7,112.4,12.1,5.6,27.4,2.4,4.5,8,10.1,4.7,10.2,7.6,9.1,35.6,69.4,8.6,2,5,3.8,28.5,27.3,11,14.5,13.3,39.4,5.3,33.1,21.9,3.5,13.2,20.5,24.4,2.1,6.6,6.6,7.7,21.8,3.6,6.1,6.6,22.1,0,10.8,0.1,2.6,4.2,4.8,0.1,0,0,0,0,3.6,0.2,0,1.2,13,20.8,17.3,9.1,2,4.5,8.9,1.7,1.3,0.1,1.2,0,1.7,8.4,4,0.2,0.6,0.5,0.1,0,0.7,2.9,0,0.1,9.3,0,2.9,11.8,0.8,2,0,7.5,0.5,5.6,0,0.1,2.7,1.9,0.1,0.1,7.1,0,0,0,0.5,0.1,0,1.2,12.3,24.2,3.7,0,0,2.8,2.4,0.4,0,1.9,5.6,10.4,0,0,2,0,1.2,0,7.6,0,0,0,0.4,0,0,0,1.1,0,0,0.1,3.6,1.8,0,0,0,0,0,0.2,32.9,63.4,40.7,64.3,35.6,69.4,28.5,27.3,33.1,22.1,0,2.4,0,18.6,11.2,49.9,9,5.1,5.3,9.1,19.2,41.2,1.8,1.7,0.6,0.3,6.8,0,0,1.2,4.1,14.9,27.1,4.6,0.8,0.8,190.7,20,17.8,0.8,1.3,19.5,2.2,6.8,1,0,81.5,2.4,0,40.3,13.5,64.5,0,20,0.9,2.1,9.5,4,0,0,4.6
SLC22A2,2-Oct,ENSG00000112499,Solute carrier family 22 member 2,O15244,6,160171061-160277638,"Predicted membrane proteins, Transporters","Ion transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,9,kidney: 61.8,Group enriched,Detected in some,13,Distal tubular cells: 77.9;Proximal tubular cells: 187.0,Cancer enriched,Detected in single,493,renal cancer: 30.8,Low region specificity,Detected in single,NA,NA,Cell type enhanced,Detected in single,NA,neutrophil: 1.0,Low lineage specificity,Detected in single,NA,NA,Cell line enhanced,Detected in some,NA,NTERA-2: 1.8;SuSa: 1.0;U-2197: 3.8,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,"HPA008549, CAB068236, CAB068237",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CAB068236: AB_2665668, CAB068237: AB_2665669, HPA008549:",unprognostic (1.01e-1),unprognostic (3.67e-1),unprognostic (2.26e-1),unprognostic (3.67e-2),unprognostic (4.24e-1),unprognostic (3.33e-1),unprognostic (2.51e-2),unprognostic (3.30e-1),unprognostic (1.42e-2),unprognostic (1.15e-4),unprognostic (1.41e-1),unprognostic (3.68e-1),prognostic favorable (1.85e-7),unprognostic (1.65e-2),unprognostic (8.20e-2),unprognostic (4.11e-1),unprognostic (2.45e-2),0,0,0,0,0.2,0,0,0.6,0.3,0,0.2,0.1,0,0,0.1,0,0,0.1,0.2,0,0.2,0.1,61.8,0,0,0,0.8,0.8,0,0,0,0.3,0.2,1.9,0.1,0,2.7,0,0.6,0.3,0,0.1,0.1,6.7,0,0.1,0.1,0,0,0,0,0,0,0.1,0.4,0.3,1,0,0.5,0.3,0,0,0,0.2,0,0.1,0.1,0.1,0,0,0,0.1,0.2,0,0,0.2,0,0,0.4,0,0,0,0.7,0.3,0.1,0.4,0,0,0.2,0,0,0,0.1,0.1,0,0,0,0,0,0,0,0.1,0,1.8,0,0.4,0,0.1,0,0.6,0,0,0.1,0,0.1,0.2,1,0.2,0.1,0,0.2,0,3.8,0,0.3,0,0,0.5,0.1,0,0.5,0,0.1,0.3,0,0.1,0.4,0,0,0,0.3,0,0,1,0.5,0,0.3,0.1,0,0,0.2,0.6,0.3,0.2,0.1,0.8,0.8,1.9,0,0,0,0,0,0,0,0.4,0,0,0,10.4,0,0,77.9,0.6,4.4,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0.5,0.3,0,0,0,0,0,0.2,0,0,187,0,0,0.3,0,0.1,0.3,0.1,0,0,0
SLC22A25,"HIMTP, MGC120420, UST6",ENSG00000196600,Solute carrier family 22 member 25,Q6T423,11,63163776-63229652,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enriched,Detected in single,165,liver: 16.5,Cell type enriched,Detected in single,9,Hepatocytes: 5.8,Cancer enriched,Detected in single,66,liver cancer: 3.2,NA,NA,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA039390,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA039390: AB_10671996,unprognostic (3.19e-2),NA,NA,NA,unprognostic (2.38e-1),unprognostic (4.51e-1),prognostic favorable (7.04e-4),NA,NA,NA,NA,NA,NA,unprognostic (1.01e-1),NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,NA,NA,0,0,0,0,0,0,0,0,0,0,16.5,0,0,0,NA,0,0,0,0,0,NA,0,0,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,0,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.8,0,0,0,0.6,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
SLC22A3,"EMT, OCT3",ENSG00000146477,Solute carrier family 22 member 3,O75751,6,160348268-160452581,"Predicted membrane proteins, Transporters","Ion transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,skeletal muscle: 98.6,Cell type enhanced,Detected in many,10,Alveolar cells type 2: 62.8;Hepatocytes: 56.3;Leydig cells: 31.4;Pancreatic endocrine cells: 33.9,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in many,NA,NA,Cell type enhanced,Detected in single,NA,gdT-cell: 1.5,Low lineage specificity,Detected in single,NA,NA,Cell line enhanced,Detected in some,NA,A549: 17.6;HeLa: 23.6;Hep G2: 14.7;hTERT-RPE1: 6.2;OE19: 7.5;RPTEC TERT1: 9.0,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,HPA029750,Approved,NA,Approved,"Vesicles,Cytosol",NA,NA,NA,NA,NA,Vesicles,Cytosol,HPA029750: AB_10603888,unprognostic (8.61e-2),prognostic unfavorable (7.19e-5),unprognostic (4.14e-1),unprognostic (1.49e-2),unprognostic (1.38e-1),unprognostic (1.87e-1),unprognostic (1.28e-1),unprognostic (3.36e-2),unprognostic (9.74e-2),unprognostic (9.36e-4),unprognostic (1.33e-2),unprognostic (2.58e-2),unprognostic (7.28e-2),unprognostic (7.96e-2),unprognostic (5.21e-2),unprognostic (8.13e-4),prognostic unfavorable (7.26e-4),4.1,6.9,1,2.1,1.3,0,5.2,1.8,0.9,7.6,4.1,0.9,4.1,0.2,14.2,11.8,4.1,9,9,1.1,1.2,1.3,2.4,15.2,12.7,9.7,2.2,0.9,10.3,1.3,0,0.9,17.8,1.9,18.9,0.6,0.9,34.5,23,98.6,5.1,2.7,10.8,4.4,0.3,2.9,3.4,0.6,0.4,3.4,5.7,2.1,3.2,7.3,0,0,0.8,0,0.1,1.5,0,0,17.6,0,0,0.3,0,0,0,0,0.1,0,0.1,1,0,0,0,0,4.6,0,0,0.2,0,0,0,23.6,14.7,0.8,0,0,0.5,4.5,2.2,0,6.2,0,0,0,0,0,0,0,0,2.6,7.5,4.9,0,0,0,9,0,0,0,1.9,0,0,0.8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.5,0,0,0,0.1,0,0,0,0,0.3,0.8,0.1,0,0,0,0,1,1.3,1.8,0.9,1.2,1.3,2.2,0.9,1.9,0.6,14.9,62.8,0,0.3,4.1,0,1.6,5.1,1.4,10.3,0,0,0.4,5,9.1,0.4,0.3,0.7,0,2.5,0.2,11,3.4,2.3,56.3,0.6,0,0,0,0.6,0.9,31.4,1.5,3.3,0,0.4,0,33.9,0,23,2.1,0,0,11.4,0.2,0.1,5.8,0.3,0,0.4,0.7
SLC22A31,NA,ENSG00000259803,Solute carrier family 22 member 31,NA,16,89195761-89201664,Predicted membrane proteins,NA,NA,NA,Evidence at transcript level,Evidence at transcript level,NA,NA,NA,Group enriched,Detected in some,21,brain: 39.3;lung: 50.7;pancreas: 69.7,Cell type enriched,Detected in some,6,Alveolar cells type 2: 129.3,Group enriched,Detected in many,9,liver cancer: 6.1;lung cancer: 26.2;thyroid cancer: 20.4,Region enriched,Detected in some,23,cerebellum: 39.3,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,5,BEWO: 23.7;Hep G2: 19.0;NB-4: 9.7;RPMI-8226: 11.4;THP-1: 6.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (2.71e-3),unprognostic (2.53e-1),unprognostic (5.02e-3),unprognostic (6.82e-2),unprognostic (8.20e-2),unprognostic (1.95e-1),unprognostic (3.00e-2),unprognostic (1.93e-2),unprognostic (2.12e-1),unprognostic (2.67e-1),unprognostic (8.98e-2),unprognostic (1.09e-1),unprognostic (8.26e-4),unprognostic (2.74e-1),unprognostic (2.05e-1),unprognostic (2.72e-3),unprognostic (1.89e-1),0.1,0.3,0,0.3,0.4,1.1,0.1,39.3,0.1,0.3,0.5,0,0,0.6,0.2,0.5,0.1,0.2,0.2,0.1,0.1,0,0.1,0.3,50.7,2.5,0,0,0.7,69.7,0.1,0,0.1,1.7,0.2,0.1,0.4,0.7,0.2,0.1,0.3,0.3,0.1,0.3,1,0.5,1.1,0,0,0.3,0,0.1,0.2,0,0.5,0,0,0.1,0,0.6,0.7,0,0,0,1.1,0,0,23.7,0.1,0,0,0,0.8,0,0,2.7,0,0,0,0,0,0,0,0.6,0,0,19,2.5,0,0.2,0,0,0,0,0,0,0.3,0.3,0,0,0.3,0,9.7,0.6,0.2,2.4,0,2.6,11.4,0,0,1,0.7,0,0,0,0.1,0.2,6.2,0,0,0,0,0,0,0.9,0,0,0.1,0.1,0,0.1,0,0,0,0,0.5,0,0,0,0,0.6,0,0,0,0,0,0,0.7,0,0.4,39.3,0.1,0.1,0,0,0,1.7,0,6,129.3,0,0,0,0,0.4,0,4,14.8,0,0,0,0,0.1,20.8,0,0,0,4.2,0.1,0,0.2,8.1,0.2,0.6,0,0,0.6,0.3,23.1,0.6,0,0,0,0,0,0.1,0,0,0,0,0,0.3,0.7,2.8,0.1,0,0,0,0
SLC22A4,"DFNB60, MGC34546, OCTN1",ENSG00000197208,Solute carrier family 22 member 4,Q9H015,5,132294443-132344206,"Disease related genes, Predicted membrane proteins","Ion transport, Sodium transport, Symport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,NA,NA,Group enriched,Detected in many,6,Ciliated cells: 89.7;Erythroid cells: 70.0,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enriched,Detected in some,7,neutrophil: 23.0,Lineage enriched,Detected in many,7,granulocytes: 23.0,Cell line enhanced,Detected in many,NA,BJ hTERT+: 35.1;U-138 MG: 14.9,Region enhanced,Detected in all,NA,cerebellum: 72.4,Low region specificity,Detected in all,NA,NA,"CAB015468, HPA036974",Approved,NA,Approved,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,"CAB015468: , HPA036974: AB_2732474",unprognostic (1.33e-1),unprognostic (2.20e-1),unprognostic (3.91e-2),unprognostic (8.42e-3),unprognostic (6.17e-2),unprognostic (6.22e-3),unprognostic (4.17e-3),unprognostic (3.33e-1),unprognostic (1.30e-1),unprognostic (9.79e-2),unprognostic (1.95e-3),unprognostic (7.82e-2),unprognostic (1.74e-2),unprognostic (2.31e-3),unprognostic (1.20e-1),unprognostic (1.95e-2),unprognostic (4.06e-2),2.7,4.1,3.5,3.8,5,22.4,3.1,3.1,4.7,2.4,5.9,4.4,1.8,4.6,2.1,3.2,0.8,14.7,2.6,3,3.9,4.9,15.4,1.6,7.2,3.8,3.2,2,5,1,7.7,6.9,6.8,12.6,5.4,3.1,13.8,2.6,4.1,9.2,1.7,18.1,1.5,9.9,7.7,2.2,0.9,2.7,0.5,1,2.7,0.8,2.5,2.2,0,1.7,23,3.5,0,0,0.6,1.1,1.7,0.1,0.4,0.8,0.6,0.5,7.6,35.1,5.9,6.1,0.7,1.9,0.3,2.1,4.4,4.4,1.9,0,1.2,4.1,1.4,0.2,0.1,3.3,0.1,0.6,2.3,0,1.4,0.2,3.2,3,2.1,2.5,0.2,3,4,4.5,0.6,0,5.4,0.2,0.1,1.9,0,0.4,0.2,0.9,0.1,0.5,0.2,8.3,0.5,0.2,0.2,0.3,1.4,3.1,14.9,1.4,5.8,1.9,0,1.5,0,4.4,2.7,1.7,0,3.5,3.5,0,0.8,0,0,0,0,1.7,0,0,0,23,0,0.2,0.2,0,0.6,3.5,5,3.1,4.7,3.9,4.9,3.2,2,12.6,2.7,3,0,0,1,0.7,1.6,0.8,2.5,89.7,13.6,0,0,0.6,0,3.2,0,2.1,5.3,70,0.3,1.6,1.4,2.2,0,0,4.2,3.2,1.2,0.6,1.5,0,0.6,4.3,0,0,0.4,1.5,1.2,1.4,0,4.9,0.3,0,1,0.4,0.2,0.4,2.1,0,1.1,0.9
SLC22A5,"CDSP, OCTN2, SCD",ENSG00000197375,Solute carrier family 22 member 5,O76082,5,132369752-132395614,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Symport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,kidney: 42.3;skeletal muscle: 93.6,Cell type enhanced,Detected in many,6,Enterocytes: 46.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,HeLa: 22.3;SiHa: 23.0,NA,NA,NA,NA,NA,NA,NA,NA,HPA063062,NA,NA,Approved,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,HPA063062: AB_2684934,unprognostic (3.88e-1),unprognostic (1.69e-1),unprognostic (2.19e-2),prognostic favorable (2.87e-5),unprognostic (5.37e-3),unprognostic (1.18e-1),unprognostic (1.50e-2),unprognostic (9.24e-2),unprognostic (1.57e-1),unprognostic (5.09e-2),prognostic favorable (7.36e-4),unprognostic (3.53e-2),prognostic favorable (8.36e-4),unprognostic (1.12e-2),unprognostic (2.98e-2),unprognostic (2.17e-2),unprognostic (1.17e-2),3,4.7,4,1.9,4.9,0.6,4.4,9,4.2,4.4,10.6,3.6,15,11.8,3.6,12.6,2.5,7.4,5.2,7.2,3.8,3.8,42.3,4.5,2.3,1.5,3.5,3.2,3.9,5.2,17.9,8.5,8.1,3.9,8.2,8.3,5.9,4.2,21.8,93.6,3.5,19.6,2.9,3.8,1.7,4.4,2.5,2.7,1,5,3.2,2.4,3.9,3.2,1.4,6.4,0.4,4.1,1.5,4,2.1,3.6,8.7,0.5,7,2.8,1.3,12.1,1.6,1.8,2.8,3.9,6.4,7.5,1.7,3.8,1.6,8.1,8.7,5.8,4.3,3.3,2.2,7.1,0.9,22.3,2.9,4.7,1.4,1.5,1.3,8.1,1.9,9.9,4.8,0.7,3.2,4,1.1,2.6,6.2,2.1,1.4,0.6,6.3,3.8,0.8,0,9.4,8.4,9.1,3,2.1,23,18,4.4,1.9,8.3,1.8,0.4,0.5,2.5,5.9,2,3.8,7.4,0.1,1.8,3.6,1.6,0,4.1,0,2.6,2.2,2.8,1.4,2.4,3.1,6.4,1.4,2.6,3,0.4,1.5,0.7,0.6,4,2.1,4,4.9,9,4.2,3.8,3.8,3.5,3.2,3.9,2.7,8.9,5.1,2.7,5.9,6.8,6.5,5.2,20.4,6.7,3.4,15.7,11.8,16.6,1.7,8.8,1.4,3,46.4,0,4.5,4.8,4,12.8,0,5.9,4,9.5,6.9,1.3,8.7,2.3,6.1,2.6,5,0,12.6,8.7,5.4,25.9,3.9,23.2,7.4,0,1.9,7.2,2.5,5.5,6.9,2.9,16.1,7.8
SLC22A6,"OAT1, PAHT, ROAT1",ENSG00000197901,Solute carrier family 22 member 6,Q4U2R8,11,62936385-62984983,"FDA approved drug targets, Predicted membrane proteins, Transporters",NA,NA,FDA approved drug targets,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,10,kidney: 94.2,Cell type enriched,Detected in some,14,Proximal tubular cells: 213.4,Cancer enriched,Detected in single,102,renal cancer: 18.8,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA074559, CAB075704",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CAB075704: , HPA074559: AB_2732260",NA,NA,NA,NA,unprognostic (2.42e-2),NA,NA,NA,NA,NA,NA,NA,unprognostic (2.25e-3),unprognostic (4.43e-1),NA,NA,NA,0.2,0.2,0.8,0.2,1.3,0.2,0.2,0.4,1.4,0.2,0.2,0.7,0,0.2,0.2,0.2,0.2,0.2,0.2,0.2,0.8,1.8,94.2,0.2,0.2,0.2,2.4,0.6,0.2,0.2,0.2,0.1,0.2,4.1,0.2,0.2,9.4,0.2,0.2,0.2,0.2,0.2,0.2,2.4,0.2,0.2,0.2,0.5,0,0.2,0,0.2,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.6,0,0,0.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.8,1.3,0.4,1.4,0.8,1.8,2.4,0.6,4.1,0.5,0,0,0,0,0,0.4,0,0,0,0,7,0,0,14.9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,213.4,0,0,0,0,0,0,0,0,0,0
SLC22A7,"NLT, OAT2",ENSG00000137204,Solute carrier family 22 member 7,Q9Y694,6,43295694-43305538,"Predicted membrane proteins, Transporters","Ion transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,6,liver: 88.9,Group enriched,Detected in some,16,Hepatocytes: 185.6;Proximal tubular cells: 86.1,Cancer enriched,Detected in some,37,liver cancer: 81.5,Not detected,Not detected,NA,NA,Cell type enriched,Detected in single,4,naive B-cell: 1.2,Lineage enriched,Detected in single,4,B-cells: 1.2,Cell line enriched,Detected in single,19,Hep G2: 14.9,Low region specificity,Detected in some,NA,NA,Not detected,Not detected,NA,NA,HPA030220,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA030220: AB_10603027,unprognostic (9.17e-2),NA,NA,unprognostic (9.73e-4),unprognostic (2.13e-1),NA,prognostic favorable (5.48e-6),NA,NA,unprognostic (1.45e-1),unprognostic (1.54e-3),unprognostic (1.74e-2),prognostic favorable (8.98e-4),unprognostic (1.29e-1),unprognostic (1.07e-1),NA,NA,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,13.8,88.9,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0.1,0,0,0,0,0.1,0,0,0,0,0,0,0,1.2,0.2,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,14.9,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0.1,0.7,0.2,0,0,0.5,0.3,0.4,0,0,0,0,0,0,0,0,0,0,0.1,0,0.1,0,0.3,0,0,0,0,0,0,0,0,0.1,0,0.2,1.2,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0.1,0,0,0,2.2,0,0,1.2,0.3,2.5,0,0,0,0,0,8.3,0,0,0,0,0,0,0,0,0,0,185.6,0,0,0,1.8,5,0,0,0,0,0,0,0,0,0,0,86.1,0,0,0,0,0,0,0,0,0,0
SLC22A8,OAT3,ENSG00000149452,Solute carrier family 22 member 8,Q8TCC7,11,62989154-63015839,"FDA approved drug targets, Predicted membrane proteins, Transporters","Detoxification, Ion transport, Transport",NA,FDA approved drug targets,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,341,brain: 33.7;kidney: 127.3;retina: 93.5,Cell type enriched,Detected in some,30,Proximal tubular cells: 197.4,Cancer enhanced,Detected in single,NA,renal cancer: 0.6,Region enriched,Detected in some,25,pons and medulla: 33.7,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in single,13,EFO-21: 1.3,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA044174,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA044174: AB_10963058,NA,NA,NA,NA,NA,NA,unprognostic (5.35e-4),NA,NA,NA,NA,unprognostic (4.66e-1),unprognostic (6.88e-3),unprognostic (1.72e-1),unprognostic (2.20e-1),NA,NA,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.4,1,0.1,0.1,3.8,0,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.7,0.1,127.3,0.1,0.1,0.1,0.1,1.3,0.1,0.1,0.1,0.2,0.1,33.7,0.1,0.1,93.5,0.1,0.1,0.1,0.1,0.1,0.1,0.3,0.1,0.1,0.1,0,0,0.1,0,0.1,0.1,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.1,0.4,1,0.7,0.1,0.1,1.3,33.7,0,0,0,0,0,0,3.7,0.8,0,0,0,5.2,0,0,6.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,197.4,0.9,0,0,0,0,0,0,0,0,0
SLC22A9,"FLJ23666, OAT4, OAT7, UST3",ENSG00000149742,Solute carrier family 22 member 9,Q8IVM8,11,63369789-63410294,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,11,liver: 32.2,Cell type enhanced,Detected in some,30,Cholangiocytes: 2.5;granulocytes: 4.6;Hepatocytes: 12.7,Cancer enriched,Detected in single,166,liver cancer: 19.3,Region enhanced,Detected in single,NA,cerebral cortex: 1.1,Low cell type specificity,Detected in some,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in some,NA,Hep G2: 2.1;Karpas-707: 1.9;U-266/70: 2.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (2.45e-1),unprognostic (7.24e-2),unprognostic (8.86e-2),NA,unprognostic (2.10e-2),unprognostic (1.08e-2),NA,unprognostic (2.26e-1),unprognostic (2.17e-1),unprognostic (2.71e-1),NA,unprognostic (3.09e-2),0,0,0.4,0,0.1,0,0,0,1.1,0,0,0,0,0,0,0,0.1,0,0.2,0,0.1,0,0.2,32.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0.6,2.8,0.8,0.9,0.5,0.3,0.4,0.5,0,0.6,0.2,0,0.9,0,0.3,0.1,0.2,0.2,0.4,0.5,0.2,0.1,0.1,0.4,0,0.5,0.1,1.3,0.3,0.3,0.5,2.1,0,0.1,0.5,0,0,0.5,0,0.1,0.2,0,0.3,1.9,0.1,0.6,0.3,0.9,0.7,0.1,0.2,0.1,1.1,0.1,0,0.5,0.1,0.2,0,0.3,0.2,0,0.4,0.5,0,0.5,0.3,0.6,0.3,2.4,0.5,1,0.3,0.6,0.3,2.8,0.8,0.7,0.4,0.5,0.2,0.5,0.2,0.3,0.2,1,0.4,0.5,2.2,0.9,0.2,0.6,0.3,0.3,0.4,0.1,0,1.1,0.1,0,0,0,0,0,0,0,0,0.1,0.1,0,0,2.5,0,0,0,0,0,0,0,0.2,0,0,0,0.2,0,0,0.1,4.6,12.7,0,0,0,0,0.6,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0.1,0,0.1,0,0,0,0
RNF167,DKFZP566H073,ENSG00000108523,Ring finger protein 167,Q9H6Y7,17,4940008-4945222,"Enzymes, Predicted intracellular proteins, Predicted membrane proteins",Ubl conjugation pathway,Transferase,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,HPA049810,Approved,NA,Approved,"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol",NA,NA,NA,NA,NA,"Vesicles, Cytosol","Mitotic spindle, Centriolar satellite",HPA049810: AB_2680894,unprognostic (1.13e-1),unprognostic (5.12e-2),unprognostic (2.29e-3),unprognostic (1.63e-2),unprognostic (3.43e-2),unprognostic (7.32e-2),unprognostic (2.18e-1),unprognostic (6.77e-2),unprognostic (7.46e-2),unprognostic (2.07e-2),prognostic favorable (2.03e-6),unprognostic (2.16e-1),prognostic favorable (4.47e-4),unprognostic (7.62e-2),unprognostic (1.93e-1),unprognostic (3.26e-1),unprognostic (1.12e-1),30.5,45.9,45.8,32.1,47,40.7,38.3,37.9,67.9,44.3,43.5,54.6,49.2,42.7,43.1,55.8,51.6,44,47.4,40.1,43.1,39.9,44.1,84.1,35.6,38.7,43.7,43.6,42.6,52.4,52.8,40.7,49,41.2,43.6,46.7,38.5,49.1,51.7,56.5,51.6,51.1,42.4,46.4,47.1,42.7,42,33.1,53.9,55.1,47.3,47.6,48.1,40.7,25.6,18.2,54.4,26.7,27.6,53,37.9,24.2,35.2,15.3,18.8,37.8,18.9,22.9,15,21,31.7,25.1,24.5,11.2,17.9,29.2,24.8,15.8,37.3,26.6,29.2,23.7,17.3,42.8,30.6,44.4,24.1,28.6,14.4,64.6,22.1,46.1,33,31.4,19.9,20.4,26.7,11.9,61.3,25.3,17.3,22.7,17.9,18.3,25.7,22.6,15.7,15.3,22.3,36.5,20.4,12.1,15,13.8,23.7,20,22.4,22.6,14.7,12.5,19,12.6,17,28.5,20.4,20.6,5.9,26.1,20.8,19.8,22.4,21.4,54.4,53,22.6,41.1,25.6,40.6,52.7,18.2,24,28.5,42.3,52.1,27.6,26.7,18,37.7,37.9,45.8,47,37.9,67.9,43.1,39.9,43.7,43.6,41.2,33.1,0,3.8,37.8,33.1,60.9,40.7,13.4,66.2,2.7,2.3,47.1,19.6,101.9,48,68.5,41.4,35.8,73.2,46.7,58.4,102.1,39.8,31.4,13.9,83.9,52.2,17.5,30.5,38.1,36.1,68.6,45.1,42,37.1,57.7,40.4,45,52.7,40.3,50.5,53.1,25.5,38.8,27.8,111.1,83.5,72.8,104.7,90,54.4,39.3
RSC1A1,RS1,ENSG00000215695,Regulator of solute carriers 1,Q92681,1,15659869-15661722,Predicted intracellular proteins,"Transcription, Transcription regulation",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,NA,NA,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in many,NA,NA,NA,NA,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA027813, HPA028676",Approved,NA,Supported,"Nucleoplasm,Cell Junctions",NA,NA,NA,NA,NA,Nucleoplasm,Cell Junctions,"HPA027813: AB_10600308, HPA028676: AB_10600895",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,0.9,0.3,1.7,0.4,2.8,2.6,0.1,0.6,2.2,0.6,NA,NA,0,1.2,0,3.5,1.2,1.1,2.9,0.3,0.5,4,7.7,2.7,2,0.4,NA,4.6,0.2,2.1,1.3,2.3,NA,3.9,1.3,NA,0.1,0.8,0.6,2.1,0.6,3,0.8,0.1,0.6,4.7,NA,NA,1.7,NA,3.2,1.1,2.2,1.1,2.8,0.5,3.5,1.7,2.3,1.5,3.3,3.9,4.8,3.2,6,4.2,6.4,2.8,4.7,7.9,7.4,6.4,5.5,7.4,2.8,6.3,3.9,2.3,12.5,4,9.7,4.9,3.1,6.9,7.7,6.8,1.3,10.1,3.5,3.3,0,13.6,7.5,1.8,4.9,5,19,7,5.7,3.3,5.3,0,5.2,1.9,2.2,4.5,6.8,3.1,1.8,6.2,3.9,1.6,5.3,2.4,4.6,4.3,3.4,0.9,4.8,4,7.4,3.6,2.1,2.1,4,12.9,1.6,2.7,2.8,0,1.2,0.5,0.4,3.5,1.4,1.1,0.5,2.3,2.8,0.2,0.6,0.5,0,1.7,0.1,0.7,2.3,1.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
SLC24A3,NA,ENSG00000185052,Solute carrier family 24 member 3,Q9HC58,20,19212646-19722937,"Predicted membrane proteins, Transporters","Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,NA,NA,Cell type enhanced,Detected in many,11,Early spermatids: 18.2;granulocytes: 26.5;Late spermatids: 14.9,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in some,53,basophil: 7.1;eosinophil: 3.3,Lineage enriched,Detected in single,72,granulocytes: 7.1,Cell line enriched,Detected in some,4,HMC-1: 41.5,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA043400, HPA045497",Uncertain,NA,Approved,"Golgi apparatus,Cytosol",NA,NA,NA,NA,NA,Golgi apparatus,Cytosol,"HPA043400: AB_2678462, HPA045497: AB_2679349",unprognostic (8.74e-2),unprognostic (1.13e-2),unprognostic (1.16e-1),unprognostic (1.41e-1),unprognostic (7.40e-2),unprognostic (2.09e-1),unprognostic (2.40e-1),unprognostic (7.62e-2),unprognostic (3.04e-2),unprognostic (3.25e-2),unprognostic (1.05e-1),unprognostic (5.40e-2),unprognostic (1.21e-3),unprognostic (3.85e-2),unprognostic (1.89e-1),prognostic unfavorable (6.08e-4),unprognostic (7.36e-3),7,2.5,10.9,4.6,11,1,3.6,7.4,9.2,17.6,8.9,5.5,7,2.9,26.3,19,15.3,17.2,14.5,1.7,27.1,12,1.2,0.6,6.2,1.5,4.5,3.4,14.8,1.2,7.9,1.6,3,5.3,8.5,4.1,5.5,6.1,13.8,26.4,5.2,4.4,21.7,2.9,1.7,2.7,1.7,3.1,0.9,2.5,11,4.9,8.1,20.7,0,0,7.1,0,0,0,0.3,0,0,0,0,0.2,0.4,0,0.4,6.9,0.2,0,0,0,0,0.1,0,0,0,0,0.1,0.2,0,0,9.2,0,0,0.4,0,41.5,0,0.1,0,0,0,0,0,0,0,0,0.2,0,4.2,0.1,0,0,0,0,0,0,0.2,0.3,0,0,4.8,0,0.3,8.9,0.1,0,0,0,0,0,0.2,0,0,0,0,0,7.1,0,3.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,10.9,11,7.4,6.5,27.1,12,4.5,3.4,5.3,3.1,3,0.6,0,1,1,9.4,0.4,0,0,2.3,1.8,0,5.4,0,0,18.2,0.1,0,0,0,0.3,1.5,0.7,26.5,0,0.6,1.6,7.5,0.6,0,14.9,3.4,0,0,0,2.6,2.9,0.1,0.9,3.9,0,1.4,0,3.1,0.5,0.4,3.6,2.9,0,0.6,2.7
SLC24A1,"CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX",ENSG00000074621,Solute carrier family 24 member 1,O60721,15,65611366-65660995,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision",NA,Congenital stationary night blindness,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in all,7,retina: 91.1,Cell type enriched,Detected in many,11,Rod photoreceptor cells: 301.7,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Not detected,Not detected,NA,NA,Low region specificity,Detected in single,NA,NA,HPA039370,Enhanced,NA,Approved,Microtubules,NA,NA,NA,NA,NA,Microtubules,NA,HPA039370: AB_10960279,unprognostic (9.47e-2),unprognostic (9.97e-2),unprognostic (1.66e-1),unprognostic (3.66e-3),unprognostic (6.39e-3),unprognostic (4.64e-1),unprognostic (8.82e-2),unprognostic (1.86e-1),unprognostic (4.69e-2),unprognostic (3.94e-1),unprognostic (2.01e-1),unprognostic (9.91e-2),prognostic favorable (2.33e-6),unprognostic (8.45e-2),unprognostic (9.22e-2),unprognostic (3.04e-2),unprognostic (1.96e-2),6.2,5.3,4.5,7.7,5,2.6,9.3,7,3.4,8.9,5,5.6,7.5,3.7,10.6,12.2,4.2,9,6.2,4.1,4.7,4.1,7.9,4.7,12,6,5.3,2.6,9.7,6.6,6.5,6.1,8.9,4,6,4.1,91.1,6.4,8.3,3.8,8.5,4.5,5,6.8,7.8,4.2,10.8,3.2,6.9,9,4.6,4.8,6,5.3,3.8,2.6,4.7,1.5,2.3,1.8,0.4,1.5,3.1,3.3,3,5,8.4,4.1,3.9,4.2,3.8,2.5,1.4,6.6,2.1,12.9,3.7,1.3,4.2,3.9,4.2,2.3,2.1,2.9,4.6,2.3,6.8,7.2,3,6.3,7.1,6.2,2.1,12.8,5.4,6.6,4.9,4.8,7.2,6.2,6.4,1.9,2.8,4.3,13.5,1.2,2,1,1.4,5.8,6,1.6,2.3,1,2.9,8,4.8,6.2,4.2,9.4,3.9,3.9,1.5,2.6,2.9,5.2,2.5,4.1,6.5,3.3,4.7,1.5,2.1,1.4,1.3,1.8,1.4,1.5,1.2,1.1,3.8,1.1,1.5,1.7,2.3,0.6,2.6,0.3,0.4,4.5,5,7,3.4,4.7,4.1,5.3,2.6,4,3.2,6,3.2,1.4,1.2,1.3,26.9,1.9,0,4,5.7,0,25.5,3.3,0,1.1,1.1,7,2.8,0,1.1,2,1.5,1.1,2.3,1.5,1.7,19.1,1.7,4.3,2.2,1.8,2.8,1.5,1.7,0,2.2,23.4,1.7,0,2.1,0.5,301.7,0,1.4,10.4,6.4,0.9,2.1,0.8,2.1,0.8
SLC24A2,NCKX2,ENSG00000155886,Solute carrier family 24 member 2,Q9UI40,9,19507452-19786928,"Predicted membrane proteins, Transporters","Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,5,brain: 31.8,Group enriched,Detected in some,18,Bipolar cells: 68.2;Cone photoreceptor cells: 257.2;Horizontal cells: 92.2,Cancer enhanced,Detected in some,NA,glioma: 1.5,NA,NA,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Group enriched,Detected in some,6,K-562: 5.7;NTERA-2: 2.0;SCLC-21H: 5.2;U-87 MG: 6.8,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (1.30e-1),unprognostic (8.57e-2),unprognostic (4.20e-1),unprognostic (1.05e-2),unprognostic (3.33e-2),unprognostic (1.48e-2),NA,unprognostic (8.46e-2),unprognostic (8.37e-2),unprognostic (1.27e-1),unprognostic (1.50e-2),unprognostic (6.51e-2),unprognostic (1.57e-2),unprognostic (2.08e-4),unprognostic (1.58e-1),unprognostic (2.11e-3),unprognostic (1.51e-2),0.2,6.1,4,0.2,11.2,0.3,0.1,2.4,31.8,0.2,0.2,NA,NA,0.2,0.5,0.2,0.2,0.2,0.3,0.2,8.9,4,0.3,0.2,0.1,0.2,8.2,NA,0.2,0.2,0.2,0,0.3,NA,0.2,0.2,NA,0.2,0.2,0.2,0.3,0.2,0.2,10.7,0.2,0.2,0.4,NA,NA,0.2,NA,0.1,0.2,0,1.2,1,2.6,1.3,1.7,1.1,0.4,0,0,0,0,0,0,0.1,0,0,0,0,0.1,0.1,0.1,0,0,0,0.1,0,0,0,0.1,0.1,0,0.2,0.1,0,0.1,0.1,0.4,0,0,0,0.1,0,0,5.7,0.2,0.1,0.3,0,0.1,2,0.3,0.1,0.1,0,0,0,0.1,5.2,0.8,0,0,0,0.1,0,0,0.1,0.1,0.1,0.5,0,0.2,0,0,6.8,0,0.1,2.6,0.8,0.9,0.7,0.8,1,0.9,0.8,0.6,0.5,1.2,1.1,1,2,1.7,1.3,1,0.8,0.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,68.2,1.7,0,0,0,0,257.2,0,0,0,0.9,0,0,0,0,0.1,0.8,0,0,0,0.1,92.2,0,2.5,0,0,0,0,0,0,0,2.3,0,0,0.4,0,7.7,0,0,0.2,0.2,0.1,0.2,0,0,0
SLC24A4,NCKX4,ENSG00000140090,Solute carrier family 24 member 4,Q8NFF2,14,92322581-92501483,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport",NA,"Amelogenesis imperfecta, Disease mutation",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,blood: 11.6;brain: 28.1,Group enriched,Detected in some,8,Bipolar cells: 223.9;Cone photoreceptor cells: 188.5,Group enriched,Detected in some,5,glioma: 0.5;melanoma: 0.8,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in some,4,classical monocyte: 7.9;intermediate monocyte: 11.6;non-classical monocyte: 9.4,Lineage enriched,Detected in many,5,monocytes: 11.6,Cell line enhanced,Detected in some,NA,Daudi: 2.7;SCLC-21H: 5.2,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,HPA063206,NA,NA,Approved,Plasma membrane,NA,NA,NA,NA,NA,Plasma membrane,NA,HPA063206:,unprognostic (1.53e-1),unprognostic (1.41e-1),unprognostic (2.22e-1),unprognostic (1.18e-1),unprognostic (1.06e-1),unprognostic (3.43e-3),unprognostic (1.34e-1),unprognostic (2.04e-3),unprognostic (3.40e-2),unprognostic (1.32e-1),unprognostic (2.48e-3),unprognostic (3.21e-1),unprognostic (1.48e-3),unprognostic (1.25e-1),unprognostic (1.08e-1),unprognostic (1.90e-2),unprognostic (1.58e-2),1.8,1,4.9,3.8,6,8.6,0.6,1.1,11.7,0.8,0.9,9.6,6.3,0.9,0.6,0.7,0.8,0.8,1.9,0.9,4.7,3.2,0.5,0.7,2.3,2.7,10.8,4.7,1,0.6,0.5,1.8,1.2,28.1,0.7,1,4.6,0.7,1.2,2.4,0.8,1.2,1.4,14.2,5,0.9,2.9,5.7,0,0.6,0,1.4,1.5,0.8,0.1,2.3,1.3,11.6,0.2,0.2,2,0.1,0.2,0.1,0.3,0.1,0.1,0.2,0.1,0,0,0,0.1,0.6,2.7,0.1,0,0.1,0.4,0,0,0,0.2,0.7,0.4,0.4,0.2,0,0.2,0.3,0,0.2,0.3,0,0.2,0,0.2,0.1,0.6,0,0.4,0,0.3,1.1,0,0.3,0.1,0.1,0.3,0,0.3,5.2,0,0.2,0.2,0.5,0.1,0.3,1.2,0.6,0.2,1.5,0.3,0.1,0.4,0.1,0.1,0.2,0.3,0.3,0.2,7.9,0,0,11.6,0.2,0,0,0,2.3,0.1,0,0,1.3,0.2,9.4,0.4,0,2,4.9,6,1.1,7.3,4.7,3.2,10.8,4.7,28.1,5.7,0,3.4,0,0.1,0,223.9,1.2,0,1.4,0,0,188.5,0,0,0,3.6,0,0,0,0,0.1,0.2,0,0,0,3.5,0,0,1.8,26.6,4.6,0.3,4,0,0,0,2.1,0.1,0,0.4,0,8.2,0,0,0,0.7,0,0.2,0,0,0.1
SLC24A5,"JSX, OCA6",ENSG00000188467,Solute carrier family 24 member 5,Q71RS6,15,48120972-48142672,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport",NA,Albinism,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,5,retina: 71.9,Cell type enriched,Detected in some,4,Melanocytes: 72.6,Cancer enriched,Detected in single,162,melanoma: 8.0,Low region specificity,Detected in some,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in single,751,SK-MEL-30: 75.0,Group enriched,Detected in some,5,hippocampal formation: 3.3;pons and medulla: 4.4;thalamus: 1.7,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (3.47e-2),NA,NA,NA,unprognostic (1.80e-1),unprognostic (1.35e-1),NA,NA,unprognostic (1.92e-3),NA,NA,NA,NA,0.1,0.1,0.5,0.1,0.6,0.1,0.6,1.5,0.5,0.1,0.1,0.2,0.1,0.2,0.1,0.1,0.2,0.1,0.4,0.1,0.5,1,0.3,0.1,0.2,0.1,1.7,0.1,0.1,0.1,0.1,1.5,0.1,0.4,0.1,0.1,71.9,0.2,0.1,0.1,15.4,0.7,0.1,0.6,0.1,0.1,3,0.4,0.1,0.1,0.2,0.1,0.1,0.1,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0.5,0,0.5,0.6,1.5,0.5,0.5,1,1.7,0.1,0.4,0.4,0,0.3,0,0,2.2,6.1,0.3,0,1.4,0,0,2,0,0,0,16.5,0,0,0,0,0,0.2,0,0,0,0.1,4.8,0,0,0,3.8,0,0,72.6,0,0,0.8,0,0,0,0,4,0,0,0,0.1,0.9,0,0,0,0
SLC8B1,"FLJ22233, NCKX6, NCLX, SLC24A6",ENSG00000089060,Solute carrier family 8 member B1,Q6J4K2,12,113298759-113359493,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Antiport, Calcium transport, Ion transport, Sensory transduction, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA040668,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA040668: AB_10793861,prognostic favorable (9.52e-4),unprognostic (1.58e-1),unprognostic (1.27e-1),unprognostic (4.30e-1),unprognostic (1.93e-2),unprognostic (2.80e-3),unprognostic (1.90e-1),unprognostic (6.52e-2),unprognostic (1.84e-1),unprognostic (2.68e-2),unprognostic (2.60e-1),unprognostic (5.14e-1),unprognostic (1.75e-1),unprognostic (1.54e-3),unprognostic (9.39e-2),unprognostic (1.14e-1),prognostic favorable (5.02e-4),12.6,43.9,7.2,15,9.5,12,11,5.5,7.8,11.8,11.1,9,7.9,7.7,9,10.9,9.3,7.2,10.4,9.2,6.5,3.7,10.6,18.6,12.2,26.2,8.2,4.5,35.1,13.2,5.5,9.3,15.5,7,10,7.5,6.2,10.4,9.6,7.1,11.2,14.1,9.3,9.6,20.8,7.6,13.9,8,29.5,8.2,8.1,14.4,8.4,10.8,3.1,11.4,18.5,14.7,3.3,18.8,8.4,12.4,2.7,1.6,3.6,8.5,5.9,5.4,4,12.6,5.7,5.6,2.9,10.4,3.4,9.4,5.9,4.9,10.1,5.2,3,2.7,7.8,1.5,6.4,6.1,3.1,14.1,16.7,14.4,6,9,6.5,2.8,4.9,13,12.6,13.5,1.7,3.2,2.8,5.1,13.5,2.9,4.3,7.1,1.9,2.2,3.9,6.1,17.7,0.1,2.9,11.8,23.8,2.8,2.4,3.7,6.6,26.9,3.9,4.7,11.2,2.5,2.1,5,2.5,4.9,9.4,3.1,2.4,9.6,18.5,5,14.7,6.4,2.2,9.2,4.9,11.4,3.1,18.8,8.6,6.3,3.3,14.1,8.5,10.9,8.4,7.2,9.5,5.5,7.8,6.5,3.7,8.2,4.5,7,8,11.9,13,4.2,11.4,3.9,1.1,3.3,7.6,4,7.9,12.2,9.8,7.1,5,11.7,1.3,9,25.1,0,15.3,7.2,8.7,13.6,20.8,10.2,20,0,4.7,3.7,16.4,1.3,22.7,20,1.7,15.4,12,3.2,17.9,13.6,26.5,3.2,0.7,32.3,11.3,0.7,3.8,6.1,8.9,7.5,9.3,15.3
SLC25A11,"OGC, SLC20A4",ENSG00000108528,Solute carrier family 25 member 11,Q02978,17,4937130-4940251,"Plasma proteins, Predicted membrane proteins, Transporters",Transport,NA,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,skeletal muscle: 100.8,Low cell type specificity,Detected in all,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA021167,Approved,NA,NA,NA,NA,NA,NA,NA,17000,NA,NA,HPA021167: AB_1857021,unprognostic (8.58e-2),unprognostic (4.06e-3),unprognostic (9.43e-2),unprognostic (2.47e-2),unprognostic (1.75e-1),unprognostic (1.48e-1),unprognostic (1.99e-1),unprognostic (1.03e-1),unprognostic (4.86e-1),unprognostic (9.48e-2),prognostic favorable (6.41e-6),unprognostic (2.84e-1),prognostic favorable (2.84e-9),unprognostic (1.26e-1),unprognostic (1.37e-1),unprognostic (1.70e-2),unprognostic (1.09e-1),11.8,17.5,17.8,11.9,20.8,10.3,11.7,18.2,34.3,11.1,15.7,16.3,10.3,17.3,12.4,10.1,18.9,16.1,14.3,82.1,19.8,17.7,24.2,22.6,10.6,13.3,19.5,16.3,12.1,15.3,16,12.3,13.3,18.7,12,13.7,22.2,16.8,15.6,100.8,16.9,14.6,13,13.8,12.8,12.3,5.2,9.6,17.4,14.6,42.4,14,15.1,10.5,26.9,50.1,39.3,53.9,42.7,32.4,51.4,16.5,44.9,22.9,22.4,22.6,14,16.2,18.8,19.3,33,27.4,28.1,8.3,25.8,25.6,18.3,16.1,33.2,29.7,34,13.1,32.5,37.7,28.3,24.9,24.3,23.1,12.1,34.5,20.1,22.2,29.1,24.7,16,22.8,27.9,12.4,25.1,27.8,29.9,39,12,12,18.4,30.1,35.5,14.1,23.3,25.4,17.4,20.5,21.3,23.7,26.8,21.5,12,24.8,19.3,15.3,14.8,9.7,20,35.9,13.4,8.1,9.7,29.2,20.6,36.4,32.7,53.9,39.3,32.4,53,30,26.9,25.1,28.9,50.1,23,25.3,27.5,35.1,42.7,47.8,33.3,29.1,51.4,17.8,20.8,18.2,34.3,19.8,17.7,19.5,16.3,18.7,9.6,23.8,21.8,25.3,43.8,33.9,56.9,133.9,56,21.4,10.3,62.8,15.7,118,157.5,53.9,10.7,38.3,80.6,23.3,47,120.4,39.9,34.3,39.2,56.3,97.1,44.5,26.5,28.3,40.3,16.2,28.1,40.6,49,141.5,43.6,45,38.7,50.7,36,151.2,45.3,51.8,41.5,14.1,30.9,38.8,85.7,41.5,73,33.1
SLC25A6,"ANT3, ANT3Y, MGC17525",ENSG00000169100,Solute carrier family 25 member 6,P12236,X,1386152-1392724,"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters","Apoptosis, Host-virus interaction, Transport",NA,FDA approved drug targets,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,blood: 85.7,Low cell type specificity,Detected in all,NA,NA,Low cancer specificity,Detected in all,NA,NA,NA,NA,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA046835, HPA071684",Approved,NA,Supported,Mitochondria,NA,NA,NA,NA,7200000,Mitochondria,NA,"HPA046835: AB_2679831, HPA071684: AB_2686431",unprognostic (1.13e-1),unprognostic (1.65e-2),unprognostic (4.79e-2),unprognostic (1.45e-1),unprognostic (2.14e-1),unprognostic (1.41e-1),unprognostic (1.01e-3),unprognostic (1.34e-1),unprognostic (8.07e-2),unprognostic (1.48e-1),unprognostic (1.37e-3),unprognostic (2.51e-1),unprognostic (3.96e-2),unprognostic (2.73e-1),unprognostic (1.69e-1),unprognostic (2.85e-1),unprognostic (4.57e-3),18.5,19.7,12.1,12.2,14,23.7,14.4,8.2,12.2,9.8,16.5,NA,NA,28.9,14.3,4.8,16.4,10.4,7,9.4,10.3,8.2,18.4,5.4,11.1,14.4,9.4,NA,25.6,38.7,10.1,14,8.6,NA,12.4,8.8,NA,45,12.5,6.1,14.9,23.3,7.7,5.8,15.4,19.2,2.4,NA,NA,16.3,NA,9.5,14.2,11.2,62.2,85.7,3.7,69,30.1,43.6,71.2,22.2,48.7,34.6,35.3,24,46.8,37.5,34.1,32.7,25.2,25.1,64.4,27.2,82.8,27.6,22.4,38,14.5,23.2,40.7,7.9,20.7,73.8,45.2,33.4,73.5,56.3,32.5,55.2,77.2,75,19.7,29,32.7,37.3,26.1,31.5,19.5,24.6,47.4,60.1,62.3,43.9,8.8,65.7,30.4,28.6,64.2,30.7,56,56.6,88.9,23.1,70.1,97,21,38.9,67,42.7,25.7,14.4,50.2,34,50.6,8.1,55.8,3.8,31.4,13.9,2.4,58.1,3.7,29.4,69,43.6,62.2,40.4,34.8,85.7,47.5,38.1,37.2,3,30.1,67.9,41,38.7,71.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,137,195.3,871.5,1042.4,1022.6,282.9,87,257.4,128.5,280.9,300.1,92.3,1322.2,1405.9,633,8.9,418,863,303.7,1275.3,963.9,807,855.9,337,132.8,1090.5,228.8,892,411.9,1235.3,26.5,618.4,976.3,715.3,1354.4,1107,100.8,835,866.6,344.4,1021.3,199.6,336.3,860.1,13.3,52.8,1155.2,1458.6,553.5,1380,1328.6
SLC25A21,"ODC, ODC1",ENSG00000183032,Solute carrier family 25 member 21,Q9BQT8,14,36678431-37172866,"Predicted intracellular proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,testis: 25.6,Cell type enriched,Detected in many,11,Erythroid cells: 93.5,Not detected,Not detected,NA,NA,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,4,K-562: 15.5;Karpas-707: 34.0,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA000662,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA000662: AB_1080000,unprognostic (6.81e-3),unprognostic (6.98e-2),unprognostic (7.21e-2),unprognostic (2.45e-1),unprognostic (2.78e-2),unprognostic (2.20e-1),unprognostic (2.44e-2),unprognostic (1.09e-1),unprognostic (7.32e-2),unprognostic (6.86e-2),unprognostic (9.16e-2),unprognostic (1.66e-1),unprognostic (6.70e-4),unprognostic (9.09e-3),unprognostic (1.95e-2),unprognostic (3.52e-1),unprognostic (1.07e-1),1.3,2.1,1.1,1,2,8.8,1.4,0.4,2.5,3,1.9,0.7,0.1,1.1,4,1.4,2.9,1.8,1.2,2.2,1.1,1.4,2.8,1.1,1.9,0.1,1.4,0.7,4.6,5.2,0.9,1.8,0.4,1.7,3.1,0.4,3.6,2.9,0.9,9.6,0.9,2.4,3,1.2,0.9,2.6,25.6,1,0.2,3.3,2.2,1.3,1.3,1.4,0,0,0,0,0,0.3,0.1,0.8,0.7,0.2,2,0,0.6,0,0.3,0.5,1,0.4,0.1,0.7,0,0.9,0.2,0,0.7,0,0.4,0.4,0.5,5.9,0.6,0.6,0.6,0.6,0,0,0.5,0.8,0,0.3,0.6,2.4,0,15.5,34,0.5,1.8,0,0,1.3,0,2.5,0,0,0,0.5,2.4,1.5,0,1.6,0.1,0.8,0.3,2.2,0,1.1,0,1,0,0,0.1,0,0,0,0,1.6,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0.1,1.1,2,0.4,2.5,1.1,1.4,1.4,0.7,1.7,1,0,0,0,1.7,0.9,0,1,0,0,0,0,0,0,1.7,0.7,1,0.4,0,93.5,8.3,0,0.8,2.3,0,0,0.2,1.6,1.7,1.3,0,0,1.4,0,0,0,0.2,3.4,5.4,0,0.7,3.1,1.5,0,1,3,2.1,0.6,0,0,0.8,0.6
SLC25A30,NA,ENSG00000174032,Solute carrier family 25 member 30,Q5SVS4,13,45393316-45418455,"Predicted intracellular proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,heart muscle: 38.0;skeletal muscle: 43.1,Cell type enhanced,Detected in many,7,Cardiomyocytes: 39.7;Hepatocytes: 38.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,HPA045260,NA,NA,Approved,Nucleoplasm,NA,NA,NA,NA,NA,Nucleoplasm,NA,HPA045260: AB_10962505,unprognostic (9.23e-2),unprognostic (9.92e-2),unprognostic (1.05e-1),unprognostic (4.28e-2),unprognostic (1.96e-1),unprognostic (2.63e-1),unprognostic (1.35e-2),unprognostic (3.16e-1),unprognostic (3.50e-2),prognostic unfavorable (3.32e-4),unprognostic (5.69e-2),unprognostic (1.58e-1),prognostic favorable (9.91e-8),unprognostic (2.24e-1),unprognostic (5.19e-2),unprognostic (4.12e-1),unprognostic (6.19e-3),7.7,6.3,6.2,4.7,5.7,5.3,7.1,3.6,6.3,6.5,4.2,2.1,9.7,2.5,7.7,7.2,5.3,3.9,4.5,38,5.8,3.8,24.6,19.5,5.9,9.3,5.4,4.3,10.8,7.5,2.4,5.7,3.4,8.1,8,3.5,9.5,6.8,9.1,43.1,4.4,3.5,9.4,7.6,6.1,4,5,4.9,1.2,6.5,6.7,4.4,6.6,9,1.6,5.3,4.3,3.4,1.7,2.7,1.1,2.3,5.1,3,13.1,15.4,9.8,1,10.9,6.4,9.5,5.7,5.3,6.3,0,9.6,11.1,7,4.5,7,11,11.3,7.6,5.7,8.6,3.3,14.1,9.1,12.3,11.7,6.4,7.5,13.9,10.4,11.2,16.4,8.7,5.2,0,19.1,2.7,4.5,8.5,4.5,2.7,6.5,11.2,5.1,4.5,20.5,1.9,0.6,3.1,6.1,9.4,8.7,5.5,7.3,16.6,6,8.9,5.1,9.8,7.5,2.3,4.5,0.1,9.7,11.7,13.6,0,2.8,4.3,2.2,3.4,1.5,1.6,2.2,2.2,4,1.5,2.7,1.2,0,1.7,1.5,5.3,0.8,1.1,6.2,5.7,3.6,6.3,5.8,3.8,5.4,4.3,8.1,4.9,6,2.1,1.5,1.9,11.4,1.7,39.7,10.2,0,1.2,14,3.9,0.7,19.9,2.2,7.6,4.1,1.4,0,1.2,0.8,2.2,2.8,4.7,38.9,3.7,0,2.4,7.4,10,2.3,4.6,5.9,5,6.4,3.9,0.8,2.4,0,6,22.1,1.1,6.5,2.2,0,1.4,5.4,0.5,4.4,3.3,1.1
SLC25A33,"BMSC-MCP, MGC4399, PNC1",ENSG00000171612,Solute carrier family 25 member 33,Q9BSK2,1,9539482-9585179,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,9,Early spermatids: 318.7;Late spermatids: 434.0;Spermatocytes: 229.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,NA,basophil: 6.1,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA049982,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA049982: AB_2680981,unprognostic (1.61e-1),prognostic favorable (4.86e-4),unprognostic (2.94e-2),unprognostic (4.80e-2),unprognostic (1.89e-1),unprognostic (6.75e-2),unprognostic (5.18e-2),prognostic favorable (7.02e-4),unprognostic (1.88e-3),unprognostic (1.07e-1),unprognostic (8.59e-2),unprognostic (2.77e-1),unprognostic (4.55e-3),unprognostic (7.27e-2),unprognostic (1.19e-1),unprognostic (4.25e-2),unprognostic (3.77e-2),14.6,5.3,11.3,3.8,15.3,11,13,8.4,20.6,4.1,6.6,6.5,3.5,3.4,4.6,18.9,4.5,3.5,5.6,6.1,9.4,12.2,13.9,15.1,6.1,4.6,15.1,8.7,3.3,8.5,4.5,6.4,2.3,12.6,6.3,5.6,10.5,7,3.8,16.8,2.6,3.4,4.1,10.4,3.3,4.7,16,7,4.2,7.6,2.8,5.1,4.1,2.5,2,1.6,6.1,1.1,1.3,1.9,0.4,4.4,2.1,5.9,9.1,4.8,2.8,3.8,4.3,4.1,7.3,6.5,4.6,3.5,12.9,5.3,3.5,7.7,1.9,14.8,2.9,9.1,9.9,9.3,12.7,3,17.9,10.5,12.6,10.1,3.3,5.1,7.3,3.5,1.8,4.3,9.7,12.3,6.8,4.1,4.6,7.9,8.7,7.3,8.2,4.9,10.8,6.2,8.3,4.6,2.5,10.3,6.7,4.9,15,12.7,5.4,5.5,9.3,1.9,4.7,6.1,6.2,5.5,8.1,14.9,21.9,3.4,14.1,5.6,6.1,0.9,0.3,1.5,1.1,1,2,1.1,0.9,1.6,1,1.9,1.9,1.3,1.3,1,1.5,0.2,0.4,11.3,15.3,8.4,20.6,9.4,12.2,15.1,8.7,12.6,7,3,12.5,21.1,88.7,45.7,12.9,6.9,28.1,6.7,6.8,8.7,49.1,10.2,169.1,11.4,318.7,15.5,10.2,0,13,34.4,13.9,74.4,24.1,53.3,18.4,9.5,63.7,9.8,7.2,434,9.2,21.8,30.4,10,22,142.8,9.5,8.6,9.6,19.9,46.4,6.5,36,229.6,117.3,31.2,32.8,12.1,24.7,85.3
SLC25A34,DKFZp781A10161,ENSG00000162461,Solute carrier family 25 member 34,Q6PIV7,1,15736405-15741396,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enhanced,Detected in many,NA,intestine: 38.8;skeletal muscle: 22.2,Cell type enhanced,Detected in many,13,Enterocytes: 16.0;Paneth cells: 5.3,Low cancer specificity,Detected in many,NA,NA,Region enriched,Detected in many,5,cerebellum: 10.4,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,SK-MEL-30: 7.4,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA069806,NA,NA,Approved,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,HPA069806: AB_2686202,unprognostic (2.06e-1),unprognostic (4.72e-1),unprognostic (1.15e-1),unprognostic (2.43e-1),unprognostic (2.58e-1),unprognostic (8.08e-3),unprognostic (1.98e-2),unprognostic (9.92e-2),unprognostic (1.55e-1),unprognostic (1.55e-1),unprognostic (1.80e-4),unprognostic (5.74e-2),unprognostic (6.10e-2),unprognostic (4.02e-1),unprognostic (1.82e-1),unprognostic (4.04e-2),unprognostic (2.40e-4),2.5,2.4,1.2,0.9,1.9,2.8,0.7,10.4,1.8,1.1,25.9,0.8,0.5,13.5,1.7,1.4,1.6,1.3,3.6,13.3,1.5,1.2,7.3,3.9,1.1,1.1,0.7,1.8,2.4,18.6,0.6,2.1,1.2,1.5,1.1,1.9,3.7,11.1,0.8,22.2,0.8,38.8,1,1.1,1.9,1.4,2.3,1.2,0.5,1.9,11,1.9,0.7,1.1,0.7,0.5,2,0.5,2.2,4.1,1.1,0.7,0.5,3.5,1.6,1.7,0.7,1.5,0.5,0.3,0.8,0.6,1.4,1.9,0.9,0.8,0.7,1.8,0.7,0.6,0.6,0.8,1.2,0.7,1.5,1.1,0.5,0.6,0.4,2.2,0.8,2.7,1,0.5,2.2,0.4,4.6,0.6,3.2,0.6,1.8,3.7,2,2.9,0.4,1,1.9,3.1,1,0.3,0.1,0.7,2.8,0.8,1,7.4,3.4,1.9,2.5,1.7,1.7,2.2,2.3,0.6,3.8,3.5,0.7,0.6,2.2,1.4,1.2,0.5,0.4,1.4,0.2,3.1,0.5,3,2,0.2,0.7,4.1,2.3,2,2.2,0.2,0.5,1.3,1.1,1.2,1.9,10.4,1.8,1.5,1.2,0.7,1.8,1.5,1.2,0,0,0,0.3,0.2,2.5,0.7,0,0,0,0,0,0.2,0,0.2,0.3,0.7,16,0,0.2,0.2,0.7,0.3,0,2.1,1.2,3.2,3.4,2.5,2.6,0.4,0.9,0.1,0,1.8,2.4,1.7,0.2,5.3,0.4,3,1.4,0,0.9,0.5,0.6,0.1,1.1,0,4.1,0.4
SLC25A35,FLJ40217,ENSG00000125434,Solute carrier family 25 member 35,Q3KQZ1,17,8287763-8295343,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,placenta: 44.4,Cell type enhanced,Detected in many,7,Spermatocytes: 27.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA051720,Uncertain,NA,Approved,"Vesicles,Mitochondria",NA,NA,NA,NA,NA,"Vesicles, Mitochondria",NA,HPA051720: AB_2681584,unprognostic (4.73e-2),unprognostic (1.36e-3),unprognostic (1.21e-2),prognostic favorable (3.37e-7),unprognostic (1.61e-2),unprognostic (1.20e-1),unprognostic (3.52e-2),unprognostic (5.27e-2),unprognostic (2.58e-1),unprognostic (8.30e-2),unprognostic (8.96e-3),unprognostic (1.18e-1),prognostic favorable (1.14e-6),unprognostic (5.31e-3),unprognostic (2.34e-1),unprognostic (1.00e-1),prognostic favorable (1.91e-5),6.8,8.2,4,10.2,8.3,7.4,8.1,2.6,6,13,7.2,11.1,18.2,8.3,14.1,11.6,5.3,8.6,7.5,4.4,8.2,3.7,14.4,4.4,7.2,8.2,8.9,5.2,3.4,9.6,6.6,12.9,44.4,9.2,8.2,7.9,11.3,6.2,24.9,3.4,4.2,7.2,6,9.7,9.4,9.8,20.2,7.2,9,9.1,4.1,7.1,7.2,4.6,3.8,7.2,9,11.1,3.2,5.6,2.9,4.5,12.5,2.1,9.4,7.2,2.8,5.2,2.9,2.7,3.3,3.6,1.5,11.7,5.2,3.1,3.4,6.7,10.1,2.7,3.6,1.8,2.8,3.3,4.4,9.2,1.8,2.7,0.5,11.9,5.9,2.1,6.2,1.1,2.3,5.1,6.1,1.2,1.8,2.7,2.5,4.7,2.4,0.7,3.1,4.2,5.1,1.5,2.3,2.5,11.6,1.1,2.8,8.6,5.2,3.7,2.3,11.6,3.3,6.7,2.2,1.7,5.3,2.5,4,2.4,1.8,5.7,7.8,5.6,4.5,7.3,9,5.5,11.1,4.3,2.6,4.8,5.6,7.2,3.8,1.7,3.5,1.4,3.2,7.8,3.6,4.9,2.9,4,8.3,2.6,6,8.2,3.7,8.9,5.2,9.2,7.2,0,4.8,5.4,1.5,0.7,3.7,1.2,2.5,0,1.2,10.4,7.9,7.3,10,2.4,2.4,2.2,2.5,0,6.2,2,1.3,1.8,4.7,2.4,5.9,1.6,8.6,2.5,3.7,3.6,1.4,2.7,0,8.2,2.7,6.8,2.6,3.1,1.1,5.7,8.9,0,0.7,27.9,0.7,0.3,14.5,3.8,3,1.1
SLC25A37,"HT015, MFRN, MFRN1, MSCP",ENSG00000147454,Solute carrier family 25 member 37,Q9NYZ2,8,23528805-23575463,"Predicted intracellular proteins, Transporters","Ion transport, Iron transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,bone marrow: 88.8,Cell type enriched,Detected in all,5,Erythroid cells: 3550.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enriched,Detected in many,18,neutrophil: 28.9,Lineage enriched,Detected in many,18,granulocytes: 28.9,Cell line enhanced,Detected in many,NA,HEL: 47.7;hTERT-RPE1: 27.9,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,HPA045680,Uncertain,NA,Approved,"Mitochondria,Cytosol",NA,NA,NA,NA,NA,Mitochondria,Cytosol,HPA045680: AB_10963693,unprognostic (6.15e-3),unprognostic (7.33e-3),unprognostic (2.04e-1),unprognostic (1.40e-1),unprognostic (1.38e-1),unprognostic (5.12e-2),unprognostic (1.35e-1),unprognostic (1.68e-1),unprognostic (3.58e-2),unprognostic (1.40e-1),unprognostic (1.02e-2),unprognostic (2.24e-1),prognostic unfavorable (4.37e-6),unprognostic (8.27e-2),unprognostic (1.71e-1),unprognostic (2.37e-1),unprognostic (7.40e-2),8.2,18.3,5.8,13.7,8.3,88.8,13.1,4.2,8.2,13.4,16.4,6.5,11.7,39.7,10.3,6.8,8.2,9.5,8.5,16.8,6.2,5.2,9.4,11.8,25.7,18.5,12.2,5.1,17.2,14.8,15.6,8.8,23.9,10.3,17.1,5.8,7.9,21.1,17.4,13.8,7.6,17.6,7.9,10.2,28.7,8,15,8.6,1.9,9,5.9,5.7,13.9,33,1.2,1.4,28.9,1.6,0.7,1.2,0.8,3.8,4.2,4.5,4.1,5.9,7.3,6.6,3,3.9,2.2,2.5,4.1,8.2,6.2,3.7,2.5,14.5,4.9,4.1,8.2,3,1,2.2,47.7,7,1.4,4.9,2.7,1.9,6.2,8,4.8,4.8,27.9,3.4,5,10.5,3.1,3.5,1.6,3.2,11.3,2.3,4.7,3.3,3.3,2.2,2.4,6.8,2.1,1.4,1.9,4.1,6.4,3,4.4,1.8,4.1,5.5,10.9,1.6,6.4,5.8,2.5,0.9,3.9,10.2,6.5,6.8,0.6,1.6,1.4,0.6,0.6,0.6,1.2,0.4,0.3,1.4,0.8,1.2,0.7,28.9,0.7,0.8,0.4,0.7,0.8,5.8,8.3,4.2,8.2,6.2,5.2,12.2,5.1,10.3,8.6,35.7,79.2,39.5,104.8,82.9,35.3,31.5,48.4,21.4,84.2,73.3,64.8,32.1,13.3,81.9,645.6,82.4,66.7,3550.9,197.4,63.8,90.2,258.9,35.8,34.3,36.1,6.4,19.5,100.7,50.6,772.4,48.6,101.8,65.8,8.2,33.2,41.6,177.5,34.5,35,24.5,60.7,19.4,95.7,12.5,47.1,47,15.3,22.7,43.1,139.3
SLC25A40,MCFP,ENSG00000075303,Solute carrier family 25 member 40,Q8TBP6,7,87833568-87876357,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,4,Kupffer cells: 32.8,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA055197,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA055197: AB_2682735,unprognostic (4.19e-2),unprognostic (1.01e-1),unprognostic (7.30e-2),unprognostic (2.15e-1),unprognostic (8.80e-2),unprognostic (4.03e-2),prognostic unfavorable (1.93e-4),unprognostic (3.73e-1),unprognostic (3.51e-2),unprognostic (3.45e-2),unprognostic (1.83e-1),unprognostic (5.78e-2),prognostic favorable (1.52e-5),unprognostic (8.42e-2),unprognostic (2.45e-1),unprognostic (2.88e-2),unprognostic (4.85e-2),8.2,12.1,13.8,12.5,20.5,10.8,13.1,19.8,26.3,10,12.3,12.4,5.9,10.2,11.1,10.2,10.4,10.2,8.7,14.7,13.3,17,13.4,10.4,12.6,15.3,17.1,15.4,14.4,9.3,13,15.9,5.8,28.2,14.4,15.7,10,11.1,8.9,9,12.7,11.1,8.5,13.5,14.8,11,9.2,11.3,20,11.4,6.6,15.1,9.8,9.7,2.6,5.9,9.3,5.8,6.3,3,2.4,11.4,3,9.6,3.7,3.9,6.3,2.8,8.3,7.3,6,8.8,2.6,16.4,13.5,5.4,4.1,9.6,5,4.6,4.7,8.7,8.5,2.3,7.1,6.9,3.2,3.8,17.2,9.6,3.8,3.4,5.4,4.3,5,6.4,10.9,7.7,20,10.2,4.9,19.9,14.5,4.4,9.5,3.5,9.9,12.2,11.8,8.7,6.2,4.7,11.3,10.6,10.5,7.9,8.1,5.1,13.6,4.4,10.3,7.7,16,7.8,11,12,17.5,7.2,21.2,21,9.3,5.4,7.1,1.9,5.8,3,2.6,2.7,2.6,5.9,2.6,3,2.7,3,6.3,5.8,1.5,3,2.4,13.8,20.5,19.8,26.3,13.3,17,17.1,15.4,28.2,11.3,3,4,12.3,4.7,6.6,4.5,12.6,17.8,2.7,7.9,7,9.8,7,13.3,3.2,8.4,4.5,5.1,0,3.5,6.6,4.7,5.3,4.7,6,10.2,3.2,2.9,7.4,32.8,2.9,7.2,14.5,20.3,1.8,10,3.3,5.6,10.8,10.3,6.8,4.2,12.9,2.6,6.5,4.9,6.9,3.1,6.9,9,4.2
SLC25A41,"APC4, FLJ40442, MGC34725",ENSG00000181240,Solute carrier family 25 member 41,Q8N5S1,19,6426037-6433779,"Predicted intracellular proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,10,brain: 8.1;testis: 26.5,Cell type enriched,Detected in some,8,Early spermatids: 91.3,Not detected,Not detected,NA,NA,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,HaCaT: 2.3;HMC-1: 7.1;K-562: 2.1;U-937: 4.2,Low region specificity,Detected in single,NA,NA,NA,NA,NA,NA,HPA043591,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA043591: AB_10964585,unprognostic (1.87e-3),unprognostic (2.52e-3),unprognostic (6.81e-2),unprognostic (8.75e-2),unprognostic (2.67e-1),unprognostic (8.29e-4),unprognostic (4.43e-3),unprognostic (2.81e-2),unprognostic (9.26e-2),unprognostic (6.85e-2),unprognostic (2.19e-3),unprognostic (3.11e-2),unprognostic (2.03e-1),unprognostic (1.56e-1),unprognostic (3.63e-2),unprognostic (2.11e-1),unprognostic (1.24e-1),0.3,0.2,2.4,0.3,6.3,0,0.5,8.1,3.2,0.3,0.5,0.3,0.3,0.4,0.3,0.8,1.7,0.4,0.3,1.6,2.6,1.3,0.3,0.3,0.3,0.3,0.6,0.3,0.3,0.3,0,0.3,0.3,0.3,0.3,0,0.3,0.5,0.9,1.3,1.2,0.3,0.5,0.6,0.3,0,26.5,0.3,0.3,0.4,0.3,0.3,1.3,0.3,0,0,0,0,0,0,0,0.5,0.3,1.1,0.4,0,0,0.7,0,0,0.4,0.2,0,0,0.3,0.4,0,0,2.3,1.6,0,0,0,1.4,0,0,0,0,0,7.1,0.7,1.7,0,0,0.4,0,0.4,2.1,0,0,0.9,0,1.7,0,0,1.4,0.1,0,0,0.1,0,0,0.2,0.4,0,0,0,0.4,1.7,0,0,0.5,0,0,0,0,0.6,0,4.2,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.4,6.3,8.1,2.7,2.6,1.3,0.6,0.3,0.3,0.3,0,0,0,0.1,0,0.3,0.4,0,0,0,0,2,0.4,0,0.2,91.3,0,0.1,0,0,0.1,0.2,0.3,0,0,0.1,3.2,0,0,0,11.5,0.9,0,0,0,0.1,0.9,0.4,0,0,0.1,1.2,0,0,0.2,0.2,0.3,0.5,0,0.2,0.1
SLC25A42,MGC26694,ENSG00000181035,Solute carrier family 25 member 42,Q86VD7,19,19063999-19112888,"Predicted membrane proteins, Transporters",Transport,NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,liver: 42.3,Cell type enhanced,Detected in many,9,Bipolar cells: 68.0;Hepatocytes: 44.5;Rod photoreceptor cells: 42.5,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in many,5,gdT-cell: 5.1;MAIT T-cell: 2.8;memory B-cell: 6.2;memory CD4 T-cell: 2.9;memory CD8 T-cell: 4.3;naive B-cell: 5.1;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.8;NK-cell: 2.8;T-reg: 2.9,Group enriched,Detected in many,6,B-cells: 6.2;NK-cells: 2.8;T-cells: 5.1,Cell line enhanced,Detected in many,NA,K-562: 17.5,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,HPA049449,Approved,NA,Supported,Mitochondria,NA,Yes,No,NA,NA,Mitochondria,NA,HPA049449: AB_2680772,unprognostic (2.27e-1),prognostic favorable (5.04e-4),unprognostic (5.79e-2),unprognostic (5.67e-2),unprognostic (1.35e-1),unprognostic (3.42e-3),unprognostic (1.27e-3),prognostic favorable (4.11e-4),unprognostic (6.89e-2),unprognostic (2.73e-1),unprognostic (1.37e-3),unprognostic (3.04e-2),unprognostic (5.29e-3),unprognostic (1.76e-1),unprognostic (2.39e-2),unprognostic (4.17e-2),unprognostic (2.03e-2),4.8,5.7,13.8,4.5,12.2,7.5,4.9,22.5,15.4,7,4.8,5.9,4.5,5.7,6.8,4.4,4.5,7.4,4.7,8.9,9.7,7.8,26.7,42.3,5.4,8.5,5.9,7.8,13.8,7.4,6.5,9.6,3.2,7.9,7.6,3,12.2,11,6.3,26.7,5.2,5.6,5.7,6.1,7.3,4.6,4.5,8.1,6.6,17.1,7.3,12.2,5.5,5.4,6.2,0.7,0.2,0.6,2.8,5.1,1.5,6.2,0.8,1.6,2.8,6.1,5.1,2.5,3,4.6,4.7,5.4,1.2,12.5,4.5,7.1,2.8,4.7,1.1,3.2,2.5,2.7,1.1,6.2,1.5,1.7,10,4.9,0.7,3.2,5.1,1.8,3.6,2.2,3.8,2.1,14.7,17.5,8.1,2.5,5.6,7.5,7.1,0.9,1.7,6.5,5.8,2.8,8.6,1.8,1.1,1.8,1.3,3.2,0.1,1.3,2.2,5.7,3.5,1.9,3.5,2,7.3,2.9,9.4,5.1,3.5,3.7,9.6,1.8,0,0.2,0.2,5.1,0.5,2.8,6.2,2.9,4.3,0.3,5.1,1.9,2.8,0,2.8,0.6,0.7,2.9,1.5,13.8,12.2,22.5,15.4,9.7,7.8,5.9,7.8,7.9,8.1,0,9.6,8.9,2.4,2.9,68,8.9,2.5,1.4,3.4,8.7,17.7,5.7,11.6,1.4,1.2,3.5,5.4,0,2.7,2.7,3.6,2.6,3.5,44.5,1.5,3.2,8.1,4.3,0.3,0.6,4.6,1.1,3.3,0,4,11.9,1.9,2.9,6,27,42.5,6.5,5.7,7.9,6.4,2.5,3.9,11.4,2.9,1.3
SLC25A44,"FLJ90431, KIAA0446",ENSG00000160785,Solute carrier family 25 member 44,Q96H78,1,156193932-156212796,"Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,8,Early spermatids: 115.9;Late spermatids: 71.2,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in all,NA,neutrophil: 33.8,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA065411,NA,NA,Approved,"Nucleoplasm,Mitochondria",NA,NA,NA,NA,NA,Mitochondria,Nucleoplasm,HPA065411: AB_2685486,unprognostic (1.58e-1),unprognostic (1.78e-1),unprognostic (4.62e-1),unprognostic (2.44e-3),unprognostic (2.75e-1),unprognostic (1.32e-1),unprognostic (5.72e-2),unprognostic (8.92e-2),unprognostic (1.97e-1),unprognostic (3.58e-1),prognostic favorable (2.49e-4),unprognostic (3.37e-2),unprognostic (2.55e-2),unprognostic (2.71e-1),unprognostic (2.67e-1),unprognostic (8.13e-2),unprognostic (2.37e-1),14.3,9,15.9,9.3,23.1,10.2,8.9,18.6,31.9,9.1,10.4,19.7,6.6,16.8,8.1,11.1,9,7.8,10.7,10.6,16.1,16.7,25.9,31.2,10.6,8.7,14.4,18.1,7.1,8.3,17.7,10.9,7.8,22.5,8.7,11.1,9.3,7,9.5,12.8,9.1,13.9,10.8,13.5,13.3,8.4,8.9,12.1,10.6,9.7,6,11.2,9.7,7.9,3.7,6.3,33.8,9.1,4.2,4.9,5.6,10.3,17.7,8.7,11.5,19,10.3,6.8,11.1,16.4,20.3,16.6,17.3,9.4,8.2,9.8,16.6,11,15.5,31.7,13.1,18,9.4,10.6,7.5,11.3,10.4,14.5,9.7,13.8,14.4,11.5,20.5,12.4,9.8,16.4,10.2,7.8,13.6,13.9,18.6,10.1,6.9,20.5,19.8,18.4,6.5,8.8,14,26.5,12.3,13.6,18.3,13,23.6,14.8,16,17.8,15.9,13.2,11.7,9.9,13.1,13.2,14,10.6,12.5,12.9,10.2,11.5,6.5,8.4,8.7,4.7,9.1,4.9,3.7,3.8,4.4,6.3,2.4,3.1,3.7,33.8,4.2,7.1,2.8,3.3,5.6,15.9,23.1,18.6,31.9,16.1,16.7,14.4,18.1,22.5,12.1,11.9,24.8,12.3,4.8,24.6,12.6,30.7,7.6,4,14.8,8.7,19.6,4.3,5,5.4,115.9,11.7,9.2,0,4.9,3.3,17.9,6.1,4.7,29.8,6.5,19.1,5.8,10.4,8.6,71.2,6.6,12.2,11.8,1.8,8.5,7.2,4.9,5.8,5.3,13.9,8.8,19.4,12.2,9.1,7.7,29.7,6.9,7.5,7.5,6.3
SLC25A45,NA,ENSG00000162241,Solute carrier family 25 member 45,Q8N413,11,65375192-65383701,"Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,pancreas: 60.5,Cell type enhanced,Detected in many,5,B-cells: 32.2;T-cells: 35.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,HDLM-2: 13.8;Karpas-707: 18.7;RPMI-8226: 13.6,Low region specificity,Detected in all,NA,NA,Not detected,Not detected,NA,NA,HPA050821,Uncertain,NA,Approved,"Nucleoplasm,Cytosol",NA,NA,NA,NA,NA,Nucleoplasm,Cytosol,HPA050821: AB_2681249,unprognostic (3.73e-2),unprognostic (2.19e-3),unprognostic (8.44e-4),unprognostic (6.17e-3),unprognostic (2.57e-2),unprognostic (2.84e-7),unprognostic (7.57e-3),unprognostic (4.59e-2),unprognostic (1.44e-1),unprognostic (4.06e-2),prognostic favorable (2.83e-4),unprognostic (1.96e-1),unprognostic (1.08e-2),unprognostic (1.45e-1),unprognostic (1.54e-1),unprognostic (6.18e-2),unprognostic (1.43e-1),2.2,1.8,2.1,4,2.3,3.1,3.2,1,2.6,1.7,4.5,4,4.7,4.1,1,5.4,1.5,1.3,1.3,2.8,2.5,1.1,3.9,7.7,5.3,9.4,1.8,2.3,1.3,60.5,4.2,4.7,1.2,2.3,2.5,1.2,3.5,5,1.3,4.1,2,11,1.5,2.3,9.6,1.9,2.4,2,5.8,9,2.8,8.2,1.9,1.7,10.8,19.2,6,10.1,13.5,11.4,2.5,0.3,4.7,0.2,6.9,1.3,0.6,3.5,0.8,2.1,0.4,0.4,1,2.2,4.1,3.9,1.9,1.8,0.6,0.5,0.3,0,13.8,1,4.5,2.5,0.3,0.8,1.4,4.8,1.6,0.1,0.5,0.4,0.4,0.7,8,0.6,18.7,0.7,1.5,3.3,0.1,0.3,0.2,2.2,6.1,0.9,13.6,0.7,0,2.3,3.1,1.4,3.7,0.7,0.4,1.9,0.7,1.3,0.5,1.8,4.5,0.3,7.8,4.9,1.2,1.4,1,2.7,6,5.5,3.9,7.9,9,8.4,8.9,7,7.5,5.7,10.8,11.4,8.5,3.3,13.5,10.1,19.2,6.3,2.5,2.1,2.3,1,2.6,2.5,1.1,1.8,2.3,2.3,2,0,3.5,32.2,5.2,2.5,9,5.5,10.2,17.4,4.5,12.2,0,1.4,0,4.9,5.2,2.9,23.9,0,4.7,1,3.3,7.8,4.6,12.1,6.3,6.4,6.4,7.4,7,3.3,6.4,13.8,5,18,12.9,7.7,4.3,8.6,3.5,6.2,0.3,6.5,2.5,2.3,0.2,1.8,1.3,35.9,7.4,3.5
SLC25A1,"CTP, SLC20A3",ENSG00000100075,Solute carrier family 25 member 1,P53007,22,19175575-19178830,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters",Transport,NA,"Congenital myasthenic syndrome, Disease mutation",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,6,Enterocytes: 221.7;Hepatocytes: 166.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in all,NA,eosinophil: 38.5,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19000,NA,NA,NA,unprognostic (2.12e-1),unprognostic (3.98e-1),unprognostic (8.17e-2),unprognostic (1.13e-1),unprognostic (9.39e-2),unprognostic (2.61e-2),unprognostic (3.11e-2),unprognostic (7.12e-2),unprognostic (1.06e-1),unprognostic (5.74e-2),unprognostic (3.90e-2),unprognostic (5.72e-2),unprognostic (4.52e-2),unprognostic (1.84e-1),unprognostic (3.46e-2),unprognostic (6.14e-2),unprognostic (9.03e-2),42.5,23.6,11.6,16.1,12.8,5.5,59.1,9.1,12.2,14.9,33.8,14.6,17.6,50.1,12.9,16.4,20.2,12.4,25.1,9.2,14,17.6,26.2,60.2,12.2,18.8,15.6,9.1,20.7,25.1,14.8,12.7,15.1,18,19.1,15.4,13.6,19.3,16.3,4.8,14,53.9,13.8,16.6,12,16.1,14.5,13.8,9.9,20.1,13,13.7,14.7,15.2,14.2,5.6,38.5,9.2,4.9,8.4,4,24.8,25.5,20.2,16.8,50,24.9,20.7,19.6,22.4,15.4,21,30.6,17.4,15.1,9.3,25.1,16.4,20.8,19,31.3,8.8,15.1,37.4,7.7,21.7,60.5,35.3,14.6,24.4,34.6,19.2,17.6,13.8,17.2,14.4,12.2,41.1,14.1,17.1,63,9,17.4,13.4,39.2,15.5,16,10.1,6.6,45.6,30.4,12.5,15.9,18.9,36.7,10.5,12.9,27.9,37.9,14,18.7,16.7,14.3,12,18.4,8.9,7.7,19.3,7,9.4,3.6,6.2,38.5,7.3,7.2,4.7,13.4,8.4,7.9,5.6,14.2,7.5,6.3,3.3,4.9,9.2,4.4,7.7,4,11.6,12.8,9.1,12.2,14,17.6,15.6,9.1,18,13.8,8.9,13.9,19.3,22.4,19.6,8.1,6.4,30.6,8.1,9.1,31.4,2,120.4,43.1,27.7,24.4,9.2,221.7,0,39.5,122.5,22.9,31.5,2.3,166.9,41,12.7,39.4,22.1,23.7,72.6,26.7,19.7,27,29.7,90.6,20.4,33.4,101.7,27.6,99.7,3.8,12.9,19.1,17.3,24.7,26.6,106.8,17.5,86.4,25.2
SLC25A10,DIC,ENSG00000183048,Solute carrier family 25 member 10,Q9UBX3,17,81712236-81721016,"Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,liver: 51.8,Cell type enhanced,Detected in many,8,Hepatocytes: 37.7;Late spermatids: 65.6;Proximal tubular cells: 75.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in some,NA,NK-cell: 3.6,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,Hep G2: 50.4;SK-BR-3: 38.8,NA,NA,NA,NA,NA,NA,NA,NA,HPA023048,Supported,NA,Supported,"Nucleoplasm,Mitochondria",NA,NA,NA,NA,NA,Mitochondria,Nucleoplasm,HPA023048: AB_2301950,unprognostic (7.17e-2),unprognostic (2.38e-2),unprognostic (2.36e-2),unprognostic (1.36e-1),unprognostic (9.50e-2),prognostic favorable (2.56e-4),unprognostic (5.66e-2),unprognostic (2.11e-1),unprognostic (1.78e-2),prognostic favorable (8.14e-4),unprognostic (6.73e-2),unprognostic (1.33e-1),unprognostic (6.02e-2),unprognostic (6.32e-2),unprognostic (2.76e-1),unprognostic (2.05e-1),prognostic favorable (1.31e-4),10.2,4.9,2.7,5.9,3.2,5.2,6.3,3.3,5.2,4.2,9.5,3.9,7.5,13.9,1.3,3.8,12.2,5.4,8.2,4.3,2.1,2.5,21,51.8,3.3,4.6,3.7,4.6,2.4,17.4,10.7,2.1,2.1,3.5,5.6,4.4,4.7,16.8,6.6,2,5.9,11.2,1.8,4.7,1.6,7.4,21.8,2.5,7.8,3.3,7.7,8.7,4.3,3.4,0.9,0.7,0,1.2,3.6,1.9,0.7,14.2,26.4,2.5,12.6,0.9,0.7,5,6,2,7.8,5.9,16,6.1,6.4,4.7,1.4,3.8,9.2,3.6,6.3,1.4,4.7,20.4,5.2,16.1,50.4,1.1,11.7,6.4,0.5,3.3,5.5,1.1,1.5,4.5,9.1,8.7,8.1,2.6,26.8,17.1,12.4,2.6,6,19.9,13,5.4,20.2,6.9,12.9,16.7,11.3,5.7,38.8,1.3,0.7,16.6,6.5,1.9,6,19.8,8.7,11,5,2.5,3.7,2.6,12.4,5.2,0,0.9,0,0.8,1.2,1.5,0.1,0.5,1.9,0.7,0.9,0.5,0.4,0,3.6,0.2,0.4,1,0.7,2.7,3.2,3.3,5.2,2.1,2.5,3.7,4.6,3.5,2.5,0,2.1,0,5.5,0,2.9,3.3,17.8,13.4,5.7,14,0,11.3,21.6,15.4,23.8,0.5,9.3,0,20.3,4.7,0.9,3.9,0,37.7,6.8,0,4.7,3.1,0.3,65.6,2,0.3,0,1,15.4,1.5,9.6,24.6,1.8,75.1,3.8,0,0.2,8.4,2.3,0,3.5,1.5,28.8,4.3
SLC25A12,Aralar,ENSG00000115840,Solute carrier family 25 member 12,O75746,2,171784370-171999859,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters",Transport,NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,skeletal muscle: 84.7,Cell type enhanced,Detected in many,8,Cardiomyocytes: 94.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA035333, HPA035334",Enhanced,NA,Uncertain,"Nuclear speckles,Cytosol",NA,NA,NA,NA,NA,Nuclear speckles,Cytosol,"HPA035333: AB_10603028, HPA035334: AB_2674577",unprognostic (3.24e-2),unprognostic (2.52e-2),unprognostic (4.07e-2),prognostic unfavorable (7.86e-4),unprognostic (2.65e-2),unprognostic (7.27e-2),unprognostic (4.21e-3),unprognostic (5.23e-2),unprognostic (1.39e-1),unprognostic (4.96e-2),unprognostic (7.76e-2),unprognostic (1.13e-1),prognostic favorable (2.91e-8),unprognostic (8.64e-3),unprognostic (2.08e-1),unprognostic (1.73e-1),unprognostic (2.70e-1),6.4,6.7,8.8,6.2,18.2,2.9,9.2,17.9,25,10.6,12.2,5.7,5.2,4.2,10.4,7.1,11.5,6.9,5.9,42.4,9.9,13.4,10.7,1.9,5.2,6.5,10.4,12.4,10,3.5,16.4,14.7,4.7,15.2,10.6,10,11,21.7,14.8,84.7,7.6,5.7,14.3,7.1,5.6,9,4.3,6.2,5.8,10.1,23.8,8.4,10,6.7,6.4,3.6,5.1,4.6,6.6,8.1,2.9,7.2,5.3,5.6,13,16.7,18.9,0.1,9.2,15.7,12.6,12.1,2.8,6.8,22.9,6.1,10.8,9.8,9.1,11.8,11.6,15.8,14,11.1,10,7.7,6.7,6.4,20,10,16.5,11.5,14.6,4.2,6.8,13,9.1,6.9,10.5,8,4.4,14.1,8.4,4.5,6.1,7.5,14.7,8.1,11.9,13.2,6.3,7.9,2.5,5.8,13.7,7.3,3.8,5,5.9,8.9,10.5,4.6,11.6,6.3,14.2,9.1,23.2,14.5,10.6,7.1,5.1,3,1.6,6.5,3.9,7.3,6.4,4.5,6.8,3.6,3.9,6.3,8.1,0.2,6.6,4.6,0.6,4.5,2.9,8.8,18.2,17.9,25,9.9,13.4,10.4,12.4,15.2,6.2,0,6,1.5,11.2,6.2,25.4,94.4,0,13.4,22.7,17.4,23.6,6,16.6,1.5,2.5,7,5.6,23.3,2.9,1.2,7,4.3,10.4,0.2,4,35,13.8,8.6,7.3,1.7,11.5,5.4,15.1,6.4,7,18.3,1.3,3.5,23,10.9,22.1,12.9,11.8,3.2,9,6.8,1,8.7,7.4,4.6
SLC25A13,"ARALAR2, CITRIN, CTLN2",ENSG00000004864,Solute carrier family 25 member 13,Q9UJS0,7,96120220-96322147,"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters",Transport,NA,"Disease mutation, Intrahepatic cholestasis",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,liver: 79.1,Cell type enhanced,Detected in many,6,Hepatocytes: 124.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,HPA018997,Enhanced,NA,Supported,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,HPA018997: AB_1857023,unprognostic (3.61e-2),unprognostic (7.99e-2),unprognostic (6.99e-2),unprognostic (7.19e-2),unprognostic (1.14e-1),unprognostic (3.44e-2),unprognostic (1.42e-2),unprognostic (6.67e-2),unprognostic (2.31e-2),unprognostic (5.46e-2),unprognostic (1.01e-1),unprognostic (6.99e-2),prognostic favorable (9.14e-4),unprognostic (1.15e-1),unprognostic (1.05e-1),unprognostic (3.32e-1),unprognostic (7.09e-2),7.7,10.3,4.2,4.9,11.8,4.1,6.7,3,7.5,5.4,12.5,21.1,15.6,8.9,5.1,8,6.9,5.9,6.7,4.5,5.6,5.3,17.7,79.1,5.5,4.9,14.5,4.8,5.9,7.3,8.2,8.8,8.9,12.4,5.9,10.2,12.6,5.7,17.3,4.6,8.2,9.7,5,13.1,7.2,7.9,4.3,12.6,1.8,7.9,3,4.8,5,5.3,3.7,8.9,3.1,6.7,2.8,2.4,2.1,16.1,14.3,16.5,5.7,2.8,2.3,23.2,4.1,3.1,10,10.1,25.6,15.2,7.3,19.6,2.6,21.8,9.7,18.5,5.9,11.8,2.8,12.2,8.3,13.5,19.9,6.7,10.5,6.5,6.1,6.3,8.5,7.7,3.8,11.4,1.1,23.3,2.8,4.8,17.8,0,9.8,29.1,17.3,8.9,4.1,9.8,16.8,23.8,15.3,7.9,26,14.2,30.2,24.3,28.7,9,8.1,6.6,7.4,16.6,17.5,12.4,5.7,14.3,4.6,9.1,10.1,12.2,0.6,4.6,3.1,2.2,6.3,2.4,3.7,1.8,2,8.9,2,1.2,1.5,0.8,2.8,6.7,4.7,1.8,2.1,4.2,11.8,3,7.5,5.6,5.3,14.5,4.8,12.4,12.6,8.9,9.3,10.5,6.9,6.5,34.3,7.1,38.2,14.7,6.8,17.4,51.1,25.9,23.2,17.3,9.5,16.9,23.5,0,16.5,20.5,14.8,9.8,13.9,124.1,20.1,9.5,36.2,12.3,22.7,6.7,12,19.6,20.3,2.8,19.4,22.1,18.9,24.6,14.9,50.8,47.6,12.9,8.3,5.4,9.1,6.9,16.7,5.7,23.3,12.2
SLC25A14,"BMCP1, UCP5",ENSG00000102078,Solute carrier family 25 member 14,O95258,X,130339888-130373361,"Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,5,Spermatogonia: 39.2,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA060316,NA,NA,Approved,Mitochondria,Intracellular and membrane,NA,NA,NA,NA,Mitochondria,NA,HPA060316: AB_2684251,unprognostic (1.65e-2),prognostic favorable (1.72e-5),unprognostic (1.82e-1),unprognostic (2.74e-1),unprognostic (1.27e-1),unprognostic (1.16e-1),unprognostic (3.36e-3),unprognostic (8.92e-3),unprognostic (3.52e-2),unprognostic (2.95e-3),prognostic favorable (1.78e-4),unprognostic (2.18e-2),prognostic unfavorable (5.52e-6),unprognostic (6.05e-2),unprognostic (1.12e-1),unprognostic (6.92e-2),prognostic favorable (1.39e-5),3.1,9.3,9.2,3.4,18.3,3.7,5.5,13.6,20.6,4.8,3.8,6.1,4.2,2.2,6.7,11,4.3,9.7,4.6,7.7,8.7,15.8,5.2,4.1,4.6,4.1,7.3,11.4,6.8,4.5,5.6,15,3.6,11.2,5.1,4.1,5.7,5.1,6.7,3.4,4.7,3.6,7.7,5.3,3.5,4.8,10.2,4.2,4.2,5.7,4.6,5.3,3.1,3.8,7.5,9.3,8.7,7.2,8.1,9.5,4.9,6.9,9.1,6.5,4.8,4.4,4.2,3.5,5.2,7,10.2,10.2,3.6,4.2,4.7,18.2,7,12.5,3.9,9.4,3.9,10.1,6,11.9,1.5,8.4,8.5,6.2,5.9,2.8,3.9,4.7,12.8,3.9,6,5.6,6.6,4.1,6.7,16.1,10.6,6.2,8.3,5.5,7.5,15,5.3,8.5,9.4,5.9,3,8.2,7.3,5.5,5.6,8.8,4.5,3.6,3.3,3.7,5.5,3.6,12.5,10.5,6.3,16.1,4.1,10,7.3,4.9,5.8,7.2,5.2,6.4,5.8,7.8,7.5,5.4,6.1,7.5,4.6,4.2,7,8.7,8.1,5.2,9.3,9.5,4.9,9.2,18.3,13.6,15.6,8.7,15.8,7.3,11.4,11.2,4.2,6,2.1,8.3,6.8,8.9,8.8,3.2,7.6,26.8,1.2,3.5,2,8,14.9,9.4,9,4.4,3.8,0,7.9,7.3,6,4.1,3.5,3.8,4.6,6.4,8.6,4.9,3.3,5.1,4.6,5.1,8.5,2.8,4,8.5,7.5,4.5,7.8,8.3,12.7,6.5,6.2,21.6,39.2,7.3,4.5,7,5.2,4.7
SLC25A15,"D13S327, HHH, ORC1, ORNT1",ENSG00000102743,Solute carrier family 25 member 15,Q9Y619,13,40789412-40810111,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in many,5,intestine: 26.0;liver: 66.4;pancreas: 24.9,Group enriched,Detected in many,4,Extravillous trophoblasts: 37.5;Hepatocytes: 30.8,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in many,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA042146,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA042146: AB_2677874,unprognostic (4.17e-1),unprognostic (4.50e-2),unprognostic (2.86e-2),unprognostic (5.19e-2),unprognostic (1.38e-1),unprognostic (3.85e-1),prognostic favorable (2.16e-4),unprognostic (2.34e-1),unprognostic (1.14e-1),unprognostic (2.54e-1),unprognostic (1.12e-1),unprognostic (2.37e-2),prognostic favorable (1.74e-4),unprognostic (4.04e-3),unprognostic (1.12e-1),unprognostic (1.57e-2),prognostic unfavorable (5.46e-4),1,1.1,1.4,4.7,1.7,1.6,2.6,1,2,1.3,13.2,1,0.2,16.3,1.6,1.5,1.8,1.2,3.1,1.9,1.3,1.6,4,66.4,1.6,2,1.6,0.9,1.8,24.9,0.8,1,1.8,1.5,1,2.6,0.9,1.4,1.6,2.5,1.3,26,1.5,1.4,1.5,2,3.8,1,2.7,8,2.9,3.8,1.2,1.1,1.7,3.4,0,3.1,2.4,5,1.6,5,9.9,9.9,13.5,3.6,4.8,12.5,3.8,1.9,4.2,2.7,10.5,9.7,32.1,4.3,6.2,8.3,8.3,15.4,10.3,3.7,7.6,7.7,24.2,4.9,13.6,6.9,8.6,3.1,5.2,4.5,5.3,13,2.6,6.5,14.7,12.4,5.1,6.5,16.4,6.4,3.8,21.2,18.8,5.1,15.9,8.1,6.9,5.1,4.6,5.5,13.6,6.9,10.9,5.9,6.9,9.1,12.8,6.2,5.3,8.5,8.1,10.7,5.8,5.5,18.8,5.6,7,10.6,0,1.3,0,4.3,3.1,2.7,1.6,2.9,2.8,3.4,1.7,3,5,0,2.4,1,0.7,1.8,1.6,1.4,1.7,1,2,1.3,1.6,1.6,0.9,1.5,1,3,0.3,0,1,0.2,1.1,1.2,2.5,0,0,0,0,2,6.6,1.7,3.6,0.4,1.3,0,3.8,37.5,0.5,1.5,0,30.8,1.6,0,1.2,0.6,1.9,5.4,0.6,0.6,1.7,0,0.2,0.3,2.2,0.6,0,3.1,1.8,0,0.8,4.1,7.7,0.1,1.3,0,3,0.8
SLC25A16,"D10S105E, GDA, HGT.1, ML7",ENSG00000122912,Solute carrier family 25 member 16,P16260,10,68477999-68527474,"Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,4,Syncytiotrophoblasts: 50.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA036243, HPA044580",Uncertain,NA,Approved,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,"HPA036243: AB_2675019, HPA044580: AB_10962723",unprognostic (1.71e-1),unprognostic (1.54e-1),unprognostic (3.08e-2),unprognostic (1.27e-1),unprognostic (6.75e-2),unprognostic (2.68e-2),unprognostic (1.23e-2),unprognostic (9.13e-3),unprognostic (1.92e-1),unprognostic (4.13e-2),unprognostic (8.65e-2),unprognostic (1.17e-1),unprognostic (8.37e-3),unprognostic (2.10e-1),unprognostic (2.79e-1),unprognostic (2.06e-2),unprognostic (1.44e-3),18.7,8,6.4,5.5,8.9,7,15.5,9.6,13.5,5.1,6.9,8.1,4.8,8.1,7.7,7.8,5.9,5.4,8.8,5.9,8.4,7.3,12,22.6,10.2,9.2,7.8,8.6,6.3,21.1,6.9,7.3,7.1,9.2,17.3,6.4,8.5,15,6.6,9.4,6.5,11,8.4,6.3,6.4,9.4,3.5,6.6,6.4,7.8,4.8,7.7,6.4,5.4,3.2,2.9,5,2.7,2.4,2.5,1.2,3,1.2,3.5,4.8,4.7,5.7,3.8,4.1,4.5,2.7,2.9,7.1,2,3.2,3,8.1,1.4,1.8,11,2.1,6.8,2.4,6.8,1.7,3.2,3.1,5.8,5.4,3.8,4.9,5.4,5,7.1,4,2.2,2.9,1.9,5.4,5.6,2.8,3.1,3.9,0.8,0.8,15.9,1.7,2.5,1,7.3,9.8,2.5,2,5.9,5.8,4.6,2.5,3.2,2.2,9.5,4.1,5.3,6.6,4.7,5.5,2.9,5.2,3.9,4.5,1.8,4,2.7,2.7,1.7,1.9,1.6,1.7,1.6,1.4,1.8,3.2,1.6,2.5,5,2.4,1.5,2.9,1.7,1.2,6.4,8.9,9.6,13.5,8.4,7.3,7.8,8.6,9.2,6.6,41.7,20.2,6.9,5.6,5.7,16.9,8,15.3,13.4,7.9,12.2,37.3,14.4,10,6.6,7.7,5.8,13.8,0,16.7,23.1,7.2,16,8.1,35,9.4,19.1,14.5,14.7,7.2,9.2,2.8,5.8,1.7,3.6,7.8,8.5,12.2,7,7.4,19.2,31.5,0,8.9,4.1,2.5,5.9,50,4.3,7.4,8.6
SLC25A17,PMP34,ENSG00000100372,Solute carrier family 25 member 17,O43808,22,40769630-40819399,"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA052708, HPA060972",Approved,NA,Supported,Peroxisomes,NA,NA,NA,NA,NA,Peroxisomes,NA,"HPA052708: AB_2681924, HPA060972: AB_2684400",unprognostic (2.75e-1),unprognostic (1.11e-3),unprognostic (1.91e-3),unprognostic (2.44e-2),unprognostic (2.61e-1),unprognostic (1.96e-2),unprognostic (2.85e-3),unprognostic (2.16e-1),unprognostic (1.72e-1),unprognostic (1.63e-3),unprognostic (8.44e-2),unprognostic (2.72e-1),unprognostic (5.59e-2),unprognostic (8.54e-2),unprognostic (1.55e-1),unprognostic (1.76e-1),unprognostic (1.18e-1),9.7,15,10.2,10.2,10.9,3.3,16.8,12.9,14.1,11.8,7.2,12.2,7.5,6.4,22.4,22.6,8.7,13.7,7.4,5.5,10.4,13.4,18.6,19.7,9,11.8,10.3,7.7,26.5,12.4,14.3,13,14.9,11.9,12.6,8.7,9.5,11.4,10.3,4.6,10.9,7.1,12.1,11.4,8.8,8.9,12.1,9.5,12.6,14.7,10.4,11.2,7.1,8.7,10.2,6.8,5.9,4.9,10.3,11.7,6.4,13.4,7.4,12.6,11,8,9.7,10.3,12.2,13.4,19.5,21.5,10.8,5.1,15.9,7.5,12,11.1,10.8,18.3,10.1,20,16.3,24.5,17.8,11.5,11.1,11.3,20.5,9.5,9.6,13.5,17.2,11.1,9,11.8,13.3,25.7,7.6,15.8,11.5,12.3,13.2,10.6,19.1,12.3,13.5,19.6,23.2,16.1,11.4,8.7,7.9,25.2,15.5,15,12.8,12.9,6.1,6.9,11,15.1,9.7,11,8.4,16.3,15.1,12,10.4,11.9,5.9,4.4,5.1,7,4.9,9.2,10.2,8.1,7.5,5.7,9.5,11.7,9.3,1.8,10.3,3.9,6.8,10.8,6.4,10.2,10.9,12.9,14.1,10.4,13.4,10.3,7.7,11.9,9.5,17.9,7.4,10.7,13,14.7,11.7,3.1,7.6,12,17,12.2,7.9,34.1,18.3,16.2,6.5,9.3,6.3,0,15.3,27,16,15.6,4.7,21.2,11.5,11.1,5.8,5.5,7.3,8.5,25,7.6,15.1,25.2,3.3,10.6,14.6,5.8,25.1,15.9,7,32.3,10.8,37.1,36.6,15.1,23.9,10,7.7,13.3
SLC25A18,NA,ENSG00000182902,Solute carrier family 25 member 18,Q9H1K4,22,17563439-17590994,"Plasma proteins, Predicted membrane proteins, Transporters","Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in many,8,adipose tissue: 13.1;brain: 49.0;liver: 50.0,Cell type enhanced,Detected in many,18,Alveolar cells type 1: 26.8;Alveolar cells type 2: 15.9;Ciliated cells: 28.1;Hepatocytes: 67.6,Group enriched,Detected in some,5,glioma: 10.6;liver cancer: 11.2,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in single,NA,eosinophil: 2.1,Low lineage specificity,Detected in single,NA,NA,Cell line enhanced,Detected in some,NA,ASC diff: 5.7;BEWO: 12.9,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,HPA068110,NA,NA,Approved,"Nucleoplasm,Mitochondria",NA,NA,NA,NA,NA,Mitochondria,Nucleoplasm,HPA068110:,unprognostic (2.15e-1),unprognostic (6.07e-2),unprognostic (4.95e-2),unprognostic (1.01e-1),unprognostic (3.79e-1),unprognostic (3.98e-2),unprognostic (1.00e-1),unprognostic (1.89e-1),unprognostic (1.45e-2),unprognostic (2.72e-2),unprognostic (8.70e-4),unprognostic (1.44e-1),unprognostic (3.92e-2),unprognostic (1.67e-2),unprognostic (1.29e-1),unprognostic (5.24e-2),unprognostic (1.62e-1),13.1,2.2,33.2,1.5,28,1.2,2.7,7.5,49,1.4,1.4,13.3,0,1.5,1.7,1.4,1.5,1.7,2.1,2.3,33.3,15.7,1.8,50,1.5,1.5,25.6,19.1,1.9,1.8,1.7,0,1.3,17.8,4.8,1.3,0,1.6,1.6,2.5,1.4,1.4,1.8,14.9,1.9,1.5,3.4,21.6,0,1.5,0,1.3,1.4,0,0.4,0.4,2.1,0.6,0,0.5,0.1,0.5,0.9,3.4,0.6,5.7,0,12.9,0.4,0,0,0,0.3,0.3,0.3,0.4,0,3.7,1.1,0.1,0,0,0.4,1.4,0.5,0.4,0.8,2.3,0.5,0.6,0,0,0,0,1.1,0,0.3,0.6,0.4,0,0.6,0.1,0.8,2.9,1.3,2.1,4.2,1.2,0,0.1,0.6,1.2,0.5,0.4,0.6,1,2.6,3.7,1.4,0.2,0.2,0.5,0.3,0.4,1.4,1.7,0,2.7,0.3,0.5,0,0.4,2.1,0.4,0.6,0,0.4,0.5,0.1,0.3,0.2,0.1,0.3,0.5,0,0.2,0.4,0.1,0.1,33.2,28,7.5,25.7,33.3,15.7,25.6,19.1,17.8,21.6,26.8,15.9,0,0.2,0,0.5,1.4,0,28.1,12.5,0,0,0.4,0,0,0.4,0.2,0,0,0,0.3,0.5,4.6,5.8,67.6,0.2,0,0,2.5,4.6,0.6,0.9,0.7,0,0,0,1.4,0,0,2.5,0.6,3.2,0,0,2.7,4.8,0.1,1.5,0,0,0.1
SLC25A19,"DNC, MCPHA, MUP1, TPC",ENSG00000125454,Solute carrier family 25 member 19,Q9HC21,17,75272981-75289510,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,"Disease mutation, Neuropathy",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,testis: 35.5,Cell type enhanced,Detected in many,6,Extravillous trophoblasts: 59.5;monocytes: 62.3,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (2.28e-1),unprognostic (7.05e-3),unprognostic (8.21e-2),prognostic unfavorable (8.72e-5),unprognostic (2.31e-1),unprognostic (1.65e-1),prognostic unfavorable (1.21e-7),unprognostic (6.71e-2),unprognostic (2.73e-1),unprognostic (2.85e-1),unprognostic (7.72e-2),unprognostic (1.77e-3),unprognostic (2.71e-3),unprognostic (3.58e-2),unprognostic (4.44e-2),unprognostic (1.17e-1),unprognostic (2.13e-1),8.1,18.5,9.9,14,15.7,6.7,5.7,9,10.9,6.5,7.9,4.3,2.6,8.5,5.8,3.1,6.8,6,5.8,7.9,7.1,6,9.1,9.2,10.7,19.3,9.6,5.7,5.4,10.6,4.5,4.1,10.8,9.2,5.1,8.5,3.2,5.4,3.8,10.6,4.5,6.8,6.6,12.3,12.2,8,35.5,8.7,9.3,7.7,3.9,16.8,7.8,5.8,19.4,18.2,1.2,14.7,5.3,10.4,8.3,9.4,11.7,2.1,6.3,4.8,2.5,6.9,6.2,2.4,7.1,7.3,20.2,6,30.3,4.5,2.2,6.2,8.4,15,7.1,8.9,8.8,24.1,13.8,14,19.3,4.1,19.6,15.7,2.1,4,11.1,9,1.6,11.7,15.4,16.8,14.5,2.2,19.7,20.2,19.7,4.6,18.6,23.1,15.8,6.9,28.7,4.9,6.6,21.3,5.3,6.6,17.7,7.6,3.7,11.1,15.9,4.1,4.3,8.5,8.2,16.5,36,17.3,31.8,3.3,22.6,5.3,0.2,12.7,1.2,10.4,14.7,10.4,19.4,8.1,9.6,14.8,16.3,9.3,9.6,1.1,5.3,8.4,18.2,9.8,8.3,9.9,15.7,9,10.9,7.1,6,9.6,5.7,9.2,8.7,6,7.9,29.8,9.4,13.5,1.3,0.6,2.5,2.7,7.9,7,2,5.7,19.9,5.9,12,7.1,5.1,0,4.6,59.5,8.6,6.2,11.5,2.8,41.1,3.2,2.9,3.1,11,18.8,2.8,30.8,23.6,62.3,4.8,1.5,4.6,5.5,3.2,4.7,5.8,6.5,7.2,33,10.5,11.3,7.4,13.1,9.7,6.4
SLC25A2,ORNT2,ENSG00000120329,Solute carrier family 25 member 2,Q9BXI2,5,141302629-141304045,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,27,testis: 12.6,Group enriched,Detected in some,9,Early spermatids: 8.6;Late spermatids: 8.3;Spermatocytes: 2.2,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in single,NA,Daudi: 1.4,Low region specificity,Detected in single,NA,NA,Not detected,Not detected,NA,NA,HPA042146,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA042146: AB_2677874,unprognostic (1.55e-1),unprognostic (3.53e-1),unprognostic (4.63e-2),unprognostic (4.30e-1),unprognostic (1.71e-1),unprognostic (1.30e-1),unprognostic (4.72e-3),unprognostic (2.81e-1),NA,unprognostic (2.62e-2),unprognostic (6.69e-2),unprognostic (1.17e-1),unprognostic (8.82e-10),unprognostic (2.56e-1),unprognostic (1.87e-1),unprognostic (1.26e-2),unprognostic (1.14e-1),0.1,0,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0,0.1,0.1,0.1,0,0.1,0.1,0.1,0,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0,0.3,0.1,0.1,0.2,0,0.1,0.1,0.1,0.1,0.2,0.1,0.1,0.1,0.1,0,12.6,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.4,0.1,0,0,0,0.3,0,0.2,0,0,0,0,0,0,0,0,0.3,0.7,0,0,1.4,0,0.5,0.1,0.4,0,0.6,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0.2,0,0,0.1,0.4,0,0,0.3,0.2,0,0,0,0.2,0,0,0,0.4,0.2,0,0.5,0,0,0.2,0.3,0,0,0,0.2,0,0.1,0.2,0,0.6,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0.3,0,0,0,0.1,0,0,0.1,0.1,0.1,0.1,0.1,0,0.1,0.1,0.1,0.1,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,8.6,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,8.3,0.3,0,0,0,0,0,0,0,0.4,0,0.5,0,0,2.2,0.7,0,0,0,0,0
SLC25A20,"CAC, CACT",ENSG00000178537,Solute carrier family 25 member 20,O43772,3,48856931-48898993,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,blood: 57.8;liver: 58.3,Cell type enhanced,Detected in many,7,Enterocytes: 38.0;Hepatocytes: 55.2;monocytes: 40.5,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,Karpas-707: 35.4;RPMI-8226: 48.7,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA016862, HPA029863",Approved,NA,Approved,"Mitochondria,Cytosol",NA,NA,NA,NA,13000,"Mitochondria, Cytosol",NA,"HPA016862: AB_1857028, HPA029863: AB_10602893",unprognostic (1.02e-1),unprognostic (1.84e-1),unprognostic (2.20e-1),unprognostic (3.46e-2),unprognostic (5.18e-2),unprognostic (3.97e-2),unprognostic (1.03e-1),unprognostic (5.96e-3),unprognostic (4.06e-1),unprognostic (1.73e-1),unprognostic (1.36e-2),unprognostic (2.51e-1),unprognostic (3.71e-3),unprognostic (3.34e-1),unprognostic (5.12e-1),unprognostic (4.22e-2),unprognostic (3.49e-2),11.9,13.7,6.7,5.6,7.3,3.4,10.2,3,5.6,3.3,19.7,4.7,5.2,25,4.7,3.1,3.3,5,9.9,37.1,7.3,4.6,16.8,58.3,6.6,4.9,8.5,5.1,2.7,16.8,5.9,5.1,3.3,5.8,5,9.1,5.4,7.4,3.7,27.4,4,32.2,5.7,5.5,8.8,7.5,4.4,6.6,9.1,5.5,5.5,5.9,4.5,9.8,9.4,33.3,57.8,29,17.3,28.4,24.7,1.4,4.5,3.6,5,11.5,4.4,0.7,8,4.3,5.6,5.8,5.6,6.9,6.6,5.7,12.6,6.8,1.4,8.8,3.5,4.2,16.8,4.2,9.2,7,7.1,5.2,9.6,17.8,5.6,4,7.5,1.2,2.2,7.2,10.1,8.2,35.4,7.3,3.7,10.5,4.8,1.8,8.1,10.2,3.8,2.1,48.7,6,3.5,1.4,5.1,7.4,0,4,5.2,11.3,4.5,5.8,6.4,1.1,9.3,5.8,13.1,9.1,7.7,9.1,6.8,8.4,13.8,29,57.8,28.4,21,18.1,9.4,16.1,20.8,27,7.8,12.7,21.3,13.5,17.3,21.4,33.3,16.1,24.7,6.7,7.3,3,5.6,7.3,4.6,8.5,5.1,5.8,6.6,6,2.4,7.5,2.3,1.5,1.1,31.1,7.6,5.3,2.3,0,5.9,1.7,3.3,3.2,1.1,3.1,38,0,3.7,1.9,4.1,2.4,1.1,55.2,15.8,0,7,9.2,13.2,1,9.8,7.5,1.7,40.5,10.8,2.8,4,13.5,11.7,12.5,1.1,0,2.2,7.1,7,1.1,1,13.8,12.8,2
SLC25A22,"EIEE3, FLJ13044, GC1, NET44",ENSG00000177542,Solute carrier family 25 member 22,Q9H936,11,790475-798333,"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters","Symport, Transport",NA,"Disease mutation, Epilepsy",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,brain: 45.0;pancreas: 43.0,Cell type enhanced,Detected in many,13,Bipolar cells: 147.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in all,NA,SCLC-21H: 44.3,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA014662,Approved,NA,Uncertain,"Nucleoplasm,Mitochondria",NA,NA,NA,NA,NA,Mitochondria,Nucleoplasm,HPA014662: AB_10600808,unprognostic (1.01e-2),unprognostic (2.12e-1),unprognostic (7.28e-2),unprognostic (4.68e-2),unprognostic (2.09e-3),unprognostic (1.43e-1),unprognostic (2.72e-3),unprognostic (8.67e-3),unprognostic (4.19e-2),unprognostic (3.70e-1),unprognostic (2.46e-2),unprognostic (1.16e-1),unprognostic (8.97e-3),unprognostic (2.61e-2),unprognostic (8.47e-2),unprognostic (1.08e-1),unprognostic (1.50e-1),4.9,5.2,23.3,8.3,19,5.7,2.7,32.2,45,3.5,4.1,3.4,2.5,10.3,3.2,2.3,4.4,5,3.8,3.2,27.8,13.2,4.1,14.2,4.6,7.5,9.6,22.8,4.8,43,4,13.4,4.4,13.5,5.2,2.9,4.6,11.4,4.2,1.1,5.8,8.5,3.3,2.8,5.3,6.8,6.6,2.6,3.5,3.1,3,5.1,4.5,2.4,2.5,3.1,4,5.7,3.6,7.2,2.3,23.4,15.2,8.9,8,3.8,6.8,8.4,11.2,9.4,12.5,7.9,15,16.1,7,8.4,9.3,14.2,20.8,9.8,13.5,2.8,13.2,18.1,6.4,7.5,9.2,16.2,10.4,10.9,6.8,8.2,9.5,10.2,3.9,5.7,8.3,13.1,11.1,5.5,14.2,10.8,9.8,19.3,14.5,23.4,12.8,4.9,16.6,7.4,3.9,44.3,19.9,6.4,15.5,8,1.4,7.5,5.3,5.6,14,9.4,6.4,10.5,9.7,5.7,9,16.8,9.3,8.3,0,2.4,4,6.6,5.6,4.2,2.5,4.1,7.2,3.1,2.1,2.5,4.2,1.5,3.6,5.7,0.9,2.2,2.3,23.3,19,32.2,37.4,27.8,13.2,9.6,22.8,13.5,2.6,6,10.4,2.2,6.3,11.2,147,1.8,5.1,2.7,4.5,8.7,31.4,5.9,3.3,22.2,11.5,4.9,7,0,17,8.9,7.4,13.6,2.3,15.3,4,41.3,12.5,1.8,1.8,5.6,4.4,2.6,3.3,6.4,7.3,13.4,14.1,7,4.6,5.6,29.9,0,6.1,1.4,6.3,11.7,2.6,5.2,5,8.1
SLC25A23,"APC2, FLJ30339, MGC2615",ENSG00000125648,Solute carrier family 25 member 23,Q9BV35,19,6436079-6465203,"Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 97.6,Cell type enhanced,Detected in many,6,Enterocytes: 100.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA009675, HPA050883",Approved,NA,Supported,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,"HPA009675: AB_2668252, HPA050883: AB_2681260",unprognostic (3.51e-1),unprognostic (1.53e-3),unprognostic (1.52e-1),prognostic unfavorable (1.29e-4),unprognostic (2.05e-2),unprognostic (3.65e-3),unprognostic (3.43e-2),unprognostic (1.31e-3),unprognostic (1.27e-1),unprognostic (3.82e-1),unprognostic (1.30e-1),unprognostic (3.25e-1),prognostic favorable (1.10e-12),unprognostic (8.95e-2),unprognostic (3.20e-1),unprognostic (5.44e-2),unprognostic (4.22e-1),12.1,13,68.2,5.2,97.6,0.4,6.3,21.5,51.7,12.5,22.3,17.6,10.3,18.2,13,11.9,31.2,16.1,10.1,36.2,66.2,25.1,17.9,13,11.3,4,25.6,33.1,15.8,10,24.5,5.5,2.2,28,14.3,23.5,12.2,32.1,20.3,37,11.9,18.6,30.7,16.9,4.3,9.9,3.7,25.9,1.2,29.2,9.7,14.1,16.8,9.3,2.5,0.9,0.8,0,0.7,4.5,0.9,20,8.1,11.8,37.1,15.9,7,5.4,5.8,9.6,11.4,13.8,20.4,13.4,11.2,14.3,14.7,12.5,17.1,24,14,9.1,0,20.2,8.1,17.2,16.2,14.8,0.5,19.2,20,12.3,10.1,4.4,23.3,11.9,12.5,23.3,14.3,2.2,14.6,7,11.5,8.5,21.6,25,3.4,3.2,17.2,30.5,3.6,0.8,11.6,4.2,25.8,10.7,13.4,13.5,17.8,4.1,3.6,15.4,0.9,3.8,2.6,3.5,9.9,1.6,19.1,5.6,0.8,0,0,4.5,0,1.1,2.5,2.7,2.3,0.4,1,4,3.4,0,0.7,0,0.9,2.6,0.9,68.2,97.6,21.5,51.7,66.2,25.1,25.6,33.1,28,25.9,8.9,18.1,7,8.3,9.3,9.8,34.8,48.4,1.4,4.5,43.6,7.9,1.2,16.6,52.9,16.5,5.5,100.4,0,24.8,1.5,5.8,13.9,6.9,27,2.1,7.9,13.3,12.9,2.1,45.5,17.5,2.2,16.9,1.8,35.6,14.6,40.3,35.4,27.6,22.6,16.4,12.9,6.2,0.3,3.2,20.5,0.7,4.3,23.9,24.3
SLC25A24,"APC1, DKFZp586G0123",ENSG00000085491,Solute carrier family 25 member 24,Q6NUK1,1,108134036-108200849,"Predicted intracellular proteins, Transporters",Transport,NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in some,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA028519, HPA063636",Enhanced,NA,Enhanced,Mitochondria,NA,NA,NA,NA,8900,Mitochondria,NA,"HPA028519: AB_10603890, HPA063636: AB_2685068",unprognostic (1.94e-2),unprognostic (7.30e-3),prognostic favorable (1.01e-4),unprognostic (7.11e-2),unprognostic (1.64e-2),unprognostic (2.91e-1),unprognostic (8.54e-4),unprognostic (1.51e-2),unprognostic (7.39e-2),unprognostic (1.29e-1),unprognostic (1.15e-3),unprognostic (6.18e-2),unprognostic (6.76e-2),unprognostic (2.21e-1),unprognostic (1.67e-1),unprognostic (1.03e-1),unprognostic (2.29e-1),19.8,10.8,3,13.1,3.3,3.8,25.2,2.3,4.5,15.9,26.6,3.9,9.6,13.6,12.4,11.8,11.4,9,16.1,12.4,2.8,3.3,15.3,2.9,17.8,10.8,3,2.7,13.5,7.2,13.2,7.7,10.4,5.3,12.4,18.2,9.8,11.2,9.7,7.4,6.9,42.4,9.7,4,17,9,5.1,1.5,10.3,13.7,10.8,9.4,10.8,18.2,2.9,4.8,4.4,7.1,1.7,4.3,2.1,24.2,5.4,16.6,5.1,11.4,15.1,8.3,8.5,10,15.1,16.7,6.6,8.1,0,7.8,15.6,6.7,9.5,4.9,13.7,20.5,6,2.5,1.5,8.1,3.2,9.5,3.9,3.2,11.2,9.7,8.8,11.3,9.8,11.5,3.5,4.1,8.2,19.1,15.9,2.2,0.8,9.8,10,6.2,4.1,21.7,7.2,10.2,12.5,3.2,5.5,12,8.6,11.2,16.4,8.3,6.9,7.8,8.6,4.4,15.3,9.1,2.3,1.3,0,2.9,7.1,5.1,2.8,4.9,4.4,2.3,5.7,2.9,2.9,2.7,2.3,4.8,2.3,1.3,2.3,0.6,1.7,7.1,1.4,4.3,2.1,3,3.3,2.3,4.5,2.8,3.3,3,2.7,5.3,1.5,50.6,26.7,15.9,17.7,13.9,14.1,12.9,20.4,57.6,36.4,17.4,7.9,5.8,18.3,29.1,2.2,20.4,70.3,0,32.1,55.2,18.8,10.7,21.9,0.4,48.5,9.5,17.4,36.8,51.2,2.1,18.1,43.2,21.9,26.2,43.1,8.9,48.3,51.2,17,19.3,31.4,51.8,17.9,4.3,1.3,13,5.1,13.1,47.4,29.8
SLC25A25,"KIAA1896, MCSC, PCSCL",ENSG00000148339,Solute carrier family 25 member 25,Q6KCM7,9,128068201-128109245,Predicted intracellular proteins,Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,5,Cone photoreceptor cells: 119.8,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA020381,Uncertain,NA,Supported,"Vesicles,Mitochondria",Intracellular and membrane,NA,NA,NA,NA,"Vesicles, Mitochondria",NA,HPA020381: AB_1857037,unprognostic (4.62e-2),unprognostic (2.66e-2),unprognostic (2.56e-2),unprognostic (1.59e-1),unprognostic (2.89e-1),unprognostic (1.40e-1),prognostic favorable (1.01e-4),unprognostic (1.20e-1),unprognostic (1.66e-1),unprognostic (1.60e-2),unprognostic (4.96e-2),unprognostic (3.70e-2),prognostic favorable (4.65e-6),unprognostic (1.21e-1),unprognostic (1.05e-2),unprognostic (1.66e-3),unprognostic (1.42e-2),29.2,15.8,7.3,8.1,12.8,5.5,10.6,8.8,20,14.4,7.2,6.3,20,7.9,14.6,8.2,22.7,17.5,31.6,5.6,7.6,9,9.5,48.4,12.4,6.7,7.5,8,13.6,52.6,12.1,19,7.6,15,8.5,5.5,13.6,7.6,63.5,31.3,9.5,10,17.3,8.7,7.8,10.5,7.3,5.3,5.4,10.8,20.2,9.7,8.6,9.6,2.9,4.6,3.8,8.4,1.5,7.6,3.9,5.7,6.1,8.6,12.4,6.5,5.6,5.7,12,11.2,10.1,6.7,10.9,6.1,7.5,3.7,5.5,5.6,10.3,6.8,3.9,3.8,8.7,5.6,4.3,12.2,6.5,10.4,5,10,7.2,3.8,9.9,7.3,3.3,6.8,12.6,15.6,16.2,6.3,13.9,8.7,5.1,8.7,18.7,9.5,8.7,7.4,15.7,3.9,6,21.4,9.2,12.6,8.1,16.7,3.5,8.9,2.9,4.3,11.5,6.8,8.6,11.8,14.2,24.8,8,7.8,2.7,9.4,3.8,2.3,1.2,4.8,7.3,2.4,1.7,5.3,4.8,4.6,2.9,4.5,7.6,0.4,1.5,8.4,1.5,3.9,3.9,7.3,12.8,8.8,20,7.6,9,7.5,8,15,5.3,20.8,41.7,5.2,37.8,23.2,18.1,2,33.1,21.4,9.1,19.2,119.8,8.5,10,10.3,0.3,33.7,36.7,23.3,10,10.4,16.9,26.9,8.1,58.9,8.4,17.5,49.5,19,13.3,0.6,8.6,18.9,20.3,18,17.3,12.8,10,28.1,7.8,8.6,65.5,19.4,63.4,4.1,8.6,37.6,19.2,8.7,15.3,47.7
SLC25A26,NA,ENSG00000144741,Solute carrier family 25 member 26,Q70HW3,3,66133610-66388116,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,"Disease mutation, Primary mitochondrial disease",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA026887,Supported,NA,Supported,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,HPA026887: AB_2189921,unprognostic (1.93e-1),unprognostic (1.29e-1),unprognostic (1.38e-2),unprognostic (1.12e-1),unprognostic (2.32e-1),unprognostic (7.83e-2),unprognostic (7.94e-2),unprognostic (5.38e-2),unprognostic (1.53e-1),unprognostic (3.54e-1),unprognostic (9.21e-2),unprognostic (8.43e-2),prognostic favorable (1.73e-5),unprognostic (4.73e-2),unprognostic (2.59e-1),unprognostic (1.33e-1),unprognostic (2.07e-1),11.8,12.9,20.2,8.5,14.8,13.3,16.5,7.9,27.2,10.3,12.6,15.8,9.2,9.7,11.1,12.9,14.3,13.1,10.1,19.5,16.9,12.8,15.7,22.7,10,15.2,17.6,11.8,20,21.2,16.2,11.6,11.9,14.6,10.8,13.4,12.6,16.1,12.6,29.8,16.5,11,16.8,14.3,11.4,12.7,18.3,12.6,12,19,14.2,12.9,13.4,10.8,12,12.2,3.6,7.1,10.5,14.4,9.1,6.3,6.2,3.8,7.7,8.5,8.8,8,5.3,10.2,7.2,6.8,8.1,8.5,6.5,3.2,9.7,8.8,4.7,4.4,9.9,7.4,6.8,10.3,9.9,4.9,11.7,10.2,13.8,8.4,12,19.7,5.7,13.8,6.9,5.3,13.2,4.4,8.7,8.6,7.9,5.8,15.9,11.1,14.4,3.6,6,6.9,11,5.9,4.7,2.9,8.9,7.7,6.7,12.6,7,5.6,10.9,6,7.6,7.2,9.5,9.3,12.9,16.8,8.4,10.5,13.2,8.2,1.3,6.8,3.6,10.9,7.1,9.9,12,12.1,11.1,12.2,10.2,14.4,12.3,0.4,10.5,4.1,11.6,11.1,9.1,20.2,14.8,7.9,27.2,16.9,12.8,17.6,11.8,14.6,12.6,29.8,20.3,23.3,31.4,31.8,17.7,96.8,20.4,13.4,12.5,17.4,11.8,29.9,29.9,25.2,20.6,19.7,19.1,0,38.7,36.6,33.9,31.6,18.5,34.2,26.5,11.1,17.9,9.2,19,19.2,15,17.8,35.4,20.8,25.5,22.4,26.4,14,20.5,46.3,21.5,19.4,29.5,21.4,30.2,32.1,27.3,46.5,33,33.6
SLC25A27,"FLJ33552, UCP4",ENSG00000153291,Solute carrier family 25 member 27,O95847,6,46652915-46678193,"Plasma proteins, Predicted intracellular proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,NA,NA,Cell type enhanced,Detected in many,8,Bipolar cells: 20.5;Cone photoreceptor cells: 27.5;Early spermatids: 23.2;Horizontal cells: 19.1;Rod photoreceptor cells: 38.2,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in many,NA,HeLa: 26.3;hTCEpi: 14.8;U-698: 16.2,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA069732,NA,NA,Supported,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,HPA069732: AB_2686185,unprognostic (2.16e-2),unprognostic (2.19e-1),unprognostic (9.86e-3),unprognostic (4.93e-2),unprognostic (1.87e-1),unprognostic (2.03e-1),unprognostic (2.81e-1),unprognostic (1.24e-1),unprognostic (1.22e-1),unprognostic (1.35e-1),prognostic favorable (6.16e-4),unprognostic (3.82e-3),unprognostic (1.01e-1),unprognostic (7.53e-2),unprognostic (1.18e-1),unprognostic (1.74e-1),unprognostic (7.47e-3),13.3,15,18.5,6.6,28.8,1.5,18.7,63.8,30.2,11.8,13.2,20.2,11.3,5,28.4,50.9,7.6,13.9,14.2,11.9,17.6,10.5,12.6,12.2,10.1,4.2,24.7,28.9,39.4,9.7,25.8,37.8,2.6,19.6,31,11.5,23.6,14.3,17.9,11.2,28.1,6.8,17,18,6.3,9.1,12.6,26.9,0.4,21.7,7.7,3.8,11.4,17.6,0,0.4,0.3,0,0,0.3,0,2,1.4,2.4,8,9.1,6.3,0.1,1.1,3.7,1.1,0.2,0,2.9,0.8,5.5,2,2.6,4.1,1.1,3.5,0.7,0,11.8,0,26.3,2.9,4.8,0.1,0.3,9.8,14.8,0,9.4,5.8,0.2,8,0.1,0,0.9,0.8,0,0.1,1.2,2,3.1,0,3.1,0.1,6,7.5,7.3,0.8,5.5,0.3,2.9,3.6,5.9,0,0.8,5,3.3,0.5,1,3.2,0,16.2,0.8,0,0.9,0,0,0,0.2,0,0.3,0,0,0,0.4,0,0,0.2,0.3,0,0,0,0,0,18.5,28.8,63.8,30.2,17.6,10.5,24.7,28.9,19.6,26.9,3,2.9,0,3.6,0.8,20.5,7,0,6.7,2.3,5.2,27.5,0,0,0.6,23.2,3.1,0.3,0,0.6,0,2.5,5.8,1.1,1.7,0.2,19.1,5.8,2.5,0.3,16,2.8,0.1,1.7,0,1.3,8.3,0.3,0,4.9,0.5,38.2,0,2.3,0.5,0.7,2,0,0,1.5,2.1
SLC25A28,"MRS3/4, MRS4L",ENSG00000155287,Solute carrier family 25 member 28,Q96A46,10,99610522-99620609,"Predicted intracellular proteins, Transporters","Ion transport, Iron transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Group enriched,Detected in many,5,Early spermatids: 121.1;Late spermatids: 296.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (2.87e-3),prognostic favorable (2.18e-6),unprognostic (8.59e-3),unprognostic (6.86e-2),unprognostic (4.29e-1),unprognostic (1.43e-2),unprognostic (3.39e-2),unprognostic (9.90e-2),unprognostic (1.47e-1),unprognostic (1.40e-2),unprognostic (9.80e-3),unprognostic (2.77e-2),prognostic unfavorable (7.28e-5),unprognostic (1.12e-1),unprognostic (2.68e-1),unprognostic (1.11e-1),unprognostic (7.62e-3),26.2,29.8,30.6,22.1,37.5,52.2,23.7,34.8,31.7,21.7,28.5,29.1,33.9,16.5,21.1,34.7,28,22.3,25.8,27.2,26.7,25.2,19.2,31.8,25.3,26.5,31.9,24.6,29,28.9,25.6,21.4,19.9,28.8,29.1,24.9,21.8,29.3,35,35.1,32.9,19.7,37.3,21.5,30.1,21.2,34.1,34.6,13.5,24.1,18.1,25.8,29.6,36.5,3,9.5,6.2,2.5,2.3,4.6,1,13.8,13.8,8.7,21.1,16.4,20.4,9,16.3,19.8,22.5,18.6,10.8,17.2,17.7,10.1,14.7,10.3,23.4,10.7,15.3,13.8,13.1,13.8,7.7,20,11.2,16.4,13.8,10.9,17.2,22.7,14.5,28.8,29.3,15.9,15.8,5.6,13.7,11.4,18.6,11.9,31.2,2,11.1,10.8,15,10.5,9.9,14.6,14.9,5.9,7.4,9.3,10.2,12.1,11.9,18.4,13.9,9.5,13.9,9.5,18.5,19.8,11.3,7.2,8.7,13.3,26.8,5.7,0,2.5,6.2,4.6,2.2,2.1,3,3.3,2.8,3.5,3,2.5,2.3,2.2,2.3,2.1,9.5,3.6,1,30.6,37.5,34.8,31.7,26.7,25.2,31.9,24.6,28.8,34.6,11.9,8.3,4.3,14.5,22.6,30.1,17.3,17.8,0,5.7,5.2,19.6,15.5,6.6,3.7,121.1,16.5,6.7,0,6.9,7.9,13.6,20.8,5.8,17.9,8.6,41.3,4.1,7.4,8.7,296.1,11.8,12,18.6,9,10.5,23.8,5,9.9,17,7.3,29.6,12.9,15.3,22.1,7.2,24,12.1,7.4,9,17.8
SLC25A29,"C14orf69, FLJ38975",ENSG00000197119,Solute carrier family 25 member 29,Q8N8R3,14,100291111-100306547,"Predicted intracellular proteins, Transporters","Amino-acid transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,thyroid gland: 83.5,Cell type enhanced,Detected in many,7,Collecting duct cells: 116.9;Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 82.2,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA030781,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA030781: AB_10603029,unprognostic (8.64e-3),unprognostic (1.20e-3),unprognostic (2.39e-2),unprognostic (1.32e-1),unprognostic (2.23e-1),unprognostic (3.63e-3),unprognostic (3.39e-3),unprognostic (2.10e-3),unprognostic (1.81e-1),unprognostic (4.00e-1),prognostic favorable (2.90e-4),unprognostic (1.32e-3),unprognostic (1.17e-1),unprognostic (2.97e-2),unprognostic (1.21e-1),unprognostic (1.21e-1),prognostic favorable (5.26e-4),6.3,11.1,9,4.3,15.2,8.3,10.5,7,14,13.5,4.4,29.7,9.5,5.9,9.8,32,6.8,22.7,8.7,7.8,10.3,9.7,19.5,6.3,10.5,5.2,29.7,10.3,10.9,5.9,5.7,13.1,4.9,25.4,12.9,4.3,22.1,20.9,9.8,6.2,14.1,5.2,6.3,30.9,6.5,8.3,9.6,23.1,2.4,83.5,3.9,5.4,5.1,5.1,1.2,2.8,4.9,2.8,0.3,2.4,0.7,4.6,10.2,13.6,17.9,3.2,1.2,8.1,3.6,4.1,7.8,4.7,2.3,3,0,9.4,1.2,3.9,5.2,5.8,1.9,2.6,1.8,2.7,4.7,14.1,4.4,7.6,2.7,6.1,3.6,6,3.5,3.3,11.9,10.7,16.3,1.5,0.5,2.2,15,16.5,14.8,6.9,4.3,10.9,21,5.7,0.3,25.8,3.4,19.9,24.8,8.6,6.2,6.7,6.1,15,4.6,11,2.8,5.5,3.9,5.7,1.4,0.6,0.6,3.2,6.7,3.4,3.6,2.8,4.9,2.3,0.4,0,0.4,1.1,2.4,2.8,1.2,0.3,1.6,3.2,0.3,0.1,1.3,1.6,0.7,9,15.2,7,14,10.3,9.7,29.7,10.3,25.4,23.1,8.9,27.4,0.5,16,5.8,18.5,1.2,12.7,34.8,25,116.9,70.7,3.9,14.9,25.9,15.8,14.7,4,0,10.3,0.8,5.3,29.3,13.9,7.4,6.6,20.6,20.1,21.5,3.4,34.1,2.3,9,10.1,8.2,7.4,18.3,13.9,14.4,5.6,10.5,82.2,12.9,6.6,2.6,4.1,5.6,15.6,1.5,12.7,10.3
SLC25A3,PHC,ENSG00000075415,Solute carrier family 25 member 3,Q00325,12,98593591-98606379,"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Symport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,heart muscle: 233.5,Low cell type specificity,Detected in all,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA045709,NA,NA,Supported,Mitochondria,NA,NA,NA,NA,5500000,Mitochondria,NA,HPA045709: AB_10965843,unprognostic (1.16e-2),unprognostic (4.68e-1),unprognostic (1.95e-2),unprognostic (1.52e-1),unprognostic (1.56e-2),unprognostic (6.38e-2),unprognostic (3.25e-3),unprognostic (9.41e-2),unprognostic (4.98e-2),unprognostic (6.43e-2),unprognostic (5.65e-2),unprognostic (7.40e-2),prognostic favorable (8.11e-7),unprognostic (3.45e-1),unprognostic (2.99e-1),unprognostic (8.66e-3),unprognostic (4.72e-2),35.7,71.2,23.6,38.3,27.2,24.6,48.9,25.1,50.2,29.8,69.6,22.4,33.8,53.9,38.5,35.9,54.6,30.1,55.1,233.5,22.9,25.3,60.2,72.6,47,75.5,27.8,26,39.6,59.7,55.5,29.1,34.2,31.6,33.8,53.3,30.9,53.5,33.5,190.6,33.8,76,46.7,19.6,35.6,51.4,16.9,15.1,42,41.5,125.8,44.4,38.5,31.9,46.8,82.3,33.4,78.5,43.3,56.6,76.3,74.7,58.4,77.5,64.2,70.6,117.4,99.9,65.6,87.5,85.1,71.2,104.8,39.3,102.2,39,79.5,38.5,64.4,78.6,88.7,89.8,38.4,62.7,60.9,43.1,69.5,86.9,71.3,48.4,111,79.4,61.8,88.9,128.1,120.1,53,65.6,30.3,101.4,55.8,66.1,79.6,71.7,64.7,96,75.6,80.8,113.4,110,75.1,39.8,53.4,78.5,70.7,108.3,68.5,95.5,78,80.7,47.4,44.8,52,65.6,51.4,60.4,71.5,37.4,42.1,61,24.4,59.5,33.4,40.1,77.2,47.4,46.8,45.7,44.3,82.3,33.3,47.9,45.3,26.4,43.3,78.5,50.3,56.6,76.3,23.6,27.2,25.1,50.2,22.9,25.3,27.8,26,31.6,15.1,199.5,265.4,295,454.5,334.1,211.9,1401.5,384.7,145.9,192.2,204.1,74.6,677,741.1,434.4,31.9,273,744.3,163.5,762.2,755.9,400.5,371.4,205.5,373.5,527.3,276.5,300.1,249.2,430.8,19.5,236.2,288.2,415,543.8,392,226.4,536.4,501.2,241.1,802.3,176.2,297.5,387.5,94.1,178.4,316.8,681.4,269.7,620.6,559
SLC25A31,"ANT4, DKFZP434N1235",ENSG00000151475,Solute carrier family 25 member 31,Q9H0C2,4,127730378-127774299,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,687,testis: 68.6,Cell type enriched,Detected in some,9,Spermatocytes: 113.2,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in single,NA,hTCEpi: 1.5,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,"HPA015064, HPA016841, HPA046835, HPA071684",Uncertain,NA,Enhanced,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431",NA,NA,NA,NA,unprognostic (8.15e-2),NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (1.62e-1),unprognostic (2.70e-1),unprognostic (5.32e-1),NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,68.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0.4,0.2,0.6,0,0.3,0,0,0,0,0,0.2,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0.2,0,1.5,0,0,0,0,0,0,0.2,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0.2,0,0.2,0.3,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,7.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.7,3.1,0,0,0,0,0,0,0,1.1,0,0,0,0,113.2,11.9,0,0,0,0,0
SLC25A32,MFTC,ENSG00000164933,Solute carrier family 25 member 32,Q9H2D1,8,103398635-103415189,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters",Transport,NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA024763, HPA047402",Uncertain,NA,Supported,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,"HPA024763: , HPA047402: AB_2680032",unprognostic (2.45e-3),unprognostic (8.19e-2),unprognostic (3.87e-3),prognostic unfavorable (7.23e-4),unprognostic (2.06e-2),unprognostic (6.50e-3),unprognostic (1.22e-2),prognostic unfavorable (2.09e-4),unprognostic (9.47e-2),unprognostic (8.43e-2),unprognostic (2.08e-1),unprognostic (9.21e-2),prognostic unfavorable (1.53e-6),unprognostic (7.82e-2),unprognostic (2.12e-1),unprognostic (1.62e-1),unprognostic (4.49e-2),24.1,14.9,11.1,19.6,17,21.6,21.6,22.1,21.9,16.3,14.7,15.4,8.8,11,19.4,13,13.1,18.8,19.6,16.4,12.6,16.5,15.2,29.6,16.1,23.9,16.4,11.6,21,13.4,17.3,30.1,16.5,24.2,14.9,14.2,15.7,13,13.1,17.8,13.9,14.1,18.5,14.1,25.1,14.4,15.3,13.6,17.2,14.9,11.7,19.8,18.3,14.2,8.9,5,1.8,4.6,5.7,9.3,6.5,15,5.4,7.4,9,10.1,11.8,4.9,12.8,18.1,14.4,15,6.6,9.3,32.8,12.2,13.8,8.6,9.7,10.6,10.8,22.4,20,7.5,24.2,4.6,8.4,17.6,11.8,11,11.6,9,16.2,24.2,5.8,14.9,9.6,14.9,12.9,14.3,6,20.1,9.7,8.9,17.7,10.9,15.1,7.9,22.6,9.8,6.9,20.7,9,6.2,10.3,21.4,6.2,9.1,8.5,10.3,17.9,11.9,20.6,16.5,9.2,8.6,34.2,15.2,17.3,13.2,0.7,3.9,1.8,7.7,4.4,9.3,8.9,8.3,8.8,5,6.5,8.6,8.7,1.1,5.7,4.6,4.3,6.5,6.5,11.1,17,22.1,21.9,12.6,16.5,16.4,11.6,24.2,13.6,3,3.5,26.5,13,20.5,8.9,9.9,10.2,1.4,3.4,5.2,5.9,10.3,6.6,7.8,3,19.4,3.2,0,8.2,11.5,13.8,8.2,9.2,13,9.3,7.9,10.9,16.5,5,2.8,8.6,7.4,10.1,10,6.3,7.1,8.1,3.5,8.1,7.4,7.4,19.4,12.6,20,17.9,22.6,11.7,13.1,6.2,14
SLC25A36,"FLJ10618, PNC2",ENSG00000114120,Solute carrier family 25 member 36,Q96CQ1,3,140941830-140979933,"Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA027036,Approved,NA,Approved,"Nucleoplasm,Mitochondria,Cytosol",NA,NA,NA,NA,NA,"Mitochondria, Cytosol",Nucleoplasm,HPA027036: AB_1857048,unprognostic (4.12e-2),unprognostic (9.98e-2),unprognostic (2.86e-1),unprognostic (1.37e-1),unprognostic (6.52e-2),unprognostic (3.46e-1),unprognostic (9.00e-2),unprognostic (1.71e-2),unprognostic (1.99e-2),unprognostic (2.47e-2),unprognostic (3.82e-1),unprognostic (2.10e-2),unprognostic (2.33e-1),unprognostic (1.20e-1),unprognostic (2.34e-1),unprognostic (6.03e-2),prognostic favorable (1.55e-4),20.2,16.9,14.9,13.4,20.5,36.5,25.2,18.7,31.3,23.5,19.4,18.3,17.3,22.3,25.6,37.3,12.2,25.1,13.7,29.5,15.9,19,29,3.1,22.4,18.6,15.6,16.7,32.6,33.9,29.7,26.3,19.1,21.6,20.6,14.8,21.1,17.5,17.7,60.6,16.2,17.2,20.4,18.5,14.1,23.6,24.4,12.2,15.4,23.7,15.1,12.7,20.7,18.5,17,14.9,15.7,13.1,18.1,16.6,10.9,23.8,5.4,17.5,14.3,16.1,20.6,22.1,9,11.5,10.1,14.3,14.9,11.4,19.9,22.4,7.6,14.5,16,21.2,8.8,20.7,15.2,17.2,16.4,13,9.4,24.2,23.4,10.2,23.2,29.6,7.4,22.7,22.7,10.6,14.7,8.7,12.9,14.7,10.3,13.9,16.1,17.4,5.9,10.1,15.1,15.6,28.2,11.9,8.2,11.3,18.5,12.2,22.2,39.1,16,15.4,13.3,10.7,14.1,7.9,24.9,8.6,26.2,17,23.2,18.2,9.8,6.9,10.5,10.4,15.7,11.4,13.1,13.3,17,11.7,12.5,14.9,16,16.6,15.7,1.8,18.1,13.1,10.9,10.2,10.9,14.9,20.5,18.7,31.3,15.9,19,15.6,16.7,21.6,12.2,92.3,107.7,22.2,58.2,60.7,96.5,82.2,38.2,133.8,62.6,68,125.7,48.2,54.7,22.9,5,40,22.6,0,33.6,33.4,49.8,72,63.6,0.4,22.8,87.4,57,29.4,35.2,11.5,55.3,36.5,54,29.7,27,70.1,26.8,17.5,55.9,52.8,122.5,58.2,54.2,29.3,61.1,47.6,41.3,41.1,40.3,64.7
SLC25A38,FLJ20551,ENSG00000144659,Solute carrier family 25 member 38,Q96DW6,3,39383324-39397351,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA041027,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA041027: AB_10794403,unprognostic (3.82e-2),unprognostic (3.27e-2),unprognostic (1.96e-1),unprognostic (6.05e-2),unprognostic (1.13e-1),unprognostic (2.58e-1),unprognostic (1.25e-1),unprognostic (1.21e-2),unprognostic (3.94e-2),unprognostic (1.94e-1),unprognostic (1.26e-2),unprognostic (5.54e-2),prognostic favorable (1.58e-5),unprognostic (1.73e-1),unprognostic (1.47e-1),unprognostic (2.06e-1),prognostic favorable (7.29e-4),14,24.6,12.2,18.2,17.1,38.1,20.9,16.7,21.9,17.2,17.8,11.9,22.2,16,21.3,18.2,13.3,17.8,18.2,12.9,12,15.3,18,35.9,14.7,22.5,12.8,16.2,29.1,41.3,27.2,21.7,12.8,13.4,21.3,24.1,15.1,15.5,18.4,30,10.6,16.4,17,11.3,18.9,21.3,17.7,13,24.7,39.8,12.5,21.5,20.5,22.7,21.6,8.1,12.4,4.2,23.2,22.7,11.9,9.7,15.6,10.3,17.3,24.2,20.1,12.9,14,19.1,20.3,18.5,10.7,2.3,27.4,8.3,12.9,17.3,7.6,22.9,16.4,15.3,17.5,18.4,21.2,13.8,15.7,32.5,14.9,14.5,25.2,19.4,19.5,39.6,19,13.1,21.9,18.9,17.3,15.1,14,17.8,26.5,27.6,14.6,18.1,6.5,11,18.9,15.9,18.6,10.3,13.1,4.8,27.6,13.5,19.8,14,14.1,11.2,16.3,11.1,23.5,19.8,23.2,36.5,16.7,12.4,19.6,10.3,12.4,4.2,7.7,17.7,2.5,20.4,21.6,18.3,19.4,6.4,19,19.6,19,0.6,23.2,3.4,8.1,22.7,11.9,12.2,17.1,16.7,21.9,12,15.3,12.8,16.2,13.4,13,20.8,27.2,29.7,11.4,10.2,13.9,15.3,17.8,13.4,6.8,26.2,5.9,28.2,18.3,13.7,5.2,9,18.2,0,14.6,27.5,14.4,13.3,21.9,24.1,13.2,4.8,12.1,10.4,9.8,6.3,14.4,8.3,11.8,13.6,25.4,16.3,12.3,21,12.7,15.4,10.3,6.5,15.6,10.4,4.7,8.9,16.2,36.2,26,7.2
SLC25A39,"CGI-69, FLJ22407",ENSG00000013306,Solute carrier family 25 member 39,Q9BZJ4,17,44319625-44324870,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Heme biosynthesis, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in all,6,Distal tubular cells: 416.1;Erythroid cells: 584.0;Late spermatids: 585.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA026785,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA026785: AB_10601715,unprognostic (8.10e-2),unprognostic (2.46e-1),unprognostic (1.41e-2),unprognostic (1.29e-1),unprognostic (6.04e-2),unprognostic (2.35e-3),prognostic unfavorable (5.90e-5),unprognostic (1.52e-1),unprognostic (1.08e-1),unprognostic (1.95e-1),unprognostic (1.29e-1),unprognostic (1.05e-1),prognostic favorable (3.58e-5),unprognostic (1.67e-2),unprognostic (2.26e-1),unprognostic (2.22e-1),unprognostic (3.21e-2),14.6,36.5,17.8,19,19.4,101,21.9,15.4,18.1,18.8,29.8,17.4,22.9,30.2,16,20.5,43.2,19.1,24.5,19.3,16.4,18.5,58.8,69.8,25,29.8,18.6,15.6,25.1,63.3,27.2,24.6,33.5,17.1,23.4,19.9,20.6,39.9,26.5,13.7,25.6,28.7,13.5,17.6,28.8,23.8,39.7,16.2,18,46.4,36.4,29.3,16.8,18.6,34,35.2,11.2,27.4,43.9,30.2,31,44.3,28.2,8.8,37,17.2,13.4,30.9,14.8,13.4,19.3,14.9,27.8,21.5,23.9,26.2,20.9,34.3,22.9,27.5,44.9,6.8,27.9,44.1,12.5,25.5,50.6,18.8,21.7,27.5,20.2,40,18,23.3,17.5,19.7,36.3,36.7,38.2,16.2,83.9,27.3,21.2,17.3,34.1,78.2,33,24.4,68.4,33.2,23.7,60,22.4,17.1,27.4,30,17,52.6,18.6,14,25.3,35.6,43.2,28.9,24,28.8,21.9,22.8,17,15.3,11.2,19.5,9.4,26.6,27.3,30.2,34,28.9,28.6,30.5,25.3,29.9,27.4,2.9,43.9,27.4,35.2,26.6,31,17.8,19.4,15.4,18.1,16.4,18.5,18.6,15.6,17.1,16.2,8.9,23.1,46.2,55.8,47.4,17.1,21.2,45.9,18.7,26.1,66.3,9.8,75.3,416.1,140.7,181.7,45,106.3,584,271,134.5,37.6,112.5,31.3,61.9,122.6,12.7,62.7,26.4,47,585.1,36.8,47.7,87.7,148.7,86.5,37.5,164.8,80.6,36.4,185.1,14,19.4,41.2,103.7,99.4,56.6,98.2,55.8,137.6,83.2
SLC25A4,"ANT1, PEO2, PEO3, T1",ENSG00000151729,Solute carrier family 25 member 4,P12235,4,185143241-185150382,"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters","Host-virus interaction, Transport",NA,"Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in all,5,heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4,Cell type enriched,Detected in many,5,Cardiomyocytes: 4236.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Group enriched,Detected in many,5,B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA046835, HPA071684",Approved,NA,Supported,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,"HPA046835: AB_2679831, HPA071684: AB_2686431",unprognostic (4.19e-2),unprognostic (1.06e-2),unprognostic (3.11e-1),unprognostic (8.85e-2),unprognostic (1.37e-1),unprognostic (2.90e-3),unprognostic (8.25e-2),unprognostic (1.26e-2),unprognostic (7.87e-2),unprognostic (1.60e-1),prognostic favorable (3.41e-4),unprognostic (2.05e-1),prognostic favorable (0.00e+0),unprognostic (1.98e-1),unprognostic (1.05e-1),unprognostic (1.73e-1),unprognostic (8.28e-3),3,4.2,6.9,2,10.8,1.4,3.1,19.4,14.4,2.6,6.6,3.7,2.9,2.8,3,3.4,6.7,3.7,3.5,163.7,7.4,7.3,8.3,4.3,3,2,6.3,6.1,3.6,3,4.6,4.6,2.2,12.8,6.2,3.4,7.9,4.4,8.5,92.5,2.3,4.1,5.5,4.5,2.1,5.3,3.1,2.3,0,4.6,62.4,3.4,4.4,2.1,3.5,3,0.4,0,0.7,4.1,1.5,0.7,3.3,2.7,5.5,3,0.3,5,2.7,0.9,3.3,3.3,7.1,1.8,2.4,2,3.3,2.6,2.6,10.4,2.9,2.2,4,8.9,1.6,4.9,8.3,6.1,1.4,1.6,2.2,7.1,5.1,1.4,7.8,2.4,4.2,3.8,1.9,2,5.1,1.6,3.2,4.4,2.3,7.1,2.6,1.4,3.3,7.5,5.1,8.8,6.7,3.2,1.4,12.6,5.1,2.6,1.2,1.8,0.2,1.5,1.7,3.5,7.9,3.6,3.1,2.4,0.3,3,0,0,0,4.1,0,3.1,3.5,1.4,3.5,0.1,2.2,1.2,3,0.4,0.7,0,3,1.2,1.5,6.9,10.8,19.4,14.1,7.4,7.3,6.3,6.1,12.8,2.3,80.4,55.4,33.5,125.8,39.2,174.4,4236.1,140.1,112.4,42.1,68,98.2,59.7,837.3,68.4,15.8,25.9,41.2,0,65.1,47.9,24.6,55,11.5,83.9,50.1,151,51.6,24.5,7.6,7.7,43.1,7.9,180.5,15.4,35.7,473.2,51.1,24.6,106.1,140.9,178.4,103.5,194.8,24,35.3,15.8,33.9,10.7,48.8,46.9
SLC25A43,NA,ENSG00000077713,Solute carrier family 25 member 43,Q8WUT9,X,119399060-119454478,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA035188, HPA078530",Uncertain,NA,Approved,Cytosol,NA,NA,NA,NA,NA,Cytosol,NA,"HPA035188: AB_10602400, HPA078530:",unprognostic (6.05e-3),unprognostic (1.48e-1),unprognostic (9.92e-2),prognostic unfavorable (3.76e-5),unprognostic (4.99e-3),unprognostic (1.59e-2),unprognostic (3.26e-2),unprognostic (2.74e-2),unprognostic (7.19e-2),unprognostic (2.14e-1),unprognostic (2.80e-3),unprognostic (1.26e-1),prognostic unfavorable (5.06e-8),unprognostic (2.63e-1),unprognostic (2.62e-1),unprognostic (1.96e-2),unprognostic (4.92e-2),12.7,3,4.4,11.1,3.7,1.3,11.8,5.9,3.8,8.9,12.3,4.3,5.6,12.8,8,7.3,23.5,5.8,6.3,6,5.1,3.4,11.4,11.3,10.4,9.5,3.8,2.7,7.8,15.6,4,3,7.3,5.8,8.5,14.2,7.4,12.8,4.4,6.3,14,13.3,7.7,8.2,9,7.9,4.3,4.3,1.9,5.7,9.6,16.2,8.9,12.9,4.3,6.3,0.2,10.7,6.6,3.2,1.4,13.6,10.1,0.7,4,14,21.2,5.4,7.5,9.6,6.1,5.9,5.2,6.9,1.5,4.6,21,18.4,10.1,7.9,7.1,5.5,11.8,2.4,4.9,3.3,7,8.7,4.6,5.2,8.7,12.6,10.1,8.5,8.7,7.5,2.7,0.9,7.3,7,24.4,0,6.5,4.6,7.2,15.9,1.2,0,2,10.1,4.7,0.6,0,10.2,21.6,12,3.4,3.8,4.6,10.4,10,2.9,10.8,11.6,0.1,5.7,3.3,10,7.7,8.8,0,3.4,0.2,1,5.1,1.8,4.3,2,3.2,6.3,3.6,1.1,1.9,0,6.6,10.7,1.6,1.6,1.4,4.4,3.7,5.9,3.8,5.1,3.4,3.8,2.7,5.8,4.3,6,8.9,6,5.9,6.9,0.1,1.4,0,1.4,6.8,3.5,0,8.9,8.3,3.6,0,7.3,16.9,0,7.9,6.7,9.3,3.1,8.1,4.9,9.7,0,7,6.2,6.5,0,7.5,9.9,10.1,11.8,10.3,0,12.1,8.6,5.3,7,0.1,0,13.3,0.4,2.2,12.2,5.7,7.2,10.3,5.1
SLC25A46,NA,ENSG00000164209,Solute carrier family 25 member 46,Q96AG3,5,110738136-110765161,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Group enriched,Detected in all,4,Early spermatids: 176.3;Late spermatids: 325.8,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA039601, HPA071582",Approved,NA,Supported,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,"HPA039601: AB_2676592, HPA071582: AB_2686422",unprognostic (1.86e-1),unprognostic (3.29e-1),prognostic favorable (8.41e-4),unprognostic (4.91e-2),unprognostic (2.27e-2),unprognostic (2.25e-1),unprognostic (2.34e-1),unprognostic (1.77e-2),unprognostic (5.14e-2),unprognostic (1.97e-2),unprognostic (1.67e-1),unprognostic (2.40e-1),unprognostic (2.25e-2),unprognostic (2.26e-1),unprognostic (2.62e-1),prognostic unfavorable (2.52e-4),unprognostic (1.98e-1),16.9,15.6,11.9,12.7,19.3,11.3,13.6,17.6,25.7,12.5,14,12.2,8.5,15.7,13.4,9.5,16.4,9.5,10,20.8,10.4,10,18.7,22,11.4,13.7,14.5,14.8,10.2,12.4,12.7,20.2,11.5,27.7,10.2,14.7,8.3,14.2,10.7,55.6,13,15.4,13.9,15,12.1,12.9,15.8,12.3,20.4,12.5,14.3,17.5,13.1,10.9,14.6,15.1,20.2,17.3,17.7,16.3,14.9,12.5,9.7,9.2,7.4,21.3,20.2,3.7,15.7,20.4,18,22.5,13.2,10.7,33.8,16.1,18.3,23.9,10.4,14.5,26,20.4,21.7,8.3,14.5,14.1,9.5,19,12.6,14.6,17,7.7,21.2,15,9.4,11.2,12.9,10.9,21.3,18.6,10,18.4,5.4,6.9,8.2,9.7,9,20.6,25.1,11.4,14.7,16.2,12,13.6,10.5,16.5,9.1,11.4,10.5,14.7,15.9,8,14.4,18.8,40.9,25.6,25.4,16.5,14.8,8.5,20.2,14.7,11.5,12.3,17.3,12.4,14.1,13.7,12.6,15.1,14.6,14.8,14.8,6.2,17.7,15.2,10.6,16.3,14.9,11.9,19.3,17.6,25.7,10.4,10,14.5,14.8,27.7,12.3,20.8,22.7,11.9,7.5,20.4,16,56.7,5.1,12,7.9,19.2,21.6,18.8,16.6,15,176.3,20.2,27.2,23.3,22.2,16.5,20.2,7.3,18.5,39.4,23.8,17.5,22.5,30.1,24.3,325.8,19.5,18.9,28.7,22.6,25.4,21.5,14.4,25.7,20.8,30.4,13.6,19.4,20.6,20,10.2,23.5,17.2,25.4,19,5.5
SLC25A47,C14orf68,ENSG00000140107,Solute carrier family 25 member 47,Q6Q0C1,14,100323337-100330378,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enriched,Detected in some,88,liver: 127.2,Cell type enriched,Detected in some,21,Hepatocytes: 185.9,Cancer enriched,Detected in single,273,liver cancer: 56.9,Not detected,Not detected,NA,NA,Cell type enhanced,Detected in single,NA,neutrophil: 1.4,Lineage enhanced,Detected in single,NA,granulocytes: 1.4,Cell line enhanced,Detected in some,NA,Hep G2: 5.7;HL-60: 1.4;RH-30: 1.4;SCLC-21H: 2.0,Low region specificity,Detected in all,NA,NA,Not detected,Not detected,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (2.54e-3),unprognostic (2.57e-3),unprognostic (5.12e-2),unprognostic (2.27e-2),unprognostic (6.07e-2),unprognostic (1.30e-2),unprognostic (4.25e-2),unprognostic (1.14e-1),unprognostic (2.89e-2),unprognostic (2.50e-1),unprognostic (1.96e-3),unprognostic (4.46e-1),unprognostic (1.44e-1),unprognostic (4.50e-1),unprognostic (5.64e-2),unprognostic (1.02e-2),unprognostic (1.94e-1),0,0,0,0,0,0,0,0,0.1,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0.1,127.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.4,0.3,0,0,0,0,0,0,0,0,0,0.4,0,0,0.1,0,0.2,0,0,0,0,0.1,0.2,0,0.1,0,0.2,0,0.1,0,5.7,0,1.4,0,0.1,0,0.1,0,0,0,0.1,0.1,0,0,0,0.1,0.4,0,0,0,0.1,1.4,0,0,0.1,2,0.2,0.6,0.2,0.2,0,0,0,0,0,0,0.2,0,0,0.1,0.5,0,0.3,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,1.4,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,3.2,0,0,0,0.3,0,0,0,1.8,0,0.1,0,0,0.4,0,0,0,0.3,0,0,0,0,185.9,0,0,0,4.3,8.8,0.4,0,0,0,0,0.3,0,0.1,0,0,1.4,0,0,0,0.2,0.1,0,0.6,0,0,0
SLC25A48,"FLJ44862, HDMCP",ENSG00000145832,Solute carrier family 25 member 48,Q6ZT89,5,135579202-135889770,"Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,NA,Tissue enhanced,Detected in many,NA,brain: 22.4;kidney: 11.7;skeletal muscle: 12.8,Cell type enhanced,Detected in some,26,Distal tubular cells: 8.3;Enterocytes: 4.5;Proximal tubular cells: 27.1,Low cancer specificity,Detected in some,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in some,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in some,NA,HAP1: 5.0;HEK 293: 4.2;HEL: 4.1;RPMI-8226: 3.7;SCLC-21H: 3.9;U-2 OS: 5.1,NA,NA,NA,NA,NA,NA,NA,NA,HPA014674,Uncertain,NA,Approved,"Intermediate filaments,Actin filaments",NA,NA,NA,NA,NA,Intermediate filaments,Actin filaments,HPA014674: AB_1859512,unprognostic (2.09e-1),unprognostic (2.24e-1),unprognostic (6.34e-2),unprognostic (1.21e-1),unprognostic (1.37e-2),unprognostic (4.71e-2),unprognostic (1.96e-2),unprognostic (1.36e-1),unprognostic (4.62e-2),unprognostic (5.41e-2),unprognostic (3.57e-2),unprognostic (1.32e-1),unprognostic (8.02e-7),unprognostic (9.13e-2),unprognostic (1.10e-1),unprognostic (1.21e-1),unprognostic (1.20e-1),1,0.8,10.8,1,13,0.9,1.6,1.3,18.8,0.9,2,10.3,0,2,1,0.7,1.3,0.7,0.9,0.9,11.9,8.1,11.7,1.3,0.7,1,22.4,4.1,0.7,3.3,0.8,0.4,1.1,5.6,1.3,1.8,0,3.5,0.6,12.8,3.2,4.1,0.7,5.4,0.9,0.8,1.2,15.2,0,1,0.5,0.7,0.8,0.3,0.6,1,2.1,1,0.8,0.7,0.2,0.4,0.3,0.1,0.3,0,0,0.5,0,0.1,0.1,0.1,0.4,0.7,0.1,0.4,0,0.1,0.5,5,0,0,0.7,4.2,4.1,0.6,0.8,0,0.3,0.6,0,0.1,0,0,0,0,0.3,0.2,0.5,0.1,0,0,1.7,0.8,0,0.1,0.1,0,3.7,0.3,0.6,3.9,0.4,0.7,0.5,1,1.3,1.8,0.6,0.5,0.4,5.1,0.3,0.2,1.7,0.5,0.2,0.4,0.4,0.3,2.1,0.3,0.7,0.5,0.5,0.6,0.5,0.5,0.4,0.3,0.6,0.6,0.7,1.5,0.8,1,1,0.5,0.2,10.8,13,1.3,9.9,11.9,8.1,22.4,4.1,5.6,15.2,0,0,0,0,2.2,0.1,0.8,0,0,0,0,0,0,8.3,0,0,0,4.5,0,0,0.1,0.8,0.3,0,0.9,0.1,0,0,0,0,0.2,0,0,0,0,1.7,0.2,0.1,2.9,0,27.1,0.1,0,0,0.1,0.5,0.6,0.1,0,1.6,0.1
SLC25A5,"2F1, ANT2, T2, T3",ENSG00000005022,Solute carrier family 25 member 5,P05141,X,119468400-119471319,"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters","Chromosome partition, Host-virus interaction, Transport",NA,FDA approved drug targets,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in all,5,Distal tubular cells: 2147.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA046835, HPA071684",Approved,NA,Supported,Mitochondria,NA,NA,NA,NA,7800000,Mitochondria,NA,"HPA046835: AB_2679831, HPA071684: AB_2686431",unprognostic (1.25e-2),prognostic favorable (7.35e-4),prognostic favorable (7.47e-4),unprognostic (1.48e-1),unprognostic (4.58e-2),unprognostic (1.45e-2),unprognostic (2.73e-2),unprognostic (1.36e-1),unprognostic (6.52e-2),unprognostic (2.47e-1),unprognostic (1.60e-1),unprognostic (2.17e-1),prognostic favorable (8.06e-6),unprognostic (1.41e-1),unprognostic (2.65e-1),unprognostic (4.36e-2),unprognostic (3.03e-1),26,28.9,26.8,32.2,29.5,36.5,36.6,21.8,39,23,74.1,16.3,26,120.7,22.5,18.3,64.1,17.5,39.5,31.4,22.5,18.8,80.7,71,38.3,53.8,27.2,23.8,18.1,128.2,22.5,14.6,30.7,24.2,18.9,84.9,20.1,58.3,21.5,16.6,42.1,157.5,33.6,20.5,34.3,68.2,16.8,17.1,87,31.1,59.9,47,30.8,33.8,51.6,97.8,18.5,113.2,33.4,48,84.9,82,78.9,30.9,53.1,19.8,29.2,57.4,30.7,33.5,64.8,58,65.5,52.1,104.2,41.3,29.4,46.8,57.8,75.8,64.1,59.2,27.5,73.1,35.1,47.7,46.6,25.1,95.3,58,31.7,72.1,66.7,42.6,24.7,67.2,53.7,28.1,43.2,35.3,182.7,84.3,96.8,65,112.7,127.2,46.3,39.1,80.8,49.3,66,37.4,35.4,52.7,80.3,62.1,32.9,33.1,48.3,27.9,30.7,44.4,68.3,110,50.7,62.9,83.4,33.9,97.5,49.5,10.1,68.1,18.5,20.7,113.2,23.9,51.6,30.1,26.9,97.8,39.7,30.1,28.3,11.3,33.4,84.9,53.9,48,84.9,26.8,29.5,21.8,39,22.5,18.8,27.2,23.8,24.2,17.1,151.8,244.7,335.6,401.9,724.7,105.3,125.5,328.6,187.4,221.8,177.9,56.9,945.1,2147,467.3,2.7,209.6,1628,163.5,919.2,321.7,246.2,228.4,191.3,343.1,785.8,25.4,385.2,119.1,477.4,13.9,134.6,447.5,519.6,300.2,755.1,85.2,524.3,956.2,104,1138.1,131.4,129.4,460.4,8.9,116.7,839.4,1329,292,958.7,657.9
SLC25A51,"CG7943, MCART1, MGC14836",ENSG00000122696,Solute carrier family 25 member 51,Q9H1U9,9,37879400-37904353,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Group enriched,Detected in many,7,Early spermatids: 74.4;Late spermatids: 125.5,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,NA,basophil: 13.4,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA046388, HPA058261",Uncertain,NA,Approved,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,"HPA046388: AB_2679649, HPA058261: AB_2683657",unprognostic (5.46e-2),unprognostic (2.28e-1),unprognostic (2.67e-2),unprognostic (5.63e-2),unprognostic (1.00e-2),unprognostic (1.35e-2),prognostic unfavorable (5.67e-5),unprognostic (6.87e-2),unprognostic (1.04e-1),unprognostic (7.98e-3),unprognostic (1.26e-3),unprognostic (5.37e-2),prognostic favorable (1.52e-4),unprognostic (8.27e-3),unprognostic (2.31e-1),prognostic unfavorable (2.21e-4),unprognostic (2.08e-2),17.6,9.1,11.7,9.9,12.9,21.2,27.6,11.3,14.2,12,10.7,12,10.8,15.3,10.3,10.2,12.6,8.1,10.7,11.5,12.9,9.3,13.3,9.7,14.6,10.8,11.9,14.9,11,16.7,20.6,12.8,9.7,11.9,10.5,9,8.2,13.3,8.4,15.9,11.7,13.4,12.2,11.4,12.6,9.7,18.8,12.4,14.4,9.8,7.6,12.9,9.1,10.2,3.1,1.4,13.4,3.9,2.1,3.6,1.1,8.2,6.6,5.1,8,24.5,10.7,5.2,7,7.3,6.1,8.9,8.6,3.6,17.4,4.1,16.6,8.6,4.1,13.6,9.9,11.8,11.9,4.2,5.3,18.2,12,13.8,8.3,7.8,10.7,11.6,9.1,11.7,9.7,11,16.7,11.6,13.9,13,4.7,10,1.9,6.3,8.5,4.8,7,6.8,10.7,6.1,6,10.7,6.9,5.6,6.8,4,9,3.7,9.1,11.9,10.3,12.1,4.8,8.7,5.3,11.2,12.2,13.5,6.1,8.5,13.4,1.9,3.2,2.1,3.9,3.6,3.1,2.3,3,1.4,2.2,2.2,2.5,1.5,2.1,1.6,0.6,3.4,1.1,11.7,12.9,11.3,14.2,12.9,9.3,11.9,14.9,11.9,12.4,8.9,0.6,4.2,5,4.1,4.3,5.7,2.5,1.4,2.3,1.8,3.9,3.2,14.9,8.3,74.4,3.4,5.1,0,6.3,11.8,4.2,3.9,3.5,3.2,10.5,1.6,3.5,0.6,5.9,125.5,3.4,5,1.7,9,4.2,3.4,7.2,7,3.9,13.4,3.4,0,3.1,10.2,10.3,5.1,3.3,3.2,3.5,3.4
SLC25A52,MCART2,ENSG00000141437,Solute carrier family 25 member 52,NA,18,31759562-31760880,Predicted membrane proteins,NA,NA,NA,Evidence at transcript level,Evidence at transcript level,NA,NA,NA,Tissue enriched,Detected in some,17,testis: 18.2,Group enriched,Detected in some,10,Early spermatids: 41.8;Late spermatids: 77.2,Not detected,Not detected,NA,NA,Region enriched,Detected in single,4,pons and medulla: 1.0,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,HeLa: 2.5,NA,NA,NA,NA,NA,NA,NA,NA,"HPA046388, HPA058261",Uncertain,NA,Approved,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,"HPA046388: AB_2679649, HPA058261: AB_2683657",unprognostic (8.97e-2),unprognostic (4.85e-2),NA,NA,unprognostic (2.93e-1),unprognostic (4.87e-1),unprognostic (2.50e-1),unprognostic (9.05e-2),unprognostic (2.97e-2),unprognostic (1.30e-4),unprognostic (7.15e-3),unprognostic (1.23e-1),unprognostic (1.44e-1),unprognostic (1.41e-1),unprognostic (3.34e-2),unprognostic (1.55e-1),unprognostic (1.41e-2),0.2,0.1,0,0,0,0,0,0,0.2,0,0,0,0,0.2,0,0.1,0,0,0,0,0,0,0.1,0.8,0,0,0,0,0,0,0,0.4,0,1,0,0.1,0,0.1,0,0.6,0.2,0,0,0,0,0,18.2,0,0,0,0,0,0,0,0.2,0.3,0.8,0.3,0.4,0.4,0,0.8,0.4,0.5,1.3,0.4,0,0.3,1,0,0,0,0,0.3,1.2,0.5,0,0.4,1.1,0,0.3,0.2,0.5,0,0.9,2.5,0.6,0,1.5,1.1,0,0.2,0,0.3,0,0,0.9,0.7,1,0,0,1.3,0.1,0.3,0.3,0,1.1,0.9,0,0,0.4,0.7,1.5,0.8,1,0.2,0.1,0.6,1.7,1.3,0.6,0.6,0.5,0.7,1.3,1.5,0.7,0.8,0.6,1.2,0.8,0.1,0.1,0.2,0.3,0.2,0.1,0.1,0.2,0.2,0.2,0.4,0.4,0,0.4,0.1,0.3,0.1,0,0,0,0,0.2,0,0,0,0,1,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,41.8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,77.2,0.9,0,0,0,0,0,0,0,0.4,0,0,0,0,6.2,0.9,0,0,0,0,0
SLC25A53,MCART6,ENSG00000269743,Solute carrier family 25 member 53,Q5H9E4,X,104099214-104157027,Predicted membrane proteins,Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,NA,NA,Cell type enhanced,Detected in many,9,Erythroid cells: 70.0,Low cancer specificity,Detected in some,NA,NA,NA,NA,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Group enriched,Detected in some,4,Daudi: 7.2;Karpas-707: 17.1,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA034959,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA034959: AB_10602025,unprognostic (4.70e-2),unprognostic (1.16e-2),unprognostic (7.16e-3),unprognostic (5.94e-2),unprognostic (2.68e-2),unprognostic (5.23e-2),unprognostic (1.98e-1),unprognostic (5.49e-3),unprognostic (4.45e-3),unprognostic (7.94e-2),unprognostic (9.76e-5),unprognostic (1.83e-1),unprognostic (2.04e-1),unprognostic (3.48e-2),unprognostic (1.74e-1),unprognostic (3.53e-1),unprognostic (1.76e-2),2.8,2.4,3.2,5.6,4.6,2.8,2.1,6.3,8.6,3.9,2.5,2.8,5.7,3.1,5.1,3.4,2.2,1.9,2.9,2.8,3.6,NA,1.8,1.6,2,8.8,3.1,2.7,3.2,4.4,1.2,5.8,1.4,3.6,4.6,2.9,3.1,3,5,1.5,2.1,3.8,4.8,4.2,6.6,3.1,3.9,4.5,1.4,2.7,0.8,8.4,4.7,9,1.7,0.5,3,0.5,1,2.9,0.7,0.1,0.1,2.1,1.3,0.1,0,0.1,0.2,0.1,0.3,0.2,0.1,0,7.2,0.2,0.1,0.4,0.1,2.4,0,0.2,0.6,1,0.8,0.2,0.2,0.2,1.4,0.8,0.4,0.1,0.3,0,0.4,0.5,0.8,0.2,17.1,0.1,0.1,0.3,0.1,2.7,0.1,0.5,2.9,1.1,0.3,0.3,0.2,1.9,2.7,0.1,0.1,0.1,0.4,0.1,0.1,0.4,0.2,1,0.1,0.5,0.2,0,2.6,0.1,1.9,0.5,0.9,0.4,0.8,1.3,0.5,2.9,1.7,1.2,2.4,0.5,1.4,0.4,1.6,3,1,0.3,0.3,1.8,0.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,2.9,11.5,6.5,4.6,3,11.7,2.5,14.7,2.3,8.7,0,3.1,21.6,3.5,2.6,4.5,15.9,70,5.2,3.6,3.8,8.3,6.9,21.2,9.4,3.2,6.9,4.9,9.8,0.4,2.8,7.2,1.7,12.6,8.3,3.5,6.4,21,2.8,11,7.8,0,4.4,2.3,2.1,5,5.1,12.8,4.3,11.5
MTCH1,"CGI-64, PSAP, SLC25A49",ENSG00000137409,Mitochondrial carrier 1,Q9NZJ7,6,36968141-36986298,"Predicted membrane proteins, Transporters","Apoptosis, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in all,NA,U-698: 146.1,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA015971,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA015971: AB_1854171,unprognostic (3.17e-2),unprognostic (1.37e-1),unprognostic (1.71e-1),prognostic unfavorable (2.06e-4),unprognostic (1.40e-1),unprognostic (1.87e-1),prognostic unfavorable (1.17e-4),unprognostic (1.29e-1),unprognostic (2.88e-2),unprognostic (1.54e-1),unprognostic (7.49e-2),unprognostic (1.35e-3),prognostic favorable (1.16e-7),unprognostic (1.32e-2),unprognostic (3.11e-1),unprognostic (6.68e-2),unprognostic (4.70e-2),32.3,50.8,46.3,25.6,57.2,45.2,31.3,28.4,86.3,34.1,26.1,43.1,32,25.8,26.7,91.7,25.8,44,34.3,47.6,46.9,56.9,31,29.6,33.7,23.4,47.1,47,38,34.7,33,52.8,28.9,49.3,34.4,27.5,31.5,34.2,58.8,21.6,37.2,23.2,32.1,45.8,27.7,28.9,21.5,32.4,21.3,98.9,18.3,23.7,23.3,56.3,14.8,17.7,23.9,23.7,10.6,17.6,8.4,28.6,19.4,26.2,32.6,39.7,27.1,15.1,33.7,31.5,47.7,49.8,31.8,17.8,14.4,30.1,56.4,45.9,25.1,28.5,27.1,55.6,15.1,27.6,14.9,33.2,24.2,28.8,9.6,14,30.4,21.3,44,21.8,41.7,40.7,19.9,26.8,14.8,30,32.1,19.2,21.6,25.7,25.8,22.3,17.9,20.4,15,26,24,42.5,18.3,24.5,21.5,29.7,27.5,27.6,26.6,44.9,47.6,38,37.2,36.3,13,13.1,146.1,17.4,26.5,37.6,6.3,19,23.9,8.9,18.9,8.3,10.1,16.7,17.6,17.7,14.8,15.5,9.3,21.7,10.6,23.7,9.8,11.7,8.4,46.3,57.2,28.4,86.3,46.9,56.9,47.1,47,49.3,32.4,44.7,85.6,50.2,157,101,0,139.3,96.8,32.1,70.5,66.3,0,156.3,142.6,190.2,6,114.2,120.7,70,149.2,190.3,178.9,169.5,28.8,45.5,161.7,0,143.2,73.1,86.8,10.9,128,80.4,129.9,242.5,104.4,0,154.2,143.8,124.5,103.2,0,51.8,128.2,16.3,60.8,107.9,207.7,55.4,120,163.4
MTCH2,SLC25A50,ENSG00000109919,Mitochondrial carrier 2,Q9Y6C9,11,47617315-47642623,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,liver: 74.8,Cell type enhanced,Detected in many,5,Early spermatids: 432.9;Proximal tubular cells: 398.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,HPA038390,Approved,NA,Approved,Mitochondria,NA,NA,NA,NA,55000,Mitochondria,NA,HPA038390: AB_10669723,unprognostic (4.94e-2),unprognostic (3.29e-1),unprognostic (1.93e-2),unprognostic (1.43e-1),unprognostic (4.27e-1),unprognostic (7.63e-3),unprognostic (1.80e-1),unprognostic (7.03e-2),unprognostic (1.51e-1),unprognostic (1.53e-2),unprognostic (1.08e-1),unprognostic (1.14e-1),prognostic favorable (9.05e-6),unprognostic (1.12e-2),unprognostic (8.75e-2),unprognostic (2.25e-1),unprognostic (1.77e-1),13.6,19.6,15.6,12.8,20.3,8.3,12.5,14.1,21.3,10.4,22.3,19.3,8.7,28.3,12.6,15.1,21.6,9.9,11.6,15,14,13.8,40.8,74.8,9.1,13.9,15.2,12.2,9.3,14.4,16.8,9.3,9.5,15.4,11.8,24.7,13.6,13.4,10,31.4,12.1,33.9,16.1,11.4,11.4,10.1,44.2,10.2,15.1,15.5,24.9,16.4,11.6,10.7,13.7,25.7,7.9,21.3,12.1,13.6,17.5,18.9,20.8,17.8,24,21.1,19.6,13.2,20.6,18.9,27.8,26.4,16.5,19.4,26.2,11.2,25.2,30.1,23.9,31.9,27.1,33.9,13.1,29.8,15,29.7,32.9,29.1,31.2,15.1,22.1,21.4,18.5,27.7,16.2,25.1,22.6,27.7,15.8,33.9,27.6,23.9,23.5,19.3,37.2,31.6,22.4,27.1,18.8,32.2,24.6,21.2,14.9,28.2,28.5,14.5,17.6,41,14.7,20.8,25.7,22.4,42.5,26.4,16.8,19.1,29.6,21.2,27.2,22.9,5.9,19.8,7.9,12.7,21.3,12,13.7,11.1,11.7,25.7,10.9,9.7,11.2,1.9,12.1,17,16.9,13.6,17.5,15.6,20.3,14.1,21.3,14,13.8,15.2,12.2,15.4,10.2,20.8,33.9,37.2,43,41.8,0,61,81.5,46.8,37.5,50.6,0,75.5,154.2,136.5,432.9,25.1,133.4,0,95.3,101.6,32.1,64.6,35.9,265.9,146.4,0,76.7,35,64.2,110.8,26.7,50.7,77.6,112.8,82.5,0,85.1,63.1,54.8,398.6,0,32.3,38.1,327.5,81,47.3,106.9,37.6,134.8,50.4
UCP1,"SLC25A7, UCP",ENSG00000109424,Uncoupling protein 1,P25874,4,140559434-140568805,"Predicted membrane proteins, Transporters","Ion transport, Transport",Ion channel,"Diabetes mellitus, Obesity",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,5,adipose tissue: 2.4;adrenal gland: 8.4;breast: 2.2;heart muscle: 7.1,Cell type enhanced,Detected in single,24,Syncytiotrophoblasts: 1.9,Cancer enhanced,Detected in single,NA,breast cancer: 1.1,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,10,BEWO: 9.8;HAP1: 7.1;JURKAT: 2.5,Not detected,Not detected,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (5.08e-3),unprognostic (4.44e-1),NA,unprognostic (2.65e-2),unprognostic (2.30e-1),unprognostic (7.17e-2),NA,unprognostic (6.08e-2),unprognostic (3.98e-2),unprognostic (1.85e-1),unprognostic (5.75e-2),unprognostic (1.38e-1),NA,unprognostic (4.45e-2),unprognostic (2.29e-1),unprognostic (1.40e-1),unprognostic (4.58e-2),2.4,8.4,0.1,0.1,0.1,0,2.2,0.1,0.1,0.1,0.7,0.1,0.1,0,0.1,0.1,0.1,0,0.2,7.1,0.1,0.7,0.1,0.1,0.2,0.1,0.1,0.1,0.6,0.2,0,0.1,0.8,0.1,0.1,0,0.1,1.1,0.1,0.1,0,0.4,0.1,0.1,0.1,0,0.5,0.1,0.1,0.6,0.1,0.1,0.1,0.1,0.6,0,0,0,0,0.6,0,0,0,0.4,0,0,0,9.8,0,0.1,0.1,0,0.2,0,0,0,0,0.1,0,7.1,0,0,0,0,0,0.1,0.6,0,0.2,0,0,0.1,0,0,0,0,2.5,0,0,0,0,0.1,0,0,0,0.3,0,0,0,0,0.1,0.1,0.5,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0.6,0,0,0.1,0,0.6,0,0,0,0,0,0,0,0,0.1,0.1,0.1,0.1,0.1,0.7,0.1,0.1,0.1,0.1,0,0,0,0,0,0,0.4,0,0,0,0,0,1,0,0,0.1,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0.2,0,1.9,0,0,0
UCP2,"BMIQ4, SLC25A8",ENSG00000175567,Uncoupling protein 2,P55851,11,73974667-73983307,"Predicted intracellular proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in all,4,blood: 219.1;lymphoid tissue: 144.8,Cell type enhanced,Detected in many,11,Erythroid cells: 420.4;Hofbauer cells: 378.7;Intestinal endocrine cells: 285.5;monocytes: 710.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,Daudi: 68.0;SK-BR-3: 87.6;U-698: 56.6,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"CAB025583, HPA075202",Approved,NA,Supported,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,"CAB025583: , HPA075202: AB_2732284",unprognostic (1.13e-1),prognostic favorable (4.65e-5),unprognostic (8.07e-2),unprognostic (1.21e-2),unprognostic (1.08e-1),unprognostic (1.15e-2),unprognostic (1.92e-1),unprognostic (1.82e-3),unprognostic (2.07e-1),unprognostic (4.59e-2),unprognostic (1.13e-3),unprognostic (1.37e-1),prognostic unfavorable (7.80e-6),unprognostic (3.77e-2),unprognostic (1.58e-1),unprognostic (3.77e-3),unprognostic (3.88e-3),19.8,9.8,5.3,40.4,9.5,24.5,15.9,1.1,4.9,8.1,7.7,10.2,20.3,11.4,4.2,12,4.5,37.9,13.1,11.5,4.4,5.5,12.8,10.6,20.2,85.6,7.8,2.4,7.2,4.7,1.2,6.2,8.7,6.5,6.5,8.9,14.2,17.4,17.2,45.3,4.3,24.7,6.4,9,91.1,12.3,5.5,5.9,144.8,17.9,19.3,55.7,19.4,2.9,141.6,219.1,101.8,135.3,119.8,180.2,172.1,0.1,14.3,3.3,9.8,1.9,0,2.5,2.4,1.6,9.8,2.8,25.1,12.2,68,34,3.7,0.8,0.6,2.3,0,4.6,17.2,0.8,39.7,6,5.2,5.9,20.8,16.7,2.2,0,9.3,0,1.9,1.3,26.2,18.2,27.8,1.9,24.5,21.5,11.2,2.6,1.5,2.9,19.9,22.7,38.5,27.4,40.6,5,6.1,12.8,87.6,4.8,9.9,25.8,18.6,1.8,0,12.6,2.9,4.7,9.5,4.5,56.6,1.7,8.3,0.1,45.7,81.5,101.8,112.6,135.3,69.9,141.6,92.3,95,88.4,134.2,86.9,91.1,11.4,119.8,111.3,219.1,180.2,172.1,5.3,9.5,1.1,4.9,4.4,5.5,7.8,2.4,6.5,5.9,3,35.4,250.6,2.3,3.1,0.9,3.6,2.5,93.7,23.9,87.2,7.9,6.6,6.6,1.2,16.1,5,4.2,420.4,6.5,10.3,6.7,15.6,84.3,0.6,378.7,0,285.5,11.6,244.1,37.5,0.9,160.3,25.3,710.6,23.4,2.9,2.5,37.6,0.4,1.9,6.3,6.5,5.3,14.4,13.4,4,9.4,172.7,24.7,21.6
UCP3,SLC25A9,ENSG00000175564,Uncoupling protein 3,P55916,11,74000281-74009435,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters",Transport,NA,"Diabetes mellitus, Disease mutation, Obesity",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,NA,Tissue enriched,Detected in some,15,skeletal muscle: 99.6,Group enriched,Detected in some,5,Early spermatids: 14.7;Late spermatids: 10.7,Low cancer specificity,Detected in some,NA,NA,Region enriched,Detected in single,4,cerebellum: 1.1,Low cell type specificity,Detected in some,NA,NA,Low lineage specificity,Detected in single,NA,NA,Cell line enriched,Detected in many,4,HDLM-2: 18.3,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in many,NA,NA,"CAB010771, HPA072225",Enhanced,NA,Approved,"Nucleoplasm,Plasma membrane,Cytosol",NA,NA,NA,NA,NA,"Nucleoplasm, Cytosol",Plasma membrane,"CAB010771: AB_261839, HPA072225: AB_2686498",unprognostic (3.76e-3),unprognostic (1.24e-1),unprognostic (2.82e-1),unprognostic (5.98e-2),unprognostic (1.12e-1),unprognostic (2.49e-2),unprognostic (3.95e-3),unprognostic (6.61e-2),unprognostic (1.25e-1),unprognostic (8.58e-2),unprognostic (2.13e-4),unprognostic (1.61e-2),unprognostic (3.25e-6),unprognostic (2.68e-1),unprognostic (1.66e-1),unprognostic (1.76e-1),unprognostic (2.50e-4),0.9,0.2,0.2,0.3,0.2,0.6,0.2,1.1,0.2,0.2,0.2,0.2,0.2,0.1,0.2,0.5,0.9,0.2,0.2,0.2,0.2,0.1,0.2,0.2,0.2,0.3,0.2,0.2,0.2,0.2,0.2,0.4,0.2,0.2,0.2,0.2,0.2,1,0.2,99.6,0.3,0.2,0.2,0.2,0.5,0.1,0.6,0.2,0.2,0.6,6.4,0.8,0.2,0.2,0.8,0.1,0.7,0.3,0.2,2.1,0.4,0.2,2.1,2.1,1.8,0.8,0.4,0.4,0.5,0.5,0.5,0.3,0.5,0.4,1.1,0.3,0.4,0.3,2.2,0.8,0.4,0.8,18.3,0.7,0.4,2.4,0.2,0.6,1.2,1.7,0.5,1.4,1.3,0.1,0.4,0.7,1,0.5,1.4,0.7,1.2,0.8,1.6,1,1.6,1.4,1.6,4.3,0.6,1.1,0.6,1.2,1.3,0.5,0.9,0.7,0.4,0.2,1.1,0.4,0.3,1.4,0.7,1.3,1.6,1.7,0.8,0.3,1.1,0.7,0,0.3,0.7,2.1,0.1,0.9,0,1.5,1.8,0,0.8,0.6,1.2,0.1,0.2,0,0.1,0.4,0.4,0.2,0.2,1.1,0.2,0.2,0.1,0.2,0.2,0.2,0.2,0,0,0.5,0.1,0.1,2.2,0.5,0,2.7,1.2,0,0,0.3,0,0.3,14.7,0.1,0,0,0.4,0.1,0.2,0.1,0,0,0.5,0,0,0.6,0.8,10.7,0,0,0,0,0.6,0.7,0.3,0,0.7,0,1.6,0,0.1,1.2,0.7,0.3,0.2,2.2,0.6,0
SLC26A4,"DFNB4, PDS",ENSG00000091137,Solute carrier family 26 member 4,O43511,7,107660635-107717809,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters",Transport,NA,"Deafness, Disease mutation, Non-syndromic deafness",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,24,thyroid gland: 79.2,Cell type enhanced,Detected in many,7,Alveolar cells type 2: 11.4;Glandular cells: 8.7;Intestinal endocrine cells: 7.0;Melanocytes: 6.8,Cancer enriched,Detected in some,8,thyroid cancer: 37.6,Low region specificity,Detected in single,NA,NA,Cell type enriched,Detected in single,5,naive B-cell: 3.1,Lineage enriched,Detected in single,5,B-cells: 3.1,Cell line enhanced,Detected in some,NA,HDLM-2: 3.5;hTERT-RPE1: 8.3;LHCN-M2: 4.6,Region enriched,Detected in some,4,hippocampal formation: 10.6,Low region specificity,Detected in all,NA,NA,HPA042860,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA042860: AB_10796680,unprognostic (1.19e-2),unprognostic (4.84e-2),unprognostic (5.44e-2),unprognostic (8.44e-2),unprognostic (3.25e-2),unprognostic (3.26e-2),unprognostic (6.69e-2),unprognostic (1.85e-1),unprognostic (5.72e-2),unprognostic (9.58e-2),unprognostic (1.60e-1),unprognostic (1.03e-1),unprognostic (6.46e-3),unprognostic (1.51e-1),unprognostic (1.71e-1),unprognostic (1.41e-2),unprognostic (1.39e-1),0.1,0,0.8,0.2,0.5,0,0.2,0,2.9,0.4,0,0.1,0,0,0.1,0,0,0,0,0.1,0.5,0.2,3.3,0,0.2,0,0.1,0.6,0.1,0.1,0.1,0.1,0,0,1.8,0,1.4,0.2,0,0.1,0,0,0,0.1,0,0.1,0.1,0,0.2,79.2,0,0.1,0.8,0.1,3.1,0.1,0.1,0.2,0.1,0.5,0.3,0.7,0.3,0.5,0,0.7,1.5,0.4,0.3,0.2,0.3,0.1,0,0.1,0.1,2.5,0.3,0,0.2,0.5,0.2,0.1,3.5,0.9,0,0.3,0.2,0.4,0.4,1.1,0,0.9,0.4,0,8.3,0.1,0.8,0,0.4,4.6,0.7,0,0.4,0,0,0.8,0.2,1.3,0,0,0.1,2.5,0.1,0,0,1.7,0.2,0,0.4,0.7,0.7,0.5,0.2,2.8,0.7,0.7,0.3,0.8,0.4,1.7,0.1,0,0,0.2,0.1,0,0,0.3,0,0,3.1,0,0.1,0.1,0.1,0.2,0.1,0.5,0.3,0.8,0.5,0,1.4,0.5,0.2,0.1,0.6,0,0,3,11.4,0,0.6,1.4,5.6,0.7,0,1.4,4.5,0,2,0.2,0,0.1,2.6,0.7,0,0,0,0.1,1.1,8.7,4.7,0,0.2,1.6,7,0.6,0.3,2,0.9,1.4,6.8,1,0,0.4,0.1,0,1.1,0,1.1,0,0.9,1.7,0.3,1.3,0,1,0,1.2
SLC26A5,"DFNB61, PRES",ENSG00000170615,Solute carrier family 26 member 5,P58743,7,103352730-103446177,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Cell shape, Hearing",Motor protein,"Deafness, Non-syndromic deafness",Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enriched,Detected in many,4,brain: 20.4,Cell type enhanced,Detected in some,14,Alveolar cells type 1: 6.0;Ciliated cells: 4.0;Ito cells: 3.7,Low cancer specificity,Detected in single,NA,NA,Region enriched,Detected in some,8,cerebellum: 20.4,Cell type enriched,Detected in single,8,basophil: 2.7,Lineage enriched,Detected in single,8,granulocytes: 2.7,Cell line enhanced,Detected in some,NA,Karpas-707: 2.9;PC-3: 2.6;U-2197: 1.8,Low region specificity,Detected in single,NA,NA,Region enriched,Detected in some,8,basal ganglia: 9.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (3.86e-2),unprognostic (5.13e-2),unprognostic (6.38e-3),unprognostic (2.76e-2),unprognostic (1.02e-2),unprognostic (5.09e-2),unprognostic (2.36e-1),unprognostic (3.56e-4),unprognostic (4.21e-3),unprognostic (8.92e-3),unprognostic (2.82e-1),unprognostic (2.97e-1),unprognostic (3.67e-5),unprognostic (3.05e-1),unprognostic (2.81e-1),unprognostic (2.94e-2),unprognostic (2.69e-3),1.3,1,0.6,0.3,0.7,2.3,3.1,20.4,0.8,0.6,0.3,0.5,0,0.9,0.5,0,0.2,0.4,0.2,0.4,0.8,0.4,0.7,0.9,2.2,1.2,1.3,0.4,0.4,0.7,2.5,4.6,0.1,2.6,3.1,0.1,0.9,1.4,1,0.6,2.2,0.5,1.2,2.9,0.9,3.2,0.9,0.2,0,1.8,0,0.2,3.2,0.4,0.2,0,2.7,0.1,0.3,0.1,0,0.2,0,0.3,0.7,0,0,0.8,0.3,0,0,0,0,1.1,0.7,0.4,0,0,0.4,0,0,0,1,0,0.2,0.9,0,0,0.2,0.5,0,0,0,0,0.3,0,0.1,0.4,2.9,0,1.2,0.8,0.3,0.1,0.5,2.6,0.3,0.1,0.4,0,0.8,0.9,1.5,0.3,0.3,0,0.6,0.7,0,0,0.6,0.6,1.8,0.4,0.8,0.4,0.4,0.2,0.2,0.3,2.7,0,0,0.1,0,0,0,0.1,0,0,0.2,0,0.1,0,0.3,0.1,0,0,0,0.6,0.7,20.4,0.8,0.8,0.4,1.3,0.4,2.6,0.2,6,1.6,0,0,0.2,0.1,0.8,0,4,1.2,0,0,0,0,0,0.3,0,0,0,0,0,0.1,0.8,0,0,0,0,0,3.7,0.8,0,0.3,0,0,0,0,0.5,0.2,0,0,0,1.1,0,0,0,0.2,0.3,0,0,0,0.6
SLC26A1,"EDM4, SAT-1",ENSG00000145217,Solute carrier family 26 member 1,Q9H2B4,4,979073-993440,"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters","Anion exchange, Antiport, Ion transport, Transport",Ion channel,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,kidney: 17.1;liver: 45.4,Group enriched,Detected in some,4,Extravillous trophoblasts: 3.3;Hepatocytes: 9.0;Proximal tubular cells: 8.5,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in some,NA,basophil: 7.0,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,Hep G2: 13.3;HMC-1: 9.1;T-47d: 9.2,Low region specificity,Detected in all,NA,NA,Not detected,Not detected,NA,NA,HPA041654,Uncertain,NA,Approved,Microtubules,NA,NA,NA,NA,NA,Microtubules,NA,HPA041654: AB_10796350,unprognostic (1.96e-2),unprognostic (1.46e-2),unprognostic (1.26e-1),unprognostic (4.91e-2),unprognostic (1.74e-1),unprognostic (2.67e-4),unprognostic (5.13e-2),unprognostic (5.82e-2),unprognostic (2.16e-1),unprognostic (3.88e-2),unprognostic (1.53e-3),unprognostic (2.92e-2),prognostic favorable (1.19e-4),unprognostic (1.18e-2),unprognostic (2.22e-1),unprognostic (1.27e-1),unprognostic (1.65e-3),1.1,6.5,1.4,1.7,1.7,1.5,1.6,4.6,2.7,1.3,7.4,1.1,1.1,6.5,1.4,1.9,1.1,1.1,2.6,1.1,1.4,1.5,17.1,45.4,1.1,1.7,1.1,1.1,1.6,4,0,2.1,1.1,1.1,1.8,0,1.1,4.2,1.1,1.5,3.1,10.5,1.1,1.1,2.4,4,1.1,1.1,1.1,2,1.1,1.1,1.1,1.1,0.4,0.3,7,0.6,1.1,1.8,0.7,1.3,2.3,0,1.8,0.2,0.4,4.2,1.9,0.1,0,0,4.5,2.6,0.7,2.3,0,1.8,1.3,0.1,0,0,2.6,0.9,3.4,3.1,13.3,0.2,2.1,9.1,0.6,0.2,0.1,0,1,0.3,2.9,3.5,0,0.4,2.9,1.3,3.6,1,1.7,7.2,7.3,0,0.3,0.7,5.1,0.2,1.4,0.5,0.2,1.2,0.4,9.2,1.4,2.1,4.8,1,4.8,1.3,7,3.2,1.2,1.7,4.4,2.1,7,0.6,0.4,0.4,0.3,0.8,0.4,1.2,0.9,0.2,0.1,0.8,1.8,0,1.1,0.3,0.3,1.6,0.7,1.4,1.7,4.6,1.6,1.4,1.5,1.1,1.1,1.1,1.1,0,0.6,0,0.2,0,0,1.1,0,0,0,0,0,0,1.7,0.1,0,0,1.3,0,0.3,3.3,0.2,0.1,1.1,9,0.6,0,0,1.3,0.3,0,0.9,0,1.7,0,0.6,0.2,0.6,0.2,0.4,8.5,0.1,0,0.3,0,0.1,0.1,0.7,0,0.6,0.1
SLC26A10,NA,ENSG00000135502,Solute carrier family 26 member 10,Q8NG04,12,57619527-57626151,"Predicted membrane proteins, Transporters","Antiport, Transport",NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enhanced,Detected in some,NA,heart muscle: 8.5,Group enriched,Detected in some,4,Bipolar cells: 9.1;Peritubular cells: 4.9,Cancer enhanced,Detected in single,NA,glioma: 1.4,Region enhanced,Detected in single,NA,cerebellum: 3.8,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,AN3-CA: 3.0;HEK 293: 3.5;NTERA-2: 5.6;RH-30: 4.4;SH-SY5Y: 7.9;U-266/70: 5.4,Low region specificity,Detected in some,NA,NA,Not detected,Not detected,NA,NA,HPA044719,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA044719: AB_10962362,unprognostic (1.16e-1),unprognostic (1.21e-2),unprognostic (8.57e-2),unprognostic (8.82e-2),unprognostic (1.86e-1),unprognostic (1.89e-2),unprognostic (7.92e-2),unprognostic (1.45e-1),unprognostic (3.12e-2),unprognostic (1.89e-1),unprognostic (6.12e-5),unprognostic (3.22e-3),unprognostic (2.65e-12),unprognostic (1.28e-2),unprognostic (3.80e-1),unprognostic (7.34e-3),unprognostic (1.40e-1),2,0.7,0.4,0.5,0.9,0,0.4,3.8,0.9,0.4,0.8,0.4,0.4,0,2.9,1.2,0.4,1.9,1.8,8.5,0.4,0.2,0.4,0.4,0.4,0.5,0.4,0.4,0.9,0.4,0,0.4,0.4,0.4,2.1,0.5,0.4,0.8,1.6,2.6,0.1,1.1,1.9,0.4,0.7,0.6,0.4,0.4,0.4,0.4,0.4,0.4,0.9,0.6,0,0,0,0,0,0,0,0,0,2.1,3,0,0,0.5,1.1,0.2,0.7,0.3,0.1,0,0.3,0.2,0,0.2,0,0.7,0,0.2,0,3.5,0.4,0.2,0.7,0.7,0,0.1,0,0,0.5,0,0.4,0,0,1,1.1,0,0,0,0,5.6,0,0,0,4.4,0,0,0,2.3,7.9,0,0,0.5,0.4,0.1,0.6,0,0.6,1.3,0.7,0,5.4,0.5,0,0.8,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0.9,3.8,0.9,0.4,0.2,0.4,0.4,0.4,0.4,0,0,0,0,0.3,9.1,0.8,0,0,0,0,0,0,0,0,0,0.7,0,0,0,0,1.3,0,0,0,0.1,0,1.7,0,0,0,1.4,0,0,0,0,1.4,0,0,4.9,0,0.8,0,1.7,0.5,0.2,0.4,0.1,0,0,0
SLC26A11,NA,ENSG00000181045,Solute carrier family 26 member 11,Q86WA9,17,80219699-80253500,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Anion exchange, Ion transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,6,Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 37.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Group enriched,Detected in many,6,dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA029893,Approved,NA,Supported,"Nucleoplasm,Golgi apparatus,Vesicles",NA,NA,NA,NA,NA,"Golgi apparatus, Vesicles",Nucleoplasm,HPA029893: AB_10600809,unprognostic (5.86e-2),unprognostic (6.66e-2),unprognostic (3.84e-2),prognostic unfavorable (1.55e-5),unprognostic (3.80e-2),unprognostic (2.63e-3),prognostic unfavorable (1.82e-6),unprognostic (2.05e-2),unprognostic (3.54e-2),unprognostic (1.03e-1),prognostic favorable (1.43e-5),unprognostic (2.86e-1),unprognostic (3.50e-1),unprognostic (9.54e-3),unprognostic (8.40e-2),unprognostic (8.69e-2),unprognostic (7.32e-2),9.9,30.9,10.2,10.2,19.3,16.3,8.4,9.1,18,11.6,8.2,12.6,14.1,8.7,11.6,14.6,6.9,9.2,10,5.1,9.4,30.5,12.4,6.9,12.8,14.3,10.5,17.4,18.3,7.9,14.9,25.6,21.1,17.2,11.8,5.1,15.6,12.2,14.8,6.5,13.1,11.9,11.6,9.3,17.3,7.3,4.8,7.3,1.8,18.1,4.9,6.7,9.8,14.1,0.4,1.3,0.1,2.3,0.1,4.9,1.9,0.5,8.2,9.7,7.5,4.9,3.6,11.2,4.7,5.9,10.6,6.6,9.4,1.7,0.1,9.6,4.9,7.7,3.1,5.4,3.5,4.2,11.2,9.7,0,10.4,8.7,12.9,0,1.5,6.6,5.7,5.1,2.3,1,8.9,1.9,4,11.9,6.2,7.7,0.4,0.2,4.3,2.3,8,0.4,1,4.3,9.6,9,3.8,11.9,4.7,11.8,12.2,15.8,14.1,0.2,6.6,8.6,5,7.3,0.5,13.5,5.1,1.3,4.4,0,6.8,0,2.3,0,1.8,0.9,2.6,0.4,3.2,2.6,1.3,0.2,4.9,2,0.1,0.1,0.3,0,4,1.9,10.2,19.3,9.1,18,9.4,30.5,10.5,17.4,17.2,7.3,6,12,0.9,9.3,4,28,2,0,2.7,5.7,12.2,55,12.2,1.7,6.3,0.4,14.1,3.9,0,5.3,7,8.2,9.4,1.1,2,14,3.2,9.8,6.2,5.9,0.2,15.8,8.3,3.3,2.8,2.5,21,3.9,3.5,11.7,4.8,37.6,32.3,4.7,0.2,1.5,4.1,21.7,5.7,2.8,5.2
SLC26A2,"DTD, DTDST",ENSG00000155850,Solute carrier family 26 member 2,P50443,5,149960737-149993455,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,NA,"Disease mutation, Dwarfism",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,intestine: 81.9,Cell type enriched,Detected in many,4,Syncytiotrophoblasts: 676.5,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,EFO-21: 24.2;RPTEC TERT1: 55.5;TIME: 28.5,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA041957, HPA058090",Enhanced,NA,Approved,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,"HPA041957: AB_10795646, HPA058090: AB_2683602",unprognostic (6.64e-2),unprognostic (1.53e-1),unprognostic (3.03e-2),prognostic favorable (7.29e-4),unprognostic (2.59e-2),unprognostic (5.64e-2),prognostic unfavorable (4.66e-4),unprognostic (2.59e-1),unprognostic (5.64e-2),unprognostic (1.19e-1),unprognostic (7.43e-2),unprognostic (2.10e-1),prognostic unfavorable (3.27e-4),unprognostic (1.70e-1),unprognostic (1.77e-1),unprognostic (8.12e-2),unprognostic (1.06e-1),8.5,15.6,2.6,23.2,3.7,1.3,4.7,6.3,2.3,3.8,81.9,3,29.4,5.4,4.8,14.2,8.3,3.1,2.6,3.1,2.5,2.6,3.8,1.6,6.8,5.3,3.7,2.3,5.1,2.9,21.4,11.1,16.9,7.6,6.1,75,4.9,27.9,36.7,11.2,6,13.4,4.3,5.5,3,2.4,2.8,3,5.2,2.7,4.4,13,4.1,2.8,1.6,1.7,7,3.3,2.5,3,1.1,3.3,3,3.8,6.2,4.6,3.3,0.9,3.1,2.8,2.5,3.1,15.7,1.8,2.5,24.2,3.3,6.1,2.4,3.6,7.3,4.6,2,2.3,3.2,2.4,1.8,3.5,5.9,5.5,3.6,4.3,4.2,5.5,6.3,6,3.2,0.8,2.6,10.6,1,2.2,3.1,1.2,1.1,4.8,3.3,5.9,1.3,55.5,14.7,1.1,2.9,5.5,1.3,9.4,3.1,2.6,3.5,28.5,5.9,4.4,5.1,3.7,1.8,2.4,1.5,5.4,7.2,8.4,7,1.1,0.8,2.5,0.8,3,1.3,1.5,2.1,1.7,1.6,2.1,2.2,1,2.5,3.3,1.7,2.6,1.1,2.6,3.7,6.3,2.3,2.5,2.6,3.7,2.3,7.6,3,41.7,13.7,7.5,12.5,4,16.1,6.7,7.6,6.7,14.8,31.4,15.7,160.9,1.7,5.2,17.7,15.3,151.8,0,8.6,5.2,16,21.5,87.8,2.4,26.4,6.4,20.3,16.5,13.8,9.9,16.1,12.2,86,16.2,37.7,15,9.4,147.9,11.7,4.4,80.3,0,10.2,9.2,10.2,4.4,676.5,9.6,53.2,4.9
SLC26A3,"CLD, DRA",ENSG00000091138,Solute carrier family 26 member 3,P40879,7,107765467-107803225,"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Antiport, Transport",NA,"Cancer-related genes, Disease mutation",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,5,gallbladder: 53.5;intestine: 110.1;lymphoid tissue: 42.8,Cell type enriched,Detected in some,11,Enterocytes: 543.6,Cancer enriched,Detected in many,14,colorectal cancer: 52.5,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,BEWO: 2.3;CACO-2: 1.9;NB-4: 1.5;RPMI-8226: 7.6,Low region specificity,Detected in single,NA,NA,Not detected,Not detected,NA,NA,HPA036055,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA036055: AB_10602401,unprognostic (1.26e-2),unprognostic (1.28e-1),unprognostic (1.12e-2),unprognostic (2.69e-1),unprognostic (4.02e-1),unprognostic (4.09e-2),unprognostic (3.05e-3),unprognostic (6.31e-2),unprognostic (1.68e-2),unprognostic (1.20e-1),unprognostic (1.14e-1),unprognostic (2.05e-2),unprognostic (8.85e-2),unprognostic (8.01e-2),unprognostic (5.52e-2),unprognostic (2.54e-2),unprognostic (3.58e-3),0.3,0.3,0.3,42.8,0.3,0,6.1,0.3,0.3,0.4,110.1,0.2,0.3,58.4,0.3,1.2,0.3,0.6,53.5,0.3,0.3,0.3,0.3,0.4,0.3,0.2,0.3,0.2,0.3,0.3,0,0.3,0.2,0.2,0.5,92.7,0.2,0.3,14.4,0.3,0.3,106.5,1.2,0.3,0.3,0.4,0.3,0.2,0.2,0.3,0.2,0.2,0.4,0.3,0,0,0,0,0,0.6,0,0,0,0,0,0,0,2.3,0,0,0,0,1.9,0,0.1,0.1,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.5,0.1,0,0,0,0,7.6,0,0,0.7,0.5,0,0,0,0,0,0,0,0,0.2,0.2,0.3,0.1,0.1,0.1,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0.6,0,0,0,0,0,0.2,0,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.2,0.2,0.2,0,0,0,0,0,0,0.2,48.4,0,0,0,0,0,0,0,1.1,0,543.6,0,0,0,0,0.2,27.5,0,0,0,13.7,0,0,0,0.3,0,0,0,26.7,0,0,40.8,0,0,0,0,0,0.1,0,0,0,0,20.4,0
SLC26A6,DKFZp586E1422,ENSG00000225697,Solute carrier family 26 member 6,Q9BXS9,3,48625723-48635493,"Plasma proteins, Predicted membrane proteins, Transporters","Anion exchange, Antiport, Ion transport, Transport","Chloride channel, Ion channel",NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,6,Enterocytes: 43.3;Mucus-secreting cells: 32.0;Paneth cells: 36.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA048363,Approved,NA,Uncertain,Cytosol,NA,NA,NA,NA,NA,Cytosol,NA,HPA048363: AB_2680371,unprognostic (1.54e-1),unprognostic (4.94e-2),unprognostic (3.34e-1),unprognostic (3.15e-2),unprognostic (2.15e-1),unprognostic (1.03e-1),prognostic unfavorable (3.92e-4),unprognostic (2.39e-1),unprognostic (2.35e-1),unprognostic (2.04e-1),unprognostic (4.09e-1),unprognostic (9.66e-3),prognostic unfavorable (1.53e-5),unprognostic (1.39e-2),unprognostic (1.17e-1),unprognostic (1.55e-1),unprognostic (3.58e-2),5.3,5.7,6.4,12.3,9.8,18.8,5.7,6.8,6.9,6.3,24.8,6,7.3,9.7,6.8,7.4,6.5,4.7,6.3,6.7,4.9,3.1,13.6,6.2,7.8,7.4,9.4,3.1,6.7,14.9,6.8,5.8,6.5,9.3,10.2,25.4,7.7,9.6,7.4,8.8,6.7,19.5,6.8,4.8,10.6,19.7,7.7,9.9,7.7,5.5,5.4,6.3,5.1,6.6,0.9,8.8,5.2,10.7,0.5,3.3,4.5,4.5,5.1,7.3,8.2,23.1,11.6,6.2,7.5,9.9,14.6,15.7,9.7,4.2,6.5,2.6,6.4,16.2,6.1,6.8,6.9,4.2,4.8,6.8,5.9,14.5,18.7,16.8,2.8,9.2,15.8,24.8,9.9,7.2,12.6,4.5,6.7,4.5,7.4,3.5,5.4,5.4,14.8,10.4,12.5,9.9,2.8,2.7,7.9,10.7,4.5,1.8,3.5,9.8,12.1,14.1,10.6,6.3,10.5,3.6,6.3,5.3,8.5,17.1,8.8,9.2,2.9,5.3,11.1,15.9,5.2,10.7,2.1,3.1,10,2.8,0.9,1.9,2,8.8,0.2,1.1,1.6,1.5,0.5,8.9,5,3.3,4.5,6.4,9.8,6.8,6.9,4.9,3.1,9.4,3.1,9.3,9.9,3,5.1,0.8,2.4,2.9,1.5,6.4,2.5,2.7,1.2,1.8,13.7,7.5,0,2.5,1.2,2.9,43.3,0,5.6,13.1,4.3,1.9,0,4.2,6.2,4.8,19.5,5.5,5.2,0.7,3.4,7,5,4.6,32,2,5.2,36.6,8.9,5.1,6.4,0,5.7,2.5,5.7,3,8.8,3.8,23.5,0.8
SLC26A7,SUT2,ENSG00000147606,Solute carrier family 26 member 7,Q8TE54,8,91209494-91398152,Predicted membrane proteins,"Anion exchange, Ion transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,15,thyroid gland: 194.5,Group enriched,Detected in some,5,Collecting duct cells: 22.7;Distal tubular cells: 11.6;Intestinal endocrine cells: 43.5;Ito cells: 15.4,Group enriched,Detected in some,11,renal cancer: 8.7;thyroid cancer: 32.4,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,CAPAN-2: 1.7;EFO-21: 1.3;HAP1: 3.0;HEK 293: 1.7;U-266/70: 3.1,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (1.63e-1),unprognostic (1.17e-1),unprognostic (5.84e-2),unprognostic (8.04e-3),unprognostic (4.15e-3),unprognostic (1.51e-1),unprognostic (2.39e-3),unprognostic (2.94e-3),unprognostic (1.24e-1),unprognostic (1.43e-1),unprognostic (1.41e-2),unprognostic (8.26e-2),unprognostic (4.82e-2),unprognostic (3.31e-2),unprognostic (2.07e-1),unprognostic (5.19e-3),unprognostic (6.83e-3),0.3,0.1,0.1,0.4,0.1,0,0.2,0.1,0.2,1.6,0.2,0,0.2,0,1.4,0.2,0.3,0.1,0.1,0.3,0.1,0.1,13,0.1,0.1,1.7,0.1,0,0.1,0.3,0.1,0.3,4.4,0.7,0.1,0,8.6,0.8,0.1,0.2,0.2,0.1,0,0.3,0.1,1.5,0.2,0,0,194.5,0,0,0.1,0.1,0.6,0,0,0,0,0.5,0,0,0,0.3,1.1,0,0,0,0,0,0,0,0,1.7,0.2,1.3,0,0,0,3,0.1,0.2,0,1.7,0.3,0.1,0,0,0,1.2,0.3,0.5,0,0,0,0,0.3,0,0,0,0,0.1,0.1,0,0.3,0,0.1,0,0,0.3,0.3,0.4,0,0,0,0,0.6,0,0,0,0.2,0.8,0,0.6,3.1,0.7,0.1,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0.6,0.5,0,0,0,0,0,0,0,0.1,0.1,0.1,0.2,0.1,0.1,0.1,0,0.7,0,0,1,0,0.3,0.2,0,0.8,0,0,0,22.7,0,0,11.6,0,4.4,0.6,0,0,0.2,0,0.4,0.3,0,0,0.1,0,43.5,15.4,0.6,1,3.4,0,3.3,0,0.7,0.1,0.8,0,0,0.1,0,0,0,0.2,0.6,0.1,0,0,0.2,0
SLC26A8,NA,ENSG00000112053,Solute carrier family 26 member 8,Q96RN1,6,35943514-36024868,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport",Developmental protein,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,12,testis: 65.2,Cell type enhanced,Detected in some,24,Early spermatids: 26.1;Late spermatids: 8.8;Spermatocytes: 42.9,Not detected,Not detected,NA,NA,Low region specificity,Detected in many,NA,NA,Cell type enriched,Detected in single,12,neutrophil: 5.4,Lineage enriched,Detected in single,12,granulocytes: 5.4,Cell line enhanced,Detected in some,NA,Karpas-707: 1.0;RT4: 2.9;T-47d: 1.0;THP-1: 2.3;TIME: 1.6,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,HPA038081,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA038081: AB_10670653,unprognostic (8.18e-2),unprognostic (1.74e-1),unprognostic (6.71e-2),unprognostic (1.31e-2),unprognostic (2.46e-1),unprognostic (7.07e-3),unprognostic (2.93e-1),unprognostic (6.31e-2),unprognostic (1.11e-1),unprognostic (1.11e-1),unprognostic (1.85e-1),unprognostic (3.78e-1),unprognostic (4.63e-6),unprognostic (7.14e-2),unprognostic (4.24e-1),unprognostic (2.31e-1),unprognostic (5.24e-8),0.3,0.2,1.3,0.5,2.2,3.7,0.3,4.2,1.8,0.2,0.2,0,0,0.2,0.2,0.2,0.2,0.2,0.2,0.2,0.8,2.1,0.2,0.2,0.2,1.1,0.7,1.7,0.2,0.3,0.2,0.1,0.2,1.9,0.2,0.2,0,0.2,0.3,0.2,0.2,0.2,0.2,0.6,0.9,0.2,65.2,0.1,0.1,0.4,0,0.2,0.2,0,0,0.2,5.4,0.4,0,0,0.2,0,0,0.3,0,0.1,0,0.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0.3,0,0,0.6,0,0,0.1,1,0,0,0,0.8,0.2,0,0,0.4,0,0,0.8,2.9,0.8,0,0,0,0.1,0.2,1,2.3,1.6,0,0,0,0.1,0,0.1,0,0,0.4,0,0,0.4,0,0,0,0,0,0,0,0.2,0,0,0,5.4,0,0,0,0,0.2,1.3,2.2,4.2,1.8,0.8,2.1,0.7,1.7,1.9,0.1,3,1.4,0,0.3,0.3,0.2,0.7,0,0,0,0,0,0,0,0,26.1,0,0,0,0,0,0.3,0.2,0,0.8,0.1,0,0,0.6,1.2,8.8,0.9,0.4,1.7,0,0,0,0.1,0,0.4,0,0.1,0,0,42.9,0.3,0.1,0.2,0,0,0.1
SLC26A9,NA,ENSG00000174502,Solute carrier family 26 member 9,Q7LBE3,1,205913048-205943460,"Predicted membrane proteins, Transporters",NA,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,6,salivary gland: 108.4,Cell type enhanced,Detected in some,23,Alveolar cells type 2: 51.6;Cardiomyocytes: 25.8;Proximal tubular cells: 10.5,Cancer enhanced,Detected in many,NA,pancreatic cancer: 9.3,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,CAPAN-2: 12.6;Hep G2: 4.7;OE19: 20.5,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,HPA051485,Enhanced,NA,Approved,Cell Junctions,NA,NA,NA,NA,NA,Cell Junctions,NA,HPA051485: AB_2681503,unprognostic (1.55e-2),unprognostic (2.70e-2),unprognostic (8.77e-2),unprognostic (3.14e-1),unprognostic (1.83e-2),prognostic favorable (8.55e-5),unprognostic (1.26e-1),unprognostic (1.68e-1),unprognostic (3.49e-1),unprognostic (8.07e-2),unprognostic (8.85e-2),unprognostic (3.41e-1),unprognostic (2.43e-1),unprognostic (2.19e-1),unprognostic (1.05e-1),unprognostic (7.45e-3),unprognostic (2.01e-1),0.1,0,0.1,0.2,0.1,0,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0,0.1,0.1,1.3,0.1,6.4,0.1,0.1,0,0.1,0.1,5.5,0.1,0.1,0.1,0.1,0.5,0,0.3,0.1,0.1,0.1,0,0.1,108.4,0.1,0.1,1.9,0.1,0.1,0.1,0.1,17.8,0.1,0.1,0.2,0.4,1.1,2.7,0.1,0.4,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,12.6,0,0.6,0,0,0.3,0,0,0,0,0,0,0,4.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,20.5,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0.1,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.1,0.1,0.1,0.1,0,0.1,0.1,0.1,0.1,3,51.6,0,0,0,0,25.8,0,4,4.5,1.8,0,0,1.7,2.9,0.4,0,0,0,2.1,0,0,0.1,2.3,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0.4,0,0,10.5,0,0,0,0,0,0,0,0,0,0.6
SLC27A1,"ACSVL5, FATP, FATP1, FLJ00336, MGC71751",ENSG00000130304,Solute carrier family 27 member 1,Q6PCB7,19,17468769-17506168,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport",Ligase,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,ASC diff: 17.6;SK-MEL-30: 29.1,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA076520,NA,NA,Approved,"Plasma membrane,Mitochondria,Cytosol",NA,NA,NA,NA,NA,Plasma membrane,"Mitochondria, Cytosol",HPA076520: AB_2732311,unprognostic (1.48e-3),unprognostic (3.03e-2),unprognostic (5.72e-3),unprognostic (5.84e-2),unprognostic (2.16e-3),unprognostic (4.36e-2),unprognostic (8.56e-2),unprognostic (3.36e-2),unprognostic (9.03e-2),unprognostic (1.85e-2),unprognostic (1.12e-1),unprognostic (2.28e-1),prognostic favorable (4.70e-4),unprognostic (5.01e-2),unprognostic (2.25e-1),unprognostic (1.02e-1),unprognostic (1.12e-1),14.5,14.3,13.1,5.2,13.9,2,9.3,20.1,19.3,11.8,6.4,44.1,10.1,4.6,8.9,6.4,5.9,14.7,11,18.3,12.9,10,5.2,5.2,8.5,6.7,22,17.2,23.2,14.5,26.1,9.8,7.5,16.1,11,2.6,9.6,26.7,13,24.2,13.7,3.7,5.5,13.4,7.1,10.9,9.6,19.3,1.3,9.9,4.7,5.3,6.9,8.8,0.5,7.4,0.3,9.9,1.7,3.2,4.6,3.6,1.8,2.5,6.1,17.6,9.8,2.1,2.6,7,3,4.5,0.2,11.3,1.2,5,4.4,2.8,4.4,0.2,4.1,0.7,1.4,0.8,0.7,0.2,1.3,3.4,0.3,4,9,2.9,3,1.2,12.5,2,2.4,0.4,0.7,1.9,1.5,2,2.9,0.7,3.6,3.2,2.8,2,0.8,1.9,1.1,0.8,1.8,1.8,0.9,29.1,1.6,3.2,0.9,1.2,5.9,3.9,4.7,1.8,2.5,1.8,0.4,6.1,3.2,4.1,0,9.9,0.3,1.7,4.7,3.2,0.5,1.2,2.1,7.2,0.3,1.6,2.1,0,1.7,1.8,7.4,0.7,4.6,13.1,13.9,20.1,19.3,12.9,10,22,17.2,16.1,19.3,3,14,1.5,14.9,6,8.2,16.7,10.2,4,9.1,8.7,25.5,3.7,1.7,9.3,0.7,4.7,0.1,0,4.1,14.7,9.7,10.3,2.3,5.8,24.7,6.4,5.2,9.2,20.6,1.7,19.8,9.1,8.5,5.4,2.6,9.7,4.9,0,11,2.7,17.6,6.5,5.2,8.1,4.3,4,1.9,6.1,1.3,7
SLC27A2,"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS",ENSG00000140284,Solute carrier family 27 member 2,O14975,15,50182196-50236395,"Enzymes, Predicted membrane proteins, Transporters","Fatty acid metabolism, Lipid metabolism",Ligase,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,4,liver: 168.1,Cell type enhanced,Detected in many,15,Cytotrophoblasts: 236.8;Hepatocytes: 188.9;Proximal tubular cells: 112.0,Cancer enhanced,Detected in many,NA,liver cancer: 49.2,Low region specificity,Detected in many,NA,NA,Cell type enriched,Detected in some,27,basophil: 27.3,Lineage enriched,Detected in many,27,granulocytes: 27.3,Cell line enhanced,Detected in many,NA,A549: 17.9;HaCaT: 32.2;HL-60: 23.1;OE19: 36.0,Low region specificity,Detected in many,NA,NA,Region enriched,Detected in single,6,hippocampal formation: 2.5,HPA026089,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA026089: AB_1857060,unprognostic (3.03e-2),unprognostic (1.13e-1),unprognostic (1.51e-1),unprognostic (2.10e-2),unprognostic (3.06e-1),unprognostic (1.10e-1),unprognostic (4.06e-3),unprognostic (3.33e-1),unprognostic (1.89e-1),unprognostic (6.38e-3),unprognostic (4.83e-2),unprognostic (1.82e-1),prognostic favorable (7.48e-6),unprognostic (5.01e-3),unprognostic (4.08e-1),unprognostic (1.22e-2),prognostic favorable (6.40e-4),1.1,8.1,0.7,4.1,0.8,1.2,3.4,1.5,1,0.5,4.2,0.4,1.3,2.5,0.2,17.5,1.2,2.6,1.3,0.2,1.1,1.1,39.4,168.1,1.7,0.8,0.3,1,0.7,6.3,2,10.4,7.4,3,1.2,4,3.2,0.6,0.3,0.2,0.6,5.3,0.1,0.3,0.4,0.4,0.7,0.1,0.1,1,0.2,1.3,1.4,0.8,0.1,0,27.3,0,1,0.5,0.2,0,17.9,0,0,0,0,0,0.3,0.1,0.3,0.5,9.3,2.5,0,0.2,0.4,0.2,32.2,8.2,0.2,0.8,12.6,10.1,13.2,16.6,8.3,0.1,23.1,9.5,0,0.7,0,0,0,0,6.1,4,0,0,2.9,0.6,15.6,0.6,36,0.6,0,0,0.6,1.7,16.3,14.9,0.9,3.1,0.4,0,0.4,1.7,8.1,0,0,0.8,0,0,0,0,0,0,7.5,0,27.3,0,0.4,0.4,0,0.4,0.1,0.4,0.4,0,0.1,0.1,0.1,0.2,1,0,0,0.5,0.2,0.7,0.8,1.5,1,1.1,1.1,0.3,1,3,0.1,0,0.6,0.9,0.8,0.9,0.7,0.3,0,54.9,6.8,8.7,0,236.8,10,0.3,0.4,0.1,20.6,0,1.7,2.6,0,1.8,5.8,188.9,14.3,1.6,4.1,3.7,2.5,0,0.3,0.1,0,0,18.6,0.5,1.6,28.1,0,112,1.5,0,0.1,1.8,2.5,0.3,45.9,4.3,21.1,4.4
SLC27A3,"ACSVL3, FATP3, MGC4365",ENSG00000143554,Solute carrier family 27 member 3,Q5K4L6,1,153774354-153780157,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Fatty acid metabolism, Lipid metabolism",Ligase,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,9,Ito cells: 131.3,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Group enriched,Detected in many,4,dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7,Cell line enhanced,Detected in many,NA,ASC diff: 35.6;HaCaT: 12.5;MCF7: 18.8,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in single,NA,NA,"HPA006935, HPA067508",Enhanced,NA,Enhanced,Endoplasmic reticulum,NA,Yes,No,NA,NA,Endoplasmic reticulum,NA,"HPA006935: AB_1080003, HPA067508: AB_2685857",unprognostic (1.88e-1),unprognostic (2.66e-2),unprognostic (1.34e-1),unprognostic (3.57e-2),unprognostic (2.70e-2),unprognostic (4.85e-2),unprognostic (6.08e-2),unprognostic (3.18e-2),unprognostic (4.22e-2),unprognostic (3.39e-2),prognostic favorable (5.23e-4),unprognostic (4.67e-2),prognostic unfavorable (6.33e-4),unprognostic (1.95e-1),unprognostic (4.41e-1),unprognostic (2.59e-1),unprognostic (2.08e-1),20.7,3.7,4.9,6.4,4.3,3.7,15,7.5,6.6,11.1,11.6,3.6,7.9,3.5,10.1,39.1,9.4,9.5,9.2,7,3.5,2.4,12.2,19.5,21.1,7,3.5,4.7,13.6,5.7,4.5,6.7,9.7,3.3,11.6,6.1,4.6,7.7,9.7,3.6,11,6.8,10.5,1.8,6.9,14.4,15.4,3.4,3.5,8.6,10.3,5.5,9.7,9.4,0.6,5.9,13.7,8.7,2.2,2.2,2.5,4,0.2,1.7,0.8,35.6,6.9,3.1,1.5,3,0.6,0.8,2.3,1.8,0.5,4.2,1.7,0.3,12.5,1.7,1.4,0.4,0.3,2.3,0.8,2.2,1,4.3,1.4,2.9,4.6,4.7,0.2,0.9,0.6,4.8,0.2,0.4,0.7,0.2,18.8,0.1,4.1,4.1,8.6,1.9,7.1,0.3,0.4,1,0.5,3.5,3.9,0.8,8.3,1.5,2.4,2.2,4.1,1.1,0.8,1.7,4.4,0,1.3,1.2,0.1,2,4.8,0.6,7.2,8.7,13.7,2.1,7.3,1.5,0.5,1,2.2,5.9,0.6,0.5,1.1,1.7,2.2,7.2,1,0.3,2.5,4.9,4.3,7.5,6.6,3.5,2.4,3.5,4.7,3.3,3.4,17.9,43.8,4.5,9.1,10.4,0.8,2.5,38.2,0,7.9,3.5,0,24.4,0,3.1,0.4,20.2,2.5,0,6.4,10.1,17.3,4.2,25.3,25.9,29.3,1.6,4.1,131.3,31.9,2.4,17.5,32.9,21.9,45.1,16,1.5,3.7,33.6,13.4,3.4,1,6.5,12.8,1.1,3.4,6.8,7.3,15.9,9.1,2.6
SLC27A4,"ACSVL4, FATP4",ENSG00000167114,Solute carrier family 27 member 4,Q6P1M0,9,128340646-128361470,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport",Ligase,"Disease mutation, Ichthyosis",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,intestine: 56.1,Cell type enhanced,Detected in many,9,Enterocytes: 75.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA007293, CAB009771",Approved,NA,Approved,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,"CAB009771: AB_2270540, HPA007293: AB_1857062",unprognostic (7.25e-2),unprognostic (1.29e-1),unprognostic (1.60e-1),unprognostic (3.92e-3),unprognostic (3.74e-2),unprognostic (2.03e-1),unprognostic (1.85e-3),unprognostic (1.31e-3),unprognostic (4.51e-1),unprognostic (4.69e-2),unprognostic (7.72e-2),unprognostic (5.07e-2),prognostic favorable (2.61e-5),unprognostic (7.29e-3),unprognostic (2.11e-1),unprognostic (3.45e-2),unprognostic (8.01e-3),7.7,7.1,9.9,7,13.6,2.5,4.9,9.4,26.5,6.5,25.7,15.8,5.2,54,6.6,5.6,26.1,4.4,9.8,7.7,11.6,15.9,17.7,20.8,5.8,5,14.8,9.6,5.6,11.3,9.8,5.4,5.8,21.9,5.7,8.3,6.7,7.5,7.3,6.7,24.3,56.1,8.1,11.6,5.1,8.6,13.2,7.9,6.8,12.7,15.2,14.9,8.5,9.5,3.7,7.2,2.6,6.2,1.9,8.1,3.3,10.2,20.1,10.3,13.2,15.7,4.8,11.8,8.7,5.5,10.1,7.3,14.4,10.1,9.6,7,9.3,12.1,35.2,12.4,10,3.1,9.6,19.1,5.7,17.7,12.5,8.5,10.5,9.2,6.3,13.7,10.4,8.3,4.5,11.4,13,13.5,6.7,9.2,25.2,12.4,10.1,4.6,23.2,32,15.2,10.1,17.8,17.2,15.5,17.9,9.8,14.5,26.7,9.5,5.4,13.3,4,16.7,12.1,11.8,13.2,10.7,6,8.5,3.1,12.3,6.3,13.6,0,4.1,2.6,8.1,5.6,6.1,3.7,5.2,6.4,7.2,1.7,4.1,4.3,1.6,1.9,6.2,6.4,3.6,3.3,9.9,13.6,9.4,26.5,11.6,15.9,14.8,9.6,21.9,7.9,0,1.4,3,1.2,2.5,9.3,2.8,7.6,1.4,0,8.7,11.8,4.9,1.7,12.4,2.2,3.3,75.1,0,13.8,5.7,3.8,2.4,9.2,15.5,9.9,7.9,12.6,4.9,7.1,3.6,1.1,2.9,1.7,12.6,14,4.8,20.8,31.7,3.9,8.1,6.2,6.5,2.7,8.8,6.9,5.4,4.3,1.7,12.4,2.6
SLC27A5,"ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2",ENSG00000083807,Solute carrier family 27 member 5,Q9Y2P5,19,58479512-58512413,"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Fatty acid metabolism, Lipid metabolism","Ligase, Oxidoreductase",NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,8,liver: 157.6,Group enriched,Detected in many,6,Early spermatids: 114.0;Hepatocytes: 338.0;Late spermatids: 303.5,Cancer enriched,Detected in all,26,liver cancer: 49.8,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in single,NA,NA,Low region specificity,Detected in many,NA,NA,"HPA007292, CAB056160, CAB068239",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CAB056160: AB_2665590, CAB068239: AB_2665592, HPA007292: AB_1857064",unprognostic (5.97e-2),unprognostic (9.12e-2),unprognostic (9.95e-2),unprognostic (6.36e-3),unprognostic (2.52e-1),unprognostic (7.46e-2),prognostic favorable (1.57e-4),unprognostic (1.04e-1),unprognostic (1.85e-2),unprognostic (2.46e-1),unprognostic (1.78e-2),unprognostic (8.56e-2),unprognostic (1.66e-4),unprognostic (2.27e-1),unprognostic (3.33e-2),unprognostic (7.80e-2),unprognostic (2.16e-1),1.3,2,5.4,1.4,5.3,1.1,2,1.9,3.9,1.7,1,1.7,1.2,1,1.1,1.1,1.4,2.6,1.1,1.3,3.7,3.8,1.9,157.6,0.9,1.4,4.3,2.5,1.4,2.6,1.1,1.3,0.8,3.4,1.4,0.8,1.3,2.7,2.1,1.4,1.1,0.9,1.5,2.7,1.1,1.1,2.3,3,1.4,1.8,0.6,1.4,1.1,1.6,13.3,10.8,2.2,3,9.6,18.7,8.9,16,22,3.9,4.1,3.7,3.9,2.4,0.9,2.1,3.1,4.3,1.7,3.5,20.9,2.7,1.1,0.6,3.4,4.5,14.1,1.3,9.7,14.9,14,22.9,18.3,5.6,7.3,5,4.5,2.4,0.4,8.5,5.3,1.5,15.9,12.9,0,3.7,13.1,18.1,15.5,2.4,13.5,12.9,9.1,0.1,28.4,10.1,7.6,5.4,7.3,0,21.7,4.7,1.1,6.4,6.4,1.2,0,2.8,0,1.8,13.8,15.4,8.5,4.5,13.7,0.8,0,2.4,2.2,8.7,3,18.7,13.3,11.2,11.4,6.5,8.9,13.9,14.3,0.3,9.6,2.1,10.8,13.3,8.9,5.4,5.3,1.9,3.9,3.7,3.8,4.3,2.5,3.4,3,0,8.2,11.5,13.1,8,11.5,5.6,22.9,9.4,5.7,5.2,0,6.4,33.2,10.3,114,11.9,1.3,0,13.3,2.3,7.6,17,4.7,338,9.1,9.5,9.7,15.4,11.3,303.5,10,8.9,15.1,1.8,3.5,6.1,7.4,0,8.9,39.7,7.6,6.5,15.5,8.8,13.2,12.3,2.9,10.2,4.7,12.1
SLC27A6,"ACSVL2, FACVL2, FATP6, VLCS-H1",ENSG00000113396,Solute carrier family 27 member 6,Q9Y2P4,5,128538013-129033642,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport",Ligase,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,adrenal gland: 23.2,Group enriched,Detected in some,5,Cardiomyocytes: 22.4;Cytotrophoblasts: 39.8;Extravillous trophoblasts: 30.2;Muller glia cells: 39.4;Syncytiotrophoblasts: 23.0,Cancer enriched,Detected in many,8,thyroid cancer: 19.7,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in some,9,BEWO: 31.9,Low region specificity,Detected in single,NA,NA,Low region specificity,Detected in many,NA,NA,HPA008987,Approved,NA,Approved,Nuclear bodies,NA,NA,NA,NA,NA,Nuclear bodies,NA,HPA008987: AB_1857065,unprognostic (5.39e-5),unprognostic (4.79e-2),unprognostic (1.04e-1),unprognostic (3.15e-1),unprognostic (3.55e-1),unprognostic (1.34e-2),NA,unprognostic (1.01e-1),unprognostic (1.34e-1),unprognostic (3.22e-1),unprognostic (2.78e-1),unprognostic (1.53e-1),NA,unprognostic (2.64e-1),unprognostic (2.14e-1),unprognostic (2.54e-2),unprognostic (9.66e-4),0.5,23.2,6.3,0.5,6.8,0.3,2.9,0.6,2.8,4.1,0.9,8.2,0,0.6,4.2,0.5,7.2,19.5,2.7,20.6,3.2,3.3,0.2,0.3,0.9,0.4,10.4,0,9.7,0.3,0.2,7.7,19.6,13.3,3.7,1.8,1.7,3.9,0.4,0.5,2.2,1.1,1,12.7,0.3,0.6,11.3,15.1,5.4,3.9,8.7,5.5,1.5,3.2,0.2,0.3,0,0,0,0.5,0,0,0,0.1,0,0,0,31.9,0.1,0,0,0.1,0,0,0,0,0.1,0,0,1.1,0,0.1,0.6,0.1,0.5,0,0,0,0,0.1,0.2,0.1,0,0,0,0.1,0,0.2,0,0.1,2.4,0,2.2,1.5,0,0,1.5,0,0,0,0.2,0.2,3.1,0,3.7,0,2.4,0,0,0,0,0.9,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0.2,0,0.5,0,0,0,0,0,0,0,0.3,0,0,6.3,6.8,0.6,2.8,3.2,3.3,10.4,0,13.3,15.1,0,0,0,1,2.9,0,22.4,0,0,0,0,0,39.8,0,0,6.2,0,0,0,0,30.2,0.9,0.1,0,0,3.4,3.2,0,0,0,1.5,0.3,0,0,0,0,39.4,0,0,0,0,0.6,0,0,0.9,1,0.6,23,0,0,0
SLC2A14,"GLUT14, SLC2A3P3",ENSG00000173262,Solute carrier family 2 member 14,Q8TDB8,12,7812512-7891148,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Differentiation, Spermatogenesis, Sugar transport, Transport",Developmental protein,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,7,testis: 52.4,Cell type enriched,Detected in many,7,Spermatocytes: 60.6,Cancer enriched,Detected in single,35,testis cancer: 7.1,Not detected,Not detected,NA,NA,Cell type enhanced,Detected in many,NA,neutrophil: 6.9,Lineage enriched,Detected in many,4,granulocytes: 6.9,Cell line enhanced,Detected in some,NA,BEWO: 12.6;CACO-2: 20.4;Hep G2: 5.3;SuSa: 25.2,NA,NA,NA,NA,NA,NA,NA,NA,HPA006539,Supported,NA,Approved,Plasma membrane,NA,NA,NA,NA,NA,Plasma membrane,NA,HPA006539: AB_1078984,unprognostic (2.52e-1),unprognostic (4.74e-3),unprognostic (1.79e-1),unprognostic (1.29e-1),unprognostic (3.35e-2),unprognostic (1.82e-3),unprognostic (8.62e-2),unprognostic (7.15e-2),unprognostic (1.89e-1),unprognostic (9.91e-3),unprognostic (1.23e-1),unprognostic (1.27e-1),unprognostic (8.46e-4),unprognostic (3.92e-2),unprognostic (3.41e-1),unprognostic (3.26e-2),unprognostic (1.22e-2),0.4,3.1,0.1,0.1,0.6,3,0.4,0.1,0.2,0.4,0.4,0.3,0.1,0,0.3,0.8,0.8,0.1,0.3,0.1,0.2,0.3,0.1,2,0.2,0.2,0.1,0.1,2.7,7.4,0,0.6,0.5,0.3,0.6,0.2,0.1,0.1,0.1,0.1,0.1,0.7,0.2,0.1,0.1,0,52.4,0.2,0.1,0.1,0.1,0.1,0.6,0.1,0.6,0.4,6.9,0.7,1.3,1.7,0.2,0,0.3,0.3,0.2,0.2,0.6,12.6,0,0,0,0.2,20.4,0.1,0,0.2,0,0,0.1,0,0,0,0.2,0,2.1,0.5,5.3,0,0,3,0,0.1,0,0,0.1,0,0.5,0.9,0.1,0,0.1,0.1,0.1,2.3,0,0,0.1,0.1,0.1,0,0.3,0.1,0,0,0.4,0,25.2,0,1.3,0.3,0.1,0.5,0.3,0.1,0.1,0.1,0.2,0.3,0,0.3,5.5,0.7,1.8,1,0.2,1.2,0.5,1,0.8,0.4,0.6,0.7,0.9,6.9,1.3,0.2,0.3,1.7,0.2,0.1,0.6,0.1,0.2,0.2,0.3,0.1,0.1,0.3,0.2,0,0.6,0,0,0.6,0,1.4,0,0,0,0,3.9,0.2,0,0,3.7,2.3,0,0,1.3,0.9,1.9,0,9.2,0.4,0.2,0,0,8,4.4,0.9,0.3,3.1,1.7,0,0,0,0.5,5.8,2.5,0,0.4,0,4.2,60.6,2.7,0.1,0.3,3.2,0,0
SLC2A4RG,"GEF, HDBP1, Si-1-2, Si-1-2-19",ENSG00000125520,SLC2A4 regulator,Q9NR83,20,63739861-63743505,Predicted intracellular proteins,"Transcription, Transcription regulation",DNA-binding,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,6,Hepatocytes: 90.0;Proximal tubular cells: 114.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Lineage enriched,Detected in single,4,T-cells: 3.1,Low cell line specificity,Detected in all,NA,NA,NA,NA,NA,NA,Low region specificity,Detected in all,NA,NA,HPA063050,NA,NA,Approved,Nuclear speckles,NA,NA,NA,NA,NA,Nuclear speckles,NA,HPA063050: AB_2684930,unprognostic (2.89e-2),unprognostic (2.32e-1),unprognostic (1.84e-2),unprognostic (5.78e-2),unprognostic (2.07e-3),unprognostic (6.48e-3),unprognostic (2.70e-1),unprognostic (1.96e-2),unprognostic (1.31e-1),unprognostic (3.44e-2),unprognostic (2.09e-3),unprognostic (1.50e-1),unprognostic (1.39e-2),unprognostic (1.41e-1),unprognostic (1.12e-1),unprognostic (1.50e-3),unprognostic (3.22e-1),30.9,10.5,6.3,7.4,6.1,13,16.4,5.4,7.5,19.3,14.2,6.7,18.9,5.2,11.7,17.9,25.1,10.1,19.6,19.3,5.2,4.4,19.3,37.5,10.6,18.6,5.8,4.2,25.1,17.3,5.1,6.9,9.4,6.3,23.4,2.6,16.1,14.7,15,71,20.2,9.1,29.4,5,14.4,11.3,13.2,3.3,6.1,9.3,19.9,16.2,19.3,11.6,0,0.7,0.5,0.2,0.6,3.1,0,17.8,12.2,5.4,9.1,4,10.1,7.3,11.7,9.5,25.6,9,22.1,31.3,2.3,19.6,5.8,9.1,18.5,1.8,13.7,2.8,10.8,5.9,2.2,9.3,12.9,11.9,7.7,6.4,10.9,18.3,5,5.7,5.8,7.2,3.3,8.6,3.6,8.8,21.6,4.6,16.4,2.7,12.8,34.8,21.5,11.7,8.6,8.5,4.9,7.3,13.6,24,14,3.1,1.3,32.8,29.1,6.9,33.8,13.9,20.5,9.4,9.8,14.2,5.4,14.9,6.8,8.8,0,0.1,0.5,2,0,0.8,0,3.1,1.8,0.3,0,3,1.9,0,0.6,0.2,0.7,1.8,0,6.3,6.1,5.4,7.5,5.2,4.4,5.8,4.2,6.3,3.3,8.9,20.5,8.2,28.4,21.8,10.7,18.2,17.8,4,9.1,40.1,9.8,26.5,66.3,6.8,5.2,19.2,10.5,23.3,9.2,14.2,34,13.4,3.5,90,12.4,9.5,2.4,15.4,14.2,3.3,26.7,8.6,3.3,14.4,18.8,22.3,13.9,9.3,32.5,114.1,6.5,32.3,17.6,0.9,5.6,33.1,7.2,22.3,14.5,10.1
SLC2A9,"Glut9, GLUTX, URATv1",ENSG00000109667,Solute carrier family 2 member 9,Q9NRM0,4,9771153-10054936,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters",NA,NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,kidney: 43.4,Cell type enhanced,Detected in many,14,Cytotrophoblasts: 16.4;Proximal tubular cells: 47.2,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in many,NA,NA,Cell type enhanced,Detected in some,NA,classical monocyte: 20.6;myeloid DC: 16.7,Group enriched,Detected in many,31,dendritic cells: 16.7;monocytes: 20.6,Cell line enhanced,Detected in some,NA,HBEC3-KT: 29.6;Hep G2: 14.2;hTCEpi: 12.5;THP-1: 12.5;U-937: 8.2,Low region specificity,Detected in single,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA066229, HPA075669",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA066229: AB_2685639, HPA075669:",unprognostic (3.21e-1),unprognostic (8.99e-3),unprognostic (1.25e-2),unprognostic (2.01e-1),unprognostic (2.14e-2),unprognostic (2.56e-2),unprognostic (8.94e-2),unprognostic (6.94e-2),unprognostic (2.86e-2),unprognostic (1.28e-2),unprognostic (3.16e-1),unprognostic (2.23e-1),prognostic favorable (1.32e-11),unprognostic (1.01e-1),unprognostic (3.88e-2),unprognostic (3.17e-3),unprognostic (1.20e-1),5.6,2.8,1,1.3,2,1.2,3.2,0.6,1.2,2.6,10.4,2.3,5.7,7.8,1.7,12,5.8,2.6,1.7,2.7,1,0.9,43.4,17.7,4.7,2.8,1.9,0.7,1.5,1.3,1.5,1.8,8.8,2.1,4.6,1.1,4.1,10.8,15.6,1.1,2.4,12,1.4,4.1,3,1.2,1.3,2.3,3,2.9,3.4,3.9,7.1,3.9,0.2,16.7,0.6,20.6,0.1,0.2,4.9,0.8,0,0,0,0,0,0.1,0.4,0.2,0,0,0.2,1.5,0,2.2,0.4,0,4.5,0,29.6,0,4.8,0.1,0,0,14.2,1,0.1,4,2.2,12.5,0,3.1,0,0,0.4,0,0.1,0.1,0,0.2,1.4,0,0.2,0.1,0.9,0,0,0.1,0.1,0.1,0,0,0,0,0,0,12.5,0.3,0,0,0,0,0,0,0,0,8.2,0,0,20.6,0.4,0.1,4.1,0.2,0.2,0.2,0,16.7,0.1,0.1,0,0.6,0.1,0.4,6.6,0.1,4.9,1,2,0.6,1.2,1,0.9,1.9,0.7,2.1,2.3,0,0,1.4,11.1,0.8,0,2.1,0,4,3.4,3.5,2,16.4,3.3,0.4,3.9,1.4,2.9,0,0.9,1.3,1.1,1,1.1,4.9,9.3,0,0,2.5,6.5,2.8,0,10.2,0,1,0.8,0.8,0.4,0,0.4,47.2,0.4,0,1,0.7,1.2,0.5,7.1,0.5,1,8.8
SLC2A12,"GLUT12, GLUT8",ENSG00000146411,Solute carrier family 2 member 12,Q8TD20,6,133988697-134052636,"Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,retina: 46.6,Cell type enhanced,Detected in many,15,Ciliated cells: 9.4;Glandular cells: 11.7;Muller glia cells: 11.4;Syncytiotrophoblasts: 30.7,Cancer enriched,Detected in many,6,prostate cancer: 18.2,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in some,NA,intermediate monocyte: 1.3;myeloid DC: 1.0,Group enriched,Detected in many,6,dendritic cells: 1.0;monocytes: 1.3,Cell line enhanced,Detected in some,NA,CAPAN-2: 7.4;hTERT-RPE1: 13.5;SuSa: 22.1;U-2 OS: 8.0,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in many,NA,NA,"HPA031593, HPA031594",Approved,NA,Supported,"Plasma membrane,Cell Junctions",NA,NA,NA,NA,NA,Plasma membrane,Cell Junctions,"HPA031593: AB_10600810, HPA031594: AB_2673948",unprognostic (2.06e-1),unprognostic (1.21e-1),unprognostic (1.69e-2),unprognostic (5.55e-3),unprognostic (2.18e-1),unprognostic (6.02e-2),unprognostic (2.24e-3),unprognostic (2.54e-2),unprognostic (2.08e-2),unprognostic (3.69e-2),unprognostic (2.38e-1),unprognostic (1.83e-1),unprognostic (2.33e-3),unprognostic (3.04e-1),unprognostic (1.65e-1),unprognostic (1.04e-2),unprognostic (1.55e-3),0.9,1.2,5.2,0.4,6.7,0.1,1.5,14.6,5.5,4.8,3,7.1,4.9,8.1,9.7,2.6,7,3.4,3,11.4,6.5,2.8,6.7,7.9,3.4,0.2,3.4,5.2,1.5,1.3,1.2,2.5,1.9,19.7,27,1.4,46.6,5.2,11.2,4.2,3.9,11.9,14.8,1.6,0.3,14.4,0.5,3.3,0.6,0.6,1.9,2.7,6.7,2,0,1,0,1.3,0,0.1,0.1,2.1,0.7,1.8,0,1.4,0.7,0.1,1.3,5.4,0.7,3,0,7.4,0.2,1.1,0.1,5.5,5.6,0,0.5,1,0,4.7,0,0.6,0.1,0.2,0,0,1,0.5,0.6,0.1,13.5,0.4,0.3,0.4,0.6,0.1,0.6,0.1,0.1,1.6,0,0.5,0,0.9,2,1.6,0.7,0.2,0.5,0,1.7,0,22.1,0,0,0,0.2,8,0.2,0.7,2.8,2.1,0,0.4,0,0,0,0.5,0,0,1.3,0.1,0,0,0,1,0,0.1,0,0,0,0.8,0,0.1,0.1,5.2,6.7,14.6,5.5,6.5,2.8,3.4,5.2,19.7,3.3,0,4.8,0,0.8,1.8,0.1,5.7,0,9.4,2.3,0,0,1.9,3.3,1.2,0,0.4,0,0,0.2,0.5,0.3,11.7,0,0.9,0.2,0,4.1,0,0,0,0,0,0,0,0,11.4,0.8,2.9,1.4,0.3,0.5,0,0.1,0,0,1.6,30.7,0,0.3,1.4
SLC2A6,"GLUT6, GLUT9, HSA011372",ENSG00000160326,Solute carrier family 2 member 6,Q9UGQ3,9,133471095-133479137,"Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,blood: 27.7;brain: 17.3,Cell type enhanced,Detected in many,7,Cone photoreceptor cells: 49.1;granulocytes: 45.2;monocytes: 68.5;Rod photoreceptor cells: 45.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,NA,non-classical monocyte: 27.7,Group enriched,Detected in many,4,dendritic cells: 7.0;granulocytes: 15.6;monocytes: 27.7,Cell line enhanced,Detected in many,NA,HDLM-2: 15.7;HMC-1: 37.0,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA042272, CAB046014",Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CAB046014: AB_2270444, HPA042272: AB_2677924",unprognostic (2.12e-1),unprognostic (1.49e-1),unprognostic (1.87e-3),unprognostic (1.71e-3),prognostic unfavorable (1.39e-4),unprognostic (1.18e-1),prognostic unfavorable (8.82e-4),unprognostic (1.26e-1),unprognostic (2.23e-1),unprognostic (5.93e-2),unprognostic (1.05e-2),unprognostic (2.49e-1),prognostic unfavorable (1.02e-11),unprognostic (7.24e-2),unprognostic (3.43e-2),unprognostic (9.36e-2),unprognostic (6.28e-3),3.8,3.1,7.2,12.7,8.3,10.5,2.1,8.1,16.3,1.4,2.5,4.3,0,3.3,2.3,3.1,1.8,1.4,3.6,3,9.1,12.1,2.3,2.7,7.4,10.8,12.4,9.1,1.7,3.2,1.1,1.8,2.5,17.3,1.6,2.1,2.9,2.2,2.2,2.1,1.9,4.9,3.3,7.3,10.6,4,2.2,2.4,1.7,1.6,0,7.1,4.9,1.1,4,7,15.6,27.7,0.4,0.6,3.1,2.5,4.7,1.7,5.1,1,1.5,1.3,2.6,4.5,2.7,2.7,2.3,3.7,2.1,6.6,2.6,12.6,4.1,1.1,3.2,0.6,15.7,0.8,2.6,3.5,2.7,3.4,0,37,2.1,0.5,4,0.5,0.2,2.7,2.5,0.4,2.2,1.9,6.1,1.5,2.7,2.5,1.2,5.6,1,2.8,11.7,3.8,7.5,2,2.7,3.9,2.1,1.3,1,8,1.1,6.9,6.5,2.5,6.8,2.1,1.1,0.8,3,1.6,0.6,1.4,15.6,7.2,0.7,0.6,14.6,0.4,4,0.1,0.4,6.4,3.9,0.2,0.5,0.4,0.4,27.7,7,0.1,3.1,7.2,8.3,8.1,16.3,9.1,12.1,12.4,9.1,17.3,2.4,3,5.5,19.9,1.3,0.3,24.3,2,5.1,2.7,0,3.5,49.1,0.3,0,32.4,6.3,4.7,1.8,0,7.9,0.5,1.9,1.1,45.2,0,4.6,22.3,3.5,2.5,19.2,1.3,0.9,31.5,3.3,68.5,1.5,3.9,16.6,31.7,0,0,45.6,32.3,7.2,2.2,6.6,0.4,0.2,3.8,1.2,0.5
SLC2A7,GLUT7,ENSG00000197241,Solute carrier family 2 member 7,Q6PXP3,1,9003300-9026345,"Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enriched,Detected in some,10,intestine: 19.3,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell type enhanced,Detected in single,NA,MAIT T-cell: 1.0,Lineage enriched,Detected in single,10,T-cells: 1.0,Cell line enhanced,Detected in single,NA,Daudi: 1.7,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,HPA039931,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA039931: AB_10671046,unprognostic (4.19e-2),unprognostic (3.68e-1),NA,NA,NA,unprognostic (1.96e-2),NA,unprognostic (2.20e-1),NA,unprognostic (1.05e-2),unprognostic (3.43e-1),unprognostic (9.05e-2),unprognostic (5.69e-4),unprognostic (5.09e-2),unprognostic (7.12e-2),unprognostic (1.60e-1),unprognostic (3.35e-1),0.2,0,0,0,0,0,0.1,0,0,0,7.6,0,0,7.2,0,0.7,0.1,0,0,0.2,0,0,0,0,0.1,0,0,0,0.2,0,0,0,0,0,0.2,0,0,0,0.1,0,0,19.3,0,0,0,0.1,1.8,0,0,0.4,0,0,0.1,0,0,0,0,0,0,1,0.1,0,0.7,0,0,0,0,0.3,0,0,0,0,0.7,0,1.7,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.7,0,0,0.3,0.4,0.5,0.2,0,0,0,0.1,0,0,0,0,0.3,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0.9,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
SLC2A1,"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR",ENSG00000117394,Solute carrier family 2 member 1,P11166,1,42925375-42959176,"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,"Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in all,4,placenta: 194.0,Cell type enhanced,Detected in many,20,Cytotrophoblasts: 686.5;Extravillous trophoblasts: 412.9;Syncytiotrophoblasts: 2076.2,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,BEWO: 44.8;CACO-2: 72.7;Hep G2: 49.6,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,"CAB002759, HPA031345, HPA058494",Enhanced,Supported,Enhanced,Plasma membrane,NA,No,No,NA,36000000,Plasma membrane,NA,"CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734",unprognostic (3.60e-2),unprognostic (5.85e-3),unprognostic (7.59e-2),unprognostic (1.31e-2),unprognostic (4.10e-3),unprognostic (3.22e-2),prognostic unfavorable (3.65e-8),prognostic unfavorable (1.09e-4),unprognostic (1.10e-1),unprognostic (4.84e-2),prognostic unfavorable (4.39e-5),unprognostic (1.87e-1),prognostic unfavorable (4.55e-9),unprognostic (1.11e-1),unprognostic (9.49e-2),unprognostic (1.17e-1),prognostic unfavorable (4.05e-4),4.2,3.7,12.4,3.9,16.9,45.2,4.1,6.7,15.5,15.2,4.8,15.1,4.3,2.4,7.6,3.4,28.8,8.5,8.6,5,15.4,13.7,7.6,2.1,2.4,5.3,18.2,5,3.4,3.7,7.3,2.9,194,15.5,5.2,3.3,44.2,8.4,7.9,1.8,42.1,2.9,2.5,17.8,3.4,5.5,2.5,12.5,1.8,4,11.5,12,22.2,24.5,8.4,14.7,1.3,0.2,3,7.5,2.7,10.7,15.6,12.8,3.2,1.5,0.5,44.8,7.1,15.4,8.8,12.9,72.7,30.1,4.1,21.2,2.1,6.2,10.1,2.8,16.5,3.9,2.4,2.6,6.7,9,49.6,4.5,3.6,1.9,1.9,12.7,5.5,5.9,26,1.4,3.5,15,0.9,3.9,19.2,1.7,2.5,8.2,5.3,3.9,1.6,4.1,5.7,8,5.2,6.8,4.8,8.3,26.3,3.1,19.2,1.1,4.6,3.2,8,5.8,1.4,16,0.7,1.5,2.5,15.8,2.6,6.5,0.3,0.2,1.3,7.5,0.2,6.9,8.4,4.1,5.1,2.9,7.3,3.2,4.7,1,3,0.1,14.7,4.7,2.7,12.4,16.9,6.7,15.5,15.4,13.7,18.2,5,15.5,12.5,0,2.6,23.8,35.5,254.3,8.1,23,25.5,28.1,9.1,26.2,62.8,686.5,5,47.8,4,9.9,16.8,303.7,10.3,412.9,42.1,25.5,5.8,1.3,74.8,4.8,17.6,0.6,1.3,0,7.2,3.2,20.3,61.3,13.7,394.9,72.4,18.7,13.8,1.6,31.1,0,20.2,0,1.7,208.3,2076.2,17.3,9,98.7
SLC2A10,GLUT10,ENSG00000197496,Solute carrier family 2 member 10,O95528,20,46709487-46736347,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,liver: 51.5,Cell type enhanced,Detected in many,8,Ciliated cells: 33.5;Hepatocytes: 41.2;Mucus-secreting cells: 60.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enriched,Detected in single,44,basophil: 13.8,Lineage enriched,Detected in single,44,granulocytes: 13.8,Cell line enhanced,Detected in many,NA,ASC diff: 19.5;HSkMC: 24.2;OE19: 20.0;SK-MEL-30: 24.8,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA041015,Approved,NA,Approved,"Nucleoplasm,Vesicles",NA,NA,NA,NA,NA,Nucleoplasm,Vesicles,HPA041015: AB_2677252,unprognostic (8.94e-3),unprognostic (2.62e-3),unprognostic (2.06e-1),unprognostic (1.85e-1),unprognostic (6.17e-3),unprognostic (1.04e-1),unprognostic (7.68e-2),unprognostic (2.80e-1),unprognostic (1.83e-1),unprognostic (8.06e-2),unprognostic (4.94e-3),unprognostic (1.70e-1),unprognostic (3.63e-3),unprognostic (1.25e-2),unprognostic (1.05e-1),unprognostic (3.00e-1),unprognostic (5.96e-2),4.7,4.6,2.6,4.3,3.3,0.1,8.7,2.1,3.1,11.4,6.7,2.7,6.7,2.6,5.4,6.6,4.8,5.6,10.2,6.7,3.3,1.4,2.6,51.5,4.8,3.4,2.2,2,7.1,22.9,15,4.2,8.3,3.8,18,8.8,9.8,11.5,11,2.1,2.4,3,9.7,2.3,1.9,12.4,3.4,1,0.8,18.1,4.5,4.6,7.1,5.7,0,0,13.8,0,0.3,0,0,0,0,4.7,4.8,19.5,16.7,14.3,9.1,12.4,4.2,5.1,0.3,16,0,6.9,16.5,0,0.1,0,0.4,2,0,0.1,1.3,0,7.6,13.8,0,0,24.2,0.4,2.6,0,4.9,1.7,0,0.1,0,7.2,16.6,0,0.4,1.7,20,1.2,0,0.7,0,0,4.3,0,0.7,1.8,3,24.8,3.5,2.3,3.7,1,9.1,4,7.2,1.1,0.1,0,0,0,0,1.9,13.8,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.3,0,0,0,0,2.6,3.3,2.1,3.1,3.3,1.4,2.2,2,3.8,1,6,4.6,0,6.8,0.6,0,2.2,10.2,33.5,11.4,1.8,0,1.9,0,5.2,0.1,4.1,2.2,0,4.9,12.8,11.7,28.1,5.8,41.2,0.9,0,3.5,9.2,2.8,0.9,24.5,0.3,1.7,0,60.1,5.6,5.1,2.9,16.3,0.7,0.5,12.9,3.9,0.4,0.2,0.9,1.7,0,6.6,10.2
SLC2A11,"GLUT10, GLUT11",ENSG00000133460,Solute carrier family 2 member 11,Q9BYW1,22,23856703-23886309,"Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Low tissue specificity,Detected in all,NA,NA,Group enriched,Detected in many,4,Cone photoreceptor cells: 280.8;Rod photoreceptor cells: 194.1,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,SK-BR-3: 12.0,NA,NA,NA,NA,NA,NA,NA,NA,"HPA042960, HPA071184",Uncertain,NA,Uncertain,"Nucleoplasm,Cell Junctions",NA,NA,NA,NA,NA,Cell Junctions,Nucleoplasm,"HPA042960: AB_2678241, HPA071184: AB_2686355",unprognostic (1.31e-1),unprognostic (1.14e-1),unprognostic (3.69e-2),unprognostic (6.97e-2),unprognostic (7.93e-2),unprognostic (1.32e-1),unprognostic (4.24e-2),unprognostic (1.60e-3),unprognostic (3.53e-1),unprognostic (4.89e-2),prognostic favorable (3.83e-4),unprognostic (2.32e-1),prognostic favorable (5.77e-7),unprognostic (1.25e-1),unprognostic (1.70e-1),unprognostic (3.85e-1),unprognostic (6.29e-2),4.3,7.8,8.5,6.1,15.3,3.5,6.2,22.9,17,4.1,4.9,6.4,17.2,3.9,7.7,9,2.8,5,5.2,8.5,11,13.4,19.5,4.9,4.5,7.1,9.5,10.9,6.6,28.8,18.6,14,21,9.7,7.6,6,10.4,6.1,11.4,13.6,4.2,4.8,10.4,9.6,5.3,6.1,4.5,6.2,1.6,9.2,2.4,6.4,4.5,5.3,2.2,4.6,1.5,1.1,1.2,1.6,0.3,2.6,1.3,1.7,7.6,1.6,3.4,0.7,1.6,2,1.8,1.3,1.8,1.8,3.4,0.9,2.2,1.6,2.2,3.2,0.9,0.9,2.3,2.9,1.7,2.8,2.6,2.5,1.6,1.8,1.3,3.2,2.7,2.3,8.4,0.7,2.7,0.7,7.6,1,2.8,0.3,0.7,2.5,1.7,2.1,4.6,0.2,3.8,5.6,0.7,4.1,2.3,0.8,12,2.7,2.1,6.2,0.8,0.5,0.7,1.2,0.7,0.8,7.1,1.9,3.3,1.5,1.2,1.8,1.5,0.4,0.9,0.9,1.1,0.7,2.1,0.8,0.8,0.2,2.2,1.6,1.1,1.2,1.2,0.7,4.6,0.2,0.3,8.5,15.3,22.9,17,11,13.4,9.5,10.9,9.7,6.2,17.9,12.9,16.6,8.2,2.9,57,29,7.6,8.1,4.5,24.4,280.8,7,11.6,4.7,5.9,3.3,3.4,0,4.9,7.6,4.5,8,2.3,5.8,5.2,35,10.4,4.9,3.1,8.5,8.6,4.2,3.3,2.8,4.9,15.4,3.5,2.9,9.2,20.7,194.1,0,6.2,3.9,5.1,2.8,16.7,7.5,7.3,5.4
SLC2A13,HMIT,ENSG00000151229,Solute carrier family 2 member 13,Q96QE2,12,39755021-40106089,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 27.7;parathyroid gland: 43.0,Cell type enhanced,Detected in many,10,Horizontal cells: 87.4,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in some,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,ASC diff: 18.5,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA006584, HPA061679",Enhanced,NA,Approved,Nuclear membrane,NA,NA,NA,NA,NA,Nuclear membrane,NA,"HPA006584: AB_1849755, HPA061679:",unprognostic (1.66e-1),unprognostic (2.52e-1),unprognostic (1.11e-1),unprognostic (9.62e-2),unprognostic (1.04e-1),unprognostic (3.31e-1),unprognostic (4.06e-2),unprognostic (1.20e-1),unprognostic (5.71e-2),unprognostic (1.83e-1),unprognostic (1.65e-1),unprognostic (2.25e-2),unprognostic (2.12e-3),unprognostic (4.07e-2),unprognostic (6.34e-2),unprognostic (1.24e-2),unprognostic (9.16e-2),3.8,7.2,9.8,3.3,18,1.2,3,4,27.7,13,7.4,2.8,0.3,6,5.9,5.3,3.7,2.9,4,4.9,8.2,14.1,10.7,6.2,3.7,1.9,14.9,11,3.1,5,43,11.1,4.6,4.8,3,6.8,2.4,4.2,2.6,1.2,2.1,8.3,4.7,2.7,2.3,5.6,2,4.1,0.6,2.2,0.9,1.4,3.9,3.9,2,0.1,1.5,0.5,0.6,0.9,0,0.6,3.6,2.6,1.2,18.5,7.7,5.3,5.8,4.1,2.6,3.4,0,1.7,2.2,4.3,4.6,3.6,0.3,1.8,1.8,2.2,1.9,5.4,1.7,9.1,1.3,2.9,4.9,2.9,3.8,1.7,1.2,2.2,1.5,1.2,2.2,0.7,5.7,5.9,0.6,0.7,4.1,2.9,0,2.5,0,4,1.2,4.8,2.2,3.3,3.4,2.3,4.5,1.5,4.1,2.5,4.3,1.1,3.5,1.3,12.4,3.4,4.5,0.1,1.4,6.4,2.8,2.2,0,0.5,1.5,0.4,0.2,0.3,0.1,0.4,0.9,0,2,0.2,0.5,0.8,0.6,0.1,0.1,0.1,0,9.8,18,4,19.8,8.2,14.1,14.9,11,4.8,4.1,8.9,17.1,4.7,1.7,3.7,4.3,3.5,10.2,5.3,2.3,8.7,0,5,0,4.3,2.5,5.2,35.1,0,10.9,2.1,7.1,2.7,10.3,8.5,7.2,87.4,19.5,8,7.9,2.1,21.3,7.4,15.1,6.4,21.3,2,8.7,29.4,7.1,6.4,1.3,6.5,6.1,0.9,1.9,4.5,3.1,4.4,11.1,1.4
SLC2A2,GLUT2,ENSG00000163581,Solute carrier family 2 member 2,P11168,3,170996348-171026750,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,8,intestine: 77.4;liver: 172.8,Cell type enriched,Detected in some,5,Hepatocytes: 433.3,Cancer enriched,Detected in some,12,liver cancer: 105.2,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,68,CACO-2: 7.3;Hep G2: 24.3,Not detected,Not detected,NA,NA,Low region specificity,Detected in some,NA,NA,"CAB010444, HPA028997",Enhanced,NA,Supported,Plasma membrane,NA,NA,NA,NA,NA,Plasma membrane,NA,"CAB010444: AB_641068, HPA028997: AB_2672860",NA,NA,unprognostic (9.56e-2),NA,unprognostic (1.24e-1),NA,prognostic favorable (2.63e-5),NA,NA,NA,unprognostic (3.10e-1),NA,unprognostic (1.02e-1),unprognostic (2.95e-2),unprognostic (6.31e-2),NA,NA,0.1,0.1,0.1,0,0.1,0,0.1,0.1,0.1,0.1,27.9,0,0,10.8,0.1,0.2,0.1,0.1,3.8,0.1,0.1,0.1,15.3,172.8,0.1,0,0.1,0,0.1,0.6,0,0.1,0,0,0.1,0,0,0.1,0,0.1,0.1,77.4,0,0.1,0.1,0.1,0.1,0,0,0.1,0,0,0.1,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.3,0,0,0,0,0,0,0,0,0,0,0,0,0.2,24.3,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0,0,0,0,0,0,0,0,0,0,86.6,0,0,0,0,0,1.7,0.2,4.6,0,0,0,0,0,0,0,0,433.3,0,0,0,6.7,8.9,0.4,0,0,0,0,0.3,0,0.1,0,0,49.1,0,0,0,0,0,0,0.1,1.9,0,0
SLC2A3,GLUT3,ENSG00000059804,Solute carrier family 2 member 3,P11169,12,7919230-7936275,"Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,bone marrow: 166.3,Cell type enhanced,Detected in many,7,granulocytes: 462.0,Cancer enriched,Detected in all,7,testis cancer: 107.9,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in many,6,basophil: 30.2;neutrophil: 55.6,Lineage enriched,Detected in all,9,granulocytes: 55.6,Group enriched,Detected in many,5,BEWO: 143.6;CACO-2: 154.0;SuSa: 113.9,NA,NA,NA,NA,NA,NA,NA,NA,"CAB002763, HPA006539",Approved,NA,Approved,Plasma membrane,NA,NA,NA,NA,33000000,Plasma membrane,NA,"CAB002763: , HPA006539: AB_1078984",unprognostic (9.20e-2),unprognostic (9.63e-3),prognostic unfavorable (8.58e-4),unprognostic (2.65e-1),unprognostic (5.29e-3),unprognostic (2.16e-3),unprognostic (1.12e-1),unprognostic (8.27e-2),unprognostic (2.35e-1),unprognostic (3.83e-2),unprognostic (8.47e-3),unprognostic (5.40e-2),prognostic unfavorable (6.36e-8),prognostic unfavorable (2.89e-5),unprognostic (1.70e-1),unprognostic (1.14e-2),unprognostic (2.91e-3),48.8,10,9.5,25.2,10.5,166.3,26.4,13.1,24.3,9.4,10,6.8,1.8,4.2,10.3,8.2,13.2,8,25.6,22.8,10.8,13.6,10.3,14.1,32.4,12.8,13.3,3.3,18.8,6.1,6.9,10.9,43.9,13.7,15,6.9,14.8,3.8,3.9,13.6,7.4,5.8,18.7,15.4,16.4,7,10.6,12.5,3.3,15.7,7,13.6,51.8,10.5,1.8,2.4,55.6,4.6,3.6,6.4,3.5,0,0.7,6.6,2.5,2.4,8.5,143.6,2.3,2.5,2.3,5.4,154,1,0.1,0,1.6,3.2,0,0.2,0.3,4.2,4.5,0.1,8.9,0.6,20.2,6.7,3.2,13,3.5,0.2,6.1,2.8,5.4,2.1,0.7,4.1,2.1,2.1,0,0.2,3.4,29.1,0.1,0,0.2,0.7,0.1,0,0,0,0,0,0.2,3,113.9,0,0.4,2.1,2.9,1.5,5.6,0.2,0,6.2,0.4,8.5,1.5,1.5,30.2,4.6,7,6.4,0.5,5.3,1.8,4.4,4.9,2.4,1.7,2.8,3.8,55.6,3.6,0.2,0.1,5.8,3.5,9.5,10.5,13.1,13.3,10.8,13.6,13.3,3.3,13.7,12.5,134,147.7,116.7,2.9,115.1,27.9,8.4,7.6,18.7,48.9,3.5,58.9,41.5,0,0.2,2.4,227.7,0,0,0,218.4,149.1,3.8,462,1,97.9,4.8,1.2,85.3,85.8,1.9,9.5,229.2,173.7,1,0,19.2,0.8,0.2,7.4,1.2,68.8,116.4,236.4,1.4,0.6,71.6,93.1,133.8,0,2.8
SLC2A4,GLUT4,ENSG00000181856,Solute carrier family 2 member 4,P14672,17,7281667-7288257,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,"Diabetes mellitus, Disease mutation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,heart muscle: 37.2;skeletal muscle: 76.8;tongue: 33.5,Cell type enhanced,Detected in many,26,Cardiomyocytes: 120.2;Sertoli cells: 32.3;Smooth muscle cells: 25.1,Low cancer specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Cell type enhanced,Detected in single,NA,plasmacytoid DC: 1.7,Lineage enhanced,Detected in single,NA,dendritic cells: 1.7,Cell line enriched,Detected in some,4,Hep G2: 10.8,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,CAB016544,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CAB016544: AB_629533,unprognostic (2.53e-1),unprognostic (7.40e-3),unprognostic (2.27e-1),unprognostic (8.12e-4),unprognostic (2.40e-1),unprognostic (6.28e-2),unprognostic (1.70e-2),unprognostic (1.66e-2),unprognostic (1.35e-1),unprognostic (3.83e-2),unprognostic (9.66e-2),unprognostic (2.24e-2),unprognostic (1.34e-3),unprognostic (4.23e-2),unprognostic (3.10e-1),unprognostic (2.30e-2),unprognostic (2.07e-2),9.9,1.4,0.6,1.8,0.7,1.1,6.4,0,0.6,4.7,13.9,0.2,4,1,4.2,7,11.8,3.2,2.9,37.2,0.3,0.1,0.7,1.2,0.5,0.7,0.8,0.1,1.9,0.4,2.9,1.2,0.8,0.5,6.3,1.4,6.4,4.6,3.8,76.8,0.9,3.3,23.5,0.2,0.2,3.8,1.5,0,0,1.2,33.5,1.6,18.6,1.6,0,1.7,0,0,0,0.4,0,0.2,0,1.8,1.5,0.7,0,0.4,0,0.1,0,0,0.6,0.1,1.2,0.2,0,0.8,0.8,0.3,0.2,0.1,0,1.8,0,0.3,10.8,0.2,0,0.1,0.2,0,0.1,0,0,0.1,1.1,0.6,0.2,0,0.4,0,0.2,0.8,0.2,0.1,2.4,0.6,0.8,0,0.1,0,1,0,1.3,0,1.8,0.8,0.1,0,0,1.5,0,0.2,0.6,0.7,0,0,0.1,0.1,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,1.7,0,0,0.6,0.7,0,0.6,0.3,0.1,0.8,0.1,0.5,0,0,0,0,0.7,1.5,0,120.2,0,0,0,0,0,0.3,6.6,0.1,5.7,1.5,0.8,0,0,0,0.4,0.5,0,2,0.1,0,0,1.8,0,3.6,0,0,6.8,0,0.5,5.6,0.1,0.2,8.1,0.2,0,32.3,25.1,2.1,2.7,1,0.8,0,1,0.3
SLC2A5,GLUT5,ENSG00000142583,Solute carrier family 2 member 5,P22732,1,9035107-9088478,"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins","Sugar transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,bone marrow: 36.7;intestine: 84.1,Group enriched,Detected in many,4,Early spermatids: 42.2;Late spermatids: 12.6;Paneth cells: 28.8;Proximal tubular cells: 18.8;Spermatocytes: 44.4,Group enriched,Detected in many,6,glioma: 11.0;renal cancer: 11.9,Low region specificity,Detected in all,NA,NA,Cell type enriched,Detected in some,6,naive B-cell: 19.7,Lineage enriched,Detected in many,7,B-cells: 19.7,Group enriched,Detected in some,5,Daudi: 51.3;THP-1: 13.0;U-266/70: 41.3;U-698: 48.2;U-937: 18.5,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in many,NA,NA,"HPA005449, HPA075145",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA005449: AB_1078985, HPA075145:",unprognostic (1.53e-1),unprognostic (1.23e-1),unprognostic (8.00e-3),unprognostic (2.25e-2),unprognostic (6.13e-2),unprognostic (2.61e-1),unprognostic (1.47e-2),unprognostic (5.35e-2),unprognostic (4.18e-1),unprognostic (6.85e-2),unprognostic (3.77e-2),unprognostic (1.18e-1),prognostic unfavorable (5.44e-5),unprognostic (8.56e-2),unprognostic (2.07e-1),unprognostic (8.19e-3),unprognostic (8.61e-2),5.2,2.2,10.3,4.1,15,36.7,3.7,1.1,9.9,2.4,50.4,9.2,0.7,44.8,0.8,4.9,2.5,1.5,0.6,1.4,8.6,6,16.2,0.6,0.9,8.1,14.1,2.4,1.6,0.6,0.5,1.9,2.1,10.4,6.7,1.6,0.8,1.8,2.4,25.1,3.1,84.1,1.9,17.8,3.1,0.7,30.2,15.4,0,0.8,3.7,7.3,1.8,2.5,19.7,0.7,3,2.1,0.6,0.3,0.8,0.1,0,0,0.1,0.2,0.3,0.2,0,0.2,0,0.1,0.4,0,51.3,0,0.1,0,0.1,0.4,0,0.1,6.6,0,0,0.9,0,0.1,0.8,0.5,0.8,0.7,0.1,0,0.8,0,0,0.1,0.7,0,0,0.3,2.8,0,0,0,1.3,0,1.6,0,0.6,0.1,0.1,0.1,0.1,0.2,0,0,13,0,0.8,0.2,0.1,0,41.3,0,48.2,0.1,18.5,0.1,3,2.1,0.2,0.2,0.5,0.1,3.4,0.2,0.2,0.7,19.7,0.3,0.2,2.2,0.6,0.1,0.4,0.1,0.8,10.3,15,1.1,9.9,8.6,6,14.1,2.4,10.4,15.4,0,0,6.7,1.8,1.8,0,1.7,0,0,0,1.8,0,0,6.6,0.1,42.2,0.5,2.6,0,0,1,0.5,0.6,1.1,0,4.2,0,1.2,0,1.2,12.6,2.6,1.8,0,1,2.2,0.2,0.4,28.8,0.4,18.8,0,6.5,0.3,44.4,3.4,0.5,0.5,0,2.5,0.1
SLC2A8,"GLUT8, GLUTX1",ENSG00000136856,Solute carrier family 2 member 8,Q9NY64,9,127397138-127408424,"Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in all,11,Early spermatids: 119.6;Late spermatids: 229.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enriched,Detected in many,5,plasmacytoid DC: 33.8,Lineage enriched,Detected in all,5,dendritic cells: 33.8,Cell line enhanced,Detected in many,NA,CACO-2: 46.6;Hep G2: 27.5,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA011935,Uncertain,NA,Approved,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,HPA011935: AB_1849760,unprognostic (6.49e-2),prognostic favorable (2.57e-6),unprognostic (9.13e-2),unprognostic (1.85e-3),unprognostic (4.23e-2),unprognostic (9.43e-3),unprognostic (2.62e-1),unprognostic (1.30e-1),unprognostic (6.33e-2),unprognostic (1.36e-1),prognostic favorable (9.86e-6),unprognostic (1.70e-1),prognostic favorable (6.55e-6),unprognostic (4.25e-2),unprognostic (3.55e-1),unprognostic (1.59e-3),unprognostic (2.04e-3),10.9,24.5,11.4,13.3,11.3,3.5,10.4,15,15.2,9,19.8,11.7,37,17.7,9.5,17.4,8.7,6,9.4,9.8,10.4,9.3,8.7,25.7,8.1,7.3,12.5,10.2,6.7,12.1,5.7,5.5,13.2,8.7,18.5,6.5,12.5,9.4,28.3,22.6,11.6,17,44.1,10.3,11.3,13.1,30.6,9.3,1.2,9.1,6.9,4.3,42.4,9.1,2.4,33.8,6.9,5.6,1.2,6.3,2,1.8,7.2,3.2,7.2,0,0,10.2,2.8,1.9,4.5,2.7,46.6,1.7,2.8,6.4,1.5,7.2,9.7,3.9,4.5,1.1,2.6,6.2,0.4,5.7,27.5,4.2,0,3,0.1,4.2,0.4,1.8,2.2,3.5,3.9,2.9,6.3,1.8,13.1,0,0,5.2,10.2,11.3,1,4.5,7.8,4.2,19.3,5.4,3.7,6.7,11.5,2.5,4.3,7.4,1.6,3,0,4.7,0.3,6.2,19.5,18.2,4.2,3.1,0,3.4,0,3,6.9,4.9,5.6,3.5,2.3,1.6,3.3,4.6,2.4,0.3,1.2,0.2,1.2,5.1,33.8,6.3,2,11.4,11.3,15,15.2,10.4,9.3,12.5,10.2,8.7,9.3,8.9,9.6,5.4,6.1,9.8,11.1,6.1,7.6,5.3,4.5,5.2,9.8,66.2,13.3,12,119.6,7.4,15.1,23.3,14.7,10.8,11.6,11,6.9,23.6,59.6,6.4,11.6,12.9,12.4,229.4,10,8.2,25.3,8.2,13.3,14.9,15.9,21.5,11,12.2,7.7,12.9,8.1,38,10.9,9.3,56.3,6.9,15.6,5.5
ASPSCR1,"ASPL, ASPS, TUG, UBXD9, UBXN9",ENSG00000169696,"ASPSCR1, UBX domain containing tether for SLC2A4",Q9BZE9,17,81976807-82017406,"Cancer-related genes, Disease related genes, Predicted intracellular proteins",NA,NA,"Cancer-related genes, Proto-oncogene",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,5,Extravillous trophoblasts: 151.3,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enriched,Detected in all,5,Hep G2: 82.6,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA026749,Approved,NA,Supported,"Nucleoplasm,Vesicles,Plasma membrane",NA,NA,NA,NA,NA,Nucleoplasm,"Vesicles, Plasma membrane",HPA026749: AB_1845114,unprognostic (5.01e-2),unprognostic (1.19e-3),unprognostic (7.61e-2),unprognostic (1.34e-1),unprognostic (1.36e-1),prognostic favorable (8.55e-4),unprognostic (2.02e-1),unprognostic (2.07e-2),unprognostic (3.43e-1),unprognostic (1.71e-3),prognostic favorable (2.67e-4),unprognostic (1.13e-1),prognostic unfavorable (1.26e-4),unprognostic (3.16e-2),unprognostic (1.13e-1),unprognostic (2.27e-1),unprognostic (1.01e-2),10.3,12.6,14.3,12.6,14.5,16.8,10.6,16.5,20.8,9.9,12.9,16.7,11.8,17.5,10.1,15.8,11.9,9.3,15.1,11.5,13.1,12.6,15.8,31.9,14.1,14.8,18.9,12.9,8.8,17.8,17,19.7,21.8,14.8,13.2,7.1,14.4,22.6,9.9,25.1,15.5,14.4,9.1,12.6,13.2,13,16.9,14.6,9.8,16.4,12.9,13,9.7,8.3,8.1,14.6,15.7,11.3,7.2,10.5,5.2,5.1,9,3.5,5.1,2.2,2.8,15.3,4.9,3.7,5.9,5.8,5.2,5.9,5.2,5,3.5,4.5,2.5,3.8,3.7,1.8,3.6,11.5,5.8,7.3,82.6,7.3,5.1,8.5,3.2,4,2.9,2.1,3.1,5.6,4.4,5.8,7.5,3.3,17.3,4.7,11.1,4.4,9.5,6.6,5.2,5.1,10.6,5.7,4.7,9.4,9.6,3.9,12.6,9,4.2,7.5,12.2,4.6,10.1,7,7.4,6.1,5.4,3.2,5.8,5.4,5.2,6,15.7,11.3,8,6.7,7.6,4,7.9,10.5,9,14.6,8.1,8,6,2.9,7.2,9.3,9.1,4.9,5.2,14.3,14.5,16.5,20.8,13.1,12.6,18.9,12.9,14.8,14.6,8.9,46,18.6,20.7,11.8,21.4,11.4,17.8,10.7,9.1,14,39.3,64.7,33.2,21.2,40.2,16,26.7,0,22.9,151.3,16.6,19.3,20.8,45.6,39.1,47.7,24,15.4,16.6,63.2,10.9,17.1,18.6,18,24.4,56.7,16.2,20.1,16.6,44,32.8,12.9,15.3,43.6,48.7,12.5,49.7,23.6,23.8,19.7
SLC30A5,"FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1",ENSG00000145740,Solute carrier family 30 member 5,Q8TAD4,5,69093646-69131069,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA035373,Approved,NA,Supported,"Nucleoplasm,Golgi apparatus",NA,NA,NA,NA,NA,Golgi apparatus,Nucleoplasm,HPA035373: AB_10794630,unprognostic (9.81e-3),unprognostic (3.33e-1),unprognostic (2.82e-2),unprognostic (8.16e-2),unprognostic (1.65e-1),unprognostic (3.88e-2),unprognostic (1.16e-3),unprognostic (2.47e-2),unprognostic (4.65e-2),unprognostic (5.41e-2),unprognostic (3.57e-2),unprognostic (2.92e-1),unprognostic (1.49e-1),unprognostic (2.53e-2),unprognostic (2.07e-1),unprognostic (2.11e-2),unprognostic (1.40e-1),19.4,22.1,14.4,19.4,15.7,13.3,29.7,14.9,18.5,25,20.9,13.2,33.7,19.7,24.3,32.4,20.5,20.3,23.5,25.4,14.5,15.4,28.6,39.2,24.3,23.7,15.5,13.1,25.4,50.5,29.6,38.1,34.3,13.9,24.5,19.8,17.6,36.8,35.3,17.1,21.2,25,18.1,13.2,20.1,20.3,18.1,12.7,22.1,33.5,18.8,19.6,18.2,28.9,8.3,13.2,12.4,6.9,5.6,9.1,3.3,15.7,12.2,11.4,20,30.1,23.2,36.2,25,22.7,15.8,24.2,11.2,19.8,20.9,31.9,17,27.7,17,15.8,18.9,26.8,24.9,18.2,23.3,15.4,18.3,24.2,14.6,26,15.6,25.1,16.2,19.4,22.2,15.3,14.5,14,25,20.1,19.9,19.2,30.4,12.9,10.7,14,15.4,14.5,37.7,23.6,14.8,20.4,16.2,19.8,19.9,33.9,16.6,19.2,32.5,13.9,10.3,13.4,25.7,24.7,22.7,27.9,16.3,20.3,26.6,25.4,12.4,6.7,10.7,6.1,6.8,6.5,8.3,9.1,8.9,8.4,6.3,8.4,7.1,5.9,5.6,6.9,13.2,6.1,3.3,14.4,15.7,14.9,18.5,14.5,15.4,15.5,13.1,13.9,12.7,17.9,15.5,9,22.6,16.7,13.9,26.2,12.7,14.7,14.8,24.4,21.6,35.4,24.9,18.8,5.2,16.6,12.3,23.3,23.5,60.9,24,28.7,41.4,17.4,19.6,7.9,12.7,19,17.3,6.7,22.5,16.4,13.5,12.6,24.9,13.4,17.8,21,20.8,16.1,22.6,25.8,20.9,9.9,14.9,18.7,43.1,20.3,21.7,24.2
SLC30A4,ZNT4,ENSG00000104154,Solute carrier family 30 member 4,O14863,15,45479611-45522807,"Plasma proteins, Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,prostate: 47.7,Cell type enhanced,Detected in many,8,Early spermatids: 59.6;Late spermatids: 60.4,Cancer enriched,Detected in all,20,prostate cancer: 34.3,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA018178,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA018178: AB_1857087,unprognostic (1.64e-2),unprognostic (1.40e-1),unprognostic (3.71e-1),unprognostic (9.49e-2),unprognostic (1.98e-1),unprognostic (3.29e-2),unprognostic (6.15e-2),unprognostic (9.74e-2),unprognostic (7.38e-3),unprognostic (1.51e-1),prognostic favorable (6.02e-4),unprognostic (2.66e-2),unprognostic (4.72e-3),unprognostic (1.29e-2),unprognostic (9.83e-2),unprognostic (8.28e-3),unprognostic (2.01e-3),3.7,2.9,6.2,4.5,11.3,1.6,4.1,6.7,8.1,3.7,8.8,7,2.3,8.5,4.3,4.1,5.6,3.4,3.1,3,5.2,3.8,5.5,3.6,2.9,3.6,6.9,4.9,3.9,2.8,6.8,3,4.6,5.1,47.7,4.4,3.1,2.7,3.5,2.4,3.6,19.9,4.7,4.5,4,3,15.8,9,1,6.2,1.8,4.5,3.1,4.4,7.1,0.5,2.6,0.3,2.4,4.3,1,2,2.6,0.7,5.6,10.2,7.2,0.5,5.4,4.9,3.3,4.7,0.3,1.8,8,1.8,5.5,1.3,1.5,2.4,2.5,3,1.9,2.2,0.2,2.6,0.2,6.6,0.2,4.2,6,4.1,4.3,1.1,5.1,3.8,3.8,1.2,4.6,6.1,0.9,2.7,0.4,0.2,0.4,0.5,4.2,4.8,1.2,2.7,0.5,1.9,2.8,3.5,4,0.9,0.9,3.5,0.3,7.1,4.9,2.8,5.9,1.8,8.6,6.2,2,2.1,0.3,3.7,2.6,0.3,0.3,4.3,0.2,3.9,3.8,2.9,2.4,0.3,7.1,2.9,4.2,1.1,2.4,0.3,0.5,0.4,1,6.2,11.3,6.7,8.1,5.2,3.8,6.9,4.9,5.1,9,3,3.8,3.2,2,6.1,2.6,2.3,0,1.4,0,1.8,15.7,0.7,0,1,59.6,5,13.6,0,1,0.2,7.2,30.7,1.1,2.4,2.5,12.7,1.2,7.4,1.8,60.4,5.8,5.8,6.8,9,5.1,4.9,0.6,14.4,7.8,8.4,2.2,6.5,5.9,29.4,16.8,5.6,0.2,4.4,2.9,1.4
SLC30A7,"ZNT7, ZnTL2",ENSG00000162695,Solute carrier family 30 member 7,Q8NEW0,1,100896076-100981753,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA018034,Uncertain,NA,Supported,Golgi apparatus,NA,NA,NA,NA,NA,Golgi apparatus,NA,HPA018034: AB_1857089,unprognostic (1.94e-1),unprognostic (1.08e-1),unprognostic (8.05e-3),unprognostic (1.79e-1),unprognostic (2.50e-1),unprognostic (3.18e-1),unprognostic (2.89e-3),unprognostic (1.24e-1),unprognostic (1.61e-1),unprognostic (1.11e-3),unprognostic (2.78e-2),unprognostic (1.95e-1),unprognostic (5.46e-2),unprognostic (1.09e-1),unprognostic (1.46e-1),unprognostic (2.25e-1),unprognostic (3.37e-1),15.6,14.2,5,13.1,6.4,10.3,12.7,7.4,7.6,13.3,10.8,6.2,17.2,10.8,13.3,13.7,10.8,9.4,13.2,9.3,5.9,5.6,13,43.1,18.1,25.6,7.7,4.6,10.5,19.1,17.1,17.7,25.2,9.2,11.9,14.7,10.8,17.5,18.1,5.7,12.6,15.8,9,8.1,16.2,13.3,7.5,6.4,24.7,13.2,10.9,17.4,10.5,11.1,5.5,8.2,13.9,14.9,8.4,10.7,5.9,10.9,5.7,6.2,13.6,13.2,13.5,15.7,7.2,19.3,8.8,11.6,5.8,7.9,4.4,15.7,14.7,7,10.9,7.2,10.7,13.5,6.9,4.5,8.6,9.7,10.4,14.8,11.3,9.2,15.4,6.9,14.8,18.1,8.5,14.2,8.4,5.2,19.3,11.9,4.9,8.2,5.7,6.6,5.5,7.1,4.1,11.1,5.7,7.8,12.8,3.4,6.7,12.9,14.5,9.3,4.9,7.2,6.3,15.3,20.8,8,19.2,11.5,13.1,6.9,4.9,21.2,9.3,5.5,13.9,10.7,7.4,10.7,10.4,9.2,5.3,9.9,8.4,8.2,5.5,8.9,9.6,5.3,8.4,14.9,7.7,7.2,5.9,5,6.4,7.4,7.6,5.9,5.6,7.7,4.6,9.2,6.4,29.8,16.3,25.1,16.5,50.9,8.9,3.2,15.3,10.7,12.5,22.7,5.9,26.3,1.7,20.8,0.6,24.6,16,0,23,19.6,25.5,36.1,36.9,38.5,19.8,4.8,21.9,35,29.4,0.9,15.8,29.5,30.4,14.4,32,7.8,29.1,24.6,15.6,16.2,12.4,6.5,22.3,6.2,7.6,55.8,34.9,29.8,20.1,24.8
SLC30A1,"ZNT1, ZRC1",ENSG00000170385,Solute carrier family 30 member 1,Q9Y6M5,1,211571568-211578742,"Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,liver: 53.3,Cell type enhanced,Detected in all,5,Hepatocytes: 83.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA015275, HPA049000",Uncertain,NA,Supported,"Vesicles,Plasma membrane",NA,NA,NA,NA,NA,Plasma membrane,Vesicles,"HPA015275: AB_1857083, HPA049000: AB_2680593",unprognostic (1.13e-1),unprognostic (2.67e-3),unprognostic (6.94e-2),unprognostic (1.81e-3),unprognostic (3.47e-1),unprognostic (1.80e-1),unprognostic (2.27e-2),unprognostic (1.82e-3),unprognostic (4.72e-1),unprognostic (1.01e-1),unprognostic (1.42e-3),unprognostic (4.78e-2),unprognostic (2.23e-2),unprognostic (3.03e-1),unprognostic (2.55e-1),unprognostic (1.02e-1),unprognostic (4.53e-2),11.4,16.6,9.3,7.5,11.4,15.5,17.3,5.2,13.6,13,15.3,6.9,4.9,17.2,7.1,7.6,9,9.2,12.9,6.1,9.7,7.9,13.4,53.3,12,3.5,9.5,8,9.5,8.9,8.8,4.8,9.3,8.7,7.3,8.9,7.7,5.9,9.2,3.6,13.9,28.1,7.5,8.3,10.7,6.4,12.5,5.5,3.1,11,5.2,4.4,7.7,8.4,0.5,2.5,3.9,4.2,1.3,1.7,1,4.7,6.9,3.8,4.9,16.6,7.7,33.7,13,9.6,6.9,6.9,3,22.6,2.6,11.4,11.9,9.6,8.1,5.7,7.5,8.3,6.7,4.3,2.1,14.1,6.9,9.3,7.4,4.8,11.5,19,8.8,14.4,10.4,4.2,1.6,8.4,12.5,8.5,4.3,1.4,4.6,11.7,5.1,5.5,4.5,1.8,9.6,21.5,12.7,3.8,6.7,12.7,6.7,29,7.5,3.4,9.7,6.8,5.2,12.1,17.3,10.3,5.5,8.4,2.2,4.8,7.5,4.5,3.9,3.9,1.3,1.2,4.2,1.7,0.5,0.9,0.8,2.5,0.3,0.9,1.2,0.4,1.3,3.2,1.7,0.8,1,9.3,11.4,5.2,13.6,9.7,7.9,9.5,8,8.7,5.5,8.9,9.8,5.1,7.2,25.3,10.9,17.9,17.8,6.7,2.3,34.9,5.9,9.8,1.7,5.4,21.7,18,37.9,46.7,10.7,27,15,12.6,4.7,83.9,29.4,6.4,9.1,15.4,33.3,2.8,9.2,15.1,20.3,5.4,23.6,26.5,7.9,31.7,7.1,29.5,8.5,6.5,11.6,33,9.4,40.4,20.5,10.2,20.5,11.4
SLC30A10,"DKFZp547M236, ZnT-10, ZNT8, ZRC1",ENSG00000196660,Solute carrier family 30 member 10,Q6XR72,1,219685427-219958647,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,"Disease mutation, Dystonia, Neurodegeneration, Parkinsonism",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,5,liver: 33.4,Group enriched,Detected in some,6,Early spermatids: 23.4;Enterocytes: 12.9;Hepatocytes: 19.8;Late spermatids: 27.7,Cancer enriched,Detected in some,14,liver cancer: 7.3,Low region specificity,Detected in all,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,HEK 293: 4.4;HEL: 2.2;Hep G2: 4.3;K-562: 2.8,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA064547,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA064547: AB_2732715,unprognostic (7.88e-2),unprognostic (1.07e-2),unprognostic (1.02e-1),unprognostic (7.25e-2),unprognostic (1.75e-2),unprognostic (3.74e-3),unprognostic (6.96e-2),unprognostic (3.72e-2),unprognostic (1.41e-1),unprognostic (1.95e-2),unprognostic (5.10e-2),unprognostic (3.10e-3),unprognostic (4.47e-7),unprognostic (3.16e-1),unprognostic (6.11e-2),unprognostic (6.19e-3),unprognostic (5.72e-2),0.3,0.3,2.9,0.7,3.5,0.4,0.3,1.8,3.9,0.3,7.1,1.9,0,5.9,0.3,0.3,0.3,0.3,0.5,0.3,3.5,1.6,0.3,33.4,0.3,0.3,1.7,1.7,0.6,0.3,0.3,0.4,0.4,2.5,0.3,1.7,0.6,0.3,0.3,0.3,0.3,6.8,0.3,0.8,0.3,0.3,1.9,1.9,0,0.3,0,0.3,0.3,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0.2,0,0,0,4.4,2.2,0,4.3,0,0,0,0,0,0,0,0,0,0,2.8,0,0,0,0,0.1,0.3,0,0,0,0,0,0,0,0,0.9,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.9,3.5,1.8,3.9,3.5,1.6,1.7,1.7,2.5,1.9,0,0,0,0,0.2,0.1,1.1,0,0,0,0,0,0,0,0.2,23.4,0,12.9,0,0,0.2,0,0,0,19.8,0.1,0,0,0.6,0.6,27.7,1.1,0,1.7,0,0.1,3.4,0,3.2,1.4,0,0,0,0,0.5,0.9,0.1,0.2,0,0.6,0
SLC30A2,ZNT2,ENSG00000158014,Solute carrier family 30 member 2,Q9BRI3,1,26037252-26046133,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,pancreas: 78.0;placenta: 20.0,Cell type enhanced,Detected in many,16,Cytotrophoblasts: 23.2;Exocrine glandular cells: 18.5;Proximal tubular cells: 27.2;Syncytiotrophoblasts: 71.2,Cancer enhanced,Detected in many,NA,thyroid cancer: 19.5,Not detected,Not detected,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Group enriched,Detected in some,4,BEWO: 4.7;RPTEC TERT1: 10.6;WM-115: 6.5,Region enriched,Detected in single,5,olfactory region: 1.5,Not detected,Not detected,NA,NA,HPA017979,NA,NA,Approved,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,HPA017979: AB_1857085,unprognostic (4.87e-2),unprognostic (6.70e-2),unprognostic (3.79e-2),unprognostic (1.79e-3),unprognostic (1.11e-1),unprognostic (2.37e-2),unprognostic (2.25e-2),unprognostic (2.59e-1),unprognostic (3.67e-2),unprognostic (1.02e-1),unprognostic (6.99e-2),unprognostic (1.10e-1),prognostic favorable (2.86e-6),unprognostic (9.38e-2),unprognostic (3.50e-2),unprognostic (1.17e-1),unprognostic (3.01e-2),0.1,0.7,0.1,0.1,0.1,0.2,0.4,0.1,0.1,0.1,0.1,0.1,0.6,0,1.3,1.1,0.1,0.1,4,2.2,0.1,0.1,10.4,0.1,0.2,0.1,0.1,0.1,0.1,78,0.1,0.1,20,0.1,0.3,0,2,1,1.4,1.7,0.4,0.6,0.1,0.1,0.1,0.1,0.4,0.1,0.1,12.8,0.2,0.1,0.5,0.1,1.5,1.1,3.1,1,1.5,0.9,0.4,0.2,0.2,0.2,1,0.3,0.1,4.7,0.4,0.2,0.1,0.1,0.9,1,0.2,0.9,0.1,0.2,0.9,0.2,0.3,0.1,0.6,0.3,0.6,0.7,0.1,0.1,0.6,0.7,0,0.2,0.1,0.1,0.3,0,0.3,0.6,1.5,0.1,0.8,0.5,0.9,0.8,0.4,0.2,0.3,0.7,0.7,10.6,0.4,0.9,0.5,0.6,1.1,0.4,1.6,0.7,0.5,0.6,0.7,1.2,0.6,0.3,1.1,0.6,0.8,0.5,0.6,6.5,3.1,1,0.4,0.9,0.4,0.5,0.7,0.6,0.8,0.2,1.5,0.6,0.8,3.1,1.5,0.5,1.1,0.5,0.4,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,3,4,0,0.7,0.3,2.4,5.1,15.3,0,0,8.7,0,23.2,5,6.8,0,0.5,0.4,0,18.5,2.4,0.6,0.6,4.6,0,3.1,0,0,0,0,0,0.3,0,3.3,1.8,0.1,0.5,5.4,0,0,27.2,1.8,6.5,0.9,0.2,0.4,0.6,71.2,0,0.6,0.7
SLC30A3,ZNT3,ENSG00000115194,Solute carrier family 30 member 3,Q99726,2,27253684-27275817,"Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,6,brain: 28.7;epididymis: 41.0;testis: 19.5,Group enriched,Detected in some,18,Cardiomyocytes: 8.1;Early spermatids: 13.1;Late spermatids: 29.1;Peritubular cells: 14.2;Spermatocytes: 18.7;Spermatogonia: 9.4,Low cancer specificity,Detected in some,NA,NA,Group enriched,Detected in many,9,amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,GAMG: 8.0;HAP1: 8.8;Hep G2: 11.7;REH: 19.0;RH-30: 9.9,Group enriched,Detected in many,5,amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6,Group enriched,Detected in many,7,amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9,"HPA060505, HPA067637, CAB079044",Enhanced,Approved,Approved,"Nucleoplasm,Nucleoli,Vesicles,Cytosol",NA,NA,NA,NA,NA,Vesicles,"Nucleoplasm, Nucleoli, Cytosol","CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875",unprognostic (2.05e-4),unprognostic (1.17e-1),unprognostic (6.84e-4),unprognostic (5.26e-2),unprognostic (2.34e-1),unprognostic (1.13e-1),unprognostic (1.43e-2),unprognostic (2.93e-2),unprognostic (2.64e-2),unprognostic (3.05e-1),unprognostic (2.20e-1),unprognostic (1.89e-1),unprognostic (4.65e-12),unprognostic (3.23e-2),unprognostic (1.76e-1),unprognostic (2.74e-2),unprognostic (2.63e-4),0.5,1.9,15.8,0.5,11.4,0.5,0.4,0.4,28.7,0.5,0.5,0,1.9,0.4,0.5,41,0.4,0.7,0.4,5,10.2,0.8,0.4,0.5,0.5,0.8,1.1,12.1,0.5,0.4,0.6,0.4,0.4,1.6,0.6,0.5,0.7,0.4,0.9,0.4,0.4,0.5,0.5,0.7,0.5,0.4,19.5,0,0,0.4,0,0.4,0.5,0.4,0,0,0,0.6,0,0.1,0,0.3,1.1,0,1.5,0,0.2,0.1,0,0,1,1,0.3,0.4,0,0,0,8,0.2,8.8,0,0.2,0,1,5,0.2,11.7,0.2,0.1,2,0,0,0.5,0,0.1,0.7,2.4,1.4,0,0.1,3.8,0,0.3,1.5,0.2,0,19,9.9,1,0,0,0,0.6,2.3,0,0,0,0,0.7,0,0.2,4.8,0.1,0,0,0,0,0,0.1,0.1,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0.6,0,0,0,15.8,11.4,0.4,28.7,10.2,0.8,1.1,12.1,1.6,0,0,0,0,0.1,0,0,8.1,0,0,0,0,0,0,0,0,13.1,0.1,0,0,0,0,0,0.3,0,0,0.1,0,0,0.6,0,29.1,0.9,0,0,0,0,0,0,0,14.2,0,0,0,0.3,18.7,9.4,0.1,0.1,0,0,0
SLC30A6,"FLJ31101, ZNT6",ENSG00000152683,Solute carrier family 30 member 6,Q6NXT4,2,32165841-32224379,"Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA055032, HPA057328",Uncertain,NA,Enhanced,Golgi apparatus,NA,NA,NA,NA,NA,Golgi apparatus,NA,"HPA055032: AB_2682677, HPA057328: AB_2683411",unprognostic (5.61e-2),unprognostic (9.11e-3),unprognostic (1.05e-3),prognostic unfavorable (6.55e-4),unprognostic (1.36e-1),unprognostic (1.48e-1),prognostic unfavorable (9.58e-6),unprognostic (2.98e-1),unprognostic (9.47e-2),unprognostic (1.88e-1),unprognostic (3.30e-3),unprognostic (7.05e-2),unprognostic (3.06e-2),unprognostic (3.51e-1),unprognostic (3.00e-1),unprognostic (1.13e-1),unprognostic (1.90e-1),15.9,17.9,10.3,11.9,13.1,5.4,15.3,21.1,13.7,16.6,14.4,14.2,10.6,12.6,22.5,12.1,16.8,13.8,13.5,13.5,10.6,8.7,17.9,18.4,14.3,17.9,17.3,8.1,17.8,23.7,15.7,19.8,18.1,13.2,13.7,15.3,14.8,17.2,12.4,18.8,15.2,14.3,14.1,20.1,16.2,14.9,12.8,15.9,21.3,17.8,9.9,18.8,15,14.2,4.3,3.9,12.5,3.1,9.2,6.1,2.6,18.3,13.8,14.2,12.4,18.1,16.3,15.8,17.3,17.1,14.2,13,10.7,17.4,8.8,11.5,13.7,16.4,11.6,16.9,11.9,18.2,17.7,9.4,19.1,7.9,13.6,11.6,20,11.9,12.1,18.7,19.1,15.4,14.5,11.4,6.3,16.1,11.8,16.2,6.8,10.5,9.2,21.4,20.7,7.3,9.4,17.2,12.9,15.7,16.2,10.7,16.3,13.6,14.7,13.6,13.9,8.1,9.2,9.7,18.2,10.1,11.9,20.3,16.1,27.9,13.1,16.2,15.7,18.3,12.5,3.1,2.6,3.6,2.7,4.9,4.3,3.3,4,3.9,3.8,5,4.6,3.5,9.2,3,3.2,6.1,2.6,10.3,13.1,21.1,13.7,10.6,8.7,17.3,8.1,13.2,15.9,8.9,6.9,8.8,4.1,8,4.9,3.5,10.2,4,1.2,7,5.9,17.2,5,6.6,1.6,9.8,7.2,0,7.4,12.5,9.8,7.6,3.5,15.5,9.4,1.6,3.5,9.2,6.3,0.4,6.1,6.4,8.5,4.6,8.5,6.3,8,7,7.4,7.9,6.1,12.9,5.1,11.1,8.9,5.5,23,5,9.8,4.3
SLC30A8,"ZnT-8, ZNT8",ENSG00000164756,Solute carrier family 30 member 8,Q8IWU4,8,116950273-117176714,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,Diabetes mellitus,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,6,pancreas: 37.1,Cell type enhanced,Detected in some,17,Early spermatids: 3.0;Late spermatids: 5.4;Pancreatic endocrine cells: 8.2;Spermatogonia: 3.0,Group enriched,Detected in some,28,breast cancer: 10.6;pancreatic cancer: 15.6,Not detected,Not detected,NA,NA,Cell type enhanced,Detected in single,NA,gdT-cell: 1.5,Low lineage specificity,Detected in single,NA,NA,Group enriched,Detected in some,34,U-266/70: 30.5;U-266/84: 21.3,Not detected,Not detected,NA,NA,Low region specificity,Detected in many,NA,NA,HPA076165,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA076165: AB_2732304,unprognostic (2.14e-2),NA,unprognostic (1.48e-2),unprognostic (1.61e-1),unprognostic (1.41e-1),unprognostic (5.38e-2),NA,unprognostic (5.57e-2),unprognostic (4.38e-1),unprognostic (3.36e-1),unprognostic (1.19e-1),unprognostic (6.66e-2),unprognostic (6.51e-3),unprognostic (2.15e-2),unprognostic (1.25e-1),unprognostic (1.99e-1),unprognostic (9.16e-3),0.1,0,0.1,0.1,0.4,0,0.2,0.1,0.1,0.1,0.3,0.1,0.1,0.2,0.3,0.1,0.1,0.1,0.1,0.1,0.1,0.1,2.4,0.1,0.1,0.1,0.1,0.1,0.1,37.1,0,0.3,0.1,0.1,0.1,0,5,6.4,0.1,0.1,0.3,0.4,0.1,0.1,0.1,0.6,2.1,0.1,0.1,0.1,0.1,0.1,0.5,0.1,0.1,0.5,0,0,0,1.5,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.7,0,0,0,0,0,0,0.6,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0.5,0,0,30.5,21.3,0.2,0,0,0,0,0,0,1.5,0,0,0,0,0.8,0,0.1,0.8,0,0,0,0,0.5,0,0.4,0.1,0.4,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0,0,0,0,0,0,0.3,0,0,0,0,0,0,1.7,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.4,0,0,0,0,0,0,8.2,0,0,1.5,0,0,0,1.4,3,0,0,0,0,0
SLC30A9,"C4orf1, GAC63, HUEL, ZNT9",ENSG00000014824,Solute carrier family 30 member 9,Q6PML9,4,41990472-42090457,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Ion transport, Transcription, Transcription regulation, Transport, Zinc transport",NA,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,HPA004014,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA004014: AB_1080005,unprognostic (4.26e-2),unprognostic (2.20e-1),unprognostic (1.31e-3),unprognostic (1.44e-2),unprognostic (1.14e-1),unprognostic (1.01e-1),unprognostic (3.19e-2),unprognostic (1.82e-1),unprognostic (2.63e-2),unprognostic (1.43e-1),unprognostic (1.55e-1),unprognostic (6.99e-2),prognostic favorable (2.86e-14),unprognostic (4.67e-2),unprognostic (1.34e-1),unprognostic (2.22e-2),unprognostic (1.39e-2),11,20.4,23.6,11.2,28.8,7,18.1,24.2,32.4,16.5,17,12.8,15.3,16.1,13.8,21.8,12.5,13.3,11.5,33.4,22.7,24.4,38.2,17.9,11.6,9,22.7,23.7,15.1,16.6,30.4,32.6,12.2,27.7,18.3,18.4,11.5,15,16.4,17.1,12.6,15.5,11.5,19.2,11.9,16.1,8.8,15.4,12,22.5,15.8,10,11.8,11.6,4,7.1,6.2,6.5,5.9,5.5,3.9,8.5,4.3,14.2,16.1,11,15.4,8.1,11.9,14.4,10.5,12.5,4.4,11.2,8.8,8.7,13.6,13.5,4.4,11.9,9.8,15,3,7.2,10.1,7.6,7.3,19.5,13.8,7.3,12.2,10.1,8.9,11.7,16.9,11.3,9,13.5,4.2,18.2,4.1,7.9,13.2,10.9,13.3,6,4,12.9,7.2,21.2,7.2,15.9,17.9,8.4,9.4,10.5,10.6,12,10.5,12.1,12.3,7.2,12.3,13.7,8.3,6.3,8.4,16.8,11.8,10.7,6.2,5.3,3,3.6,6.5,4.2,4,4.2,4.6,7.1,3.8,5.5,4.3,2.6,5.9,5,5.1,4.7,3.9,23.6,28.8,24.2,32.4,22.7,24.4,22.7,23.7,27.7,15.4,44.7,38.5,16.7,19.2,13.5,33.9,83.2,25.5,49.5,34.2,36.6,23.6,37,87.9,31.8,3.9,18.8,23.6,0,31.7,28,22.1,27.9,33.5,23.6,21.4,47.7,32.1,22.7,21,6.9,19.2,20.3,23.6,28.9,35.3,24.3,29,10.5,21.2,80,36.5,6.5,23.1,11.7,14.9,19.8,41.3,14.9,36.5,19.2
SLC35A4,NA,ENSG00000176087,Solute carrier family 35 member A4,"L0R6Q1, Q96G79",5,140564456-140569103,"Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,4,Late spermatids: 94.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA062210,NA,NA,Approved,"Nucleoplasm,Cytosol",NA,NA,NA,NA,NA,Nucleoplasm,Cytosol,HPA062210: AB_2684712,unprognostic (3.01e-3),unprognostic (1.35e-2),unprognostic (5.88e-2),unprognostic (1.09e-1),unprognostic (2.46e-2),unprognostic (1.65e-2),unprognostic (1.91e-3),unprognostic (9.63e-2),unprognostic (3.61e-2),unprognostic (9.32e-2),unprognostic (1.78e-2),unprognostic (2.87e-1),prognostic favorable (4.56e-5),unprognostic (2.96e-2),unprognostic (3.04e-2),unprognostic (2.06e-2),unprognostic (1.55e-1),22,30.4,12.3,18.6,17.1,8.4,19.6,14,21.8,18.2,25.5,24.9,22.6,19.2,18.2,19.8,30.3,20.6,26,25.7,13.1,10.3,35.1,39.2,23.1,22.5,16,11.1,19,28.3,28.2,14.9,24.6,19.4,20.4,26.5,20.5,32.6,15.9,54.3,28.3,30.6,19.8,13,28.5,21.7,30.5,15.3,26,29.2,28,27.5,18.3,18,15.4,32.8,15.8,36.9,26.9,27.6,32.4,15.5,46.7,18.7,35.2,25.7,16.1,27.9,22.7,15.3,27.7,29.2,56.5,18,46,28.1,21.3,32.3,17.2,0,33.1,23.8,55.9,25.6,34.4,45.6,0.2,18.3,33.6,26,21.3,25.9,27.5,24.7,13,23.7,22.8,26.6,46.5,27.4,28.8,35,14.6,12.7,22.4,23.9,26.1,37.9,39.9,20.7,30.8,20.9,27.9,28.7,47.8,22.3,19.2,39.7,14.4,27.7,24.9,17.4,24.7,25.4,19.3,45.3,19.3,18.4,38,28.9,7.5,26.9,15.8,27.6,36.9,26.3,14.3,22.1,24.7,32.8,15.4,25.9,23,9.9,26.9,33.3,12,14.7,32.4,12.3,17.1,14,21.8,13.1,10.3,16,11.1,19.4,15.3,11.9,24.8,21.9,20.2,9.3,12.2,23.8,43.3,6.7,17,15.7,3.9,26.8,38.1,28.1,58.7,14.7,37.1,0,30.4,42.8,19.5,22.2,20.7,19.5,28.5,12.7,24.2,27.6,21.1,94.4,11.5,15.8,16.9,31.5,27.2,20.3,31.1,21,11.7,31.1,8.5,32.3,12.6,5.4,16.4,10.2,25.5,20.3,28.7,29.1
SLC35A5,FLJ20730,ENSG00000138459,Solute carrier family 35 member A5,Q9BS91,3,112561709-112585577,"Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,7,Early spermatids: 94.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA035519, HPA057964",Uncertain,NA,Approved,Golgi apparatus,NA,NA,NA,NA,NA,Golgi apparatus,NA,"HPA035519: AB_10601487, HPA057964: AB_2683566",unprognostic (7.89e-2),unprognostic (2.33e-1),unprognostic (7.17e-2),unprognostic (1.11e-1),unprognostic (1.89e-1),unprognostic (7.09e-2),unprognostic (1.45e-1),unprognostic (4.78e-2),unprognostic (8.60e-3),unprognostic (2.60e-1),unprognostic (8.21e-2),unprognostic (3.51e-1),prognostic favorable (4.10e-5),unprognostic (2.26e-1),unprognostic (1.97e-1),unprognostic (8.05e-2),unprognostic (3.42e-1),13.4,17.7,19.4,11.2,22.1,4.4,13,14.2,24.1,15,13.6,32.7,9.7,14.9,15.2,15,13,13.3,13.8,9.6,22.9,22,18.2,18,12.8,12.4,37.8,19.5,16.9,12.6,17.9,17.6,17.2,27.5,14.8,14.8,14.4,11.7,13.4,5.5,8,15.5,14.1,42.9,12.7,12.5,15.4,26.6,11.6,23.8,6.4,13.1,13.2,10.4,12,15.2,15.7,20.1,5.2,11.5,7.8,11.3,10.3,17.6,10.7,23.1,22,10.2,18.5,13.5,16,18.3,7.6,13,10.3,15.9,16.2,18.1,14.3,12.8,8.9,20.1,7.7,6.3,12.9,9.9,6.7,19.1,11.5,12.4,19.1,17.8,14.1,8.7,20.1,14.2,7.9,7.4,12.7,21.9,4,8.7,7.3,11.9,13,11,7.7,6.6,10.6,19.7,8.5,10.3,14,12,5.9,21,12.7,7.9,8.1,15.9,23.3,12.8,5,8.5,8.9,12.8,17.9,17.3,9.6,17,8.4,12.6,15.7,8.9,19.8,8.3,12,8.5,7,15.2,11.5,11.5,9.4,11.2,5.2,20.1,7.2,8.4,7.8,19.4,22.1,14.2,24.1,22.9,22,37.8,19.5,27.5,26.6,3,8.5,10,7,5.7,12.3,4.7,10.2,5.3,6.8,14,0,30.6,8.3,6.8,94.9,12.4,12.4,0,6.7,20.1,15.1,7.4,13.9,10.2,15.8,35,7.5,12.9,19.1,17.6,15.8,9.1,25.3,11.8,10.7,18.5,6.5,12.9,16.3,12.3,14,25.8,9.9,15.4,10,5.8,24.9,10.9,8.5,2.7
SLC35A1,"CMPST, hCST",ENSG00000164414,Solute carrier family 35 member A1,P78382,6,87470623-87512336,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,Congenital disorder of glycosylation,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,5,Mucus-secreting cells: 73.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (3.04e-2),unprognostic (1.93e-1),unprognostic (6.33e-2),unprognostic (2.55e-2),unprognostic (2.82e-1),unprognostic (4.07e-2),unprognostic (1.38e-1),unprognostic (1.18e-1),unprognostic (1.58e-2),unprognostic (3.01e-3),unprognostic (7.26e-2),unprognostic (3.85e-1),prognostic unfavorable (2.70e-6),unprognostic (2.85e-1),unprognostic (8.51e-2),unprognostic (5.48e-2),unprognostic (1.04e-1),11,18,14,9.2,19.8,6.3,20.5,24.1,22.9,19.2,25.3,10,8,12,20.1,15.1,10,13.6,12.7,10.6,15.2,13.8,15.7,20.8,24.2,10.3,16.3,11.6,15.8,11.6,13,24.4,12.6,21.4,24.9,31.6,13.1,19.4,11.4,9.1,15.9,14.5,18.9,12.2,14,18.8,8.1,14.5,18.6,14.2,8.2,11.8,17.4,12,9.4,24.6,21.6,28.4,8.7,15.1,17.2,2,5,9.1,10.7,24.9,22.8,7.3,6.1,5.4,5.1,7.1,4.3,37.8,7.6,7.5,7.5,14.2,8.1,10.9,4.9,6.6,10.8,8.1,8.6,6.8,7.6,16.4,11.1,6,11.6,12,6,11.8,12.1,12.2,11.2,11,12.6,7.5,19,3,16.9,4.9,26,8.2,9.6,8.9,8.1,15.8,8.8,6,6.6,11.2,21.1,9.7,10.9,18.7,22.9,11.3,7.4,5,8.1,4.9,9.4,13.6,2.8,6.2,19.9,10.5,21.6,28.4,11.6,9.8,22.1,15.1,9.4,10.6,11.9,24.6,8.7,13.6,12.6,7,8.7,21.5,9.1,13.6,17.2,14,19.8,24.1,22.9,15.2,13.8,16.3,11.6,21.4,14.5,41.7,25.2,6.9,15.8,13.2,6.9,5.2,17.8,16,10.3,15.7,11.8,20.9,6.6,8.2,5.8,14.3,15.8,0,7.9,15.9,17.7,17.6,21.8,17.4,14.5,11.1,14.5,47.3,30.6,4.9,15.3,13.6,20.3,10.8,73.6,18.1,8.5,14,18,9.3,6.4,19.4,16.5,7.5,9.7,12.9,23,13.8,25.5,7.4
SLC35A2,"UGALT, UGAT, UGT, UGT1, UGT2, UGTL",ENSG00000102100,Solute carrier family 35 member A2,P78381,X,48903180-48911958,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,"Congenital disorder of glycosylation, Disease mutation, Epilepsy",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA036087,Approved,NA,Supported,Golgi apparatus,NA,NA,NA,NA,NA,Golgi apparatus,NA,HPA036087: AB_10604093,prognostic unfavorable (3.16e-4),unprognostic (3.34e-1),unprognostic (4.88e-3),unprognostic (1.11e-1),unprognostic (8.15e-3),unprognostic (4.25e-3),prognostic unfavorable (9.64e-5),unprognostic (3.47e-1),unprognostic (2.50e-1),unprognostic (1.63e-1),unprognostic (1.94e-3),unprognostic (9.58e-2),unprognostic (3.16e-2),prognostic favorable (8.23e-4),unprognostic (1.38e-1),unprognostic (1.61e-1),unprognostic (5.13e-2),11.4,17.2,10.5,9.7,12.2,10.9,21.9,5.9,18.4,16.2,22.7,20.5,13.4,13.5,11.5,24.2,17.2,23.1,14.3,12.8,10.3,10.9,18.8,43.6,14.5,18.9,12,9.7,10.6,30.6,18.8,16.2,29.8,12.7,14.1,23.1,10.3,16.9,14.7,12.9,15.9,13,9,13.8,12.1,19.8,8.8,10.3,8.8,13.3,12.5,13,11.3,11.4,7.5,18.5,24.2,15.7,7.8,10.9,6.9,20.5,23.7,8.1,11.5,17.4,14.1,11.9,21.2,20.7,21.2,25.6,25.5,36.3,7.7,10.1,23.2,29,29.6,21.8,16.3,17.6,10.2,14.7,8.5,14.9,19.9,20.3,16.2,18.4,15,27.6,18.7,17.7,12.1,12.4,11.1,16.1,12.8,15.7,19.5,7.9,13.4,16.8,23.1,28.9,8.5,14.5,23.6,19.2,16.8,9.4,15.2,22.1,24,12.1,15.9,35.2,12.7,8.9,12.8,13.1,23,11.9,20,13.6,8.5,15.5,13.3,15.8,11.4,14.4,24.2,10.2,15.7,10.9,7.5,9.2,9.6,17.5,7.3,5.8,10.6,15.9,7.8,10.6,18.5,8.8,6.9,10.5,12.2,5.9,18.4,10.3,10.9,12,9.7,12.7,10.3,8.9,17.1,6.7,10.5,12.6,4.5,4.2,10.2,20.1,6.8,15.7,0,27.3,3.3,23,2.5,11.9,18.8,23.3,28.6,22.7,14.8,16.6,2.3,14.9,21.4,6.4,12.2,12.3,10.1,1,9.2,11.9,10.1,30.7,30.3,9.4,20.7,17.5,10.3,10.5,4.6,6.5,7.3,5.6,4.1,15.3,40.2,9.6,17.4,22.6
SLC35A3,NA,ENSG00000117620,Solute carrier family 35 member A3,Q9Y2D2,1,99969351-100035637,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,"Autism spectrum disorder, Epilepsy, Mental retardation",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,5,Enterocytes: 139.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA015253,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA015253: AB_1857106,unprognostic (1.05e-1),unprognostic (2.69e-1),unprognostic (1.57e-3),unprognostic (5.89e-2),unprognostic (9.64e-2),unprognostic (1.61e-1),unprognostic (1.72e-1),unprognostic (4.02e-2),unprognostic (2.59e-2),unprognostic (1.47e-1),unprognostic (1.76e-3),unprognostic (1.69e-1),unprognostic (1.02e-1),unprognostic (1.49e-3),unprognostic (2.32e-1),unprognostic (2.73e-2),unprognostic (9.34e-2),10.7,9.4,6.5,16.7,6.8,5.9,16.2,7.4,8.9,12.4,31.4,5.5,16.2,29.1,10.5,10.8,14.9,9.5,12.5,7.1,5.4,4.8,13.2,21.9,18,10.9,7,6.3,7.9,13.8,12.8,8.6,12.2,9.6,14.4,32.7,6,22.3,21.9,7.5,10,41,15.3,7.6,6.3,19.9,5.1,5.6,24.7,15.3,7.9,8.1,13.9,13,4.3,9,6.4,3.7,7.7,5.2,3.2,17.4,4.7,4.3,4.5,9.8,8.6,17.3,15.6,9.5,6.2,9,3.1,9.5,9.4,19.6,9,8.7,10.1,8.1,7,14.2,11.5,5.9,8.5,6.7,7.4,6.2,13.5,1,4.6,7.9,7.4,14.6,7.4,7.1,7.5,14,14.1,12.5,4.3,8.9,7.1,5.3,10,15.9,2.8,13.2,5.9,11.3,10.1,5.6,3.1,10.8,20.9,8.2,4.2,12.7,10.3,8.2,9.4,8.5,20.7,8.3,8.4,9.8,7,15,8.5,3.9,6.4,3.6,2,4.2,3.7,4.7,4.3,4.2,4.9,3.1,3.4,5.2,4.4,1.2,7.7,2.9,9,4.8,3.2,6.5,6.8,7.4,8.9,5.4,4.8,7,6.3,9.6,5.6,74.5,25.8,14.7,19.1,22.1,16.3,7.4,22.9,64.3,35.2,52.4,19.6,15.3,6.6,14.1,3.5,17.5,139.9,0,13.4,24.2,13.2,46,16.2,42.7,12.4,9.5,19,23.9,17.4,0,12.4,12.9,8.5,9,96.8,16,18.6,71.9,12.4,28.5,22.5,6.5,15.1,11.9,5.7,26,19.5,21.8,78.5,31.8
SLC35B2,UGTrel4,ENSG00000157593,Solute carrier family 35 member B2,Q8TB61,6,44254096-44257890,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA029638,Approved,NA,Approved,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,HPA029638: AB_10602402,prognostic unfavorable (7.90e-4),unprognostic (2.47e-3),unprognostic (2.30e-1),unprognostic (1.39e-2),unprognostic (2.36e-1),unprognostic (1.65e-2),prognostic unfavorable (8.59e-5),unprognostic (3.84e-1),unprognostic (2.51e-1),unprognostic (7.03e-3),unprognostic (4.27e-2),prognostic favorable (6.07e-4),unprognostic (3.60e-2),unprognostic (1.13e-1),unprognostic (4.07e-1),unprognostic (1.28e-1),unprognostic (1.06e-1),18,28.2,14.8,12.6,15,10.7,17.7,16.2,24.8,18.3,18.9,35.8,19,13,22.6,23.4,14.3,18.6,27.1,17.7,15.2,10.9,32.3,35.5,16.1,12.9,17.1,14.6,16.7,38.1,27.4,11.1,26.1,19.8,19,20.2,23.8,49.6,20.4,17.5,15.6,16.4,20.5,24.7,18.4,20.6,16.3,18.7,12.2,19.3,17.8,17.6,19.6,14.3,12.9,14.4,21.8,8.6,10.8,21.1,10.2,23.1,13.3,16.7,32,27.5,29.1,12.2,25.4,42.1,25,30.8,11.7,21.6,5.2,22.9,31.4,26.9,22.1,11.4,28.6,17.6,15.3,14.7,10.4,10.5,13.9,25.7,22.2,17,29.8,30.1,23,11.3,34.6,18.3,11.9,14.9,22.4,29.9,27.2,8.2,18.6,7.4,69.9,15.5,8.2,10.8,26.4,27,17.2,20.8,20,12.5,13.9,28.6,10.9,25.8,20.4,18.1,19.7,13.1,19.6,22.1,17.3,19.7,12.1,26.3,17.7,40,21.8,8.6,13.2,21.1,6.5,17.8,12.9,11.9,16.1,7.7,7.7,11,14.2,0.7,10.8,2.3,14.4,9.6,10.2,14.8,15,16.2,24.8,15.2,10.9,17.1,14.6,19.8,18.7,6,11.5,22.3,25.5,11.9,9.7,6.7,43.3,5.3,11.4,26.2,2,50.8,11.6,69.2,0.4,9.8,13.7,0,64.7,44.1,30.6,27,34.6,15.3,32.9,9.5,18.9,16,9.9,1.2,21.6,10,50.6,32.5,20.3,42.2,56.9,27.4,18.7,11.5,12.5,0,16.7,15.2,67.3,12.2,29.4,13.1,29.9,18.4
SLC35B4,"FLJ14697, YEA4",ENSG00000205060,Solute carrier family 35 member B4,Q969S0,7,134289332-134317051,Predicted membrane proteins,"Sugar transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,6,Bipolar cells: 50.1;Cytotrophoblasts: 73.7;Syncytiotrophoblasts: 69.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA049779,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA049779: AB_2680878,unprognostic (1.84e-1),unprognostic (1.94e-2),unprognostic (7.19e-2),unprognostic (2.49e-2),unprognostic (1.77e-3),unprognostic (3.47e-2),unprognostic (3.23e-2),unprognostic (1.25e-2),unprognostic (1.57e-1),unprognostic (3.32e-2),unprognostic (6.88e-3),unprognostic (1.86e-1),unprognostic (2.24e-3),unprognostic (3.18e-2),unprognostic (2.86e-1),unprognostic (9.81e-2),unprognostic (1.00e-1),7.8,10.1,9.6,7.4,16.8,2.7,5.3,22.4,21.6,6.8,5.4,10.8,4.8,4.5,9.4,10.1,5,6.8,6.1,4,10.1,12.4,15.9,11.6,5.1,6.3,9.4,9.6,10.3,4,6.4,6.7,17.5,12.7,8.4,5.7,9.9,3.8,10,3.5,4.9,5.9,10.8,8.6,6.5,5.2,6.9,8.6,6.8,5.4,2,7.2,6.4,4.3,3.2,6.5,1.3,4.6,4,5.7,2.9,3.8,12.8,11.3,16.8,11,9.3,5.8,9.7,8.1,8.6,7.3,4.9,3.6,12.9,3.3,10.4,11.3,4.1,16.6,8.6,14.4,8.1,12.4,8.7,7.5,6.5,8.1,12.2,7.9,8.1,3.7,10.3,8.8,6.5,8.3,9,8.4,4.8,12.9,3.4,10.8,9,23.3,3.9,11.6,7.9,9.9,6.3,4.8,4.7,4,23.2,8.6,2.9,10.6,9.8,1.6,7,9.2,11.3,3.7,6.7,9.5,15.9,21.8,15,20.1,11.6,12.9,1.3,3.4,0.7,3.8,4.6,5.7,3.1,3.5,4.7,6.5,3.2,3.4,5,0.4,4,3.5,4.5,3.7,2.9,9.6,16.8,22.4,21.6,10.1,12.4,9.4,9.6,12.7,8.6,8.9,4.8,6.4,4.8,1.9,50.1,5.3,7.6,8.1,9.1,1.8,43.2,73.7,10,7.7,1.5,8.7,3.1,0,4.6,21.6,9.3,4.4,1.1,14.4,18.3,39.7,4.1,4.9,8.6,2.9,10.3,8.6,5,3.6,3.8,16.4,6.9,3.1,11.7,13.6,20.5,6.5,4.2,10.8,21.7,2.9,69.6,7.1,3.1,3.4
SLC35B1,UGTREL1,ENSG00000121073,Solute carrier family 35 member B1,P78383,17,49700943-49709014,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA048655, HPA057418",Approved,NA,Approved,"Nucleoplasm,Endoplasmic reticulum,Vesicles",NA,NA,NA,NA,NA,"Endoplasmic reticulum, Vesicles",Nucleoplasm,"HPA048655: AB_2680481, HPA057418: AB_2683432",unprognostic (1.35e-1),unprognostic (2.15e-2),unprognostic (1.09e-3),unprognostic (6.36e-2),unprognostic (8.31e-2),unprognostic (2.86e-3),unprognostic (6.17e-3),unprognostic (4.39e-2),unprognostic (2.47e-2),unprognostic (4.00e-3),unprognostic (3.37e-2),unprognostic (4.42e-2),prognostic unfavorable (5.69e-7),unprognostic (6.28e-2),unprognostic (7.88e-2),unprognostic (2.58e-1),unprognostic (1.44e-2),8.5,8.3,8.4,7.4,11.8,8,10.7,8.2,14,9.3,13,9.3,9.2,13.7,7.6,26.5,9.4,9.9,7.3,15.8,8.6,9.2,16,46.7,10.1,16,9.8,7.9,7.5,22.3,13.5,13.2,12.4,9.9,7.4,13.1,8.4,22.4,12.7,33.7,9.2,27.3,8,8.1,10.2,9.3,9.1,7.1,6.5,19.7,13.8,10.8,9.9,6.7,6.6,25,8.1,15.1,7,9.5,7.9,13.6,22.9,17.2,27,15.8,9.9,19.5,14.5,23.6,30.9,24.8,47.3,16,9.5,34,20.1,18.6,10.2,27.1,17.3,33.9,11.6,19.8,12,15.1,27.7,27.6,22.5,11.4,10.1,19,22.2,27.8,7.9,19,15.6,11.7,27.4,21.2,27.8,16.5,14.6,7.6,25.6,25.9,11.1,18.6,25.7,15.1,14.5,14.9,19.1,8.5,6.8,9.9,19.3,21.8,15.4,8.1,23.6,10.5,25.2,19,14.5,23.8,14.2,15.4,17.1,20.6,8.1,15.1,5,9.5,13.5,6.9,6.6,6.5,8.9,16.7,3.6,6.6,6,6.7,7,9.1,25,7.4,7.9,8.4,11.8,8.2,14,8.6,9.2,9.8,7.9,9.9,7.1,14.9,27.2,30.7,36.3,19.8,25.8,35.5,20.4,30.8,31.8,26.2,33.4,49.1,29.9,55.6,40.4,35,41.9,0,89.2,91.8,36.1,53.6,41.5,49.5,66.9,20.6,48.6,22.7,21.3,11.3,27.9,37,35.4,45.9,30.5,41.4,64.2,27.5,19.4,37.9,30.4,12.9,15.3,44.2,33.8,22,67.3,35.2,36,37.4
SLC35B3,"C6orf196, CGI-19, dJ453H5.1, PAPST2",ENSG00000124786,Solute carrier family 35 member B3,Q9H1N7,6,8413068-8435611,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA054661, HPA057801",Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA054661: AB_2682561, HPA057801: AB_2683532",unprognostic (2.84e-1),unprognostic (1.52e-1),unprognostic (1.10e-2),unprognostic (1.34e-1),unprognostic (1.17e-1),unprognostic (1.30e-1),unprognostic (1.19e-1),unprognostic (4.93e-2),unprognostic (5.23e-3),unprognostic (5.00e-2),unprognostic (9.45e-2),unprognostic (9.27e-2),unprognostic (3.43e-1),unprognostic (2.32e-1),unprognostic (2.20e-1),unprognostic (3.08e-3),unprognostic (3.88e-3),12.2,12.1,12.1,11.3,22.6,4,13.7,11.4,15.8,14.2,23.5,12.5,27,16,11.9,43.2,12.4,10.9,16.3,12.3,13.5,10.2,18.5,22.2,12.6,12.5,20,11.9,10.2,22,17.6,16,18.7,15.9,14.6,24.7,8.5,19,35.4,6.4,13,27.1,10.8,20.5,16.4,18.3,9.6,17.5,13.1,20.1,10,13.3,15.9,14.9,10.4,9.7,10.2,13.7,19.7,13,8.8,11.3,7.5,8.4,12.9,19.3,24.9,6.2,26,21.4,9.7,12.9,23,10,8.8,16.9,19.5,14.2,7.9,8,7.2,15.6,13.6,8.6,4.3,5.4,11.5,19.5,7.6,10.4,18.5,11.1,11,11.7,13.7,12.9,6.3,9.7,3.6,19.7,9,4.9,9.1,5.6,13,8.1,4.8,7.2,10,23.3,11.4,8,6.5,7.8,5.6,12.6,22.5,4.8,13.3,13,17,4.8,10.9,12.3,9.7,17.3,6,8.8,7.2,20.2,10.2,10.1,9.1,10.6,8.9,13,8.2,11.1,11.4,9.7,10.4,12.9,10.8,9.5,19.7,13.7,4.6,12,8.8,12.1,22.6,11.4,15.8,13.5,10.2,20,11.9,15.9,17.5,6,11.7,8.1,11.9,11.9,4.2,8.8,15.3,26.8,10.3,27.9,3.9,18.1,6.6,17.9,5.2,15.8,24.7,0,21.6,24.2,23.9,20.6,5.8,22.4,17.4,9.5,14.3,19,15.5,5.9,14.4,10.1,20.3,17.2,40.9,5.1,15.7,35.3,11.3,22.6,2.7,12.9,18.6,32.1,17.7,15.4,13.7,8.7,28.3,18.2
SLC35C1,"FLJ11320, FUCT1",ENSG00000181830,Solute carrier family 35 member C1,Q96A29,11,45804072-45813015,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Sugar transport, Transport",NA,"Congenital disorder of glycosylation, Disease mutation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,liver: 74.7,Cell type enhanced,Detected in many,4,Cardiomyocytes: 49.8;Enterocytes: 46.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA064001,Enhanced,NA,Supported,Golgi apparatus,NA,NA,NA,NA,NA,Golgi apparatus,NA,HPA064001: AB_2685171,unprognostic (2.62e-2),unprognostic (5.16e-2),unprognostic (7.82e-2),unprognostic (1.57e-2),prognostic unfavorable (9.68e-4),unprognostic (8.22e-2),unprognostic (9.40e-2),unprognostic (1.56e-2),unprognostic (2.83e-2),unprognostic (1.28e-1),unprognostic (4.09e-2),unprognostic (2.73e-1),unprognostic (7.68e-2),unprognostic (1.83e-3),unprognostic (2.18e-1),prognostic favorable (3.64e-4),unprognostic (2.30e-2),14.9,4.8,5.1,7.2,4.5,1.5,14.3,4.4,7.3,7,13.8,4.4,4.9,17.4,7.1,3.2,22.5,6.1,8.8,5.3,5.4,3.9,6,74.7,7.1,7.1,3.9,3.6,4.9,11.4,4.9,7.8,10.5,5.6,6,9.8,3.6,15.5,7,8.5,3.4,17.4,6.8,5,6.5,13.4,7.4,4.8,5.6,5.2,7,10.9,9.4,8.6,4.7,8.3,9.9,10.5,4.3,16.7,8.6,5.2,13.7,3.1,8,10.2,10.3,10.5,11.6,10,6.7,7.5,6.2,8.7,5,5.5,13.1,10,14,6.5,6.8,3.2,13,7.8,2.8,11,11.2,22.4,5.5,8.7,12.3,8.2,5.1,5.6,8.1,8.8,5.1,6.3,7.5,7.1,11.5,2.8,4.2,13.9,19.4,19.4,3.8,5.2,11.8,7.5,13.3,3.1,4.5,8.6,8.3,4.7,3.4,7.4,2.9,13.3,14.1,8.2,24.8,8.2,5.5,12.9,2.5,10.1,7.2,7.7,5,10.2,9.9,10.2,10.5,11.1,4.7,16.7,13.4,8.3,3.6,8.5,7.4,1.6,4.3,6.9,7.2,10.8,8.6,5.1,4.5,4.4,7.3,5.4,3.9,3.9,3.6,5.6,4.8,0,9.1,3,8.5,3.2,1.7,49.8,25.5,8.1,4.5,5.2,2,12,0,18.1,3.4,7.6,46.6,0,37.1,12.3,11,8,2.3,37.2,13.3,3.2,9.2,6.7,7.1,4.1,6.1,5.3,1.7,9,30.4,2.5,36.3,43.2,5.3,3.5,1,0,5.2,4.3,3.3,2,12.8,5.2,19.9,16.9
SLC35C2,"bA394O2.1, C20orf5, CGI-15, OVCOV1",ENSG00000080189,Solute carrier family 35 member C2,Q9NQQ7,20,46345980-46364458,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA027011,Approved,NA,Supported,"Nucleoplasm,Golgi apparatus",NA,NA,NA,NA,NA,Golgi apparatus,Nucleoplasm,HPA027011: AB_2672082,unprognostic (7.25e-2),unprognostic (1.78e-1),unprognostic (1.01e-1),unprognostic (2.27e-2),unprognostic (1.06e-2),unprognostic (2.90e-1),prognostic unfavorable (1.08e-4),unprognostic (1.34e-1),unprognostic (1.23e-1),unprognostic (2.56e-1),unprognostic (4.05e-2),unprognostic (1.29e-2),prognostic unfavorable (8.68e-4),unprognostic (9.31e-2),unprognostic (7.15e-2),unprognostic (1.18e-2),unprognostic (3.88e-1),16.8,25.9,19.4,26.7,24,25.6,17.5,30.3,25,19.1,19.3,22.8,21.3,22,19.2,20.9,23.4,24.3,20.2,13.5,19,12.9,20.7,26.7,17.4,22.9,19.9,13.6,21,30.5,18,23.7,29.8,17.7,23.6,12.2,28.9,30.9,17.3,13.4,25.6,20.7,15.8,19.3,26.1,21.6,19.6,23.3,19.7,23,13.5,23.4,19.1,19.3,17.4,42.9,26.8,21.9,18.3,28.3,23.5,14.3,17.4,8.1,6.4,11.3,10.9,15,7.8,14.9,8.8,10.5,24.3,22.9,9.6,26.8,9.3,11.9,20.3,4.6,17.7,3.3,7.8,13.6,8.5,10.6,19.4,21.5,11,10.1,15.7,22.7,12.5,14.6,9.7,7.3,10.6,13.3,17.7,6.5,34.8,7.8,16.5,10.5,15.4,16.9,7.3,8.7,18.6,11.1,14.2,12,16.6,7.3,38.1,24.4,5.2,22.5,19.3,7,22.7,14.5,11.4,12.4,23.7,19.4,9.9,25.7,12.6,10.1,19,21.9,26.8,23.8,21.5,22.2,17.4,24.4,24,23.9,16.9,28.3,25.5,19.5,18.3,16.7,42.9,22.1,23.5,19.4,24,30.3,25,19,12.9,19.9,13.6,17.7,23.3,14.9,15.5,28.6,25.7,12.8,31.2,5.9,17.8,12,18.2,26.2,39.3,80.2,11.6,34,4.6,13.5,26.5,0,53.8,43.9,23.9,32.4,14.9,23.7,33.9,17.5,20.2,28.3,19.1,4.3,17.8,17,20.3,45.1,31.2,21.9,31.3,30.6,18,15.4,29.4,19.4,14.4,15.6,21,14.4,66.2,25.9,27.7,28.5
SLC35E1,FLJ14251,ENSG00000127526,Solute carrier family 35 member E1,Q96K37,19,16549831-16572382,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA016570, HPA062214",Approved,NA,Enhanced,Golgi apparatus,NA,NA,NA,NA,NA,Golgi apparatus,NA,"HPA016570: AB_2190214, HPA062214: AB_2684713",unprognostic (1.76e-2),unprognostic (2.81e-1),unprognostic (7.31e-2),unprognostic (2.92e-2),unprognostic (2.37e-1),unprognostic (1.23e-1),unprognostic (5.35e-2),unprognostic (1.04e-1),unprognostic (1.20e-1),unprognostic (6.99e-2),unprognostic (9.07e-2),unprognostic (3.02e-2),unprognostic (2.23e-2),unprognostic (1.21e-2),unprognostic (1.27e-1),unprognostic (2.54e-1),unprognostic (3.75e-2),15.2,12.7,11.9,9.3,12.3,10.3,13.5,11.7,19.2,15.1,12.4,8.7,22.4,9.7,11.3,10.3,14.2,11.2,13.7,12.6,9.3,9.7,11.6,20.1,13.5,9.5,8.3,7.9,11.9,34.5,25.8,14.4,23.9,10.7,17.9,9.4,11.4,23.7,21.4,23.1,14.3,13.4,10,5.9,9.7,17,6.4,7.2,14,13.8,12.3,13.9,15.2,14.1,5.9,3.2,7.9,5,4.5,5.2,2.9,17.9,7.1,5.1,11.3,19,14.8,12,13.1,14,10.7,12.7,8.3,12.9,9.4,21.1,20.3,10.6,12,13.8,14.6,12.3,10.7,20,8.5,8.2,9.8,15.2,14,10.3,11.8,17.3,11.9,17.8,14,10.3,10.9,13.1,12.7,14.2,17,10.2,6.5,5.9,16.7,24.1,9.9,7.8,11,11,11.6,8.6,8.5,9,14.5,8,6.6,10.1,6.9,11.3,14.3,7.1,19.3,15,16.5,17.5,10.6,21.2,14.9,8.8,5,3.9,7.9,4.1,2.5,5.2,5.9,4.3,3.6,2.7,2.8,3.2,2.5,4.8,4.5,5,3.2,4.8,2.9,11.9,12.3,11.7,19.2,9.3,9.7,8.3,7.9,10.7,7.2,35.7,43.9,15.8,12.5,19.5,27.6,13.7,33.1,14.7,33,27.9,33.4,10.8,0,17.8,2.8,14.6,18.1,0,31.7,22.5,12.7,25.9,8.1,24.2,15.2,28.6,17.7,23.4,21.8,2.7,15.8,19.4,8.5,8.2,25.5,20.8,33.5,14,19.8,8.6,25.4,6.5,12.3,10.9,15.4,22.6,27.2,20.2,15.5,26.8
SLC35E2,KIAA0447,ENSG00000215790,Solute carrier family 35 member E2,P0CK97,1,1724838-1745999,Predicted membrane proteins,NA,NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Low tissue specificity,Detected in many,NA,NA,Cell type enhanced,Detected in many,11,Alveolar cells type 1: 26.8;Alveolar cells type 2: 22.1;Ciliated cells: 10.7;Club cells: 11.4;Horizontal cells: 12.7,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA006118, HPA062711",Uncertain,NA,Approved,"Nucleoplasm,Nucleoli",NA,NA,NA,NA,NA,Nucleoplasm,Nucleoli,"HPA006118: , HPA062711: AB_2684844",unprognostic (3.03e-1),unprognostic (2.56e-1),unprognostic (4.54e-3),unprognostic (1.35e-1),unprognostic (1.16e-1),unprognostic (1.28e-4),unprognostic (9.52e-4),unprognostic (6.57e-2),unprognostic (2.36e-1),unprognostic (1.28e-1),unprognostic (9.15e-3),unprognostic (4.86e-1),unprognostic (2.05e-1),unprognostic (2.83e-1),unprognostic (8.41e-2),unprognostic (2.43e-3),unprognostic (4.87e-4),3,4.1,8,5.2,5.1,0.6,3,9.8,6.2,4,3,2.9,1.6,4.9,6,10.5,4.5,5.8,7.6,3,5,3.5,2.5,2.4,4.8,11.6,4.4,4.7,5.5,3.5,6.9,5.9,3.5,4,3.6,5.4,3.6,9.1,1.6,4.7,6.4,4.8,3.7,3.7,6.8,6.2,6.2,5.5,5.5,3.5,3.8,4.3,4.3,7.7,5,5.2,6.4,3.4,3.1,6.5,3.2,1.6,1.6,5.4,11.5,11.2,11,3.6,7.4,15.3,7,9,4.6,15.1,4.9,1.3,1.7,1.7,7.5,1.4,2.9,7.6,6.8,1.7,6.4,7.5,1.2,2.3,1.3,7.2,8.8,3.7,1.2,6.3,5.8,2.1,9.2,2.1,2.2,1.3,1.2,1.9,3.2,1,0.9,1.9,3.7,5,1,7.4,5.3,15.2,3.1,2.2,9.2,8.8,1.3,17.9,3.6,9.6,7.3,1.5,2.2,0.4,3,0.4,1.6,5.2,3.9,1.2,6.4,3.4,2.1,5.5,2.6,6.5,4.5,4.8,5.3,1.5,5,5.5,4.8,4,3.1,1.6,5.2,4.5,3.2,8,5.1,9.8,6.2,5,3.5,4.4,4.7,4,5.5,26.8,22.1,0,0.5,0.5,5.1,0,2.5,10.7,11.4,0,2,0.8,0,0,0,0.7,0.7,0,0,0.4,1,0.4,2.3,0.8,0.6,12.7,0,1.8,0.6,0,2.8,0.3,0,0,0.7,1.2,0,0,3.2,0,3.9,0,0,0.7,1.3,1.5,0.2,4.9,1.2,0.4
SLC35E2B,NA,ENSG00000189339,Solute carrier family 35 member E2B,P0CK96,1,1659529-1692728,"Predicted membrane proteins, Transporters",NA,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,4,Cone photoreceptor cells: 72.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA045641, HPA062711",Uncertain,NA,Uncertain,Nucleoplasm,NA,NA,NA,NA,NA,Nucleoplasm,NA,"HPA045641: AB_2679402, HPA062711: AB_2684844",unprognostic (9.00e-2),unprognostic (2.13e-1),unprognostic (8.74e-3),unprognostic (1.01e-1),unprognostic (1.82e-1),prognostic favorable (7.64e-4),unprognostic (1.18e-1),unprognostic (4.09e-2),unprognostic (5.70e-2),unprognostic (5.83e-2),unprognostic (2.04e-2),unprognostic (2.20e-1),unprognostic (2.92e-1),unprognostic (2.68e-2),unprognostic (6.61e-2),unprognostic (2.54e-2),prognostic favorable (5.15e-4),7.4,9.7,11.3,5.8,9.3,6.4,14.2,15.5,14.5,8.1,15.4,9.7,15.4,12.5,10.2,10.5,6.8,9,9.8,5,11.7,7.5,7.7,14.2,8.6,18.8,10,8.5,15,16.6,6.5,14.4,11,9.2,9.7,7.3,8.7,12.1,10.2,10.4,10.5,12.1,13.6,7.1,12.8,8.2,3.9,12.6,8.5,9.8,7.2,10.2,7.3,13,4.8,8.7,6.8,3.9,4.5,9.5,5,6.1,7.7,27.5,19.4,15.4,14.7,6.9,3.4,8,4,4.1,3.5,8.4,8.3,12.4,16.4,9.9,4.5,10.9,5.9,3.5,11.7,10.3,12.3,13.7,9.9,15.3,11.6,10,13.7,13.8,10.7,12,21.4,16.8,16,14.6,14.9,9.3,3.8,15.2,13.2,9.5,5.1,9.1,12.7,5.8,14.4,9.9,3.4,18.6,23.8,12.7,11.2,20.1,12.5,9,15.8,12.4,11.5,6.1,4.9,4.1,12.5,9.6,17.5,9.1,21.1,8.1,1.7,3.9,3.3,8.3,3.5,8.9,4.3,6.8,9.5,2.8,4.8,8.1,6.7,6.8,4.5,2.5,8.7,6.4,5,11.3,9.3,15.5,14.5,11.7,7.5,10,8.5,9.2,12.6,11.9,27,23.5,6.5,6.5,33.6,15.3,35.7,13.4,27.3,3.5,72.6,11.2,0,5,0.8,18.6,25.2,0,5.3,7.3,19.3,8.4,22,18.1,8.9,28.6,24.5,30.1,33,1.3,28.1,8,11.8,6.4,23.6,12.3,4.8,17.5,25.1,2.2,66.3,6.5,9.5,6.1,15.5,8.4,7.3,30.6,26.7,6.7
SLC35E3,BLOV1,ENSG00000175782,Solute carrier family 35 member E3,Q7Z769,12,68746106-68793964,"Predicted intracellular proteins, Predicted membrane proteins, Transporters",NA,NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in all,NA,REH: 19.2;U-698: 19.5,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA049403,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA049403: AB_2680747,unprognostic (1.49e-1),unprognostic (6.47e-2),unprognostic (2.19e-1),prognostic favorable (1.78e-4),unprognostic (1.61e-2),unprognostic (2.49e-1),unprognostic (1.26e-4),unprognostic (2.64e-1),unprognostic (2.65e-2),unprognostic (1.58e-1),unprognostic (1.25e-2),unprognostic (6.98e-2),unprognostic (6.85e-3),unprognostic (1.48e-1),unprognostic (3.22e-2),unprognostic (2.89e-3),unprognostic (1.80e-1),8.1,12.3,7.9,7.2,11.9,12,12.4,14.1,13.7,8.2,6.2,18.9,3.5,5.7,7.4,9.6,8.7,5.5,5.8,6.2,8.9,7.4,8,12.7,7.6,9.2,13.9,10.6,8.7,9.8,7.7,6.7,5.8,14.4,10.2,5.9,9.7,11.8,5.8,7.3,14.5,5.5,7.4,15.7,8.2,9.2,5.7,11,18.8,6.9,5.3,9,8,6.6,4.4,3.7,9.5,3.8,3.6,4.6,1.5,2.2,2.4,3.7,2.3,4.8,2.2,3.4,2,4.1,4.6,2,4.9,2.8,10.5,1.3,4.1,3,3.2,2.1,4.2,2.8,2.3,3.7,4.5,3,8.1,3.5,2.3,2.3,4.8,3.2,5.7,2.9,3.3,3.7,3.6,2.3,3.9,4.6,3.4,2.9,7.3,3.7,1.5,3.5,19.2,5.9,2.6,3.4,5.5,2.9,5,4,3.2,2.6,3.8,5.7,1.1,2.7,5.6,2.3,3.2,2.1,8.6,4.2,19.5,6.7,2,2.9,4.7,3.3,4.2,4,3.1,4.6,3.1,3.2,3.2,2.4,4.4,3.6,2.9,9.5,3.6,3.8,3.7,2.7,1.5,7.9,11.9,14.1,13.7,8.9,7.4,13.9,10.6,14.4,11,11.9,24.8,17.1,19.2,7,61.6,12.9,10.2,26.8,21.6,17.4,37.3,21.6,5,16.2,3.2,12.8,7.1,0,19.5,20,16,14.6,17.4,20.2,13.6,41.3,12.6,14.7,21.1,1.7,14.1,26.5,6.8,19,8.4,28.1,16.8,5.8,21.5,11.3,61.9,25.8,12,9.6,13.5,6.6,10.4,29.9,12.3,14.9
SLC35E4,NA,ENSG00000100036,Solute carrier family 35 member E4,Q6ICL7,22,30635652-30669016,"Predicted membrane proteins, Transporters",NA,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,skeletal muscle: 20.2;testis: 22.5,Cell type enhanced,Detected in many,13,Early spermatids: 93.5;Late spermatids: 68.4,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,HDLM-2: 15.0;U-2197: 14.5;U-87 MG: 15.5,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA049558,Approved,NA,Approved,Cytosol,NA,NA,NA,NA,NA,Cytosol,NA,HPA049558: AB_2680817,unprognostic (2.09e-1),unprognostic (1.88e-1),unprognostic (2.05e-1),unprognostic (1.01e-2),unprognostic (4.99e-2),unprognostic (2.04e-1),unprognostic (3.03e-4),unprognostic (5.71e-2),unprognostic (7.85e-2),unprognostic (1.76e-1),unprognostic (1.05e-2),unprognostic (2.39e-2),unprognostic (3.45e-7),unprognostic (2.77e-3),unprognostic (1.77e-1),unprognostic (2.24e-2),unprognostic (8.05e-3),4,2.5,5.6,3.3,11.8,3.4,2.6,4,11.4,2.7,5.9,8.1,2.1,2.7,4.2,3.5,4.5,3.1,2.9,5.6,5.2,4.7,2,1.1,2.4,2.1,13,6.3,2.8,4.1,3.1,2.8,1.6,6.6,2.9,4.2,2.4,2.6,3.5,20.2,7.3,2.5,3.5,2.6,2.4,3.8,22.5,10.1,0,2,6.6,2.1,3.6,7.6,0.7,3.6,1.6,2.8,2.1,3.2,0.9,6.5,2.9,1.1,2.2,3,7.7,0.6,4.3,3.8,3,2.8,0.2,1.8,0.4,2.3,4.4,4.2,4.2,1.9,2.5,1.5,15,2.1,0.1,2.1,0.2,4.3,0.3,1.8,2.4,1.1,11.9,3.7,4.7,10.1,0.5,0.6,2,4.6,1.9,0.2,1.3,1.3,1.9,10.9,1.2,2.2,0.2,1.4,0.5,6,2.3,4.4,1.9,2.1,0.5,1.3,0.5,13.4,12.7,4,14.5,4.1,0.6,0.5,0.2,15.5,0.2,3.3,1.6,2.1,0.3,0.9,2.8,1.4,0.3,2.1,3.2,3.6,0.7,2.1,1.7,0.8,2.1,2.2,1,2.3,0.9,5.6,11.8,4,11.4,5.2,4.7,13,6.3,6.6,10.1,0,1,0.9,2,12.9,8.8,1.6,0,8.1,1.2,1.8,21.6,0,0,3.2,93.5,4.9,2.6,0,2.1,0.4,3.7,1.5,1.1,0,1.7,11.1,2.4,4.9,0.3,68.4,3.1,4.5,3.3,2.8,2.6,17.3,1.9,5.7,3.5,0.3,9.3,0,4.1,21.8,3.4,16.7,0.1,2.5,4.4,1.4
SLC35F3,FLJ37712,ENSG00000183780,Solute carrier family 35 member F3,Q8IY50,1,233904933-234324516,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 26.0,Cell type enhanced,Detected in some,9,Basal glandular cells: 2.4;Distal tubular cells: 3.3;Exocrine glandular cells: 3.0;Glandular cells: 1.7;Intestinal endocrine cells: 1.7,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enriched,Detected in single,49,plasmacytoid DC: 7.1,Lineage enriched,Detected in single,69,dendritic cells: 7.1,Cell line enriched,Detected in some,7,HDLM-2: 49.4,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA051327, HPA061582",Uncertain,NA,Approved,"Nucleoli,Golgi apparatus",NA,NA,NA,NA,NA,Golgi apparatus,Nucleoli,"HPA051327: AB_2681443, HPA061582: AB_2684563",unprognostic (1.11e-2),unprognostic (1.73e-2),unprognostic (2.07e-1),unprognostic (1.54e-1),unprognostic (1.26e-1),unprognostic (8.62e-2),unprognostic (2.69e-5),unprognostic (3.38e-2),unprognostic (1.94e-1),unprognostic (2.60e-1),unprognostic (3.86e-2),unprognostic (9.09e-2),unprognostic (1.57e-3),unprognostic (7.83e-2),unprognostic (2.11e-1),unprognostic (3.62e-1),unprognostic (3.58e-1),0.8,3.5,4.6,1.3,26,0.7,6.8,25.1,16.7,1.4,0.8,0.5,0,0.8,1,2.5,1.6,1.7,0.8,0.6,5.4,4.6,1.6,0.6,1.2,2.4,4.8,6.6,0.6,3.6,4.6,2.8,0.7,4.1,2,0.8,0,6.6,1.1,1.1,0.8,0.9,1.1,4.8,1,2.5,1.1,4.3,0.5,1.9,0.3,1.9,0.8,0.6,0,7.1,0,0.1,0,0,0,1.4,3.9,0.7,0,0,0,0,0.5,0,0,0,0,7.4,0,0,0,0.1,0.3,0,3.6,0,49.4,0.1,0,2.7,0,0,0,0,0,0.1,0,5.8,0.8,0,0.1,0,0,0,0,0,0,0.6,0,4.4,0,0,0,3.6,0,2.1,1,0,0,0,0,0,0,0,0,2.4,0,0,0.1,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0.1,7.1,0,0,4.6,26,25.1,11.6,5.4,4.6,4.8,6.6,4.1,4.3,0,0,0,2.4,0.3,0.1,0.6,0,0,0,0,0,0,3.3,0.8,0.6,0,0,0,3,0,0,1.7,0,0,0,0,1.7,0,0,0.8,0,0,0,0,0,0,0.7,0,0,0,0.4,0,0,0.7,1.3,0.1,0,0,0,0
SLC35F1,"C6orf169, dJ230I3.1",ENSG00000196376,Solute carrier family 35 member F1,Q5T1Q4,6,117907526-118317676,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,8,brain: 41.9,Cell type enhanced,Detected in some,13,Bipolar cells: 11.0;Early spermatids: 10.7;Horizontal cells: 15.9;Late spermatids: 17.4;Melanocytes: 13.5;Muller glia cells: 27.9,Group enriched,Detected in some,16,glioma: 15.1;melanoma: 3.6,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in single,NA,neutrophil: 1.0,Low lineage specificity,Detected in single,NA,NA,Group enriched,Detected in some,9,AF22: 23.9;WM-115: 40.1,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA019576,Enhanced,NA,Approved,"Nucleoplasm,Centriolar satellite,Cytosol",NA,NA,NA,NA,NA,Nucleoplasm,"Centriolar satellite, Cytosol",HPA019576: AB_2190216,unprognostic (1.46e-1),unprognostic (5.67e-2),unprognostic (7.08e-2),unprognostic (1.37e-3),unprognostic (3.31e-1),unprognostic (4.99e-2),unprognostic (1.39e-1),unprognostic (4.04e-1),unprognostic (3.64e-2),unprognostic (3.04e-2),unprognostic (4.44e-3),unprognostic (2.19e-1),unprognostic (8.83e-4),unprognostic (3.04e-3),unprognostic (6.03e-2),unprognostic (8.32e-2),unprognostic (2.02e-1),2.8,2.7,13.8,2.1,14.5,0.9,1.2,3.6,41.9,1.7,3.5,4.3,0,1.6,2.7,5.5,1.8,1.5,1.8,5.3,10.4,10.2,1.7,1,1.1,1,9.3,15.3,1.4,1.4,1,0.6,1,5.6,2.3,2.3,2.6,1.7,2.9,1.2,1.6,1.8,2.6,4.1,1.6,1.4,1.8,5.6,0,1.8,0,1,1.4,2.6,0.2,0.6,1,0.1,0.3,0.9,0.1,0,0,23.9,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,3.1,0,0,0,3.2,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,2.9,0,0,0,0,2.5,0,0,0,0,0,0,0,0.6,0,0,0,0,0.8,0,0.4,0,0,0.2,0,2.9,3.4,0,0,0.1,0,40.1,0.1,0.1,0.2,0,0.1,0,0,0,0,0,0.2,0,0.9,1,0.3,0,0.6,0,0.1,13.8,14.5,3.6,17.4,10.4,10.2,9.3,15.3,5.6,5.6,0,0,0,0,0.3,11,4.3,0,0,2.3,0,2,0,0,0,10.7,0,0,0,0.3,0,0.2,0.9,0,0,0.1,15.9,0,0,0,17.4,0.6,0,13.5,0,0,27.9,0,0,1.1,0,1.8,0,0.7,0.9,1.2,0,0,0,0,0
SLC35F2,FLJ13018,ENSG00000110660,Solute carrier family 35 member F2,Q8IXU6,11,107790991-107928293,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,salivary gland: 43.2,Cell type enhanced,Detected in many,5,Basal keratinocytes: 40.9;Suprabasal keratinocytes: 44.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,PC-3: 54.7,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA048185, HPA050695, HPA060150",Enhanced,NA,Approved,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,"HPA048185: AB_2680304, HPA050695: AB_2681217, HPA060150:",unprognostic (7.73e-2),unprognostic (3.28e-3),unprognostic (8.37e-3),unprognostic (5.77e-2),unprognostic (1.38e-3),unprognostic (3.07e-2),unprognostic (7.26e-2),prognostic unfavorable (4.03e-4),unprognostic (6.22e-2),unprognostic (8.20e-2),prognostic unfavorable (5.92e-6),unprognostic (1.24e-1),unprognostic (4.10e-2),unprognostic (1.34e-1),unprognostic (7.33e-2),unprognostic (3.25e-2),unprognostic (1.19e-1),3,2.5,2.4,7.4,2.2,1.3,2.7,2.1,2.4,7.4,8.1,1.8,3.8,8.4,2.6,4.8,5,6.2,5.9,2.4,3.7,2.6,5.6,2,4,7.7,2.4,2.2,3.4,3.4,0.3,2.6,9.7,1.9,10.6,9.8,5.2,43.2,2.7,2.3,8.5,7.4,1.8,4.2,2.7,2.8,3.7,2.3,1.8,3.2,6.7,6.9,3.4,3.7,9.3,5.9,0.5,0.2,2.9,11.2,1.6,8.5,5.6,0.6,7.9,4.7,7,8.1,2,1.1,5.3,6.8,24.2,9,14.2,20.3,5.9,28.6,17.9,11.3,18.1,10.5,11.8,10.4,7.9,5.5,10,7.7,18.5,4,4.8,10.5,17.5,37.9,15.9,27.6,11.3,20.7,5.9,3.7,5.1,7.6,17.8,6,18.9,54.7,15.5,7.2,18.6,28.3,7.8,13.8,5.8,6.4,14.9,3.9,7.9,11,3.9,20.5,9.7,16.1,0.2,20.4,15.4,17.4,15.6,6.2,5.9,6.3,0.1,0.2,0,2.8,0.1,7.3,9.3,4.8,4.9,5.9,6.1,1.8,2.5,0.5,2.9,0,0.3,11.2,1.6,2.4,2.2,2.1,2.4,3.7,2.6,2.4,2.2,1.9,2.3,8.9,1,11.1,30.1,40.9,1.1,0.5,0,0,15.9,3.5,11.8,0.7,3.3,10.1,0.3,5.8,14,0,7.2,13.5,5.1,19,2.3,0,5,0,5.8,0,0.8,0.9,0.9,3.9,21.9,6.4,10.2,1.3,17,10.5,2.5,5.5,7.5,6.5,4.1,0.3,4.9,44,3.8,2.5,22.6,15.2
SLC35F4,"C14orf36, FLJ37712",ENSG00000151812,Solute carrier family 35 member F4,A4IF30,14,57563922-57982194,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Group enriched,Detected in some,6,brain: 29.5;seminal vesicle: 10.5,Cell type enhanced,Detected in some,24,Cone photoreceptor cells: 3.9;Early spermatids: 5.9;Peritubular cells: 2.8;Rod photoreceptor cells: 14.2,Not detected,Not detected,NA,NA,Region enriched,Detected in many,6,cerebellum: 29.5,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,4,RPMI-8226: 4.5;U-87 MG: 6.3,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,HPA043853,Uncertain,NA,Approved,Nucleoli fibrillar center,NA,NA,NA,NA,NA,Nucleoli fibrillar center,NA,HPA043853: AB_10963083,unprognostic (2.37e-1),unprognostic (2.10e-1),unprognostic (3.56e-1),unprognostic (2.66e-4),unprognostic (4.88e-2),unprognostic (8.64e-2),NA,unprognostic (1.38e-1),NA,unprognostic (1.76e-2),unprognostic (3.94e-2),unprognostic (1.39e-1),unprognostic (4.03e-3),unprognostic (3.50e-2),unprognostic (1.05e-2),unprognostic (9.68e-3),unprognostic (9.23e-2),0.1,0.1,1.2,0.1,4.9,0.1,0.1,29.5,1.1,1,0.2,0.1,0.5,0.2,1.5,0.2,0.1,0.2,0.5,0.1,0.9,2.2,0.4,0.1,0.1,0.1,0.8,1.2,0.3,0.1,0.1,0.2,0.1,2.9,3.5,0.1,2.4,0.1,10.5,0.1,0.1,0.4,1.1,1.3,0.1,0.1,2.7,0.7,0,2,0,0.1,0.2,0.3,0,0,0,0,0,0.3,0,0,0,0.1,0.2,0,0,0.2,0,0,0,0,0,0.4,0,0.2,0,0.9,0,0,0,0,0,0.1,0,0,0.1,0,0,0,0.1,0.2,0,0,0,0,0,0.1,0.3,0,0,0.1,0,0.4,0,0,0.2,0,4.5,0,0,1.2,0,0,0,0,0,0,0.1,0,1.2,0.1,0,0,0,0,0,6.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,1.2,4.9,29.5,1.1,0.9,2.2,0.8,1.2,2.9,0.7,0,0,0,0,0,2,0.3,0,0,0,0,3.9,0,0,0,5.9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.7,0,0,0,0,0,0.6,0.1,0,2.8,0,14.2,0,0,0,0,0,0,0,0,0
SLC35F5,FLJ22004,ENSG00000115084,Solute carrier family 35 member F5,Q8WV83,2,113705011-113756823,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA034828, HPA049229",Uncertain,NA,Uncertain,Plasma membrane,NA,NA,NA,NA,NA,Plasma membrane,NA,"HPA034828: AB_2674350, HPA049229: AB_2680682",unprognostic (1.59e-2),prognostic unfavorable (2.60e-4),unprognostic (8.37e-2),unprognostic (3.87e-3),unprognostic (5.62e-2),unprognostic (4.73e-3),unprognostic (3.94e-2),unprognostic (5.68e-2),unprognostic (1.19e-1),unprognostic (1.63e-2),unprognostic (1.93e-2),unprognostic (1.77e-1),prognostic favorable (1.71e-5),unprognostic (1.64e-1),unprognostic (1.84e-1),unprognostic (2.33e-1),unprognostic (4.83e-2),20,46.8,7.9,11.7,9.2,3.6,13.8,10.6,9,16.9,18.1,15,18.9,14.5,14.2,12.6,20.4,10.7,14.9,20,8.2,7.9,44.7,29.5,15,12.7,10.4,5,19.1,23.6,21.6,20.6,24.6,11.7,16.1,16.5,14.1,23.4,16.9,20,15.1,32.4,13.1,9.6,12.6,13.7,12.6,10.3,9.2,33.1,14.6,16.7,14.1,16.7,3.4,6.8,5.8,9.1,6.2,4.3,3.2,9.9,9.4,5.1,2.8,47.8,33.3,15.2,16.5,17.4,10.6,15.8,18.7,18.4,9.3,21.3,21.2,27.1,9.2,9.1,8.6,14.7,3.7,3.7,6.5,6.5,16.5,16.4,9.4,17.7,28.8,11.5,13.5,19.2,16.9,11.2,2.5,8.3,9.1,22.5,6.9,2.8,4.8,5,11.7,7.7,3.9,10.3,5.9,37.4,13.5,1.6,3.8,12.2,13.2,9.2,10.2,10.4,5.4,10,16.8,8.9,8.7,5.2,6.1,8.1,6.3,13,5.3,10.9,5.8,5.4,3.7,2.9,8,3.8,3.3,2.6,3.1,6.8,3.4,2.9,2.1,4.3,6.2,9.1,3,4.3,3.2,7.9,9.2,10.6,9,8.2,7.9,10.4,5,11.7,10.3,20.8,16.6,2.4,27.7,22.6,10.8,21,22.9,20.1,28.4,69.8,21.6,39.1,10,25.8,21.3,12.6,39.7,0,25,60.1,22.6,31.6,24.2,22.1,24.5,4.8,13.9,10.4,14.3,11,11.5,11.2,8.5,19,23.1,20.9,21.3,26.6,13.1,35.7,17.6,0,12.2,42.6,11.7,29.6,55.5,10.4,21.3,29.8
SLC35F6,"ANT2BP, C2orf18, FLJ20555, TANGO9",ENSG00000213699,Solute carrier family 35 member F6,Q8N357,2,26764284-26781231,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in all,NA,HHSteC: 48.6;Karpas-707: 42.8,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA034655,Approved,NA,Approved,"Nucleoplasm,Vesicles,Cytosol",NA,NA,NA,NA,NA,Vesicles,"Nucleoplasm, Cytosol",HPA034655: AB_10696359,unprognostic (2.26e-1),unprognostic (7.45e-2),unprognostic (1.74e-1),unprognostic (1.54e-1),unprognostic (7.71e-2),unprognostic (1.03e-1),prognostic unfavorable (1.11e-4),prognostic unfavorable (3.71e-4),unprognostic (3.44e-2),unprognostic (1.35e-1),unprognostic (3.24e-1),unprognostic (2.60e-1),unprognostic (3.84e-1),unprognostic (1.07e-2),unprognostic (9.95e-2),unprognostic (1.10e-1),unprognostic (1.06e-2),37.3,24.1,9.7,10.5,11.7,6.5,42.2,8.3,15.6,17.9,14.5,16,12.4,10.4,14.1,14,25.2,12.5,14.4,15,10.4,11.6,37.4,25.4,15.3,22,12.3,9.3,20.4,12.6,13.1,12.2,26.6,11.9,15.3,9,13.8,16.7,14.2,16.7,30.9,14.7,15.4,11.4,14.8,16.3,11.7,9.1,10.5,24.1,20.4,15.5,13.8,18.2,3.1,7.1,7.8,19,8.6,8.8,5.9,8.3,14.7,4.5,11.4,15.5,7,6.9,4.7,7.3,6.1,5.6,9.2,16,2.2,8,6.6,15.1,10.4,6.4,9.5,4.3,3.8,3.1,2.5,5.6,7.7,48.6,2.7,12.8,11.1,9.8,6.9,23.2,2.8,7.1,3.4,4.7,42.8,6.1,13.5,3.4,2.4,2.5,6,3.9,3,12.9,3.5,16.2,6.7,3.4,4.5,8,13.1,8.5,3.9,4.9,2.8,6.4,8,8.5,10.9,5.2,8.3,10.4,4.3,8.6,4.6,7.2,7,12,5.3,8.8,16.5,5,3.1,6.1,8,7.1,2.5,4.2,6,7.8,8.6,19,5.5,3.8,5.9,9.7,11.7,8.3,15.6,10.4,11.6,12.3,9.3,11.9,9.1,11.9,8,6.7,11.8,15,17.3,11.2,25.5,5.3,7.9,31.4,5.9,22.1,6.6,29.6,1.5,19.2,18.8,0,33.5,20.1,22.4,12.8,1.1,19.2,46.2,14.3,8.7,28.8,43.7,1.1,17,26.4,27,10.8,8.7,18.9,38.9,9.1,11.3,49.9,9.7,25.8,29.9,3.7,6.5,22.5,31.8,13.8,9.7,10.6
SLC36A4,"FLJ38932, PAT4",ENSG00000180773,Solute carrier family 36 member 4,Q6YBV0,11,93144171-93197964,"Predicted membrane proteins, Transporters","Amino-acid transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA017887,Enhanced,NA,Approved,"Golgi apparatus,Plasma membrane,Cytosol",NA,NA,NA,NA,NA,"Golgi apparatus, Plasma membrane, Cytosol",NA,HPA017887: AB_2190238,unprognostic (1.23e-2),unprognostic (1.08e-1),unprognostic (2.17e-3),unprognostic (1.32e-3),unprognostic (3.66e-2),unprognostic (8.77e-2),unprognostic (1.08e-3),unprognostic (7.83e-3),unprognostic (3.06e-2),unprognostic (7.97e-2),unprognostic (2.09e-2),unprognostic (8.04e-3),unprognostic (7.07e-2),unprognostic (4.40e-2),unprognostic (1.74e-1),unprognostic (9.45e-3),unprognostic (4.20e-2),8,11,16,12.6,19.3,24.1,6.5,20.7,20.2,8,7.3,8.7,2.1,3,10.4,3.6,7.8,6.2,8.4,9.2,14.2,14.8,13.7,11,8.2,7,16.8,10.3,8.6,8,8,17.2,8.7,17.6,7.5,9.4,5.4,5.4,9.1,3.4,5.9,4.2,11.5,20,5.7,6.4,6,13.4,5.6,12.7,2.3,9.2,8.6,7.7,1.6,2.9,8.1,7.7,0.8,2.6,1.8,5.1,9.3,19,3.8,6.7,13.7,10.7,9,15,13.4,16.3,7.4,17,6.3,5.2,8.3,7,6.4,5.8,3.3,12.3,10.5,6.8,7.2,19.5,4.9,5.3,18.1,10.8,6.6,10.4,7.7,4.9,6.3,7.1,9,0.6,0.1,13.6,1.3,7.9,13.7,7.6,2,9.4,3.6,11.3,2.6,4.5,7.7,17.6,22.9,13.1,5.1,3.2,14.5,9.3,5.3,7.9,25.3,7.8,14.9,13,2.6,5.2,0,5.7,7.6,13,0.2,7.7,8.1,1.3,3.9,1.8,1.3,1,1.6,2.9,1.6,2.6,1.7,2.5,0.8,2.5,1.1,0.8,1.8,16,19.3,20.7,20.2,14.2,14.8,16.8,10.3,17.6,13.4,11.9,8.6,18.2,35.2,27.2,21.1,7.7,12.7,21.4,6.8,19.2,21.6,9.5,29.9,19.1,1.7,18,0.7,0,37.9,21.2,11.6,37.1,4.6,6.4,13.1,25.4,26.5,10.4,59,3.1,16.7,44.6,20.3,10,17.4,13.3,27.9,5.8,14.5,12.3,23,6.5,17.6,6.2,2.7,28,13.6,10.7,4.3,23.7
SLC36A1,"LYAAT-1, PAT1, TRAMD3",ENSG00000123643,Solute carrier family 36 member 1,Q7Z2H8,5,151437046-151492381,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,brain: 43.3,Cell type enhanced,Detected in many,10,Early spermatids: 49.3;Enterocytes: 37.0;Kupffer cells: 22.4;Late spermatids: 21.6;Paneth cells: 21.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in many,4,basophil: 15.9;classical monocyte: 6.6;neutrophil: 14.5,Group enriched,Detected in many,5,granulocytes: 15.9;monocytes: 6.6,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA035937,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA035937: AB_10672995,unprognostic (5.49e-2),unprognostic (4.04e-2),unprognostic (1.24e-1),unprognostic (8.27e-3),unprognostic (1.91e-1),unprognostic (2.02e-1),prognostic unfavorable (6.30e-5),unprognostic (1.86e-1),unprognostic (2.44e-1),unprognostic (1.29e-3),unprognostic (5.08e-2),unprognostic (2.78e-1),prognostic unfavorable (1.83e-6),unprognostic (2.66e-2),unprognostic (1.03e-2),unprognostic (2.49e-1),unprognostic (1.42e-1),5.6,4.7,5.1,6,11.1,19.3,4.4,43.3,15.3,3.8,11.1,5,11.6,32.5,4.6,3.8,5.4,3.8,8.3,3.7,4.2,4.1,7.3,3.5,6,4.5,6,6.8,4,6.5,32.1,6.3,4.4,13.9,9.9,17.5,4.1,5.1,7.6,7.6,3.9,28.7,5.2,4.1,9.2,4.8,11.2,5,7.1,3.7,3.6,4.2,7.2,4.5,1.7,2.1,15.9,6.6,0.3,1.9,0.8,3.9,6.8,3.6,2.4,9,6.6,19.3,11.5,6.4,8,9,15.6,5.8,9.1,6.8,13.7,8.5,9.7,11.3,7.1,7.9,2.5,9.8,2.8,11.1,5.2,11.6,6.7,15.5,4.8,8.3,6.7,4.4,2.2,7,5,6.4,8,6.7,4.3,1.9,3.4,3.5,4.9,6.4,0,8.6,3.6,2.1,5.9,3.2,6.2,7.1,8.6,4.1,7.6,6.5,9.8,7,10.7,6,17.3,6.4,3.8,5.3,5.9,6.8,11.8,7,15.9,6.6,2.5,1.2,2.8,0.8,1.6,1.1,1.9,2.1,1.7,0.9,0.8,14.5,0.3,2.8,0.4,1.1,0.8,5.1,11.1,43.3,15.3,4.2,4.1,6,6.8,13.9,5,0,1.7,0,1,1.3,1.2,2.2,7.6,0,1.2,1.8,2,0.5,0,1.6,49.3,1,37,0,1.7,7.2,2.3,2.8,1.1,1.7,12.1,1.6,0,4.9,22.4,21.6,4.6,3.8,1.7,1,6.1,0.8,1.6,21,11,3.9,0.8,0,1.9,0.5,1.9,1.1,0.2,2.1,6.9,1.8
SLC36A2,"PAT2, TRAMD1, tramdorin",ENSG00000186335,Solute carrier family 36 member 2,Q495M3,5,151314978-151347590,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,9,kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1,Cell type enriched,Detected in some,9,Proximal tubular cells: 44.0,Cancer enriched,Detected in single,9,renal cancer: 0.5,Region enhanced,Detected in single,NA,midbrain: 1.2,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in some,NA,HL-60: 1.9;NB-4: 2.0,Low region specificity,Detected in some,NA,NA,Low region specificity,Detected in single,NA,NA,"HPA044002, HPA062229",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA044002: AB_10964214, HPA062229: AB_2684717",unprognostic (3.47e-1),unprognostic (3.40e-1),NA,unprognostic (2.26e-2),unprognostic (6.23e-2),unprognostic (8.38e-3),unprognostic (4.66e-3),unprognostic (3.03e-1),unprognostic (7.73e-2),unprognostic (1.92e-2),unprognostic (2.11e-1),unprognostic (1.92e-1),unprognostic (1.20e-3),unprognostic (1.43e-1),unprognostic (1.05e-1),unprognostic (2.18e-1),unprognostic (3.89e-2),0.6,0.1,0.1,0,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0,0.1,0,0.1,2.6,0.5,0.1,0,0.2,0.1,0.1,60.3,0.1,0.1,0,1.2,0,0.1,0.1,0,0.1,0,0.4,0.1,0,1.1,2,0,36.8,0.1,0.1,0,0.2,0.1,0.1,0.7,0,0,0.1,16.1,1.4,0.1,0.1,2.1,1.5,4.3,0.8,1.5,0.9,0.3,0.1,0.3,0.4,0.7,0.3,0.1,1,0.4,0,0.1,0,0.6,0.3,0.8,0.3,0.2,0.3,0.4,0,0.7,0,1.5,1.5,0.3,0.8,0.3,0,1.9,0.5,0.1,0.1,0,0,0,0.5,0.5,0.1,1.4,0.2,0.3,0.4,2,1.2,0,0.2,0.5,0.4,0.2,0.2,0.1,0.4,0.4,0.1,1.2,0,0.2,0.3,0.3,0.5,0.2,0.2,1.2,0.2,0.5,0.2,0.4,0.3,0.3,0.1,3.2,0.8,0.9,0.7,0.6,0.6,1.1,0.6,0.6,0.2,2.1,0.7,0.9,4.3,1.5,0.6,1.5,0.5,0.3,0.1,0.1,0.1,0.1,0.1,0.1,1.2,0,0.4,0,0,0,0,0,0,0,0.6,0,0,0,1.8,0,0,5,0,4.4,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,4.5,0,0,0,0,0,0,0,0,0,44,0,0,0.3,0,0,0,0,0,0,0
SLC36A3,"PAT3, TRAMD2, tramdorin2",ENSG00000186334,Solute carrier family 36 member 3,Q495N2,5,151276762-151303766,"Predicted membrane proteins, Transporters",NA,NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enriched,Detected in single,17,testis: 14.5,Group enriched,Detected in some,57,Early spermatids: 47.0;Late spermatids: 85.3,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (5.41e-1),NA,NA,NA,unprognostic (5.38e-1),NA,unprognostic (7.01e-2),unprognostic (2.13e-1),NA,NA,NA,unprognostic (2.20e-2),unprognostic (3.98e-1),unprognostic (2.57e-2),NA,unprognostic (2.18e-2),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,14.5,0,0,0,0,0,0,0,0.8,0,0.1,0.2,0.3,0.1,0,0,0.8,0.2,0,0,0,0,0,0,0,0,0.8,0.7,0.3,0,0,0,0.3,0,0,0,0,0.5,0,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0.5,0,0,0.4,0,0,0.3,0.3,0,0,0,0,0,0,0,0.2,0,0,0,0.1,0.2,0,0.1,0,0.1,0.4,0,0,0,0.8,0,0,0.1,0.3,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,1.2,0,0,0,0,0,47,0,0,0,0,0,0,0,0,0,0,0,0,0,0,85.3,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0.2,0,0,0,0,0
SLC38A4,"ATA3, NAT3, PAAT",ENSG00000139209,Solute carrier family 38 member 4,Q969I6,12,46764761-46832408,"Predicted membrane proteins, Transporters","Amino-acid transport, Ion transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,22,liver: 128.2,Cell type enriched,Detected in some,16,Hepatocytes: 251.9,Cancer enriched,Detected in many,14,liver cancer: 61.0,Not detected,Not detected,NA,NA,Group enriched,Detected in some,8,basophil: 3.0;NK-cell: 1.9,Group enriched,Detected in many,8,granulocytes: 3.0;NK-cells: 1.9,Cell line enhanced,Detected in some,NA,ASC diff: 8.8;LHCN-M2: 21.7;RH-30: 7.2;RT4: 42.4,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (3.81e-2),unprognostic (7.46e-3),unprognostic (5.22e-3),unprognostic (1.75e-2),unprognostic (3.12e-1),unprognostic (1.11e-1),prognostic favorable (5.37e-4),unprognostic (3.06e-2),unprognostic (2.57e-3),unprognostic (1.75e-2),unprognostic (1.95e-1),unprognostic (6.06e-2),unprognostic (2.84e-2),unprognostic (1.89e-2),unprognostic (8.28e-2),unprognostic (6.31e-3),unprognostic (2.21e-2),0.2,0.1,0.1,1.4,0,0,0.1,0.1,0.2,0.1,0.9,0,0.3,0,1.7,0.1,0.6,0.1,0.3,1.1,0,0,5.9,128.2,0.1,0,0,0,0.1,2.1,0,0,1,0.1,0.4,0.2,0.1,0.3,0,2.9,0.4,0.1,1.4,0,0.3,0,0.2,0,0.2,0.2,0.4,0.2,0.7,0,0.1,0.3,3,0,1.9,0.1,0,0,0,0,0,8.8,1.1,1.7,1,2.8,0.9,0.9,0.5,2,0,1.7,3.7,0,0.5,0,0.3,0.9,0,0,0,0,0.1,0.3,0.2,0,2.1,0,0,0.7,0,0,0,0.1,0,21.7,0,0,0,0.6,0,0,0,7.2,0,0,42.4,0.1,0,0.1,0,0,0.2,0,0,0,0,0.4,0,0,0.1,0,0.1,0.2,0.1,0,3,0,0,0.1,0,0,0,0,0,0,0.1,0,0,0,1.9,0,0.3,0,0,0.1,0,0.1,0.2,0,0,0,0,0.1,0,0,0,0,0,0.7,0,1.3,15.3,0,0,1.8,0,2,0,0,0.2,0.1,1,0,0,0.4,1.9,0.4,0,251.9,0.4,0,0,3.1,3.9,0.2,0.3,0,0,0,0.2,0,0.3,0.2,0,0.3,0,0,0,0,0,0.5,0.7,0,0.6,0
SLC38A1,"ATA1, NAT2, SAT1",ENSG00000111371,Solute carrier family 38 member 1,Q9H2H9,12,46183063-46270017,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Ion transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,7,Bipolar cells: 374.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,U-698: 77.9,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA039460, HPA052272",Uncertain,Supported,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA039460: , HPA052272: AB_2681781",unprognostic (8.92e-3),unprognostic (3.23e-2),unprognostic (9.47e-2),prognostic unfavorable (4.76e-6),unprognostic (1.00e-1),unprognostic (3.74e-1),prognostic unfavorable (6.95e-8),unprognostic (2.01e-3),unprognostic (1.38e-1),unprognostic (4.19e-3),unprognostic (2.44e-2),unprognostic (3.99e-2),unprognostic (1.19e-2),unprognostic (1.17e-1),unprognostic (2.56e-1),unprognostic (3.00e-1),unprognostic (5.55e-2),5.3,3.1,9.2,18.4,14.9,11.7,44.8,28.7,24.1,7.8,23.1,15.2,26,8.7,13.4,5.4,14.3,10.9,9,23.7,11.9,16.5,11.5,5.8,7.7,30.5,12.6,13.3,9.9,21,51.9,22.5,45,24.7,16.2,20.5,7.1,14.1,29.9,62.9,15.8,16.8,14.6,22.4,15.6,17.9,1.3,8.7,26.5,22.5,16.6,27.1,14.5,8.5,21.2,15.4,8.8,0.3,22.2,26.5,14.4,15.2,15.9,5.7,21.4,2.6,0.9,29.3,12.2,19.9,5.5,8.8,27.2,15.1,34.9,23.3,14.8,17.2,23.4,19.1,25,10.4,21.5,10.1,2.4,26.4,10.1,22.7,24.5,0.9,4.5,38.5,1.7,67.3,13.9,12.4,22.6,12.6,29.3,17.5,19,21.7,4.3,21.2,0,24.9,19.6,1.4,24.3,21.7,21.9,23,15.9,25.3,31.1,14.3,23.2,18.1,18.1,26,4.3,4.1,0.1,12.4,28,24,77.9,14,48.3,3.7,0.3,0.3,8.8,19.4,0,26.5,17.9,20.3,22.3,12,21.2,23.8,21.2,0.8,22.2,0.1,15.4,21.4,14.4,9.2,14.9,28.7,21.1,11.9,16.5,12.6,13.3,24.7,8.7,32.8,36.5,89.1,59,86.8,374,184.5,40.8,29.4,33,202.4,133.5,88.8,3.3,51.7,0.1,21.5,54.6,0,40,70.3,12.8,33.7,3.5,5.9,10.4,7.9,38.9,4.9,9.7,0,2,19.2,25.3,7.2,68.9,47.9,44.6,40.3,0.7,1,55.9,0,40.3,0,0.4,107.3,155.3,109.7,62.4,59.6
SLC38A10,"MGC15523, PP1744",ENSG00000157637,Solute carrier family 38 member 10,Q9HBR0,17,81245000-81295547,"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Ion transport, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA021374, HPA023161, HPA024631",Enhanced,NA,Enhanced,Golgi apparatus,NA,NA,NA,NA,44000000,Golgi apparatus,NA,"HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860",unprognostic (2.18e-2),unprognostic (1.54e-1),unprognostic (7.40e-2),unprognostic (3.00e-3),unprognostic (2.06e-2),unprognostic (1.69e-1),unprognostic (2.12e-1),unprognostic (2.63e-1),unprognostic (1.84e-1),unprognostic (1.92e-2),prognostic favorable (2.92e-4),unprognostic (8.39e-2),prognostic unfavorable (5.34e-7),unprognostic (6.55e-2),unprognostic (3.15e-1),unprognostic (1.31e-1),unprognostic (2.45e-1),22.8,18.6,8.1,17,11.3,18.5,43,9.9,10.2,15.8,23.8,13.8,22,21.8,17.4,30.7,13.2,15.2,28.4,17.3,7.4,9.2,18,59.2,24.6,23.7,11.6,6.7,23.7,55.1,6.8,30.2,23.2,10,16,6.5,15.1,33.3,26.1,8.7,11.2,26.2,10.9,10.4,21,19.1,25,12.3,20.2,25.9,10.3,15.8,18.4,13,6.6,10,17.2,15.4,4.6,9.8,7.9,17.3,30.5,5.3,28.1,20.6,9.7,31.9,21.4,19.3,13.1,15.5,14.1,29.2,13.3,24.5,14.7,14.5,21,5.4,10.7,4.9,13.3,16,13.4,10.9,23.9,18.4,13.1,32.1,16.8,8,11.8,7.7,10.7,25.1,9.7,9.9,20.6,9.8,22.1,8,22.5,5.3,16.1,15.1,13,11.2,13.4,9.2,16.4,10.3,26.7,17.2,10.8,23.3,7.8,15.4,27.5,24.6,21.2,12.4,15.8,11.4,18.1,7.9,7.6,12.6,20.4,21.7,11,10.2,17.2,8.1,12,9.8,6.6,7.8,9.8,6.3,6.6,5.4,5.8,8.2,4.6,15.4,10,5.5,7.9,8.1,11.3,9.9,10.2,7.4,9.2,11.6,6.7,10,12.3,23.8,35.2,11.2,10.8,7.3,11.5,14.7,40.8,6.7,18.2,10.4,17.7,47.8,5,33,17.9,21,56.4,0,23.2,52.2,22.1,16.5,15,66.3,42.5,23.8,43.3,27.6,39.2,46.8,30.5,26.6,13.5,19,55.6,28.3,24.6,42.1,25.8,20.3,9.1,32.3,15.3,16.7,21.5,6.4,52.3,17.5,40.8,10
SLC38A11,"AVT2, FLJ39822",ENSG00000169507,Solute carrier family 38 member 11,Q08AI6,2,164896186-164955525,"Predicted membrane proteins, Transporters","Amino-acid transport, Ion transport, Sodium transport, Transport",NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enhanced,Detected in many,NA,epididymis: 35.6,Cell type enhanced,Detected in some,27,Intestinal endocrine cells: 167.1;Sertoli cells: 71.1;Smooth muscle cells: 32.0,Cancer enriched,Detected in many,5,prostate cancer: 7.6,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in some,54,memory B-cell: 2.7;naive B-cell: 7.9,Lineage enriched,Detected in single,79,B-cells: 7.9,Cell line enriched,Detected in some,9,BJ hTERT+: 75.6,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in many,NA,NA,HPA043432,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA043432: AB_10793948,unprognostic (1.52e-1),unprognostic (2.59e-1),unprognostic (4.14e-1),unprognostic (1.41e-1),unprognostic (1.41e-1),unprognostic (1.69e-2),unprognostic (6.28e-3),unprognostic (3.53e-2),unprognostic (2.41e-1),unprognostic (2.12e-1),unprognostic (1.15e-3),unprognostic (1.99e-1),prognostic favorable (2.00e-8),unprognostic (1.69e-1),unprognostic (1.20e-1),unprognostic (2.43e-2),unprognostic (2.36e-2),1.8,3.9,5.1,1.4,8,0.4,1.1,1.4,9.7,2.7,1.5,2.7,6.5,5.4,2.1,35.6,1.3,1.2,19.1,1.1,5.6,4,7.2,2.5,0.6,2.8,5.8,2.6,0.6,2.7,2.1,11.7,0.5,22.1,9.9,2.7,15.6,1,15.9,1.8,0.8,2.6,2.1,2.4,11.2,10.2,1.1,3.2,0,2.1,2.9,1.4,2.1,1.5,7.9,0,0,0,0,0,0.1,0,0.2,0,0,0,0,0,8.7,75.6,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0.1,0,0,0,1.6,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.7,0,0,0,7.9,0,0,0,0,0,0,0,0.1,5.1,8,1.4,9.7,5.6,4,5.8,2.6,22.1,3.2,0,0,2,0.2,0,0,0.7,20.4,0,0,3.5,0,0.4,0,1.6,1.4,0,0.5,0,0.5,0.4,0.2,4,0,3,0,0,167.1,0,0,1.2,0,0,0,0,0.4,0,1.2,2.9,0,1.9,0,71.1,32,0,0,0.3,1.3,0,0.4,0.1
SLC38A2,"ATA2, KIAA1382, SAT2, SNAT2",ENSG00000134294,Solute carrier family 38 member 2,Q96QD8,12,46358189-46372867,Predicted membrane proteins,"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in all,8,Basal keratinocytes: 993.3;Suprabasal keratinocytes: 942.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,hTERT-HME1: 135.9,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA035180,Approved,NA,Uncertain,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,HPA035180: AB_10669901,unprognostic (6.61e-3),unprognostic (2.87e-2),unprognostic (4.88e-2),unprognostic (2.51e-2),unprognostic (2.96e-1),unprognostic (1.00e-2),unprognostic (7.78e-2),unprognostic (5.50e-3),unprognostic (1.20e-1),unprognostic (3.79e-1),unprognostic (9.24e-3),unprognostic (1.75e-1),unprognostic (1.47e-1),unprognostic (5.08e-2),unprognostic (3.80e-1),unprognostic (1.83e-1),unprognostic (8.68e-2),44.7,45.4,19.9,23.3,34.5,27,72,34.5,40.6,36.2,25.5,23.6,20,11.6,45.2,16.2,47.1,36.6,46.8,39.2,24.2,14,27.4,102.9,51.9,34.5,54.4,15.2,49.3,27.3,54.3,16.2,76.6,32.6,25.7,17.8,17.7,36.6,20.3,47.8,69.5,25.1,40.4,60,28.6,29.2,19.7,43.8,40.7,32,35.6,26.2,36,49.3,12.1,24.7,17.9,13.5,30,15.3,12.7,8.4,20,17.4,47.6,40.5,40.9,12.6,40.1,103.1,35.2,29.1,11.9,16.1,0,54,68.5,23.5,29.2,12.1,37.3,34.5,6.8,6.8,11,24.4,36.6,62.3,8.9,11.7,40.9,81.3,22.2,135.9,86.7,29.8,12.4,10.8,17.1,62.4,10.6,10.9,13.1,14.8,0,20.9,9.9,12.9,21,21.5,19.1,11.5,9.9,27.1,7.6,24.4,19.7,15.4,20.9,49,16.9,13.4,7.2,6.3,19.7,18.6,10.4,16.3,32.4,8.3,17.9,13.5,10.5,14.3,7.8,11.1,12.1,12,14.2,20.8,11.9,15.2,15.3,10.5,30,10.1,24.7,13.9,12.7,19.9,34.5,34.5,40.6,24.2,14,54.4,15.2,32.6,43.8,77.4,94.1,77.1,114.9,993.3,38.3,137.9,99.3,25.4,56.9,54.1,66.8,40.9,5,36.4,4.2,142.4,78.6,186.9,43.6,41.4,160.4,157.7,78.7,245.9,47.8,50.9,73.5,233.9,166.5,5,243.7,110.6,237.8,20.8,107.5,73.3,64.3,63,79.9,22.3,73.5,278.1,220.9,7.2,14.7,942.6,32.2,136.8,67.6,105.8
SLC38A3,"G17, SN1",ENSG00000188338,Solute carrier family 38 member 3,Q99624,3,50205246-50221486,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,5,liver: 107.8,Group enriched,Detected in many,7,Bipolar cells: 86.1;Cone photoreceptor cells: 176.7;Hepatocytes: 93.4;Muller glia cells: 75.9;Rod photoreceptor cells: 112.3,Cancer enriched,Detected in many,9,liver cancer: 140.0,NA,NA,NA,NA,Cell type enhanced,Detected in some,NA,basophil: 5.6,Low lineage specificity,Detected in many,NA,NA,Group enriched,Detected in some,4,Hep G2: 32.4;SCLC-21H: 10.8,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA031871,NA,NA,Approved,"Microtubules,Cytosol",NA,NA,NA,NA,NA,Cytosol,Microtubules,HPA031871: AB_2674080,unprognostic (2.14e-1),unprognostic (2.10e-1),unprognostic (8.60e-2),unprognostic (6.19e-4),unprognostic (7.37e-2),unprognostic (9.61e-2),unprognostic (2.34e-2),unprognostic (2.30e-2),unprognostic (4.68e-3),unprognostic (1.46e-1),unprognostic (2.06e-1),unprognostic (5.71e-2),unprognostic (1.23e-3),unprognostic (1.90e-1),unprognostic (2.37e-1),unprognostic (1.52e-1),unprognostic (1.96e-1),0.7,0.3,3.4,0.3,5.2,0.5,0.7,2.4,10.5,0.3,0.3,10.3,0,0.7,0.4,0.4,0.6,0.4,0.4,2,4.1,NA,1.5,107.8,0.3,0.4,3.4,4,2.4,11.6,1.8,0.7,0.6,7.8,0.4,0.3,22.2,0.9,0.3,10.4,0.5,0.4,0.3,4.7,0.3,0.9,0.7,5.2,0,0.6,1.9,0.4,0.3,0,1.1,1,5.6,0.8,1.5,0.8,0.2,0,0,0.8,4.9,0,0,1.3,0,0,0.9,0.4,2.9,0.1,0.1,0.8,0,0.2,0,1.3,0,0.6,0.1,0.4,0,0.6,32.4,0.1,0.3,0,0,0,0.1,0,3.7,0,0.3,0.1,0.3,0,0,0.1,0.4,0.5,0.1,0,0.4,0.3,0,0.1,0.2,10.8,0.9,0.5,0.1,0,1.5,1.3,0.2,0,0.2,0.9,0,0.7,0.3,0,0.1,0.1,0.2,0.1,5.6,0.8,0.9,0.6,0.2,0.4,0.7,0.5,0.4,0.2,1.1,0.6,0.8,3.3,1.5,0.2,1,0.4,0.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,1.9,0.1,0,86.1,2.8,15.3,0,0,0,176.7,0.2,0,0.7,0.1,0,0,0,1.9,0.1,0,0,0,93.4,0.1,7.9,3.4,0,3.3,0,2,0,0,1,0,75.9,0.8,0,0.4,1.4,112.3,0,0,1,1.8,0,1.1,0,0,0
SLC38A5,"JM24, SN2",ENSG00000017483,Solute carrier family 38 member 5,Q8WUX1,X,48458537-48470256,"Predicted membrane proteins, Transporters",NA,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,5,pancreas: 87.7,Cell type enhanced,Detected in many,14,Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 93.7,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,HaCaT: 35.6;HBEC3-KT: 54.3;HeLa: 53.5;hTCEpi: 40.4;Karpas-707: 47.8;RPMI-8226: 87.9,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA047411,Enhanced,NA,Approved,"Vesicles,Plasma membrane,Cytosol",NA,NA,NA,NA,NA,"Vesicles, Plasma membrane",Cytosol,HPA047411: AB_10964355,unprognostic (2.81e-1),unprognostic (4.87e-2),unprognostic (7.92e-3),unprognostic (1.58e-1),unprognostic (1.29e-3),unprognostic (1.26e-1),unprognostic (7.75e-2),unprognostic (5.79e-2),unprognostic (1.52e-1),unprognostic (3.80e-3),prognostic unfavorable (2.13e-4),unprognostic (2.99e-2),prognostic unfavorable (2.22e-16),unprognostic (1.27e-3),unprognostic (1.45e-1),unprognostic (2.86e-1),unprognostic (2.20e-1),1.5,0.9,5.3,4.7,7.1,17.3,0.9,3.5,11.6,4,4.9,7.7,0.1,5.1,1.8,1.3,3.7,2,1.5,2.4,6.9,5.7,0.7,0.4,9.4,3.3,7,2.7,3.7,87.7,0.4,0.4,2.8,14.6,5.1,6.4,1.5,4.4,3.7,0.4,8,3.5,2.8,7.3,4.8,4.5,0.5,4.6,2.4,7.9,3.6,3.4,4.8,3.1,7.4,8.3,0.3,0.4,5.4,16.2,5.7,23,0,0,0.2,0.4,2,0,1.5,0,0,0,0,0,24.2,0,10.2,0,35.6,27.6,54.3,0,7.7,0,13.1,53.5,16.6,4,26.8,0,3.8,40.4,0.5,0.1,0,0.4,5.9,24.1,47.8,5.4,0,5.8,9.3,12.5,0,0.1,21.3,0.1,87.9,0,0,2.2,0.1,0,0.1,0,0.1,0,1.1,0.7,0.1,0,0,0,0,0.1,8.7,0.2,0.1,0.1,0,0.2,0.2,11.5,0.4,16.2,7.4,12.6,10.8,1.5,4.7,6,7.7,0.3,5.4,0,8.3,13,5.7,5.3,7.1,3.5,11.6,6.9,5.7,7,2.7,14.6,4.6,0,1.1,0.8,1.6,23.7,0.6,0.4,0,1.4,0,5.2,17.7,0.1,0,4.9,0.4,3.1,2.3,23.3,67.4,0.4,5.6,0.9,4.6,0.4,2.5,0,0,0,0,0.7,2.3,1.1,8.5,2.8,12.3,0,93.7,3.5,1.1,0,0.2,0,1,0,0,7.4,0,8.5,19.1,0.9
SLC38A6,NAT-1,ENSG00000139974,Solute carrier family 38 member 6,Q8IZM9,14,60981114-61083733,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Ion transport, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,9,Early spermatids: 130.6;Hofbauer cells: 89.9;Late spermatids: 97.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,ASC diff: 33.9,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA018508,Approved,NA,Approved,"Plasma membrane,Cell Junctions,Microtubules",NA,NA,NA,NA,NA,Cell Junctions,"Plasma membrane, Microtubules",HPA018508: AB_2190518,unprognostic (7.08e-2),unprognostic (4.14e-2),unprognostic (1.75e-1),unprognostic (3.49e-1),unprognostic (1.00e-1),unprognostic (1.74e-2),prognostic unfavorable (9.47e-6),unprognostic (9.89e-3),unprognostic (2.38e-1),unprognostic (2.18e-2),unprognostic (2.20e-1),unprognostic (5.13e-2),prognostic unfavorable (1.37e-5),unprognostic (1.73e-1),unprognostic (4.63e-2),unprognostic (1.47e-1),unprognostic (2.90e-1),26.1,16.9,8.3,6.7,16.6,4,11.4,9.7,14,8.1,7.1,5.2,5.5,4.5,10,20.5,5,8.4,14.4,5.4,8.8,8.6,16.9,9.2,12.2,9.6,8.6,10.9,9.9,6.1,23.8,21.5,13.7,14.3,8.1,10.1,10.9,11.7,6.4,4.1,4.6,5.6,8,7.6,10.8,6.4,10.9,6.5,8.8,9.7,7.1,7.2,11.6,8.1,2.4,5.2,0.2,8.6,0.7,5.2,3.4,7.1,10,3.2,5.9,33.9,12.3,2.2,5.4,16.2,5.1,4.8,2.5,19.6,1.7,9.3,4.9,10.8,6.3,3.1,5.5,4.8,2.4,1.4,3,4.1,6.5,11.1,1.5,5.8,9.7,2.3,5,5.9,21.1,6.8,2.7,4.1,3.7,17.9,4,2.7,3.9,2,4.3,6.6,0.5,9.5,5.5,15,4,1.5,1.2,4.5,3.3,8.7,4.7,4.7,2.6,7.2,8,3.4,9.3,3,0.7,2.1,0.6,16.4,1.3,6.3,0,8.4,0.1,2.2,8.6,2.6,2.4,4,2.9,4.4,2.2,3.3,4.3,0.2,0.7,5.4,5.2,5.2,3.4,8.3,16.6,9.7,14,8.8,8.6,8.6,10.9,14.3,6.5,20.8,4.1,2.7,10.8,4.6,18.5,2.8,5.1,34.8,5.7,5.2,21.6,5,1.7,4.1,130.6,6.7,2.2,0,2.5,7.9,8.5,6.5,5.8,4,89.9,4.8,4.1,3.7,20.7,97.9,10,19.2,5,1.8,2.3,14.2,6,2,5.6,16.8,25,0,6.6,15.1,10.6,2.5,5.6,4.4,2.8,5.9
SLC38A7,FLJ10815,ENSG00000103042,Solute carrier family 38 member 7,Q9NVC3,16,58665109-58685104,"Predicted membrane proteins, Transporters","Amino-acid transport, Ion transport, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Group enriched,Detected in many,14,Early spermatids: 273.8;Late spermatids: 600.3,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA041777,Uncertain,NA,Approved,"Nucleoplasm,Plasma membrane,Cytosol",NA,NA,NA,NA,NA,"Plasma membrane, Cytosol",Nucleoplasm,HPA041777: AB_10796782,unprognostic (2.16e-3),unprognostic (2.30e-2),unprognostic (6.23e-3),prognostic favorable (6.87e-4),unprognostic (3.49e-1),unprognostic (8.08e-3),unprognostic (9.76e-3),unprognostic (6.34e-3),unprognostic (1.98e-2),unprognostic (2.02e-1),unprognostic (2.77e-1),unprognostic (4.90e-2),prognostic favorable (2.87e-4),unprognostic (1.85e-1),unprognostic (4.38e-2),unprognostic (7.50e-2),unprognostic (4.93e-3),7,11.1,10.6,6.7,10,2.7,7.2,7.7,13.7,6.2,5.3,10.6,6.8,4.8,6,7.4,6,4.2,6.5,13.8,7.2,7.2,7.4,12.1,5.2,4.3,6.1,11,4.7,5,16.9,10.2,8.4,8.3,5.2,6.9,8.9,6.1,5.6,9.6,5.3,4.9,8.5,5.8,10.3,5.4,27.1,6.6,4.2,8,8.1,5.1,6.5,6.3,2.8,6.1,2.5,8.6,2.3,5.2,6.6,4.4,7,6.9,10.6,14.4,8.7,13,10.5,12.2,14.8,10.3,6.5,6.9,2.8,6,14.6,11.9,10.8,6.6,7.3,8.8,1.8,6,3.2,5.8,10.5,21.9,6.6,9.2,17.4,15.4,10.3,6.8,8,15.1,6.7,9.4,4.3,10.7,5.3,2.6,3.9,7.5,4.7,10.4,9.6,7.5,7.6,6.5,10.2,5.1,7.7,15.8,10.8,4.6,9.7,5.1,2.8,11.8,8.1,6.2,14,3.1,6.3,4.1,3.2,11,4,6,0.2,8.6,2.5,5.2,8.4,3.1,1.9,3.3,3.8,6.1,2.8,2.7,2.9,0.8,2.3,7.5,2.1,2.2,6.6,10.6,10,7.7,13.7,7.2,7.2,6.1,11,8.3,6.6,3,4.1,0.5,3.9,3.4,9.7,11.2,2.5,4,3.4,10.4,11.8,7.3,3.3,12.6,273.8,4.7,3.9,0,7.4,7.9,5.7,3,1.1,8.5,31.3,15.9,12.6,8.6,8.6,600.3,8.9,7.1,8.5,2.8,3.6,8,10.5,3.5,8.1,4.6,7.1,6.5,5.1,6.2,6.1,3.8,12.8,1.8,5.1,2.7
SLC38A8,NA,ENSG00000166558,Solute carrier family 38 member 8,A6NNN8,16,84009667-84042636,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Ion transport, Sodium transport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,NA,Tissue enhanced,Detected in some,NA,brain: 6.1;liver: 4.5,Group enriched,Detected in some,8,Early spermatids: 2.8;Late spermatids: 9.5,Cancer enriched,Detected in single,14,melanoma: 6.5,Group enriched,Detected in some,5,amygdala: 6.1;cerebral cortex: 2.6;hypothalamus: 2.5,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,CACO-2: 1.5;HMC-1: 2.2;SCLC-21H: 8.7;SK-MEL-30: 1.3;SuSa: 1.2,Low region specificity,Detected in some,NA,NA,Low region specificity,Detected in many,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (9.69e-2),unprognostic (6.16e-2),NA,unprognostic (8.00e-3),unprognostic (6.40e-2),unprognostic (1.03e-1),unprognostic (8.20e-3),unprognostic (1.89e-1),unprognostic (7.70e-2),unprognostic (2.59e-1),unprognostic (2.16e-2),NA,unprognostic (3.54e-2),unprognostic (1.37e-1),unprognostic (1.45e-1),NA,NA,0.2,0.1,6.1,0.2,0.6,0,0.2,0.2,2.9,0.2,0.2,0.2,0.2,0.3,0.2,2.2,0.2,0,0.2,1.4,0.6,2.5,0.2,4.5,0.2,0.2,0.7,0.2,0.2,1.3,0.5,1.6,0.2,0.2,0.2,0,0.2,0.2,0.2,0.2,0.1,0.2,0.2,0.2,0.2,2.3,2.4,0.2,2.1,0.2,0.2,0.2,0.2,0.2,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0.3,0,0,0,0,1.5,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.6,0,0,2.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,8.7,0.1,0,0,1.3,1.2,0.1,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.1,0.6,0.2,2.6,0.6,2.5,0.7,0.2,0.2,0.2,0,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0,2.8,0,0,0,0.2,0,0,0.1,0,0,0.8,0,0,0,0,9.5,0.6,0,0,0,0,0.3,0,0,0.4,0,0.4,0,0,0.3,0.6,0,0,0,0,0
SLC38A9,FLJ90709,ENSG00000177058,Solute carrier family 38 member 9,Q8NBW4,5,55625845-55773194,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,placenta: 44.2,Cell type enhanced,Detected in many,20,Cytotrophoblasts: 168.8;Early spermatids: 189.6;Syncytiotrophoblasts: 518.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in all,NA,BEWO: 49.9,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA043785, HPA061702",Uncertain,NA,Supported,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,"HPA043785: AB_10961859, HPA061702:",unprognostic (4.80e-2),unprognostic (1.18e-1),unprognostic (3.26e-2),prognostic unfavorable (7.24e-5),unprognostic (2.49e-1),unprognostic (8.19e-2),unprognostic (8.35e-2),unprognostic (7.95e-2),unprognostic (5.47e-2),unprognostic (9.44e-2),unprognostic (1.74e-1),unprognostic (4.87e-1),unprognostic (4.18e-3),unprognostic (1.76e-1),unprognostic (2.25e-1),unprognostic (2.84e-2),unprognostic (1.12e-1),7.2,6.3,8.2,6.9,8,5.2,6.8,9.9,9.7,6.4,7.5,9.2,6.7,6.6,7.5,5.9,9,5.8,7.1,3.9,6.2,6.4,6.7,13.5,6.4,8.4,9.4,6.4,6.9,18.2,10.1,11.8,44.2,8.6,5.9,8.5,6.7,7.6,5.3,5.2,6.2,7.1,7.2,8.8,8.9,7.7,15.8,8.5,13.3,7.1,5.7,11.4,8.7,6.9,10.8,10.8,7.4,11.8,8.9,10,6.4,8.1,8.3,6.9,9.3,9.6,9.9,49.9,6.8,9.6,8.3,13.7,13.3,11.2,13.3,11.6,5.6,13.6,10.1,9.3,8,10.9,7.1,8.7,4.2,8.9,8.9,15.4,7.5,5.1,12,9.7,9.2,10.8,6,9.3,8.7,9.1,8.9,7.7,6.9,9.4,7.2,12.8,3.1,7.5,7.2,11.6,13.4,11.2,6.5,3.8,6.1,7,4.3,11.6,10.1,9.4,15.3,12.6,1.7,5.6,12.2,7.1,9.6,19.6,8,4.3,7.7,4.7,4.8,11.8,7.4,7.8,10.2,10,10.8,6.3,9,10.8,6.2,9.2,7.7,2.9,8.9,7.5,10.8,8.1,6.4,8.2,8,9.9,9.7,6.2,6.4,9.4,6.4,8.6,8.5,6,1.9,9.5,3.9,2.9,5.4,2,15.3,4,7.9,8.7,7.9,168.8,1.7,7.8,189.6,6.8,4,0,9.9,52.8,5.4,4.1,2.3,18.4,23,1.6,4.1,9.8,10.6,73.4,6.9,8.2,5,8.2,5,5.1,9.5,7,4.6,5.7,7.9,6.5,4.5,14,4.3,3,518.4,8.7,5.2,4.2
SLC39A14,"KIAA0062, NET34, ZIP14",ENSG00000104635,Solute carrier family 39 member 14,Q15043,8,22367249-22434129,"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins","Ion transport, Transport, Zinc transport",NA,"Disease mutation, Dystonia, Neurodegeneration, Parkinsonism",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,liver: 135.5;pancreas: 77.2,Cell type enriched,Detected in many,8,Hepatocytes: 491.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in all,NA,BJ hTERT+: 66.5,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,"HPA016508, HPA056732",Enhanced,NA,Approved,"Endoplasmic reticulum,Golgi apparatus,Plasma membrane",NA,NA,NA,NA,950000,"Endoplasmic reticulum, Golgi apparatus, Plasma membrane",NA,"HPA016508: AB_1857148, HPA056732:",unprognostic (1.67e-1),unprognostic (6.67e-3),prognostic favorable (5.00e-5),unprognostic (9.83e-3),unprognostic (9.21e-3),unprognostic (8.99e-3),unprognostic (1.99e-1),unprognostic (2.91e-2),unprognostic (4.95e-2),unprognostic (5.66e-2),unprognostic (6.64e-2),unprognostic (1.53e-1),prognostic unfavorable (3.79e-7),unprognostic (4.88e-2),unprognostic (8.73e-2),unprognostic (1.63e-2),unprognostic (1.11e-3),15,16.1,2.6,7.7,5.4,0.1,45.5,2.4,6.1,3.6,13.7,1.9,2.8,31.6,6.7,2.8,3.9,5.6,9.8,41.1,2.8,2.4,10.4,135.5,4.8,5.3,3.7,1.9,10.6,77.2,3,6.4,4,9.2,5.1,11.4,4.1,20.2,4.4,46.1,4.4,18.2,14.1,4.7,2.3,16.2,5.9,2.8,0.7,25.1,2.1,1.4,11.3,19,5,1.8,2.5,0.5,2.9,8.7,3.9,10.4,13.9,3.9,7.8,14,11.8,8.5,15,66.5,23.5,37.1,46.2,9.9,10.4,8.5,17.6,61.2,11.5,19.2,18.7,38.8,10.8,11,8.3,11.1,46.5,33.3,5.7,9.1,12.5,15.3,41.6,29.1,11.9,10.4,7.5,7.2,10.7,11.9,4.8,8.6,3.6,23.7,16.6,10.7,12.3,7.3,22.2,8.6,4.5,6.6,10.3,15.3,6.6,31,8.7,5.2,8.3,5.7,29.2,14.9,18.4,15.4,6.2,5.6,13.6,41.3,7.6,17,0,0.5,2.5,8.3,0.1,8.7,5,4.8,6.3,1.8,2.6,5.7,7.6,0.2,2.9,0.1,0.8,3.8,3.9,2.6,5.4,2.4,6.1,2.8,2.4,3.7,1.9,9.2,2.8,3,4.8,3.7,8.8,29.7,7.1,50.1,50.9,0,3.4,7,2,0.2,1.7,48.7,0.4,31.6,63.6,0,63.9,2.1,30.9,17.2,0,491.4,1.5,46.1,32,31.9,15.9,1.8,22.2,1.6,42.2,4.6,51.4,4.6,55.6,28.8,39.3,21.4,7.4,0,46.7,0,2.4,18.3,0.5,4.9,33.7,9.8
SLC39A7,"D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7",ENSG00000112473,Solute carrier family 39 member 7,Q92504,6,33200445-33204439,"Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA053999,Approved,NA,Supported,Endoplasmic reticulum,NA,NA,NA,NA,NA,Endoplasmic reticulum,NA,HPA053999: AB_2682338,unprognostic (3.63e-2),unprognostic (1.23e-1),unprognostic (1.21e-1),unprognostic (3.24e-2),unprognostic (8.95e-2),unprognostic (2.51e-1),prognostic unfavorable (3.62e-4),unprognostic (4.87e-2),unprognostic (9.92e-2),unprognostic (7.20e-3),unprognostic (3.29e-1),unprognostic (2.40e-1),unprognostic (1.99e-2),unprognostic (4.80e-1),unprognostic (1.50e-1),unprognostic (8.22e-3),unprognostic (1.12e-2),14.7,25.1,9,12.1,9.5,6.1,15.8,11.9,11.9,24.7,19.8,12.2,43.3,17.3,20.1,24.6,14.4,13.6,25.6,20.7,8.7,8.9,24.6,55.1,20.2,11.6,12.6,9.6,14.4,49.2,37.1,24.2,43.8,18.8,22.8,22.9,16.8,48,41.7,10.4,11.3,18.8,20.1,10.6,15.2,21.1,9.5,10.7,9.9,28.2,14.4,17,16.6,13.9,2.6,3.4,6.2,2.8,4.2,5.1,2.1,8.5,9.9,15.2,14.1,22.9,15.7,13.3,22.9,30.1,17.8,21,16.2,8.3,6.4,11.2,25.5,13.8,9.7,11.5,13.5,15.9,8.1,10.2,10.9,11.6,20.8,16.6,10.8,13.2,14.8,11.4,15.7,17,17.6,14.2,6.8,11.9,10.5,12.2,9.7,5.9,6.3,6.5,12.5,9.1,6.4,8.9,10.6,11.9,10.7,9.9,8,9.3,22,12.5,9.6,21.3,10.1,14,16.4,10,12.2,15.2,16.5,14.5,5.7,9.9,10.3,18.1,6.2,2.4,2.3,5.1,2.8,4.8,1.8,3.2,3.9,2.3,2.6,2.9,3.3,2.4,4.2,1.6,3.4,3,2.1,9,9.5,11.9,11.9,8.7,8.9,12.6,9.6,18.8,10.7,23.8,33.3,14.5,25.7,32.1,27.2,29.7,28.1,22.7,33,24.4,27.5,88.4,5,60.8,0.6,33.7,62.8,23.3,75.1,113.6,62,56.4,19.7,31.1,38.7,11.1,24.3,29.4,17,1.9,42.6,23.9,38.8,27.9,109.3,41.2,56,56.2,40.3,20.1,22.2,19.4,33.9,7.9,10.6,35.8,141.1,27.4,54.4,33.5
SLC39A10,"DKFZp564L2123, FLJ90515, KIAA1265",ENSG00000196950,Solute carrier family 39 member 10,Q9ULF5,2,195575977-195737702,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,brain: 41.0;thyroid gland: 39.9,Low cell type specificity,Detected in all,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA036512, HPA036513, HPA066087",Approved,NA,Approved,"Nucleoplasm,Plasma membrane,Cytosol",NA,NA,NA,NA,49000,"Nucleoplasm, Cytosol",Plasma membrane,"HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613",unprognostic (1.06e-1),unprognostic (3.87e-3),unprognostic (5.33e-2),unprognostic (1.33e-3),prognostic favorable (1.46e-5),unprognostic (7.40e-2),prognostic unfavorable (4.39e-5),unprognostic (2.10e-2),unprognostic (8.73e-2),unprognostic (2.84e-2),prognostic unfavorable (3.23e-4),unprognostic (8.46e-2),unprognostic (9.71e-2),unprognostic (1.34e-2),unprognostic (3.68e-1),unprognostic (2.47e-2),unprognostic (6.89e-2),6.6,10.9,16,6,24.8,3.7,6.2,10.8,41,9.8,3.8,4.2,4.9,3.6,9.4,3.3,3.5,8.5,7.6,4.7,15,11.2,7.8,2.1,6.3,6.5,8.5,24.4,7.4,5.7,5.8,5.7,10.7,15.7,16.7,4,1.4,4.8,6.5,3.3,5.7,5.7,6.7,10.2,14.4,4.3,7.9,6.2,10.6,39.9,1.7,6.4,6.1,4.9,9.4,18.4,19.3,2.7,11,4.6,1.5,2.9,9.9,18.9,5.2,3.7,8.8,9.8,13.7,6.7,6.6,3.3,14.8,10.6,4.1,20.9,7.8,5.1,4.2,11.5,12.6,8.4,2.1,8.6,4.6,15.4,12.1,4.1,16.8,1.9,5.2,1.8,7.3,8.4,23.4,14.8,4.2,13.3,5.8,10.6,2.8,4.8,5.2,22,17.2,7.8,11.3,6.6,10.2,28.8,4.9,7.3,10,13.7,28,7.2,34.5,4.5,10.5,14.5,12.1,14,7.9,7.1,2,1.2,2.4,9.7,7.9,12.2,19.3,2.7,1.9,4.5,2.5,3.5,6.8,4,3.7,3.3,9.4,3.5,4.6,0.5,11,1.8,18.4,3.9,1.5,16,24.8,10.8,39.7,15,11.2,8.5,24.4,15.7,6.2,3,10.9,18.2,9.3,22.8,21.9,7.3,7.6,6.7,29.6,34.9,7.9,41.3,1.7,17.6,23.2,27,2.9,23.3,9.5,54.8,20.3,18.5,12.7,2.5,21.6,7.9,15,24.5,18.1,11.5,17.5,29.7,6.8,8.2,5.1,15.6,17.5,2.9,17.7,14.9,19.9,12.9,13.8,47.8,27,17.9,19.6,21.5,4.5,6.4
SLC39A12,FLJ30499,ENSG00000148482,Solute carrier family 39 member 12,Q504Y0,10,17951839-18043292,"Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in many,13,brain: 42.3;retina: 19.2,Cell type enriched,Detected in some,30,Muller glia cells: 85.4,Cancer enriched,Detected in single,8,glioma: 3.0,Low region specificity,Detected in all,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in single,NA,U-2 OS: 1.3,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (1.43e-2),NA,NA,NA,unprognostic (2.67e-1),unprognostic (3.30e-1),NA,unprognostic (8.70e-2),unprognostic (1.02e-1),NA,unprognostic (8.35e-2),unprognostic (1.33e-1),unprognostic (3.40e-6),unprognostic (1.94e-1),unprognostic (8.11e-2),unprognostic (3.76e-2),NA,1.2,1,13.7,1,14.6,0.9,2.3,2.2,31.2,0.9,1,14.8,0,0.9,0.9,0.9,0.9,0.9,0.9,1,21.4,5.5,0.9,0.9,1,0.9,9.9,5.6,0.9,1.2,0.9,1.5,1.1,42.3,1,1.1,19.2,1,0.9,0.9,0.9,0.9,1,1.5,1,0.9,1.4,8.7,0,0.9,0,0.9,1,0.1,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0.2,0,0,0,0,0,0,0.4,0.3,0.1,0.5,0,0.5,0,0,0,0,0,0,0,0.1,0.4,0,0,0,0,0,0,0,0.2,0,0,0,0,0.1,0,0.3,0.1,0,0,0,0,0.1,0,0,0.2,0,0,0,0,0,0,1.3,0.4,0.3,0.1,0,0,0.6,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.7,14.6,2.2,17.5,21.4,5.5,9.9,5.6,42.3,8.7,0,0,0,0,0,0.3,0.2,0,0,0,0,0,0,0,0,1.5,0,0,0,0,0,0,0,0,0,0.1,0,0,0.6,0,0.5,0.3,0,0,0,0,85.4,0,0,0,0,2.9,0,0,0,0.6,0.1,0,0,0,0
SLC39A6,LIV-1,ENSG00000141424,Solute carrier family 39 member 6,Q13433,18,36108532-36129385,"Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,7,Glandular cells: 212.3,Cancer enhanced,Detected in all,NA,breast cancer: 361.9,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA042377,Approved,NA,Uncertain,"Nucleoplasm,Plasma membrane,Cytosol",NA,NA,NA,NA,NA,Cytosol,"Nucleoplasm, Plasma membrane",HPA042377: AB_2677968,unprognostic (7.60e-2),unprognostic (2.27e-2),unprognostic (5.50e-3),unprognostic (2.58e-3),unprognostic (1.02e-1),unprognostic (4.87e-3),prognostic unfavorable (5.33e-4),unprognostic (1.79e-1),unprognostic (2.00e-1),unprognostic (1.18e-1),unprognostic (3.19e-1),unprognostic (4.50e-2),unprognostic (7.63e-3),unprognostic (2.16e-1),unprognostic (4.74e-2),unprognostic (1.45e-1),unprognostic (1.30e-1),11.1,12.6,14.3,8.6,13.4,4.3,63.5,19.4,14.7,15.7,8.7,16,68.7,4.1,24.7,24.5,9.8,27.7,10.3,8.2,14.2,17.5,12.3,7.7,7.9,8.2,18.3,8.7,30.5,15.5,32.1,23.9,52.5,16,55.2,5.9,25.1,15.5,51.5,7.7,22.6,5.7,12.7,21.7,11.2,8.1,9.9,13.5,8,15.7,10.7,11.3,23.8,20.2,12.6,25.2,22.2,14.6,12.9,15.6,9.7,10.4,13.2,31.7,18.6,33.5,24.8,8.3,28.5,33.8,19.1,22.5,7.3,11.6,11.3,14.4,27.4,13.3,25.5,27.6,26.7,29.1,25.1,10,4.9,18.6,10.6,21.3,16.5,12.4,22.6,59.1,29,25.3,17.6,2.8,9.4,2.5,22.8,26.8,16,16.2,3.7,7.6,5.7,7.5,16.8,18.1,14.8,21.3,35.2,33.4,29.4,35.1,10.3,48.1,13.6,14,7.8,4.6,46.7,7.8,8.8,14.3,21.5,20.8,8.6,16.1,11.7,24.5,19.5,9.8,22.2,13,14.6,15.6,12.6,11.1,11.5,12.2,12.3,9.8,14.2,7.5,12.9,13.7,25.2,12.2,9.7,14.3,13.4,19.4,12.4,14.2,17.5,18.3,8.7,16,13.5,35.7,16,13.7,44.4,40.8,40.2,16.6,10.2,42.8,60.3,40.1,31.4,5.4,1.7,46.8,16.8,10.8,2.8,0,32.7,50.5,40.3,212.3,23.1,7.9,18.4,22.3,24.5,7.4,15.6,14.6,34.5,25.1,64.1,24.4,6.7,35.8,34,0,44.9,13.9,25.8,38.8,37.6,43.4,22.9,65.1,19.9,16,4.1,55.4
SLC39A9,FLJ11274,ENSG00000029364,Solute carrier family 39 member 9,Q9NUM3,14,69398015-69462388,"Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,4,Hepatocytes: 62.5,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA007921, HPA075390",Approved,NA,Approved,Endoplasmic reticulum,NA,NA,NA,NA,NA,Endoplasmic reticulum,NA,"HPA007921: AB_1080007, HPA075390: AB_2686748",unprognostic (2.37e-1),unprognostic (9.29e-2),unprognostic (1.57e-1),unprognostic (2.53e-1),unprognostic (4.35e-2),unprognostic (1.10e-1),unprognostic (5.50e-2),unprognostic (1.71e-1),unprognostic (2.49e-1),unprognostic (2.75e-1),unprognostic (1.57e-1),unprognostic (1.92e-1),prognostic favorable (1.05e-6),unprognostic (1.20e-1),unprognostic (1.83e-1),unprognostic (1.09e-2),unprognostic (2.16e-2),15.8,22.2,19.5,11.3,19.2,8.8,24.8,15,26.3,19.5,25.5,22.4,20.6,20.8,19.1,25.6,22.3,16.5,16.7,14.5,18.9,19.1,31.2,52.9,15.7,13,17.8,13.7,16.3,28,24.5,24.6,29.7,17.1,19.4,22.7,17,65.2,24.2,7.7,16.7,27.8,16.3,19.3,16.3,19.8,17.4,14.1,18.3,22.4,13.7,19.2,14.5,14.6,9.9,17.2,12.5,14.8,9.2,12.5,9.2,29.4,23.2,14.9,15,25.6,19.9,13.4,18.1,21,15.5,17.9,17.4,27.9,24,13.2,20.9,7.9,24.3,16.2,17,19.6,16.2,8.7,15.2,13.2,13.2,19.2,11.2,21.6,16,27.2,14.2,21.4,16.6,16.2,20.4,11.6,24,18,16.4,16.7,12.1,11.9,24.7,16.5,16.9,21,15.6,20.9,32.2,15.3,25.1,17.5,30.6,10.5,12,43,18.3,17.2,28.4,20.3,11.8,12.3,26.4,14.7,18.5,26.8,12.8,23.1,11.9,14.8,12.5,11.7,14.1,12.5,9.9,10.2,11.5,17.2,7.7,10.3,11.2,12,9.2,13,8.3,7.4,9.2,19.5,19.2,15,26.3,18.9,19.1,17.8,13.7,17.1,14.1,17.9,13,13.7,6.6,10.8,7.2,7,20.4,12,10.3,15.7,5.9,12.4,5,12.6,13.3,14.6,36.8,0,21.6,13.5,14.1,18.8,11.5,62.5,14,9.5,28.3,23.4,21.5,15.1,12,9.3,6.8,10,31.8,10.4,22.1,20.1,12,14.6,11,6.5,12.9,11.8,6.4,10.9,14.9,8.2,22.3,12.4
SLC39A1,"ZIP1, ZIRTL",ENSG00000143570,Solute carrier family 39 member 1,Q9NY26,1,153959099-153968184,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,6,Cytotrophoblasts: 292.9;Extravillous trophoblasts: 244.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (6.27e-2),prognostic unfavorable (4.83e-4),unprognostic (1.13e-1),unprognostic (2.63e-1),unprognostic (2.07e-2),prognostic unfavorable (5.26e-5),prognostic unfavorable (4.12e-7),unprognostic (2.36e-2),unprognostic (2.62e-2),unprognostic (4.41e-1),unprognostic (4.83e-3),unprognostic (1.93e-1),unprognostic (5.10e-3),unprognostic (2.54e-2),unprognostic (1.23e-1),unprognostic (5.51e-2),unprognostic (6.68e-2),32.5,31.8,12.5,20.6,19.3,3.8,28,11.1,14,21.8,24.1,16.6,18.2,15.9,28.7,20.8,25.6,20.8,31.9,25.5,13.2,9.3,39,53.7,34.7,19.5,20.7,10.1,28.1,27.8,20.7,13,65.5,16.2,29.5,17.2,20.1,21.9,22.3,18.6,25.6,22.4,22.2,18.6,28.1,23.6,14.9,17.4,15.2,46.9,24.5,18.5,23.7,28.5,17.4,22.3,26.9,34.7,11.1,14.1,20.4,24.1,27.9,22.8,19.2,21.6,22.2,50.1,15.7,38.1,26.2,29,41.1,62.4,9.4,50.3,21.5,21.9,54.4,23.1,23.8,15,29.4,18.7,12.8,29.7,18.1,24.7,9.7,14.9,26.8,22.2,20.6,20.6,24.5,18.7,10.9,12,11,21,49.2,9.8,12.5,32.3,49.8,22.1,11.1,19.8,11.4,41,17.5,10.2,23.9,29.6,76.1,27.1,30.6,40.8,20.8,16.9,24.3,22.1,17.2,22.5,13.3,17,12.1,17.3,7.7,32.1,5.9,27.3,7.8,14.1,30.6,8.8,13.9,10.7,10.6,22.3,17.4,11.7,10.6,26.9,11.1,34.7,20.2,10.1,20.4,12.5,19.3,11.1,14,13.2,9.3,20.7,10.1,16.2,17.4,8.9,3.5,16.6,81.5,50.3,7,11.8,50.9,5.3,3.4,50.6,2,292.9,11.6,174,0.7,65.7,26.4,0,99.6,244,77.9,82.7,36.8,23.7,103.7,17.5,18.5,31.3,47.4,2,44.8,38.9,45.5,117.2,28,38,101.5,25.9,58.4,35.1,5.8,45.3,63.7,14.4,23.2,46.7,128,19.2,32.9,64
SLC39A11,C17orf26,ENSG00000133195,Solute carrier family 39 member 11,Q8N1S5,17,72645949-73092712,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,7,Late spermatids: 49.0;Mucus-secreting cells: 73.3,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,HMC-1: 48.4,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA021455,NA,NA,Approved,Nucleoplasm,NA,NA,NA,NA,NA,Nucleoplasm,NA,HPA021455: AB_2670710,unprognostic (2.29e-2),unprognostic (2.75e-1),unprognostic (1.25e-1),unprognostic (2.19e-1),unprognostic (1.61e-1),unprognostic (1.82e-2),unprognostic (1.19e-1),unprognostic (3.44e-2),unprognostic (1.72e-1),unprognostic (1.37e-1),unprognostic (3.45e-3),unprognostic (2.30e-1),unprognostic (1.57e-3),unprognostic (5.26e-2),unprognostic (1.17e-1),unprognostic (4.96e-3),unprognostic (3.85e-2),10.4,7.4,12.4,7.8,17.9,10.7,10.8,5.3,14.4,9.3,13.3,19.8,6.6,11.5,4.8,9.6,13,5.6,8.6,4.2,13.3,6.3,7.9,21.9,8.2,4.8,27.8,6.6,2.8,23.8,3.1,3.8,7,15.3,5.3,13.8,6.7,16.6,5.2,3.7,11.2,12.7,5.7,15.7,6.5,27.6,4.1,22.5,6,20.6,3.6,8.6,8.3,7.6,6,14.9,9.8,16.2,8.7,6.9,6.3,4.3,7.9,0.9,3.8,6.9,5.6,5.4,4.6,4.1,2.1,2.9,2.9,19.7,5.4,4.8,4.7,3.4,3.7,1.3,2.3,3.3,5.8,2.8,5,2.1,3.4,4.1,5.3,48.4,4.8,4.5,4.4,2.6,2.3,2.2,2.8,2.6,6.8,2.7,6.1,3.4,11.6,0.7,13.3,3.4,2.3,3.6,4.5,3.5,4.5,2.2,3.1,2.5,18.7,2.8,3.9,12.8,7.4,1.8,4.2,4,3.6,2.8,5.5,2.5,3.8,6.9,10.8,2.4,5.5,16.2,9.8,6.9,15.4,4.6,6,5.3,5.2,14.9,3.9,3.8,5.2,2.5,8.7,11.9,10.5,6.5,6.3,12.4,17.9,5.3,14.4,13.3,6.3,27.8,6.6,15.3,22.5,0,4.6,3.7,4.4,3.9,2.3,2,7.6,6.7,7.9,3.5,0,4.7,0,6.8,19.2,3.6,19.9,23.3,12.3,14.7,3.6,5.1,29.9,25,25,4.8,8.1,4.3,15.5,49,3.7,7.6,10.1,15.4,73.3,3.9,8.3,20.4,3.2,9.8,1.5,12.9,6.1,1.9,2.5,3.9,4.1,3.2,14.7,6.3
SLC39A13,FLJ25785,ENSG00000165915,Solute carrier family 39 member 13,Q96H72,11,47407132-47416501,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,Ehlers-Danlos syndrome,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Group enriched,Detected in many,11,Early spermatids: 250.1;Late spermatids: 701.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA043971,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA043971: AB_10959744,unprognostic (7.84e-2),unprognostic (1.02e-2),prognostic unfavorable (2.60e-4),unprognostic (1.18e-1),unprognostic (8.56e-3),unprognostic (3.81e-2),unprognostic (7.44e-3),unprognostic (1.36e-1),unprognostic (5.40e-2),prognostic unfavorable (2.73e-5),unprognostic (1.39e-2),unprognostic (2.04e-2),prognostic favorable (1.96e-4),unprognostic (3.16e-1),unprognostic (1.73e-1),unprognostic (8.61e-2),unprognostic (4.12e-1),17,19.2,14.1,19.7,17,6.3,15.1,25.6,21.8,17.8,18.6,18.8,12.4,12.1,32.1,20.2,17.1,18.5,19,35.5,16.1,10.3,39.9,17.6,23.2,14.8,18.5,15,21.3,20.7,19,21,34.5,15.5,20.5,6.3,23.8,20,24.9,19.8,27.1,12,22.8,10.6,15.3,16.1,25.9,16.4,9.8,18.7,9.3,10.4,19.5,15.7,5.8,5,6.5,14.4,6.7,13.2,5.2,7.4,6.6,7.8,8.7,19.1,26.8,2.2,30,22.2,16.8,19.2,2.6,5.1,2.9,8.2,22.5,16.6,12.6,2.3,20.1,4.7,8.4,8.8,1.5,15.7,5.3,28.7,2.5,3.7,22.3,14.5,10.6,8.7,21.1,17.9,5.6,1.4,6.4,18,6.6,5.4,3.7,3.7,6.3,9.9,6.6,11.4,2.9,28.4,3.6,6.9,12.5,9,16.1,8.4,3,10.7,3.8,24.9,25.7,11.9,29.3,13.6,5,1.6,1.2,28.4,3.6,18.6,2,3.6,3,13.2,13.7,8.8,4.5,8.7,9.3,4.6,5.8,8.3,6.8,6.5,6.7,14.4,5,4.5,5.2,14.1,17,25.6,21.8,16.1,10.3,18.5,15,15.5,16.4,8.9,5.4,2.2,16,16.3,23.6,15.5,10.2,1.4,5.7,27.9,11.8,8.4,8.3,29.6,250.1,17.6,4,0,18.1,14.1,34,9.3,5.7,5,17.2,30.2,9.2,19,4.8,701.9,30.5,10.7,18.6,44.1,7.3,15.8,25,6.2,37.8,7.3,15.8,45.3,20.3,12.5,5.7,3.6,16.4,8.6,5.5,6.7
SLC39A2,ZIP2,ENSG00000165794,Solute carrier family 39 member 2,Q9NP94,14,20999255-21001871,Predicted membrane proteins,"Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,NA,Tissue enhanced,Detected in many,NA,ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8,Cell type enriched,Detected in some,4,Muller glia cells: 21.3,Low cancer specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in single,67,HaCaT: 23.1,Low region specificity,Detected in single,NA,NA,Low region specificity,Detected in many,NA,NA,"HPA030489, HPA073231",Uncertain,NA,Approved,"Plasma membrane,Cytoplasmic bodies",NA,NA,NA,NA,NA,Plasma membrane,Cytoplasmic bodies,"HPA030489: AB_10601488, HPA073231:",unprognostic (2.76e-2),unprognostic (4.86e-2),unprognostic (9.72e-2),unprognostic (2.37e-1),unprognostic (2.46e-1),unprognostic (2.71e-1),unprognostic (3.42e-1),unprognostic (1.70e-1),unprognostic (4.43e-1),unprognostic (6.20e-3),unprognostic (3.31e-1),unprognostic (2.80e-1),unprognostic (3.62e-2),unprognostic (1.91e-1),unprognostic (5.80e-2),unprognostic (3.71e-1),unprognostic (2.30e-3),0.1,0.1,0.1,0,0.1,0,1.3,0.3,0.4,5.6,1.2,0,44.3,0,0.8,0,13,0.3,0.1,0.2,0.4,0,0.1,0.1,0.1,0,0.2,0.1,0.1,0,0.4,0.2,1,0.2,8.5,0.8,0.4,2.7,50.6,0.1,23.8,0.1,0.2,0.1,0.1,0,0.1,0,1.3,0.1,6.1,3.3,1.2,9.4,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.2,0,0.1,0,0,0,0,0.2,0,0,0,23.1,0.1,0,0,0.1,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0.2,0,0,0,0.1,0,0.3,0.2,0,0.2,0,0,0.2,0,0.1,0,0,0,0,0,0.3,0.3,0,0,0,0.1,0,0,0,0.1,0.1,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.1,0.3,0.4,0.4,0,0.2,0.1,0.2,0,0,0,0,1.5,0.7,0,0.4,0,0,0,0,2,0,0,0,0.1,0,0,0,0,0,0.4,3.5,0,0,0.1,0,0,0,0,0,0,0,0,0,0,21.3,0.1,0,0,0,0.7,0,0,0,0,5.3,0.2,0,0.8,4.2
SLC39A3,ZIP3,ENSG00000141873,Solute carrier family 39 member 3,Q9BRY0,19,2732204-2740152,"Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in all,10,Early spermatids: 234.7;Late spermatids: 338.5,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,U-937: 90.6,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA042139, HPA058526",Uncertain,NA,Approved,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,"HPA042139: AB_10793875, HPA058526: AB_2683743",unprognostic (1.81e-1),unprognostic (1.47e-2),unprognostic (1.16e-1),prognostic favorable (9.76e-5),unprognostic (2.26e-1),unprognostic (2.44e-2),unprognostic (9.88e-3),unprognostic (1.01e-1),unprognostic (6.03e-2),unprognostic (3.66e-2),unprognostic (4.37e-3),unprognostic (4.07e-2),unprognostic (1.75e-3),unprognostic (9.22e-3),unprognostic (6.58e-2),unprognostic (7.97e-2),unprognostic (1.80e-2),11.1,15.5,13.3,8.3,18,23.9,13.3,10.6,28,12.7,10.8,14,8.3,10.2,14.3,19.5,10.5,14.6,10.5,11.7,14.4,13,11,23.6,9,11.7,11.5,12.9,11,11.9,17.8,15.5,10.6,14.9,10.8,8.8,10.7,12.4,11.7,11.2,8.1,9.4,14,11.1,12.9,9.3,50.1,8.8,13,12.5,6.8,9.4,14.2,7.8,24.4,38,29.6,17.5,13.1,17.5,15.4,11.9,9.7,7.3,18,15.2,10.4,7.4,8.7,10.3,16.1,16.5,10.5,7.8,7.4,5.6,14.9,12.8,9.7,11.2,11.6,10.1,0,8,32.5,7.2,10.5,16.8,26.9,47.6,9.3,18.8,11.9,9.8,5.8,8.2,13.9,35.6,33.1,10.8,7.7,13.2,20.2,7.8,10.6,12.9,17.5,4.8,22,7.6,9.3,10.1,9.2,7.6,5.4,18.1,4.9,9.5,35.3,5,11.3,6.2,17.5,12.6,9,14.1,7,8.5,90.6,13.4,16.4,17.5,29.6,17.5,16.1,15.4,24.4,15.4,14.9,23.4,24.4,12.9,14.5,7.8,13.1,15.5,38,9.7,15.4,13.3,18,10.6,28,14.4,13,11.5,12.9,14.9,8.8,3,3.2,33.4,14.3,9.2,19.5,6.7,28.1,5.3,5.7,7,7.9,32.9,14.9,40.6,234.7,14.4,18.4,70,53.8,46.9,22.6,24.4,25.3,27.7,57.4,46.1,23.1,17.2,18.1,338.5,19.8,24.6,23.6,28.9,16.6,28.8,36,20.3,26.2,18,15.4,25.8,15.1,118.7,27.5,8.5,22.1,20,23.4,14.6
SLC39A4,"AEZ, AWMS2, ZIP4",ENSG00000147804,Solute carrier family 39 member 4,Q6P5W5,8,144409742-144416895,"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins","Ion transport, Transport, Zinc transport",NA,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,9,intestine: 77.7,Cell type enhanced,Detected in many,5,Enterocytes: 153.2;Proximal tubular cells: 139.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in single,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,11,CAPAN-2: 17.7;Hep G2: 45.3,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (2.59e-1),unprognostic (2.35e-3),unprognostic (9.16e-2),unprognostic (3.84e-2),unprognostic (5.63e-3),unprognostic (1.46e-1),unprognostic (5.40e-2),unprognostic (1.54e-1),unprognostic (1.61e-1),unprognostic (3.28e-2),unprognostic (1.41e-2),unprognostic (1.24e-1),prognostic favorable (9.04e-4),unprognostic (2.78e-2),unprognostic (3.97e-1),unprognostic (9.04e-3),unprognostic (1.87e-1),0.2,0,0.5,1.1,0.2,0.1,0.2,0.2,1.1,0.2,73.9,0.2,0.2,42.1,0.2,0.4,0.2,0.3,0.7,0.2,0.2,0,8.3,0.4,1.3,0.2,0.2,0.2,1.5,0.6,0,0.3,0.4,0.2,0.4,0.1,0.2,0.5,0.2,0.2,0,77.7,0.2,0.2,0.2,1.2,0.4,0.2,0.2,2.3,0.2,0.2,0.2,0.2,0,0,0,0,0,0,0.3,1.1,0.1,0,0,0,0,1.2,0,0,0,0,1.1,17.7,0,0.5,0,0,0.1,0,0,0,2.9,0.4,0.7,0.1,45.3,0,0,1.2,0,0,0,0,0,0,0.3,0.7,1,0,0.7,0,0.1,0,0.2,0,0.2,0,0.5,0,0.2,0.4,0.9,0,0.2,0,0.2,0.8,0,0,0,0.1,0,0,0.4,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0.5,0.2,0.2,1.1,0.2,0,0.2,0.2,0.2,0.2,17.9,22.7,23.4,28.9,16.7,0.1,5.6,22.9,26.8,13.6,40.1,0,15.3,43.1,36.9,1.1,9.8,153.2,23.3,37.2,53.2,13.5,30.9,36.9,22.7,29.1,3.2,40.9,7.4,15.7,1.3,7.5,21.5,20.3,27.1,76.6,7.1,53.4,115.8,6,139.9,1,6.5,11.4,1.6,32.4,26.2,9.4,12.9,78.9,35.2
SLC39A5,NA,ENSG00000139540,Solute carrier family 39 member 5,Q6ZMH5,12,56230049-56237846,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,NA,intestine: 77.8;liver: 38.2;pancreas: 101.1,Group enriched,Detected in many,6,Cone photoreceptor cells: 110.0;Enterocytes: 260.0;Hepatocytes: 140.6;Mucus-secreting cells: 92.0;Paneth cells: 142.5;Proximal tubular cells: 149.4;Undifferentiated cells: 142.6,Cancer enhanced,Detected in many,NA,liver cancer: 36.3,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,51,CACO-2: 22.8;Hep G2: 32.9,Region enhanced,Detected in single,NA,basal ganglia: 0.9,Not detected,Not detected,NA,NA,HPA018423,NA,NA,Approved,"Nucleoplasm,Vesicles",NA,NA,NA,NA,NA,Vesicles,Nucleoplasm,HPA018423: AB_1857154,unprognostic (5.94e-3),unprognostic (8.29e-2),unprognostic (1.82e-2),unprognostic (2.19e-7),unprognostic (1.73e-1),unprognostic (7.79e-2),unprognostic (1.56e-1),unprognostic (1.36e-1),unprognostic (1.08e-1),unprognostic (1.32e-1),unprognostic (7.33e-2),unprognostic (2.93e-3),prognostic favorable (5.05e-4),unprognostic (2.75e-1),unprognostic (1.15e-1),unprognostic (1.23e-1),unprognostic (1.96e-4),0.2,0.1,0.2,4.1,0.2,0,0.2,0.2,0.2,0.2,40.5,0.2,0.2,48.6,0.2,2.3,0.2,0.1,5.9,0.2,0.2,0.1,22.5,38.2,0.2,0.2,0.2,0.2,0.2,101.1,0,0.2,0.2,0.2,0.2,9.1,0.2,0.2,0.2,0.2,0.1,77.8,0.2,0.2,0.2,0.1,0.3,0.2,0.2,0.2,0.2,0.2,0.2,0.2,0,0,0,0.1,0,0.7,0,0,0.1,0.1,0.1,0.1,0.2,0.3,0,0,0,0,22.8,0.2,0,0.1,0,0,0.1,0,0.1,0,0.3,0.1,0.1,0,32.9,0.1,0,0.1,0.1,0,0.1,0,0,0,0,0,0.1,0,0.1,0,0.4,0,0.5,0,0.1,0.1,0.2,0.3,0,0.2,0.2,0,0,0,0,0,0,0,0,0.1,0.2,0,0,0,0,0.1,0,0,0,0.1,0,0.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0.2,0.2,0.2,0.2,0.1,0.2,0.2,0.2,0.2,0,0,2.2,0,0.6,0.6,0.2,12.7,0,0,3.5,110,0,16.6,0.3,0.4,0.1,260,0,17.7,0,0.1,0.1,0,140.6,0.1,0,24.3,2.5,1.3,0,0,0,0,1,92,0.5,12.1,142.5,0,149.4,1.3,0,0,0,0,0.4,0,0,142.6,0
SLC39A8,BIGM103,ENSG00000138821,Solute carrier family 39 member 8,Q9C0K1,4,102251041-102431258,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Ion transport, Transport, Zinc transport",NA,Congenital disorder of glycosylation,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,lung: 67.3;salivary gland: 54.6,Group enriched,Detected in many,5,Alveolar cells type 1: 723.6;Alveolar cells type 2: 227.4;Extravillous trophoblasts: 184.5,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,BJ hTERT+: 45.5;HL-60: 33.1;Karpas-707: 49.4,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in many,NA,NA,"HPA038832, HPA038833",Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA038832: AB_2676226, HPA038833: AB_10670910",prognostic favorable (6.69e-4),unprognostic (1.29e-2),prognostic favorable (1.34e-4),unprognostic (1.91e-2),unprognostic (6.50e-2),unprognostic (9.59e-2),unprognostic (6.07e-2),unprognostic (2.74e-1),unprognostic (1.20e-3),unprognostic (6.32e-2),unprognostic (5.46e-3),unprognostic (2.78e-2),prognostic favorable (6.34e-6),unprognostic (3.25e-1),unprognostic (6.54e-2),unprognostic (6.40e-2),unprognostic (7.13e-3),22,2,3.7,11.4,5.5,10.3,6.1,2.8,4.3,31.4,18.1,2.2,1.1,2.1,3.9,7.3,1.7,7.2,2.6,17.8,4.3,3.5,6.2,18.4,67.3,8.6,5.1,1.6,5.4,42.1,25.7,6.7,44.8,5.9,5.7,14.9,4.3,54.6,2.3,1.8,5.1,3.4,3,8.8,6.5,2.5,2.3,3.2,7.5,4.9,2.3,5.6,5.8,6,3.1,2.7,1,1.5,11.5,10.5,3.4,5.5,5.5,1.2,0,4.6,10.6,2.9,0.6,45.5,1.7,2.7,0.2,20.6,5.4,6,0.1,5.7,0.4,3.8,1.2,1,9.3,11.3,14.1,11.6,0.1,1.8,33.1,4.8,5.6,1.4,0.8,2.6,4.5,0.6,13.4,14.1,49.4,8.8,3.7,11.9,15.5,3.7,7.5,5.4,3,0,17.6,9.6,2.1,1.6,4,15.5,0.2,1.5,1.1,3.8,12.4,3.1,5.5,2.1,11.2,8.7,22.1,9.2,25.6,9.1,21.7,5,0,1.5,1,5.6,1,9.8,1.3,10.5,9,2.7,3.1,7.9,5.4,0.1,11.5,0.3,1,3.9,3.4,3.7,5.5,2.8,4.3,4.3,3.5,5.1,1.6,5.9,3.2,723.6,227.4,10.4,9.5,10.4,0.8,22.6,7.6,1.4,27.3,5.2,3.9,12.1,10,1.9,0.3,8,3.3,23.3,28.2,184.5,25.7,10.8,3.5,22.1,43.3,3.2,23.1,6.7,29.8,0.4,1.1,25.3,27,16.2,72.2,4.5,16.3,7,1.1,8.1,1.2,6.5,14.6,2.7,5.9,6,50.7,13.8,56.9,6.8
SLC43A1,"PB39, POV1, R00504",ENSG00000149150,Solute carrier family 43 member 1,O75387,11,57484534-57515786,"Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in many,5,gallbladder: 27.0;liver: 91.8;pancreas: 100.5,Cell type enhanced,Detected in many,14,Cholangiocytes: 40.8;Hepatocytes: 109.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in some,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,Hep G2: 23.8;NB-4: 28.3;U-937: 27.3,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA018813, HPA018826",Enhanced,NA,Approved,"Golgi apparatus,Vesicles,Plasma membrane",NA,NA,NA,NA,NA,"Golgi apparatus, Vesicles, Plasma membrane",NA,"HPA018813: AB_1857164, HPA018826: AB_1857165",unprognostic (3.04e-1),unprognostic (1.15e-1),unprognostic (9.19e-2),prognostic favorable (3.19e-4),unprognostic (2.51e-2),unprognostic (5.48e-2),unprognostic (2.32e-1),unprognostic (6.71e-3),unprognostic (1.63e-1),unprognostic (3.12e-2),unprognostic (6.06e-2),unprognostic (2.72e-1),prognostic unfavorable (2.97e-5),unprognostic (1.39e-2),unprognostic (1.48e-1),prognostic unfavorable (5.27e-4),unprognostic (7.30e-2),4.7,3.3,0.8,2.2,0.8,9.3,7.4,0.7,1.3,6,4.8,0.9,3.9,2.5,5,6.8,4.1,3.3,27,3.2,0.7,0.6,3.4,91.8,2.9,3.3,0.8,1.1,6.5,100.5,0.1,1.3,1.8,0.7,6.2,2.8,11.4,14.9,2.1,7.5,5.6,2.6,7,0.9,2.5,7.6,3.1,0.7,0.8,7.4,2.9,3.1,7.6,3.5,3.1,8.2,8.1,6,6.9,11.1,5.2,0.4,0.6,0.7,8,10.5,7.7,0.1,4.2,5.4,1.2,3.1,2.5,1.1,23,1.1,3.1,1.5,0.3,7.1,0.4,1.5,1.1,1.8,11.8,0.2,23.8,13.8,20.7,2.9,9.7,1.7,2,9.3,2.9,5.3,13.8,16.5,4.3,1.5,0.8,0.1,28.3,2.6,10.4,5.4,19.7,3.9,10.2,0.2,0,9.4,1.4,0.7,0.1,9.2,0.2,0.6,10.5,2.1,1.2,2.9,10.6,0.6,4.8,1.5,13.5,0.6,27.3,1.6,8.1,6,0.7,11.1,2.4,9.5,3.1,5.2,8,8.2,1.7,5.1,7.2,0.5,6.9,0.1,1.9,9.1,5.2,0.8,0.8,0.7,1.3,0.7,0.6,0.8,1.1,0.7,0.7,0,8.2,0.8,1.6,6.3,5,4.9,40.8,1.4,1.2,0,0,0.1,3.3,2.5,22.9,4.6,0.9,23.3,30.5,0.4,5.4,1.9,3.5,109.6,6.1,0,5.8,14.7,7.6,11.8,14.4,1.8,5,0,6.1,0,18,0,7.4,0,0.3,6.5,6.2,0.5,0.4,3.1,0.1,6.4,9.8,0.9
SLC43A2,MGC34680,ENSG00000167703,Solute carrier family 43 member 2,Q8N370,17,1569267-1628886,"Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,placenta: 92.7,Group enriched,Detected in many,6,Cytotrophoblasts: 312.2;Syncytiotrophoblasts: 788.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,NA,neutrophil: 15.0,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,CACO-2: 15.5,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA021564,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA021564: AB_1857169,unprognostic (5.95e-3),unprognostic (4.45e-2),unprognostic (1.72e-1),unprognostic (2.42e-2),unprognostic (2.58e-2),unprognostic (2.80e-2),unprognostic (1.05e-2),unprognostic (5.02e-2),unprognostic (6.49e-2),unprognostic (2.80e-1),prognostic favorable (1.05e-6),unprognostic (1.96e-1),prognostic favorable (5.40e-5),unprognostic (1.84e-1),unprognostic (4.14e-2),unprognostic (1.01e-1),unprognostic (2.20e-1),5.5,2.7,5.4,13.7,5.7,12.2,3.6,14.8,11.9,2.6,2.6,5,2.1,7,2.1,4.1,1.4,5.9,3.9,1.6,5.6,7.2,15.8,3,6.8,8.3,5.1,3.8,2.3,1.6,1.5,6.2,92.7,5.8,2.8,2.4,4.9,4,3.5,23.2,1.3,11.6,4.7,3.5,8.9,2.8,1.5,1.3,5,5.8,2.2,3.5,5,1.3,1.3,3.1,15,5.4,0.5,0.3,2,0.9,2.6,0.8,7.6,1.6,1.3,10.4,0.5,0.3,1.8,0.8,15.5,1.7,4.5,5.2,0.8,0.7,1.8,4.6,0.9,0.3,0,0.4,0.8,2.3,3.9,1.9,0.1,1.4,1.6,1.4,1.1,0.5,0.2,7.3,0.5,1.9,0,0.3,3.6,9.2,0.9,0.8,2.4,0.3,2.6,0,5.3,3.5,8.9,3.1,1.6,2.3,6.3,0.2,3.4,6.3,5.4,9.5,0.2,1.1,2,0.6,0.5,9.4,2.2,0.4,0.9,0.2,2.5,5.4,5.3,0.3,4.6,0.1,1.3,0.2,0.2,3.1,1.2,0.2,0.2,15,0.5,4.5,1.7,0.2,2,5.4,5.7,14.8,11.9,5.6,7.2,5.1,3.8,5.8,1.3,14.9,40.5,18.3,5.4,4.2,22.8,2.7,15.3,21.4,22.7,34.9,23.6,312.2,16.6,21,2.9,4.5,16.2,0,6.3,29.6,10.2,7.2,11.5,1.3,81.4,19.1,10.9,16.5,88,1.9,10,84.8,0,73.9,12.2,23.6,6.4,21.6,8.5,19.3,35.8,0,5.7,3.1,3.2,3.8,788.9,3.8,10,4.2
SLC43A3,"DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1",ENSG00000134802,Solute carrier family 43 member 3,Q8NBI5,11,57406954-57427580,"Predicted intracellular proteins, Predicted membrane proteins, Transporters",NA,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,liver: 149.9;thyroid gland: 69.0,Cell type enhanced,Detected in many,5,granulocytes: 63.7;Hofbauer cells: 71.5;Sertoli cells: 64.7,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,HL-60: 71.0;HMC-1: 62.7;RPMI-8226: 80.1;WM-115: 76.4,Region enriched,Detected in many,4,olfactory region: 12.7,Low region specificity,Detected in all,NA,NA,"HPA030551, HPA077244",Approved,NA,Approved,"Nucleoplasm,Vesicles,Plasma membrane",NA,NA,NA,NA,NA,Vesicles,"Nucleoplasm, Plasma membrane","HPA030551: AB_10604094, HPA077244: AB_2732335",unprognostic (2.64e-1),unprognostic (7.63e-2),unprognostic (9.67e-3),unprognostic (7.41e-3),unprognostic (6.59e-3),unprognostic (5.30e-3),unprognostic (1.29e-1),unprognostic (4.91e-2),unprognostic (1.36e-1),unprognostic (2.26e-1),unprognostic (5.73e-2),unprognostic (3.97e-2),prognostic unfavorable (3.97e-13),unprognostic (8.16e-2),unprognostic (1.77e-1),unprognostic (8.34e-2),unprognostic (1.00e-1),32.3,6.3,2.5,12.4,4.3,18.8,16.8,2.2,3,11.9,9.6,3.6,2.4,2.7,10.1,6.5,12.6,8.9,11.4,12.5,3.1,1.5,4.2,149.9,16.5,8.8,4,1.8,16,7.2,1.2,1.8,5.1,3.4,11.6,4.2,9.4,12.2,3.1,15.4,11,6.2,10.3,4.7,11.6,6.9,6.8,2.3,10.4,69,11.5,13.8,20.3,15.4,2.7,23.6,6.1,36.8,1.1,7.8,14,40,0,2.3,0,7.8,11.5,0.1,3.1,13.3,4.6,7.9,0,8.8,23.1,1.4,7.3,2.4,23.1,6.7,4.1,9.3,0.1,0,36,13.7,0,15.9,71,62.7,34.5,0.1,44.6,0.5,3.3,12.9,10.7,41.1,22.4,17.8,0,14.9,45.6,3.5,0,0.7,30.9,0.4,80.1,11,0,5.5,0,8.8,0.2,37.4,0.2,3.4,10.8,6.8,0.2,12,30.4,8.7,0,0.1,5.8,27.5,25.8,76.4,3.2,28.8,6.1,5.7,34.5,6.5,2.7,4,7.8,23.6,2,3.1,3.2,2.5,1.1,36.8,23.6,6.9,14,2.5,4.3,2.2,3,3.1,1.5,4,1.8,3.4,2.3,14.9,41.4,4.5,6.7,41.6,0.5,2.8,30.6,5.3,34.2,1.8,0,0.5,0,47,1,23.3,0,0,5.5,2.2,20.2,3.4,63.7,53.8,71.5,0,0,11.6,17.3,1.4,9.2,55.1,28.7,0,0.5,0.9,10.9,0,11.7,0,0,64.7,18.4,1,0.2,15.4,0.7,15,0.6,2.5
SLC45A2,"AIM-1, MATP, OCA4",ENSG00000164175,Solute carrier family 45 member 2,Q9UMX9,5,33944616-33984730,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Melanin biosynthesis, Sensory transduction, Vision",NA,"Albinism, Disease mutation",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,9,retina: 39.9,Cell type enhanced,Detected in some,31,Early spermatids: 2.4;Late spermatids: 3.1;Melanocytes: 11.8,Cancer enriched,Detected in some,18,melanoma: 47.6,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in some,27,SK-MEL-30: 37.6,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (2.97e-1),unprognostic (3.99e-2),unprognostic (3.55e-1),unprognostic (2.39e-2),unprognostic (2.36e-2),unprognostic (1.09e-1),unprognostic (8.45e-2),unprognostic (5.34e-3),unprognostic (4.06e-2),unprognostic (8.45e-2),unprognostic (7.39e-4),unprognostic (1.40e-2),unprognostic (1.84e-3),unprognostic (1.55e-1),unprognostic (1.50e-3),unprognostic (2.48e-2),unprognostic (3.39e-1),0.2,0,0.3,0.2,0.4,0,0.2,0.7,0.4,0.2,1.1,0.2,0.2,0,0.5,0.2,0.2,0.4,0.3,1.5,0.4,0.6,0.8,3.1,0.2,0.2,0.3,0.2,0.2,0.2,0,0.2,0.2,0.2,0.8,1.2,39.9,0.2,0.2,0.4,4.5,0.2,0.3,0.4,0.2,0.6,2.8,0.2,0.2,0.2,0.2,0.2,0.3,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,1.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.1,0.1,0,0,37.6,0,0,0.2,0,0,0,0,0,0.4,0.9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0.4,0.7,0.4,0.4,0.6,0.3,0.2,0.2,0.2,0,0,0,0,0.6,0.6,0.4,0,0,0,0,0,0,0,0,2.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.1,0,0,11.8,0,0,0,0.1,0,0,0,0,0,0,0,0.2,0.4,0,0,0,0
SLC45A1,DNB5,ENSG00000162426,Solute carrier family 45 member 1,Q9Y2W3,1,8317826-8344167,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Sugar transport, Symport, Transport",NA,"Disease mutation, Epilepsy, Mental retardation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 24.0,Cell type enhanced,Detected in some,7,Bipolar cells: 6.7;Horizontal cells: 9.5;Muller glia cells: 5.7;Peritubular cells: 5.3;Sertoli cells: 6.5,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in some,NA,non-classical monocyte: 7.1,Group enriched,Detected in many,7,monocytes: 7.1;T-cells: 1.8,Cell line enhanced,Detected in some,NA,ASC diff: 5.9;GAMG: 4.2;HHSteC: 7.8;U-87 MG: 10.1,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA078818,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA078818:,unprognostic (1.77e-3),unprognostic (1.37e-2),unprognostic (4.32e-3),unprognostic (8.32e-2),unprognostic (3.22e-3),unprognostic (1.56e-1),unprognostic (4.96e-2),unprognostic (2.09e-1),unprognostic (1.20e-1),unprognostic (1.43e-1),unprognostic (1.39e-3),unprognostic (3.18e-1),unprognostic (5.67e-2),unprognostic (8.53e-3),unprognostic (2.16e-1),unprognostic (1.70e-1),unprognostic (2.51e-3),5,6.6,8.5,2.4,15.3,1.1,2.6,13.8,24,6,4.4,5.4,2.1,2.5,6.8,3.6,3.9,5.2,4.3,3.1,6,7.9,4.3,1.1,2,2.1,6.1,12.4,4.4,4.1,4.1,8.1,1.9,13.1,4.9,2.2,3.2,1.5,7.7,4,1.7,2.8,4.3,4.6,4.4,2.6,3.8,4.6,0,2.4,0.8,1.5,3.6,3.3,0.6,0.2,0,7.1,0,1.8,0.7,0,2.7,0.5,1.1,5.9,3.9,0.1,0.2,1.2,0.4,0.8,0,0.4,0,0.2,0.8,4.2,0,0.1,0.3,0.1,2.3,0,0,0.2,0,7.8,0,2.2,2,0.2,0.9,0,1.4,0.6,0.6,0,0,1.4,0,0,0,1.3,0,1.7,0,1.2,0,0,0,2,2.8,0,0,0,0.2,0.2,0,2.5,0.1,0.5,2.3,0.4,0,0,0,10.1,0,0.1,0,0.2,0,1.3,1.3,1.8,0.6,0.9,0.9,0.2,0.1,0.6,0.6,0,0,7.1,0,0.6,0.7,8.5,15.3,13.8,24,6,7.9,6.1,12.4,13.1,4.6,0,0,0.5,1.2,0.3,6.7,0.8,0,0,0,1.8,3.9,0,0,0.5,1.9,0.9,0,0,0.2,0,0.9,1,0,0,0.1,9.5,0,1.3,0,4,3.1,0,0,0,0,5.7,0.1,0,5.3,0.6,4.4,6.5,2.9,0.2,0,0.3,0,0,0,0.3
SLC45A3,"IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein",ENSG00000158715,Solute carrier family 45 member 3,Q96JT2,1,205657851-205680459,"Cancer-related genes, Predicted membrane proteins, Transporters",Transport,NA,Cancer-related genes,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,5,prostate: 115.0,Group enriched,Detected in many,11,Glandular cells: 50.8;granulocytes: 117.6,Cancer enriched,Detected in all,49,prostate cancer: 539.9,Low region specificity,Detected in many,NA,NA,Cell type enriched,Detected in single,226,basophil: 22.6,Lineage enriched,Detected in single,226,granulocytes: 22.6,Cell line enriched,Detected in some,30,HMC-1: 141.5,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in many,NA,NA,"HPA019073, HPA019075",Enhanced,NA,Approved,"Nucleoplasm,Vesicles",NA,NA,NA,NA,NA,Vesicles,Nucleoplasm,"HPA019073: AB_1857177, HPA019075: AB_1857179",unprognostic (1.80e-1),unprognostic (1.08e-3),unprognostic (3.13e-2),prognostic unfavorable (4.04e-5),unprognostic (6.93e-2),unprognostic (2.36e-2),unprognostic (1.15e-1),unprognostic (1.50e-1),unprognostic (1.84e-1),unprognostic (1.10e-1),unprognostic (2.90e-2),unprognostic (1.18e-1),unprognostic (3.03e-2),unprognostic (3.16e-1),unprognostic (1.55e-1),unprognostic (1.96e-1),prognostic favorable (7.33e-5),0.8,1.5,2.5,1.5,6.2,0.7,0.8,0.4,5.8,1.9,2.1,19,0,2.1,0.9,0.6,0.9,1.1,1.8,0.7,4.2,2,1.1,4,1.7,1.6,13.2,1.6,1,0.7,0.5,1.9,0.6,7.2,115,1.6,0.2,0.9,0.7,2.2,0.9,2.1,0.8,12.4,5,6.4,1.4,11.1,0,0.5,0.7,0.7,1.5,0.4,0,0,22.6,0,0,0,0.2,1.5,0.5,0.4,0.4,0,0,0.3,0.2,0,0.5,0.4,1.1,2.9,0.4,0.7,0,0.5,0.5,0.2,0.5,0,0.6,0.4,4.7,0.1,0.3,0.3,0.8,141.5,0,0.1,0.3,0,0.3,1.6,0.7,0.7,0.2,0.2,0.3,0.1,1.3,2,2.7,1.7,0.1,0.7,0.2,0.6,2.2,0.2,0.5,0.2,3.5,0.6,0.4,0.8,0.2,1.5,0.2,1.6,0.5,1.1,0,0.1,0,0.3,0.2,1.1,22.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,2.5,6.2,0.4,5.8,4.2,2,13.2,1.6,7.2,11.1,0,5.6,1.3,1.1,0,0.2,1.7,5.1,2.7,1.2,1.8,0,0.4,0,1.8,0.1,0.6,3.4,0,0.5,0.1,0.6,50.8,117.6,4.9,2,0,0,0,0.6,0,1.7,0.9,0,1,7.4,0.2,2.4,7,1.4,1.8,0,6.5,1,0,1.5,0.1,0,0,4.4,0.8
SLC45A4,KIAA1126,ENSG00000022567,Solute carrier family 45 member 4,Q5BKX6,8,141207166-141308305,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,7,Bipolar cells: 32.9;Collecting duct cells: 47.1;Cone photoreceptor cells: 51.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in some,7,eosinophil: 9.4;neutrophil: 8.6,Lineage enriched,Detected in single,19,granulocytes: 9.4,Cell line enhanced,Detected in many,NA,HMC-1: 15.6;OE19: 23.2,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA023154,Uncertain,NA,Approved,Plasma membrane,NA,NA,NA,NA,NA,Plasma membrane,NA,HPA023154: AB_2191204,unprognostic (7.79e-3),unprognostic (1.06e-1),unprognostic (4.30e-2),unprognostic (1.44e-1),unprognostic (6.06e-2),unprognostic (3.96e-2),unprognostic (1.26e-1),unprognostic (4.49e-3),unprognostic (1.02e-1),unprognostic (5.31e-2),unprognostic (2.12e-1),unprognostic (1.84e-1),prognostic favorable (1.73e-6),unprognostic (8.79e-3),unprognostic (1.13e-1),unprognostic (1.77e-2),unprognostic (2.40e-2),5.6,3.9,6.9,7.6,7,10.2,4.3,10,19.1,14.2,6.6,2.7,8.5,5.4,6.7,8.9,5,11.6,6.9,9.3,8.2,5.9,12.2,1.6,10.1,7.6,5.1,8.4,5,14.2,5.4,20.6,17.8,11.5,9.5,3.9,11.4,15.6,16.3,6.4,7.4,6,4.3,3,6.8,24.4,28.5,2.9,6.6,8.7,1.8,6.4,7.8,4.4,0,0.4,9.4,0.1,0.2,0.5,0.1,3.7,8.6,3.1,4.9,0.2,0.2,13.8,2.1,1.3,1.9,1.5,5.4,10,0.8,9.4,0.8,2.7,3.1,1.7,1,0.9,5.9,2.5,2.4,2.5,0,1.5,0.9,15.6,0.7,1.4,1.5,0.8,0.4,1.3,4,4.6,0.6,0.5,9.2,8.4,1.9,4.1,23.2,3.5,2.6,0.2,2.4,6.8,6.8,4.9,3.9,2.3,0.8,3.6,2.2,1.6,5.6,0.7,0,2.1,3.3,4.1,3.1,9.9,1,1.9,3.7,3.6,1.3,0.1,9.4,0.2,0.1,0.2,0,0.2,0.5,0.1,0,0.2,0.2,8.6,0.2,0.1,0.4,0.2,0.1,6.9,7,10,19.1,8.2,5.9,5.1,8.4,11.5,2.9,8.9,10.1,0,5.7,2.4,32.9,11.1,10.2,17.4,6.8,47.1,51.1,7.1,0,6.2,9.5,1.4,9.5,0,2.4,0.6,2,6,1.1,0,5.6,3.2,2.4,0.6,2.7,4.1,2,2.7,3.3,0,6.3,2.8,5.6,5.8,2.1,3.3,9.3,0,2.1,4.2,1.9,2,13.6,1.5,3.3,9.5
SLC46A1,"HCP1, MGC9564, PCFT",ENSG00000076351,Solute carrier family 46 member 1,Q96NT5,17,28394756-28407197,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters",Transport,NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,intestine: 52.7,Cell type enhanced,Detected in many,5,Bipolar cells: 25.6;Hepatocytes: 24.9;Hofbauer cells: 21.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enriched,Detected in many,5,CACO-2: 67.6,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,CAB011614,Approved,NA,Supported,"Plasma membrane,Cytosol",NA,NA,NA,NA,NA,"Plasma membrane, Cytosol",NA,CAB011614: AB_2270597,unprognostic (1.10e-1),unprognostic (8.62e-2),unprognostic (1.40e-1),unprognostic (7.59e-2),prognostic unfavorable (5.62e-4),unprognostic (9.11e-2),unprognostic (4.05e-2),unprognostic (1.36e-2),unprognostic (1.94e-1),unprognostic (3.80e-2),unprognostic (1.04e-3),unprognostic (6.15e-2),unprognostic (2.10e-3),unprognostic (2.16e-1),unprognostic (2.94e-1),unprognostic (2.15e-1),unprognostic (1.04e-1),3.1,17.8,4.6,2.5,7,1.3,5.1,13.2,5.2,2.9,43.8,5.2,9.4,45.4,2.2,4.5,1.8,6.7,3,2.2,4.4,6,3.8,17.9,3.2,4.9,4,4,4.4,5,8.1,7.8,5,5,3.7,2.7,6.1,5.7,5.8,2,2,52.7,2.6,4.6,4.9,2.3,2.2,4.2,2.2,4,0.4,1.2,2.4,2.4,2.7,2.6,7.1,5.9,2.9,1.7,0.8,1.7,7.4,2.5,4.1,2,0.4,7.8,2.1,1.5,1.7,2,67.6,2.1,0.2,1.2,1.1,5,5.8,2.8,4.7,1.5,4.3,6.6,0,4.6,5.7,0.7,0,3.4,1,8.7,1.8,5.4,2.4,0.1,0.6,2.8,0.4,0.3,2.3,0,0.2,1.5,1.7,1,0.1,2,0.8,1.3,3.9,6.6,3.5,14.5,6.8,0.9,3.6,5.3,1.1,0.2,0.2,3,0.4,2.2,3.1,3.5,0.1,0.4,0.4,1.6,7.1,1.6,1.1,0.8,5.9,1.4,2.7,0.9,0.7,2.6,1.7,1,1.7,2.3,2.9,4.3,1.1,1.6,0.8,4.6,7,13.2,5.2,4.4,6,4,4,5,4.2,11.9,4,3.2,1.9,0.3,25.6,1.8,15.3,4,1.2,7,3.9,16.6,0,2.8,3.4,1,1.3,0,3.9,7.3,3.1,2.2,1.1,24.9,21.1,19.1,1.2,2.5,13,13.5,3.7,3.9,0,1,2.1,1.6,3.5,0.9,3.2,4.1,5.6,6.5,1,0,0.2,0.3,3.7,0,1.2,1.4
SLC46A2,"Ly110, TSCOT",ENSG00000119457,Solute carrier family 46 member 2,Q9BY10,9,112878920-112890913,"Predicted membrane proteins, Transporters",Transport,NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enhanced,Detected in many,NA,ductus deferens: 21.1;lymphoid tissue: 31.8;skin 1: 22.3,Group enriched,Detected in some,7,Alveolar cells type 2: 35.7;Kupffer cells: 13.2,Cancer enhanced,Detected in some,NA,lung cancer: 1.4,Low region specificity,Detected in single,NA,NA,Cell type enhanced,Detected in some,NA,classical monocyte: 17.0;intermediate monocyte: 8.7,Lineage enriched,Detected in many,4,monocytes: 17.0,Cell line enhanced,Detected in some,NA,U-138 MG: 1.1;U-2197: 1.1,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,HPA020098,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA020098: AB_2670363,unprognostic (1.26e-1),unprognostic (5.15e-3),unprognostic (1.10e-2),unprognostic (1.53e-3),unprognostic (3.57e-3),unprognostic (2.10e-2),unprognostic (4.56e-1),unprognostic (2.18e-1),unprognostic (8.10e-2),unprognostic (1.50e-3),unprognostic (3.50e-1),unprognostic (1.38e-1),unprognostic (1.77e-2),unprognostic (2.37e-1),unprognostic (2.71e-2),unprognostic (1.83e-1),unprognostic (7.82e-2),0.2,0.1,0.1,0.5,0.1,0,1,1.1,0.5,17.7,0.1,0,21.1,0,3.6,10.4,1.4,0.1,0.3,0.1,0.1,0.3,0.2,0.2,17.1,1.9,0.1,0.2,0.1,0.2,0,0.1,0.2,0,0.8,0,0.1,0.4,9.9,0.1,22.3,0.2,0.6,0.2,1,0.1,1.5,0,31.8,0.1,0,0.3,5.4,0.7,0,3.8,0.2,17,0,0,4.1,0,0,0,0,0,0,0.6,0,0,0.2,0,0,0,0.3,0.1,0,0,0.1,0,0,0,0,0.3,0,0,0,0,0,0.6,0,0,0,0,0.5,0,0,0,0.4,0,0,0,0.1,0,0,0,0,0.3,0,0,0.5,0.1,0,0,0.7,0.2,0.1,0.2,0,0,1.1,0,1.1,0.2,0.2,0.3,0,0,0,0,0,17,0,0,8.7,0,0,0,0,3.8,0,0,0,0.2,0,6.5,0.1,0,4.1,0.1,0.1,1.1,0.5,0.1,0.3,0.1,0.2,0,0,0,35.7,0,0,0,0,0.4,2.5,1.4,2.3,0,0,0,0,0,2.9,0,0,0,0,0,0,0,0,0,2.2,0,0,0.6,13.2,1.6,0,3.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1
SLC46A3,"DKFZp686A1775, FLJ42613",ENSG00000139508,Solute carrier family 46 member 3,Q7Z3Q1,13,28700064-28718970,"Predicted membrane proteins, Transporters",NA,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,intestine: 62.9;liver: 50.0,Cell type enhanced,Detected in many,7,Enterocytes: 58.8;Hepatocytes: 50.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,RPTEC TERT1: 20.5;T-47d: 15.0,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA039930,Approved,NA,Approved,"Plasma membrane,Actin filaments,Cytosol",NA,NA,NA,NA,NA,"Plasma membrane, Cytosol",Actin filaments,HPA039930: AB_10673263,unprognostic (5.16e-2),unprognostic (1.01e-1),unprognostic (1.15e-1),unprognostic (2.61e-1),unprognostic (3.88e-1),unprognostic (1.22e-1),unprognostic (4.53e-3),prognostic favorable (7.09e-4),unprognostic (3.13e-1),unprognostic (3.33e-1),unprognostic (1.26e-1),unprognostic (5.69e-2),unprognostic (7.35e-2),unprognostic (1.14e-1),unprognostic (5.60e-2),unprognostic (9.14e-3),unprognostic (6.47e-3),6.9,14.2,3.8,5.9,5.7,1.4,6.4,7.6,6.5,8.3,19.6,6.9,2.8,24,5.2,7.4,3.1,4.1,12.7,8.1,4.2,4.2,10.4,50,6,11.4,4.7,3.9,5,5.5,4.2,18.2,5,6.6,5.3,10.1,17.4,10.3,5.6,8.2,4,62.9,4.5,5.1,11.6,4.8,9.3,3.7,11.8,6.8,3,6.9,6.1,4.7,9.1,10.4,22.6,15.9,5.6,11.2,7.4,0,2,0,5.5,4.5,1.8,0.1,2,11.1,2.2,3.2,0.1,4.7,3.8,3.7,2.8,8.4,0.4,2.5,1,3.3,2.8,4.9,2.5,0,0,8.4,0,3.3,7.2,2.1,3.3,5.4,2.2,4,11.3,2.7,0,10.5,2,6.2,0.4,0.2,5.6,1.7,2.6,9.9,0.1,20.5,0.6,0.9,0.3,0,10.2,4,2.4,15,3.3,1.5,1.1,2.1,0.3,11.7,3.1,1.5,0.5,0.6,0,2,22.6,8,3,9.8,11.5,8.4,6.6,7.9,9.6,10.4,9.1,11.2,10.6,8.2,5.6,15.9,9.7,9.2,7.4,3.8,5.7,7.6,6.5,4.2,4.2,4.7,3.9,6.6,3.7,0,4.8,5.1,0,1.6,22,7.7,17.8,10.7,1.2,8.7,7.9,0.5,1.7,11.8,3,8.9,58.8,0,4.9,0.2,5.4,0.6,24.4,50.6,9.7,20.6,3.5,19.6,25.4,1.7,1.4,14.5,6.8,4.6,7,14.1,3.8,5.8,2.1,8.4,9.5,0,2.8,2.3,0.5,1.5,0.6,10,10,0.1
SLC4A4,"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5",ENSG00000080493,Solute carrier family 4 member 4,Q9Y6R1,4,71186757-71572087,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Symport, Transport",NA,"Disease mutation, Retinitis pigmentosa",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,kidney: 47.4;pancreas: 113.8,Cell type enhanced,Detected in many,9,Cholangiocytes: 107.0;Ductal cells: 81.5;Enterocytes: 173.4;Proximal tubular cells: 149.5,Group enriched,Detected in many,5,glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in some,NA,gdT-cell: 2.8;memory CD8 T-cell: 2.4,Lineage enriched,Detected in single,5,T-cells: 2.8,Cell line enhanced,Detected in some,NA,BJ: 13.9;fHDF/TERT166: 6.3;hTERT-RPE1: 6.0;RPTEC TERT1: 14.9;U-138 MG: 7.9,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"CAB022493, HPA035628, HPA035629, HPA079220",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220:",unprognostic (3.92e-2),unprognostic (1.63e-1),prognostic favorable (7.69e-4),unprognostic (5.32e-2),unprognostic (1.01e-1),unprognostic (5.09e-2),unprognostic (4.24e-2),unprognostic (7.49e-2),unprognostic (1.46e-1),unprognostic (9.22e-3),unprognostic (1.04e-1),unprognostic (1.74e-1),prognostic favorable (1.18e-4),unprognostic (7.00e-2),unprognostic (2.92e-1),unprognostic (2.05e-3),unprognostic (2.04e-1),2.4,0.9,14.3,4.3,19.9,0.7,1.1,18.1,15.2,5.8,17.2,4.5,0.1,22.4,0.8,0.7,1.1,1,24.9,2.9,13.1,8.1,47.4,9.4,5.8,0.6,9.7,11.2,1,113.8,10,4.1,1.6,18.1,14.6,17.1,11.1,1.5,1.1,1.3,0.7,10.4,1.3,21.6,0.9,8.3,0.7,8,0,9.5,0,0.6,2.6,0.9,0,0.1,0,0,0.5,2.8,0.3,0,3.6,1,0,0,0,0.1,13.9,1.9,2.3,1.8,0,0.1,0,0.1,6.3,0.6,0,0.2,0,5.7,0,1.8,0.9,0,0,0.4,0,0,0.3,0,0,0,6,0,0.9,0,0.6,1.2,0,4.7,0.2,0.1,0.2,0,0,0,0.9,14.9,4.2,1,0.1,0,0,0.2,1.2,0,0,0,7.9,0.7,5.7,0.6,0,0,0,5,0,0.2,0,0,0,2.8,0,1.4,0,0.8,2.4,0.1,0,0,1,0,0.5,0,0,0,0.3,14.3,19.9,18.1,12.4,13.1,8.1,9.7,11.2,18.1,8,3,32.5,1.3,4.2,0,0,20.1,107,14.7,31.8,24.4,0,0.2,13.3,81.5,6.6,1.9,173.4,0,21.6,0.1,1.1,63.3,1.1,31.7,0.2,0,8.2,1.8,0.6,1,0,1,1.7,1.8,66.7,3.3,19.9,56.6,0,149.5,1.1,6.5,2.5,0.1,0.4,0,0.2,6.9,42.6,7
SLC4A7,"NBC3, SBC2, SLC4A6",ENSG00000033867,Solute carrier family 4 member 7,Q9Y6M7,3,27372721-27484420,"Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,intestine: 48.5,Group enriched,Detected in many,10,Cone photoreceptor cells: 691.1;Rod photoreceptor cells: 667.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,hTERT-HME1: 38.2,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,"CAB022494, HPA035857",Enhanced,NA,Supported,"Plasma membrane,Focal adhesion sites,Cytosol",NA,NA,NA,NA,NA,Plasma membrane,"Focal adhesion sites, Cytosol","CAB022494: , HPA035857: AB_10795135",unprognostic (2.94e-2),unprognostic (6.34e-2),unprognostic (1.80e-3),unprognostic (1.91e-1),unprognostic (8.48e-3),unprognostic (2.68e-1),unprognostic (6.79e-4),unprognostic (4.13e-2),unprognostic (1.40e-1),unprognostic (1.64e-1),unprognostic (1.83e-1),unprognostic (8.58e-3),prognostic unfavorable (7.91e-6),unprognostic (1.09e-2),unprognostic (6.68e-2),unprognostic (1.93e-1),unprognostic (7.26e-2),14.5,5,3.2,10.5,4.6,3.3,17,4,4.8,10.8,38.2,5,8.8,48.5,8.1,12.6,8.4,6.5,12.5,9.3,5,3.8,15.3,3.7,9.3,10.3,4.8,1.9,9,3.3,2.4,4.4,5.6,4.5,10.3,6.9,20,8.3,8.4,5.6,5.6,43.4,18.2,5.8,9.7,7.8,6.1,5.5,6.8,6.3,14.7,15.5,15,14.9,1.8,2,0.1,0.9,2.4,3.9,0.7,5.9,11.1,10,4.6,4.7,8.4,7.1,20.2,9.4,7.8,6.1,3,3.1,13.5,1.7,7.8,7.5,2.6,9.5,9.8,12.4,11.4,3.1,6.2,7.6,3.2,8.1,14,5.4,6.7,4.3,11.8,38.2,16.5,12.8,8.9,4.1,4.8,16,2.1,13.9,3.2,6.6,0.7,11,9.5,7.9,2.7,18.3,4.2,2.5,6.3,9.2,6.8,3.1,8.9,15.5,5.4,8.9,18.4,5.1,12.7,15.6,1.8,1.9,7.7,16.1,9.9,8.4,0,0.5,0,3,0.6,2,1.2,3.8,3.9,1.4,1.8,1.5,2.7,0.1,2.4,0.9,2,3.2,0.7,3.2,4.6,4,4.8,5,3.8,4.8,1.9,4.5,5.5,0,12.8,13.2,28.2,26.1,65.7,18.7,15.3,5.3,25,59.3,691.1,4.5,8.3,13.6,6.7,25.3,5.8,0,6.2,23,30.2,41.3,23.1,5.9,16.9,6.4,36.7,14.7,33.1,5.9,8.3,36.7,33.7,20.8,50.6,45.2,13.6,12.7,9.2,10.5,667.4,38.8,32.8,32.4,21.7,26.8,6.8,33,12.2,33.6
SLC4A1,"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR",ENSG00000004939,Solute carrier family 4 member 1 (Diego blood group),P02730,17,44248385-44268141,"Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Anion exchange, Ion transport, Transport",Blood group antigen,"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,bone marrow: 95.7;placenta: 32.7,Cell type enriched,Detected in some,66,Erythroid cells: 1261.4,Cancer enriched,Detected in single,91,renal cancer: 16.3,Not detected,Not detected,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,Region enhanced,Detected in single,NA,cerebellum: 0.4,Low region specificity,Detected in all,NA,NA,"HPA015584, CAB034438, HPA063911",Enhanced,NA,NA,NA,NA,NA,NA,NA,160000000,NA,NA,"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151",unprognostic (1.36e-1),unprognostic (1.42e-1),unprognostic (3.36e-1),unprognostic (2.44e-2),unprognostic (2.32e-2),unprognostic (1.56e-2),unprognostic (1.55e-1),unprognostic (1.59e-1),unprognostic (1.68e-1),unprognostic (1.58e-1),unprognostic (6.72e-3),unprognostic (1.19e-1),unprognostic (9.28e-3),unprognostic (1.93e-2),unprognostic (2.18e-1),unprognostic (1.94e-1),unprognostic (2.13e-1),0.9,0.1,0.3,0.2,0.4,95.7,0.2,0.8,0.2,0.1,0.1,0.6,0,0.2,0.1,0.4,0.6,0.2,0.2,2.6,0.2,0.3,18.6,1.3,12.9,0.8,0.6,0.1,2.8,0.1,0,0.6,32.7,0.9,0.6,0.1,1.2,0.1,0.1,1.2,0.2,0.1,0,1,8.4,0.1,0.3,0,0.7,1.9,0,0.2,3.9,11.8,1.8,1.4,6.3,1.2,2.9,1.5,0.7,1.3,0.5,1.4,1.7,0.6,0.7,1,0.3,0.4,0.3,0.8,1.4,3.2,0.7,0.6,0.3,0.4,1.4,0.5,0.5,1.1,1.3,1.3,1.7,1.6,2.2,0,0.8,2.3,0.8,0.5,0.8,0.8,0.5,0.2,0.6,4.8,3.5,0.4,0.6,1,3.5,0.9,0.7,0.5,2.5,0.7,1.9,0.3,0.8,2.2,1,1.3,1.4,0.5,0.7,2.5,1.8,1,2.4,2.1,1.4,1.4,1,2.3,1.1,1.6,2.2,1.1,6.1,1,2,1.1,0.9,1,1.1,1,0.9,0.5,1.8,1.5,1.2,6.3,2.9,1.2,1.4,0.7,0.7,0.3,0.4,0.8,0.2,0.2,0.3,0.6,0.1,0.9,0,6,1.1,0,0.9,0,0.4,0.7,0,0,1.2,19.2,0,0.3,3.3,0,0.5,0,0,1261.4,0,0.9,0.3,0.4,0,0,1.3,0,0,0.6,0.3,0,0,0,0,0,0,0.2,0,0,0.4,0.2,0,0,0.2,0.9,0.4,0,0.7,0,0,0.5
SLC4A10,"NBCn2, NCBE",ENSG00000144290,Solute carrier family 4 member 10,Q6U841,2,161424332-161985282,"Predicted membrane proteins, Transporters","Antiport, Ion transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in many,9,blood: 31.2;brain: 48.1,Cell type enriched,Detected in some,12,Bipolar cells: 116.7,Cancer enhanced,Detected in single,NA,glioma: 1.3,Low region specificity,Detected in all,NA,NA,Cell type enriched,Detected in some,8,MAIT T-cell: 31.2,Lineage enriched,Detected in single,78,T-cells: 31.2,Cell line enriched,Detected in some,11,Karpas-707: 14.0,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA034755, HPA076725",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA034755: AB_10670296, HPA076725:",unprognostic (4.64e-4),unprognostic (3.88e-1),unprognostic (2.88e-2),unprognostic (3.65e-2),unprognostic (1.19e-2),unprognostic (7.89e-3),unprognostic (5.99e-4),unprognostic (1.12e-1),unprognostic (2.27e-1),unprognostic (1.64e-1),unprognostic (2.50e-2),unprognostic (9.27e-2),unprognostic (5.65e-2),unprognostic (9.23e-3),unprognostic (1.87e-1),unprognostic (2.10e-3),unprognostic (2.26e-1),1,3.7,21.6,1.9,24.1,1.2,1.3,14.9,48.1,1.1,3.3,2.1,0,1.4,1,2.8,1,1.8,1.5,1,20.4,10.8,1,1.3,1.1,1.1,4.3,29.6,1,2.9,1,4.4,1,17.7,1.3,2.7,1.7,1,1.1,1,1,1.5,1.1,1.9,3,1.3,1.4,3.5,0,1,0,1.5,1.3,0.3,0,0,0,0,0.4,31.2,0.2,0,0,0,0,0,0,0,0,1.2,0,0.1,0,0.9,0.1,0,0,0,0,0,0,0.1,0.4,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,14,0.2,0.2,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0.1,0.1,0,0,0,0,0,0.5,0,0.1,0,0,0,1.2,0,31.2,0,0.6,3.8,0,0,0,0,0,0.4,0,0,0,0.2,21.6,24.1,14.9,37.9,20.4,10.8,4.3,29.6,17.7,3.5,0,0,0,0,0,116.7,0.4,0,0,0,0,7.9,0,0,0,9.6,0,0,0,0,0,0,0,2.3,0.6,0,0,0,1.8,1.2,8.4,0,0,0,0,2.2,2.4,0.1,0,0,0,6.7,0,0,0.9,0.2,0,0,4.4,0,0
SLC4A11,"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1",ENSG00000088836,Solute carrier family 4 member 11,Q8NBS3,20,3227417-3239559,"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Anion exchange, Ion transport, Symport, Transport",NA,"Corneal dystrophy, Deafness, Disease mutation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,salivary gland: 34.4;thyroid gland: 42.7,Cell type enriched,Detected in some,4,Collecting duct cells: 106.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in many,NA,NA,Cell type enhanced,Detected in some,NA,non-classical monocyte: 1.4;T-reg: 1.1,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,HaCaT: 36.0;Hep G2: 21.0,Low region specificity,Detected in single,NA,NA,Low region specificity,Detected in single,NA,NA,"HPA018120, HPA058377",Uncertain,NA,Uncertain,"Nucleoplasm,Vesicles",NA,NA,NA,NA,NA,Nucleoplasm,Vesicles,"HPA018120: AB_1857186, HPA058377:",unprognostic (2.33e-1),prognostic favorable (9.03e-4),unprognostic (1.18e-2),unprognostic (3.05e-2),unprognostic (1.00e-1),unprognostic (6.52e-2),unprognostic (9.66e-3),unprognostic (3.73e-2),unprognostic (3.10e-3),unprognostic (1.52e-3),unprognostic (2.94e-1),unprognostic (2.64e-1),prognostic favorable (6.21e-6),unprognostic (7.37e-2),unprognostic (4.30e-1),unprognostic (2.33e-1),unprognostic (6.89e-3),0.8,3.1,3.3,0.8,4.9,0.3,2.4,2.1,2.8,8.6,0.2,1.3,0.8,0.1,0.9,2,7.5,1.1,2.2,0.5,3,0.6,11.4,0.1,1.3,0.9,1.4,1.1,0.6,0.1,0.4,2.4,0.3,1.8,2.2,0.3,1.1,34.4,5.8,3.5,5.3,0.3,0.2,1.4,0.3,1.9,3.2,1.2,0.2,42.7,3.3,5.1,2.6,2.1,0,0.7,0,1.4,0,1.1,0.4,5.4,7.8,0.9,4.1,2.7,0.7,11.1,2.7,1.7,1.4,0.8,0.5,7.2,0,3.2,0.9,3.4,36,4.2,8.5,0.2,0,1.7,0.3,3.4,21,1.7,1.9,7,0.3,3.5,1.7,1.6,1.2,3.6,5,0.7,5,1.4,3.5,0.2,0.2,6.2,6.7,10.6,1.2,5.3,1.7,8.7,15.3,0.4,2.5,1.4,9,0.2,2.9,3.4,3.4,6.1,1.1,3.7,0.2,1.3,0.2,0.3,0,0,1.3,0.5,0,0,0,0,0,0.1,0,0,0.5,0.7,0,0.3,0,0,0,1.4,0,1.1,0.4,3.3,4.9,2.1,2.8,3,0.6,1.4,1.1,1.8,1.2,0,0,0,1.7,0.7,0.1,1.2,0,5.3,2.3,106.4,0,0,0,0.7,3.5,0.3,0,0,0.4,0.1,0.3,2,0,0,0.3,0,0,1.8,0.3,1.5,0,0,0,1,0.1,0,2.2,0.6,0.4,0.3,0,25.8,0.5,0.6,5.2,0.4,0,0,0,2.6
SLC4A1AP,"HLC3, kanadaptin",ENSG00000163798,Solute carrier family 4 member 1 adaptor protein,Q9BWU0,2,27663471-27694976,"Predicted intracellular proteins, Transporters",NA,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,6,Spermatocytes: 127.5,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA036679,Approved,NA,Supported,"Nucleoplasm,Vesicles,Plasma membrane",NA,NA,NA,NA,NA,Nucleoplasm,"Vesicles, Plasma membrane",HPA036679: AB_2675244,unprognostic (5.63e-2),unprognostic (1.01e-1),unprognostic (4.62e-2),prognostic unfavorable (1.49e-4),unprognostic (2.21e-1),unprognostic (7.89e-3),prognostic unfavorable (3.76e-7),unprognostic (1.32e-1),unprognostic (7.74e-2),unprognostic (1.83e-2),unprognostic (1.06e-1),unprognostic (9.66e-2),unprognostic (9.68e-2),unprognostic (2.29e-2),unprognostic (1.42e-1),unprognostic (2.40e-2),prognostic unfavorable (1.79e-4),12.3,16.1,18.8,14.2,27,12.7,13.9,27.4,29,11.5,11.3,15.8,8.7,11.6,12.8,12.2,14.2,12.3,9.8,18.6,17.9,19.6,15.3,15,12.8,14.6,17,20.5,15.2,13.3,23.8,16,14.5,29.1,12.6,12.3,9,12.4,12.1,26,15.1,12,12.5,15.4,13.1,12.5,29.9,16.8,16.1,14.6,14.9,15.1,11.1,11,16.7,13.3,40.8,17.9,22.5,19.5,14.1,22,12.9,13,12.1,13.4,12.4,19.1,18.4,12.7,19.4,15.9,18.8,16.2,14,17.1,14.7,20.5,15.8,20.8,14.2,17.4,19.4,17,16.1,13.5,20.6,16.4,22.9,15.4,11.1,18.1,19.3,18.3,16.3,19.7,13.8,23.2,15.3,17.8,13.4,15.4,22.5,13.1,14.6,12.7,12.8,28.5,16.1,19.9,10.3,14.2,14,14.3,19.6,17.6,13.8,11.8,15.1,19.9,18.1,16.4,12.5,21.4,25.3,35.7,44.8,19.6,18.5,14.4,40.8,17.7,24.2,17.6,16.9,17.4,13.5,16.1,15.3,13.3,16.7,19.5,16.5,16.5,22.5,17.9,10.7,17.1,14.1,18.8,27,27.4,29,17.9,19.6,17,20.5,29.1,16.8,29.8,21.6,5.2,11.5,10.5,20.1,26,12.7,22.7,29.6,17.4,17.7,21.1,5,23.4,23.8,18.3,9.7,0,31.5,17,12.3,7.8,37,14,21.3,23.8,15.6,12.9,15.8,3.1,16.1,13.3,16.9,27.1,10.6,21,27.1,8.6,18,12.6,20.2,32.3,10,127.5,65,10.5,20.4,15,8.5,7.6
SLC4A2,"AE2, BND3L, EPB3L1, HKB3, NBND3",ENSG00000164889,Solute carrier family 4 member 2,P04920,7,151057210-151076527,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Anion exchange, Antiport, Ion transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,liver: 94.2;retina: 100.7,Cell type enhanced,Detected in many,5,Syncytiotrophoblasts: 76.5,Low cancer specificity,Detected in all,NA,NA,Region enriched,Detected in all,7,pons and medulla: 73.3,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in many,NA,NA,HPA019339,Enhanced,NA,Approved,"Nuclear speckles,Plasma membrane,Cytosol",NA,NA,NA,NA,NA,"Nuclear speckles, Plasma membrane",Cytosol,HPA019339: AB_1844825,unprognostic (1.19e-1),unprognostic (3.33e-3),unprognostic (8.12e-3),unprognostic (1.10e-1),unprognostic (1.20e-1),unprognostic (1.49e-1),prognostic unfavorable (9.04e-6),unprognostic (1.24e-1),unprognostic (4.23e-1),unprognostic (3.30e-1),unprognostic (1.07e-1),unprognostic (3.21e-1),prognostic favorable (1.26e-4),unprognostic (4.67e-3),unprognostic (1.22e-1),unprognostic (1.28e-1),unprognostic (2.36e-2),9.9,13.5,4.7,10.4,7.4,6.7,10.5,3,8.6,12.4,18.6,29,6,12.1,16.2,6.3,7.7,10.8,14.1,11.9,10.1,3.8,35.5,94.2,12.3,7.2,10.4,4.8,12.6,34.1,30.6,5.3,31.4,73.3,10.5,4,100.7,11.9,8.3,8.7,9.5,26,10.7,10.4,10.1,27.1,6.5,8.5,8.8,9.7,7,5.9,11.7,10.6,2.5,5.6,2.1,4.2,0.5,2.7,1.9,15.9,52.8,10.4,21.4,10.4,6.1,23.8,19.4,10.5,15.9,13.8,30,25.6,9.6,42.6,9.2,23.4,15.7,10.6,9.4,2.9,27.6,15.8,12.6,25.7,15.2,17,6.5,40.6,8.9,8.3,18,4.6,17.1,8.8,13.6,38.9,8.1,12.3,30.6,18.6,11.2,24.7,21.5,19.6,14.7,5.7,11.2,13,12.1,8.6,31.2,17.7,33.5,16.5,8.2,13.8,12.8,19,21.4,10.9,21,28.5,8.8,11.8,5.4,32.7,16.3,42.9,0,4.2,2.1,2.7,3.9,1.9,2.5,2.1,1.8,2.4,1,2.4,2.4,1,0.5,2.5,5.6,1,1.9,4.7,7.4,3,8.6,10.1,3.8,10.4,4.8,73.3,8.5,8.9,10.9,6.7,4.5,9.8,7.9,3.6,17.8,1.4,2.3,19.2,23.6,28.5,14.9,31,0.6,9.8,17.3,0,30.9,9,16.2,5,48.3,31.4,23.1,14.3,26.5,14.7,15.1,1.3,12.7,9.9,25.3,9,11.1,22.3,39.3,14,18.7,18.9,8.8,12.9,15.5,3.2,7.7,6,76.5,8.3,18.9,3.1
SLC4A3,"AE3, SLC2C",ENSG00000114923,Solute carrier family 4 member 3,P48751,2,219627327-219641980,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Anion exchange, Antiport, Ion transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,heart muscle: 103.6;ovary: 30.2,Group enriched,Detected in many,17,Cardiomyocytes: 201.0;Horizontal cells: 527.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in some,36,myeloid DC: 2.3;plasmacytoid DC: 8.9,Lineage enriched,Detected in single,58,dendritic cells: 8.9,Cell line enhanced,Detected in many,NA,hTERT-RPE1: 13.4,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA063498,NA,NA,Approved,Nucleoplasm,NA,NA,NA,NA,NA,Nucleoplasm,NA,HPA063498: AB_2685025,unprognostic (9.49e-2),unprognostic (5.72e-3),unprognostic (8.92e-4),unprognostic (1.77e-2),unprognostic (6.61e-3),unprognostic (1.47e-1),unprognostic (2.60e-1),unprognostic (2.39e-2),unprognostic (4.13e-2),unprognostic (2.32e-2),unprognostic (1.01e-2),unprognostic (1.88e-1),unprognostic (8.15e-3),unprognostic (1.97e-1),unprognostic (3.27e-2),unprognostic (1.06e-1),prognostic unfavorable (4.12e-4),1.8,5.4,11.8,1.6,22.5,1.2,2,8.8,22,2.8,1.3,3,0.4,1.4,3.4,2.6,2.9,2.7,2.3,103.6,10.4,8.2,1.6,1,1.3,1.4,6.5,9,30.2,2.7,4.5,9.9,2.5,24.1,4.2,1.1,4.9,3.1,4.3,1.2,1.6,1.3,3.1,1.6,2.6,1.4,4.2,3.5,0,1.5,0,1.3,1.6,0.9,0,8.9,0,0.1,0,0,0,6.2,0.2,2.2,6.5,0.4,0.4,4.4,3.9,4.1,5.3,3.8,4.5,3.6,0,1.5,1.4,9.2,3.6,1.1,7.1,1.6,0,1,0,0,0.1,1.1,0.1,0.3,3.1,6.7,0,2.1,13.4,0,0,0.2,0,1.5,2.1,0,0,3.6,0.2,5.3,0,0,0,3.6,1.5,1.3,6.4,2.5,6.8,3.3,7.5,0.6,1.6,0,3.3,5.8,0,3.1,0,0,0,2.7,0,8.5,0,0,0,0,0.1,0,0,0,0,2.3,0,0,0,0,0,0,8.9,0,0,11.8,22.5,8.8,22,10.4,8.2,6.5,9,24.1,3.5,0,0,0,0.6,0.2,8.9,201,0,0,1.2,1.8,0,10.5,1.7,2.8,2,0.1,0,0,1.5,2.5,2.2,0.3,0,0,1.6,527.6,0,0,0,11.9,14.1,1.1,0,1,0,7,1.3,0,21.2,0.3,6.7,6.5,1.4,0.5,1.1,0.6,11.6,0,0,0
SLC4A5,NBC4,ENSG00000188687,Solute carrier family 4 member 5,Q9BY07,2,74216242-74343414,"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins","Anion exchange, Ion transport, Sodium transport, Transport",NA,Cancer-related genes,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,5,retina: 109.1,Cell type enhanced,Detected in some,28,Cone photoreceptor cells: 33.4;Horizontal cells: 158.9;Rod photoreceptor cells: 43.4,Cancer enriched,Detected in single,11,thyroid cancer: 3.3,Group enriched,Detected in many,5,cerebellum: 3.4;pons and medulla: 9.0,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,U-266/70: 14.6,Low region specificity,Detected in some,NA,NA,Low region specificity,Detected in all,NA,NA,HPA036621,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA036621: AB_10696779,unprognostic (1.30e-1),unprognostic (3.78e-2),unprognostic (2.75e-2),unprognostic (1.83e-4),unprognostic (3.38e-1),unprognostic (2.36e-2),unprognostic (2.56e-3),unprognostic (5.37e-4),unprognostic (1.39e-1),unprognostic (2.55e-1),unprognostic (1.55e-3),unprognostic (3.24e-2),unprognostic (1.72e-5),unprognostic (1.57e-1),unprognostic (1.06e-2),unprognostic (8.47e-2),unprognostic (9.27e-4),1.2,0.4,1,0.8,0.8,1.6,1.1,3.4,1.2,0.7,0.8,2.5,0.6,0.3,0.9,1.7,0.6,1.4,0.8,0.7,1.2,1,0.7,3.2,1.7,1,1,0.6,1.3,0.9,1.5,2.3,0.6,9,0.9,0.3,109.1,1.3,0.8,1.1,3.7,0.7,0.9,1.6,0.7,0.5,16.1,0.7,1,21.4,0.6,0.7,0.9,0.9,2.5,5.8,6.1,0.9,1.7,2.5,0.6,0.4,0.8,1.4,1.4,1.5,2.6,1.9,0.4,1.4,0.8,1.2,0.4,1,2.2,0.4,0,0.5,0.1,1.6,0.2,0.3,1.9,0.9,3.3,1.4,0.8,0.2,1.1,2.3,0.7,2,0.1,0.3,0.7,0.5,1.6,0.7,2.4,0.3,5.2,0.5,2.2,1.1,1,0.3,1.1,1.4,0,0.3,1,1,2.1,0.5,1.7,2.3,1.4,1.6,2.2,0,1.5,2.4,1.6,0.5,14.6,2,1.7,0.9,1.2,0.3,6.1,0.9,0.9,1.5,0.8,1,1.8,2.3,2,0.6,2.5,2.1,2.5,4.2,1.7,0.3,5.8,2.4,0.6,1,0.8,3.4,1.2,1.2,1,1,0.6,9,0.7,3,6.7,0,0.6,0.6,12.6,0.4,2.5,4,4.5,0,33.4,0,0,0.3,0.4,0.8,0,0,0.6,0,0.4,0.8,0,0,0.1,158.9,0,0,0,0,1.1,0.2,1.7,0,0.1,2.9,0.2,0,0.4,0,43.4,0,0.4,1.7,1.4,0.4,0,0,0,0.5
SLC4A8,NBC3,ENSG00000050438,Solute carrier family 4 member 8,Q2Y0W8,12,51391317-51515763,Predicted membrane proteins,"Anion exchange, Antiport, Ion transport, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 28.6;pituitary gland: 20.0;testis: 15.3,Cell type enhanced,Detected in many,13,Bipolar cells: 85.2;Cone photoreceptor cells: 168.9;Horizontal cells: 109.7;Spermatocytes: 91.6,Group enriched,Detected in some,6,breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,BEWO: 17.6;HMC-1: 12.4;SCLC-21H: 13.2,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA077895,NA,NA,Approved,Plasma membrane,NA,NA,NA,NA,NA,Plasma membrane,NA,HPA077895:,unprognostic (4.01e-1),unprognostic (8.15e-2),unprognostic (2.49e-2),unprognostic (6.39e-2),unprognostic (1.29e-1),unprognostic (1.96e-2),unprognostic (3.46e-2),unprognostic (7.72e-4),unprognostic (3.13e-2),unprognostic (7.03e-3),unprognostic (1.07e-4),unprognostic (1.70e-1),unprognostic (9.60e-6),unprognostic (1.35e-1),unprognostic (2.57e-1),unprognostic (3.21e-2),unprognostic (2.47e-1),1,6.5,5.8,2.2,13.3,1.7,3.1,9.2,22.9,2.7,1.1,9.8,0,1.4,1.2,5.4,0.7,3.7,1.1,1,10.9,5.6,3.2,0.8,2.8,3,6,9.3,7.3,2.4,1,20,1,28.6,1.4,1.4,2.2,1.5,1.7,0.8,1,2,1.1,4.7,2.2,3,15.3,5.1,0,0.8,0,2.7,1,0.7,1.1,2.6,3.4,3.1,1.7,1.7,0.7,0.2,0.8,9.9,0.1,0.4,0.5,17.6,2.7,4.5,4.4,2.8,5.8,0.2,3.6,0.4,3.6,2.4,0.1,3.9,0.2,4.1,0.7,0.5,1.8,0.3,0,0,0.6,12.4,0.1,0.2,2.2,0.5,2.6,5.1,1.6,0.1,6.4,2.2,2.1,5.2,1.1,4.3,1.1,2.9,0.1,0,0,0.5,0.1,13.2,8.9,1,1.4,0,3.2,1.6,0.4,4.7,2.8,1.5,0.2,3.4,3.2,1,0.2,3.9,0.5,0.4,1.3,2.1,3.4,1.7,1.4,0.4,0.6,0.6,1.6,2.6,1.1,0.6,1,2.3,1.7,3.1,1,0.3,0.7,5.8,13.3,9.2,22.9,10.9,5.6,6,9.3,28.6,5.1,0,8.3,0.5,0.6,0,85.2,1.7,0,38.8,9.1,1.8,168.9,1,6.6,0.1,48.8,1.1,0.3,0,1.2,4.3,0.5,1,7,0,2.1,109.7,5.8,0.6,1.2,22.8,2.6,3.3,1.7,0,0.2,13.6,0.1,2.9,3.5,0.8,18.4,0,0.8,91.6,6.4,0.1,0.3,2.5,0,1
SLC4A9,AE4,ENSG00000113073,Solute carrier family 4 member 9,Q96Q91,5,140360202-140375143,"Plasma proteins, Predicted membrane proteins, Transporters","Anion exchange, Antiport, Ion transport, Transport",NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enriched,Detected in some,7,kidney: 26.7,Cell type enhanced,Detected in single,21,Distal tubular cells: 1.7,Cancer enriched,Detected in single,8,renal cancer: 0.9,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,JURKAT: 3.8;U-698: 2.0,Region enhanced,Detected in single,NA,pons and medulla: 1.0,Low region specificity,Detected in all,NA,NA,HPA051307,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA051307: AB_2681434,unprognostic (1.68e-1),unprognostic (4.22e-2),unprognostic (2.20e-1),unprognostic (1.47e-1),unprognostic (1.10e-1),unprognostic (2.13e-1),unprognostic (1.02e-2),unprognostic (3.28e-3),unprognostic (2.78e-1),unprognostic (2.47e-1),unprognostic (4.78e-2),unprognostic (1.19e-1),unprognostic (4.24e-2),unprognostic (2.99e-2),unprognostic (3.06e-2),unprognostic (5.04e-2),unprognostic (1.82e-2),0,0,0.2,0,0.2,0,0,0,0.2,0,0,0,3.6,0.1,0,0,0,0,0,0.1,0.2,0.1,26.7,0,0,0,0.4,0,0,0,0,0.1,0,0,0.1,0,0,0,0.8,0,0,0,0,0.5,0,0.1,0.4,0,0,0.1,0,0,0.2,0,0.1,0,0.4,0.1,0,0.5,0,0.1,0.1,0,0.1,0,0,0.1,0,0,0,0,0.9,0.6,0.2,0.2,0,0.7,0.6,0,0.2,0,0.1,0.2,0.1,0.1,0,0,0,0.1,0,0,0,0.1,0,0.1,3.8,0,0.8,0,0.4,0,0.2,0.1,0.6,0,0.1,0,0,0,0.2,0.1,0,0,0,0,0.1,0.2,0.2,0.2,0.1,0.2,0.1,0,1,0.5,2,0,0.1,0.2,0,0.1,0.4,0.1,0,0,0,0.5,0,0,0.1,0,0.3,0.2,0,0,0,0.4,0,0.2,0.2,0,0.1,0.2,0.1,0.4,0,0,0,0,0,0,0.2,0,0,0.1,0,0,0,0,0,0.1,1.7,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.9,0.7,0.1,0,0,0,0.1
SLC52A1,"FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1",ENSG00000132517,Solute carrier family 52 member 1,Q9NWF4,17,5032600-5052009,"Disease related genes, Predicted membrane proteins",Transport,"Host cell receptor for virus entry, Receptor",NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,NA,Group enriched,Detected in some,4,intestine: 25.6;placenta: 34.6,Cell type enriched,Detected in some,5,Syncytiotrophoblasts: 685.8,Low cancer specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in some,NA,A549: 4.5;BEWO: 3.8;EFO-21: 3.6;HMC-1: 9.0;SK-BR-3: 5.1;T-47d: 3.0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (8.81e-3),prognostic favorable (9.54e-4),unprognostic (9.34e-2),unprognostic (7.30e-4),unprognostic (6.31e-2),unprognostic (1.24e-1),unprognostic (1.05e-1),unprognostic (3.82e-3),unprognostic (1.72e-1),unprognostic (2.36e-1),unprognostic (1.15e-1),unprognostic (7.19e-2),unprognostic (5.17e-5),unprognostic (1.37e-1),unprognostic (1.03e-1),unprognostic (4.07e-2),unprognostic (6.60e-2),0.1,0,0.1,0.1,0.2,0.1,0.3,0.3,0.6,1,20,0.2,0.6,24.4,0.5,0.1,1.5,0.8,0.1,0.1,0.1,0.1,0.2,0.1,0.5,0.1,0.1,0.1,0.2,0.1,1,0.1,34.6,0.3,1.4,0.1,0.1,0.5,0.3,0.1,7.4,25.6,0.1,0.1,0.6,0,0.7,0.1,0.6,0.2,0.4,0.7,2.5,1,1.4,0.6,3.7,0.6,1.4,1.2,0.3,0.2,4.5,0.1,0.2,0.2,0.2,3.8,0,0,0.6,0.6,0.1,0.2,0.3,3.6,0.1,0.7,0.4,0,0.3,0.1,0.1,0.2,0,0.7,0.3,0.1,0.1,9,0.1,0.1,0.2,0.1,0.2,0.2,0.7,0.1,1.2,0,0.3,0.5,0.4,0.4,0.1,0.2,0.1,0,0.3,0.1,1.4,0.1,0.3,0.8,5.1,0.1,0.2,3,1.4,0.6,0.3,1.1,0.1,0.2,0.3,0.1,0.3,0.2,0.1,0.5,2.6,0.6,0.9,0.7,0.4,0.6,0.6,0.9,1.2,0.2,1.4,1.1,0.8,3.7,1.4,0.4,0.6,0.5,0.3,0.1,0.2,0.3,0.6,0.1,0.1,0.1,0.1,0.3,0.1,0,0.3,0,1.3,1,0,0.6,0,8.1,0,0,0,134.6,0,0,0.1,0.1,5.7,0,0,10.3,1.1,0.3,0,0,13.6,0,1.2,2.5,0,0,0,0,0,0,1.3,0,0,0.8,0,0,0,0,0,0.9,0.9,1.5,685.8,0,1.1,0.7
SLC52A2,"D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2",ENSG00000185803,Solute carrier family 52 member 2,Q9HAB3,8,144354135-144361286,"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters",Transport,"Host cell receptor for virus entry, Receptor","Deafness, Disease mutation, FDA approved drug targets",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in all,NA,PC-3: 51.0,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,HPA063036,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA063036: AB_2684928,unprognostic (7.80e-3),prognostic unfavorable (7.55e-4),unprognostic (2.15e-1),unprognostic (2.94e-1),unprognostic (3.09e-2),unprognostic (3.94e-2),prognostic unfavorable (2.04e-6),unprognostic (7.74e-3),unprognostic (9.20e-2),unprognostic (2.24e-2),unprognostic (4.85e-2),unprognostic (3.99e-2),prognostic unfavorable (1.23e-4),unprognostic (3.12e-2),unprognostic (1.73e-1),unprognostic (1.51e-1),unprognostic (1.07e-1),16,12.8,7.3,13.2,8.8,9.9,23.7,19.2,10.5,10.9,18.1,7.5,19.3,19.6,10.7,19.9,14.6,7.4,16.3,8,7.7,9,14.7,12.4,10.7,10.7,13,5.9,10.6,22.4,7.9,10.9,19.5,9.5,10.8,9.3,7.2,21.3,14.1,7,12.6,17.8,8.5,7.9,15.2,16.8,17,7.4,11.5,12.4,11.6,14.6,8.6,13.1,7.7,9,9.2,7.4,5.7,6.3,1.9,12.8,18.5,2.6,6.9,4.9,3.7,13.4,9.9,7,9,7.2,14.7,15.5,6.1,16.3,7.1,6.6,15.3,4.4,7.6,1.9,7.5,10.5,10.6,10.6,13.3,16,3.9,9.1,5.1,9.2,8.2,6.8,4.4,5.2,5.8,14.5,7.8,4.7,37.4,6,10.3,5.6,16,51,11.2,3.1,13.8,7.3,9.5,8.2,9.8,12.2,12.7,11.4,2.5,10,5.1,7.4,7.4,16.8,18.4,14.2,3.9,5.4,4.6,12.2,9.7,8.5,1.2,4.2,9.2,5.9,6.1,3.7,4.2,4.7,6.3,5.2,7.7,4.6,3.1,1.4,5.7,7.4,9,5.7,1.9,7.3,8.8,19.2,10.5,7.7,9,13,5.9,9.5,7.4,6,5.4,19.3,19.4,27.7,10.9,2.5,12.7,4,14.8,12.2,2,74,0,60.6,2.5,20.6,60,0,58,74.5,27.7,31.3,10.3,4,47.5,11.1,16.7,17.8,14.8,4.2,11.8,20.9,28.7,55.1,32,13.5,64.4,42.1,18.7,12.9,8.9,19.4,26.4,31.7,39.6,31.6,43.9,20.8,38.1,32.6
SLC52A3,"bA371L19.1, C20orf54, hRFT2, RFVT3",ENSG00000101276,Solute carrier family 52 member 3,Q9NQ40,20,760080-776015,"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters",Transport,NA,"Deafness, Disease mutation",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,testis: 32.5,Cell type enhanced,Detected in many,11,Collecting duct cells: 22.7;Cytotrophoblasts: 15.8;Enterocytes: 25.3;Syncytiotrophoblasts: 43.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in some,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in some,NA,CAPAN-2: 25.9;OE19: 17.9;RT4: 6.0;SK-BR-3: 9.5;T-47d: 11.6,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA049391, HPA059078",Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA049391: AB_2680743, HPA059078: AB_2732630",unprognostic (4.53e-2),unprognostic (1.11e-1),unprognostic (8.60e-2),unprognostic (7.84e-2),unprognostic (1.29e-1),unprognostic (9.03e-3),unprognostic (2.12e-3),unprognostic (1.43e-3),unprognostic (1.15e-2),unprognostic (4.36e-2),unprognostic (4.39e-3),unprognostic (4.82e-2),unprognostic (2.04e-3),prognostic favorable (5.51e-6),unprognostic (3.04e-1),unprognostic (2.21e-1),unprognostic (1.44e-1),2,0.4,7.3,1.4,5.9,0.5,2.8,3.5,9,2.6,9.6,2.1,12,13.1,1.8,1.9,4.6,2,3,3.3,6.6,4.2,10,0.4,1.4,0.7,5.6,1.3,1.2,2.2,0.6,0.5,6.7,7.3,7.9,6.3,0.5,5.5,15.8,1,1.7,16.3,1.5,4.7,0.4,5.2,32.5,6,0,0.7,1.2,0.9,4.7,2.2,1.1,0.7,2.4,0.6,1.1,0.8,0.4,3.3,0.9,0,0,0,0,1.9,0,0,0,0,2.3,25.9,0,3.8,0,0.2,3.8,0,2.8,0,0,0,0.2,0.3,0.1,0,0,0.1,0,1.1,0,0,0,0,0,0.1,0.1,0,0,0,0,0.2,17.9,2.3,0,0,0.3,0,6,0,0.1,3.8,9.5,0,0.4,11.6,0,0,0.1,0,0,0,0,0,0,0,0,0,2.4,0.6,0.5,0.4,0.2,0.4,0.5,0.4,0.4,0.1,1.1,0.4,0.8,2.2,1.1,0.4,0.7,0.3,0.4,7.3,5.9,3.5,9,6.6,4.2,5.6,1.3,7.3,6,8.9,1.9,0,2.2,0.6,0.4,0.4,0,0,3.4,22.7,2,15.8,1.7,5.6,0.7,2.9,25.3,0,1.6,0.7,0.2,5,0,0,2.1,0,0,0,0,2,0.9,0.3,1.7,0,4.9,0,4.1,14.4,0.4,0,0,0,0.2,0.5,0.7,1,43.6,0,9.3,6.2
SLC5A12,"MGC52019, SMCT2",ENSG00000148942,Solute carrier family 5 member 12,Q1EHB4,11,26667019-26723427,"Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,4,intestine: 60.8;kidney: 90.3,Cell type enriched,Detected in some,18,Proximal tubular cells: 145.9,Cancer enriched,Detected in single,26,renal cancer: 9.0,Region enriched,Detected in single,7,basal ganglia: 1.2,Low cell type specificity,Detected in some,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in some,NA,Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,HPA060904,Enhanced,NA,Supported,"Nucleoplasm,Plasma membrane",NA,NA,NA,NA,NA,Plasma membrane,Nucleoplasm,HPA060904: AB_2684385,unprognostic (3.69e-3),unprognostic (6.92e-2),unprognostic (1.79e-1),unprognostic (2.86e-1),unprognostic (2.01e-2),unprognostic (9.35e-3),unprognostic (4.21e-3),unprognostic (4.49e-2),unprognostic (2.36e-3),unprognostic (1.71e-1),unprognostic (2.03e-2),unprognostic (3.43e-1),unprognostic (2.91e-3),unprognostic (1.34e-1),unprognostic (8.53e-2),unprognostic (1.42e-2),unprognostic (9.40e-3),0,0,0.1,0,1.2,0.2,0,0,0.1,0,11.3,0,0.2,1.7,0,18.5,0,0,0,3.4,0.1,0.1,90.3,0.4,0,0,0.1,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,60.8,0,0.1,0.1,0,0.1,0,0,0,0,0,0.1,0,1.5,0.8,1,0.7,0.9,0.7,0.1,0.4,0.1,0.2,0.6,0.1,0,0.5,0.1,0,0,0,0.6,0.2,0.6,0.8,0.2,0.1,0.2,0.2,0.1,0.1,0,0,0.1,0.7,0.1,0.2,0,0.2,0.1,0,0.1,0,0.2,0.1,0.3,0.4,5.2,0.1,0.3,0.2,0.5,3.8,0.7,0.1,0.1,0,0.6,0.1,1.1,2,0.3,1.7,0.2,0,7.8,2.8,0.5,0.6,0.4,0.2,0.4,0.2,2.3,0.7,0.2,0.2,0,0,1,0.5,0.1,0.6,0.7,0.4,1.1,0.4,0.4,0.5,1.5,0.7,0.6,0.4,0.9,0.6,0.8,0.1,0.1,0.1,1.2,0,0.1,0.1,0.1,0.1,0,0,0,0,0,0,0,0,0,3.8,0,0,0,3.5,0,0.1,8.3,0,0.7,0,1.7,0,0,0.2,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0.4,0.8,0,0.3,0,145.9,0.2,0,0,0,0.4,0,0.1,0,0.4,0
SLC5A8,AIT,ENSG00000256870,Solute carrier family 5 member 8,Q8N695,12,101155493-101210407,Predicted membrane proteins,"Apoptosis, Ion transport, Sodium transport, Symport, Transport",NA,Tumor suppressor,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,5,"cervix, uterine: 14.3;kidney: 13.8;thyroid gland: 21.2",Cell type enhanced,Detected in some,20,Alveolar cells type 2: 7.7;Horizontal cells: 9.5;Intestinal endocrine cells: 30.3;Proximal tubular cells: 10.3,Cancer enhanced,Detected in many,NA,renal cancer: 7.6,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in single,10,SK-BR-3: 8.4,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,prognostic favorable (9.04e-6),unprognostic (1.84e-1),NA,unprognostic (1.17e-2),NA,unprognostic (1.27e-3),NA,unprognostic (1.24e-1),NA,NA,unprognostic (5.20e-1),unprognostic (1.16e-2),prognostic favorable (1.97e-4),unprognostic (6.16e-2),unprognostic (2.30e-2),unprognostic (2.87e-2),NA,0,2.5,0,0,0,0,0,0,0.3,14.3,0,0.2,0,0.2,0.2,0,0,0,0,0,0,0.2,13.8,0,1.9,0,0,0.3,1,0,0,0.1,0,0.6,0.9,0,1.4,3,0,0,0.1,0.3,0,0,0,0,0.2,0,0,21.2,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.8,0,0,8.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0.2,0,0.3,0.6,0,0,7.7,0,0,0,4,0.6,0,1.4,1.2,1.8,0,0,1.7,0,4.4,0,0,0,0,0,0,2,0,0,0,9.5,30.3,0,0,0.5,0,0,0,0,0,0,0,0,0,10.3,0,0,0,0.5,0.4,0,0,0,0,0.1
SLC5A11,"KST1, SGLT6, SMIT2",ENSG00000158865,Solute carrier family 5 member 11,Q8WWX8,16,24845841-24911628,Predicted membrane proteins,"Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,NA,brain: 48.0;intestine: 21.8,Group enriched,Detected in some,4,Enterocytes: 1.7;Paneth cells: 2.9;Proximal tubular cells: 5.0,Low cancer specificity,Detected in some,NA,NA,Low region specificity,Detected in all,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,6,Hep G2: 18.9;Karpas-707: 5.3,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,HPA035331,Uncertain,NA,Approved,"Nucleoplasm,Cytosol",NA,NA,NA,NA,NA,Nucleoplasm,Cytosol,HPA035331: AB_10601489,unprognostic (2.57e-1),unprognostic (7.90e-3),unprognostic (1.34e-2),unprognostic (2.65e-2),unprognostic (2.00e-2),unprognostic (1.08e-1),unprognostic (1.27e-2),unprognostic (9.90e-2),unprognostic (8.08e-2),unprognostic (2.85e-1),unprognostic (2.85e-3),unprognostic (6.68e-2),unprognostic (1.17e-2),unprognostic (1.59e-1),unprognostic (1.58e-1),unprognostic (8.07e-2),unprognostic (1.45e-3),0.6,0.6,4.3,0.6,21.8,0.5,2.8,1.9,11.2,0.6,1.7,29.7,0,10.9,0.6,0.5,0.5,0.6,1.4,0.7,12.1,7.4,9.9,1,0.6,0.7,48,2.4,0.6,0.5,0.5,0.2,0.5,18.3,0.6,0.8,0,0.6,0.8,0.7,0.5,21.8,0.5,34.7,0.6,0.6,0.8,22.9,0,0.6,0,0.7,0.6,0.1,0.4,0,0,0,0.5,0.4,0,0,0.9,0,0,0,0,2.1,0,0,0,0,0.4,0,0.2,0.1,0,0.4,0,0,0,0,0,0.2,0,0,18.9,0,0,0.1,0,0.1,0,0,0,0,0,0.1,5.3,0.1,0,0.1,0,0.1,0.2,0.2,0,0,0,0,0.1,0,0.3,0,0.1,0.1,0.3,0,0,0.1,0,0,0,0.1,0.5,1,0,0,0,0.1,0,0,0,0.1,0,0,0,0.3,0.4,0,0.4,0.2,0,0,0.5,0,0,0,0,4.3,21.8,1.9,8,12.1,7.4,48,2.4,18.3,22.9,0,0,0,0,0.1,0,0.3,0,0,0,0,0,0,0,0,0.1,0,1.7,0,0,0.7,0,0.1,0,0.2,0.1,0,0,0,0,0,0,0,0,0,0,0,0,2.9,0,5,0,0,0,0.2,0.4,0,0.1,0,0,0
SLC5A1,"D22S675, NAGT, SGLT1",ENSG00000100170,Solute carrier family 5 member 1,P13866,22,32043032-32113029,"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Sugar transport, Symport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,11,intestine: 274.9,Cell type enhanced,Detected in many,13,Cardiomyocytes: 111.5;Cholangiocytes: 117.2;Early spermatids: 40.8;Late spermatids: 54.9,Low cancer specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in some,12,OE19: 27.0,Region enriched,Detected in single,26,cerebellum: 8.6,Not detected,Not detected,NA,NA,"CAB015467, HPA051805, HPA055106",Enhanced,NA,Approved,"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol",NA,NA,NA,NA,NA,"Nucleoplasm, Golgi apparatus","Nuclear membrane, Cytosol","CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695",unprognostic (1.96e-1),unprognostic (1.04e-1),unprognostic (2.24e-2),prognostic favorable (2.59e-4),unprognostic (3.85e-2),unprognostic (2.75e-2),unprognostic (1.60e-2),unprognostic (2.15e-1),unprognostic (9.22e-2),unprognostic (4.83e-2),unprognostic (6.21e-2),unprognostic (9.53e-2),prognostic favorable (6.97e-7),unprognostic (4.68e-3),unprognostic (1.98e-1),unprognostic (6.00e-2),unprognostic (1.45e-2),0.2,0,0.2,1.3,0.2,0,1.5,0.2,0.2,2.2,181.5,0.2,2.9,95.5,0.3,0.8,1.9,0,14.1,24.5,0.2,0,1,0.9,0.3,0.2,0.2,0.2,0.2,0.4,0,1,0.2,0.2,0.8,1.6,0.2,5.7,3.5,0.2,4.6,274.9,0.2,0.2,0.7,1.2,0.8,0.2,0.2,0.2,3.5,1.5,0.2,2,0.3,0.1,0.6,0.8,0.3,0.3,0,0,0,0,0,0,0,0.5,0,0,0,0,2.1,0.4,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0.8,0,27,0,0,0,1.6,0,0,0.6,0.8,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0.2,0.1,0.2,0.3,0.1,0,0.1,0,0,0,0.3,0.1,0.2,0.6,0.3,0.8,0.1,0,0,0.2,0.2,0.2,0.2,0.2,0,0.2,0.2,0.2,0.2,0,0,0,1.8,0.6,0,111.5,117.2,0,4.5,0,0,0,0,2.4,40.8,0,26.1,0,1.2,0,0.2,19.7,0,0,0,0,24.5,0,0,54.9,1.1,0,0,0,8.7,0,0.6,14.7,1.4,1.9,0,0,0,4.2,0.5,4.8,0,0,19.6,4.8
SLC5A10,SGLT5,ENSG00000154025,Solute carrier family 5 member 10,A0PJK1,17,18950345-19022595,"Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,5,kidney: 70.6,Group enriched,Detected in some,4,Late spermatids: 20.1;Proximal tubular cells: 51.2,Cancer enriched,Detected in some,11,renal cancer: 6.3,Not detected,Not detected,NA,NA,Group enriched,Detected in some,5,intermediate monocyte: 3.0;non-classical monocyte: 7.9,Lineage enriched,Detected in many,7,monocytes: 7.9,Cell line enriched,Detected in some,5,U-937: 11.0,Not detected,Not detected,NA,NA,NA,NA,NA,NA,HPA052014,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA052014: AB_2681694,unprognostic (3.74e-1),unprognostic (2.92e-1),unprognostic (3.04e-2),unprognostic (6.11e-2),unprognostic (6.56e-2),unprognostic (3.36e-4),unprognostic (7.36e-2),unprognostic (2.39e-1),unprognostic (1.52e-1),unprognostic (8.94e-2),unprognostic (3.24e-2),unprognostic (1.53e-1),unprognostic (1.09e-2),unprognostic (3.43e-2),unprognostic (2.61e-2),unprognostic (2.75e-2),unprognostic (2.11e-1),0.1,0.1,0.1,0.5,0.1,1.8,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.3,0,0.1,0.7,0.1,0,70.6,0.4,0.3,0.8,0.1,0.1,0.1,0.1,0,0.1,0.1,0.1,0.1,0,15.1,0.1,0.1,0.1,0.7,1.1,0.1,0.2,3.1,0.1,0.3,0.1,0.1,0.2,0.1,0.1,0.1,0.1,0.4,1.2,0.1,7.9,0,0.6,0.5,0,0,0.1,0,0.4,0,1,0,0,0,0,0.2,0.1,1.8,0.5,0,0.1,0,0,0,0,0,0,0.1,0,0.4,0,0,0.1,0,0,0,0,0,0,0.4,0,0,0,0.8,0.1,0.1,0,0.5,0.1,0.7,0,0.1,0,0,0,0,0,0,2.2,0.7,0,0.1,2.3,0,0,0.3,0,0,0,0.7,0,11,0,0.1,0,0,0.1,3,0,0.4,0.3,0,1.2,0.3,0.6,0.2,0,0,7.9,0,0.2,0.5,0.1,0.1,0.1,0.1,0.1,0,0.1,0.1,0.1,0.1,0,0,0,0,0.6,0,0.3,0,0,0,0,0,0,8.3,0.3,8.7,0,0,0,0.2,0.5,0,0.1,0,0,0.1,0,0,1.3,0,20.1,0,0,1.7,0,0,0,0.2,0,0,51.2,0,0,0,0.2,0.2,0.3,0.2,0,0,0
SLC5A2,SGLT2,ENSG00000140675,Solute carrier family 5 member 2,P31639,16,31483002-31490860,"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Sugar transport, Symport, Transport",NA,"Disease mutation, FDA approved drug targets",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,17,kidney: 33.7,Group enriched,Detected in some,11,Early spermatids: 46.9;Late spermatids: 103.8;Proximal tubular cells: 139.8,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell type enhanced,Detected in some,NA,memory CD4 T-cell: 1.6,Group enriched,Detected in many,16,NK-cells: 1.4;T-cells: 1.6,Cell line enhanced,Detected in some,NA,BEWO: 1.2;EFO-21: 2.0;Hep G2: 2.6;NB-4: 1.3;U-2 OS: 1.2;U-266/84: 1.8;U-937: 1.0,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,HPA041603,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA041603: AB_10960540,unprognostic (1.61e-1),unprognostic (2.95e-1),unprognostic (2.84e-1),unprognostic (3.00e-2),unprognostic (8.04e-2),unprognostic (8.23e-3),unprognostic (1.49e-1),unprognostic (2.25e-3),unprognostic (2.57e-1),unprognostic (1.12e-2),unprognostic (6.43e-2),unprognostic (2.47e-1),unprognostic (1.42e-3),unprognostic (5.88e-2),unprognostic (2.14e-1),unprognostic (4.18e-2),unprognostic (3.22e-1),0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,33.7,0,0,0,0,0,0,0.1,0.1,0,0,0,0,0,0,0,0,0,0,0.6,0,0,0,0,1.9,0,0,0.1,0,0,0,0,0,0,0,0,1.4,1.6,0.6,0.1,0.4,0,0.9,0,0,1.2,0,0,0,0,0,0.2,0,2,0,0.1,0,0,0,0,0.6,0.5,0,0,2.6,0,0,0,0,0,0,0,0.4,0,0,0,0.1,0,0,0,1.3,0,0,0,0.1,0.1,0,0,0,0.4,0,0,0,0.1,0,0.5,0,0,0.3,1.2,0.1,0,0,1.8,0,0,1,0,0,0,0,0,0,1.1,0,1.6,0.5,0,0,0.5,0.1,0,1.4,0,0,1.4,0.6,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0.2,0,0.3,0,1.4,0,8.7,0,0.2,6.6,0.7,46.9,0,0.3,0,0.4,0.1,0.1,0.1,0,0,0.2,0,0,0,0,103.8,2,0.4,0,0,0.2,0,0.7,0,1.4,139.8,0,0,0,3.2,0.9,0.3,0.1,0,0.6,0
SLC5A3,"SMIT, SMIT1",ENSG00000198743,Solute carrier family 5 member 3,P53794,21,34073570-34106262,"Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,kidney: 46.0,Cell type enhanced,Detected in many,7,Collecting duct cells: 130.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA029791,NA,NA,Supported,Plasma membrane,NA,NA,NA,NA,NA,Plasma membrane,NA,HPA029791: AB_10601892,unprognostic (9.70e-2),unprognostic (4.99e-2),unprognostic (2.23e-1),unprognostic (7.57e-2),unprognostic (1.07e-1),unprognostic (4.54e-2),unprognostic (4.48e-3),unprognostic (1.63e-1),unprognostic (3.02e-2),unprognostic (2.55e-1),prognostic unfavorable (1.98e-5),unprognostic (1.30e-1),prognostic unfavorable (4.72e-4),unprognostic (1.82e-1),unprognostic (1.82e-1),unprognostic (2.21e-1),unprognostic (8.60e-2),10.1,9.5,10.5,7.3,11,3.6,26.6,8,10.1,6.5,7.6,4.6,9.4,5,11.3,9.1,7.5,8.5,4.9,6.8,11.6,6.8,46,9.5,8.5,7.6,11.7,4.7,9,5.8,6.3,6.6,15.8,13.6,7,8.8,11.3,6.4,6.9,7.8,10.1,7.4,5.9,14.7,4.9,7.8,10.6,9,5.9,42.7,4.4,8,6.5,22.1,0.8,2.3,0.7,1,1,2.6,0.7,6.3,5.7,11.9,8.4,10,8.2,5.7,7.2,22.1,4.5,6.9,9.4,13.9,10.2,5.9,14.6,8.5,3.3,14.4,4.1,7.7,10.6,3.7,10.6,5.3,3.1,2.6,4.5,4.5,3.9,10.7,12.3,4.9,13.9,2.7,8.5,10.4,2.4,11.6,4.3,4.8,3.7,6,2.4,5.6,4.9,2.1,4.6,17.8,8.9,6.2,2.9,15,4,3.4,7.4,2.4,4.8,2.6,8.9,6.9,16.9,2.9,12.7,10.9,7.7,17.9,6.6,5.9,0,1,0.2,2.6,0.9,2.1,0.8,1.4,1.7,0.9,0.8,1.9,2.6,0.7,1,0.4,2.3,0.4,0.7,10.5,11,8,10.1,11.6,6.8,11.7,4.7,13.6,9,14.9,12.2,8,40.9,0,28.5,7.6,12.7,16,23.9,130.9,19.6,21.2,18.3,3.4,8.6,4.5,28,0,4.5,15.7,10.7,71.1,41.4,15.3,12.8,35,47.1,6.7,12.1,5.2,6.1,9.8,0,24.4,48.3,6,5.8,46,19.4,6.5,20.8,12.9,2.2,12.1,18.9,0,23.6,17.3,26.6,32.3
SLC5A4,"DJ90G24.4, SAAT1, SGLT3",ENSG00000100191,Solute carrier family 5 member 4,Q9NY91,22,32218476-32255341,"Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,NA,Tissue enriched,Detected in some,29,intestine: 73.6,Not detected,Not detected,NA,NA,Cancer enriched,Detected in some,10,melanoma: 7.0,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in some,19,SK-MEL-30: 25.2,NA,NA,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (1.93e-1),unprognostic (1.57e-1),unprognostic (3.10e-3),unprognostic (1.63e-2),unprognostic (1.28e-2),unprognostic (2.85e-3),unprognostic (2.97e-2),unprognostic (3.80e-2),unprognostic (3.58e-2),unprognostic (1.06e-1),unprognostic (2.65e-3),unprognostic (4.50e-1),unprognostic (1.99e-5),unprognostic (2.34e-1),unprognostic (1.63e-1),unprognostic (2.28e-1),unprognostic (2.69e-1),1.2,0.1,0.4,0.4,0.4,0.1,1.6,0.4,0.5,1.2,41.7,0.4,0.4,18,1.8,0.4,0.4,1.2,0.6,0.9,0.5,0.6,1,0.4,2.5,0.4,0.6,0.4,0.4,0.6,0.4,0.4,0.4,0.4,0.9,0.1,0.4,0.4,0.4,0.4,0.3,73.6,1.5,0.6,0.6,0.2,0.7,0.4,0.4,2.4,0.4,0.4,0.4,1.3,0,0.3,0,0.6,0,0.4,0,0,0,0.1,0.1,0,0,0,0,0,0,0,0,0,0,0.3,0,0.1,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0.1,0.2,0,0,25.2,0,0,0,0,1.3,0.1,0,0,0,0,0,0,0,1,0,0.6,0,0,0,0.4,0,0,0.2,0.3,0,0,0.1,0,0,0,0,0,0,0.4,0.4,0.4,0.5,0.5,0.6,0.6,0.4,0.4,0.4,0,0,0,0,0,0.3,0.2,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0.2,0,0,0,0,0,0
SLC5A5,NIS,ENSG00000105641,Solute carrier family 5 member 5,Q92911,19,17871973-17895174,"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Symport, Transport",NA,"Congenital hypothyroidism, Disease mutation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,6,brain: 31.5;salivary gland: 66.8;stomach 1: 32.7,Group enriched,Detected in some,6,Ciliated cells: 5.3;Club cells: 7.9;Spermatogonia: 7.9,Low cancer specificity,Detected in many,NA,NA,Region enriched,Detected in many,12,pons and medulla: 31.5,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enriched,Detected in some,4,BEWO: 16.0,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in many,NA,NA,"CAB022364, HPA049055",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CAB022364: , HPA049055: AB_2680614",unprognostic (2.72e-2),unprognostic (8.94e-2),unprognostic (1.50e-1),unprognostic (1.85e-1),unprognostic (1.81e-1),unprognostic (4.02e-2),unprognostic (2.57e-1),unprognostic (1.94e-2),unprognostic (3.07e-1),unprognostic (2.01e-2),unprognostic (3.03e-1),unprognostic (3.93e-2),unprognostic (5.51e-8),unprognostic (1.07e-2),unprognostic (1.69e-1),unprognostic (1.54e-2),unprognostic (3.23e-1),0,0,0.1,0.1,0.4,0.1,0.1,2.4,2.3,5.1,0.1,9,0,0,0.1,0,0.2,0.1,0.4,0,1.7,0.1,0.1,0,0.2,0.2,0.3,2.7,0,0.1,0,0.2,0,31.5,0.1,0,5.5,66.8,0,0.2,0.2,0.3,0,1.9,0.2,32.7,0.4,0.1,0,7.1,0,0.1,0,0.1,1.3,0.8,2.5,1.4,1,4.3,0.9,0,0,0.1,0.1,0,0,16,0,0,0,0,0.1,0.4,0.3,0.3,0,0.1,0.2,0,0,0,0,0,0.2,0.3,0.1,0,0,0.5,0,0.1,0,0,0.1,0,0.1,0.3,0.1,0,0.5,0,0.2,0.2,0.7,0.1,0,0,0.1,0,0.1,0.1,0.3,0.1,0.5,0,0.2,1.2,0,0.1,0.1,0,0.1,0,0.2,0,0.1,0,3.7,0,2.5,0.6,0.4,1.1,1.4,1.3,1,3.2,0.6,0.8,1.3,4.3,3.2,2.2,1,0.4,0.4,2,0.9,0.1,0.4,2.4,2.3,1.7,0.1,0.3,2.7,31.5,0.1,0,1.1,0,0,0.3,0,0.6,0,5.3,7.9,0,0,0,0,0.2,0,0,0,0,0.5,1,0.1,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0.3,0,7.9,0.3,0,0.5,0,0
SLC5A6,SMVT,ENSG00000138074,Solute carrier family 5 member 6,Q9Y289,2,27199587-27212958,"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,liver: 64.0;placenta: 51.7,Cell type enhanced,Detected in many,12,Cytotrophoblasts: 98.8;Extravillous trophoblasts: 89.2;monocytes: 78.5;Syncytiotrophoblasts: 190.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in all,NA,BEWO: 69.3;SK-BR-3: 74.6,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA036958,Approved,NA,Approved,Plasma membrane,NA,NA,NA,NA,NA,Plasma membrane,NA,HPA036958: AB_10672343,unprognostic (5.85e-2),unprognostic (8.32e-3),unprognostic (1.38e-1),unprognostic (2.61e-3),unprognostic (9.38e-2),unprognostic (7.14e-2),unprognostic (3.20e-3),unprognostic (7.92e-2),unprognostic (6.96e-2),unprognostic (9.80e-2),unprognostic (2.05e-2),unprognostic (7.46e-2),prognostic unfavorable (3.60e-7),unprognostic (2.40e-3),unprognostic (1.20e-2),unprognostic (4.56e-3),unprognostic (4.18e-2),20.9,4.6,5,7.6,8.5,8.5,15.9,7.9,8.1,4,6.4,5.6,6.4,10.9,7.4,36.7,5.5,5.9,6.3,3.5,5.3,5.7,5.9,64,6,6.4,7,8.1,5.6,6,4.5,4.2,51.7,7.1,4.8,6.6,5.6,6.7,10.6,7.9,4.6,7.6,4.9,4.4,4.8,4.8,17.5,6.1,5.8,5.1,4.3,13,4.6,10.1,6.8,10,2,9,6.3,10.4,5.8,16.7,17.4,11.1,14.6,10.3,3.7,69.3,6.1,4.1,9.3,6.4,25.6,6,11.6,9.3,3.3,10.1,9.4,23.7,7,6.5,9,13.9,20.6,7.4,39.2,12.2,26.4,10.8,12.9,6,11.4,8.9,2.6,8.3,9.5,30.1,4.8,5.9,34.4,8.9,12.9,32,19.4,6.4,15.1,13.1,16.8,5.3,16.1,9.4,13.9,6.6,74.6,8.8,11.3,16.6,5.7,3.8,10.3,14.1,6.2,16.3,8,18.3,18.5,5.6,18.6,14.4,0.1,6.5,2,8.5,7.3,10.4,6.8,8.3,8.2,9.7,6.7,8.5,10.1,0.3,6.3,9,10,8.2,5.8,5,8.5,7.9,8.1,5.3,5.7,7,8.1,7.1,6.1,0,4.1,13.4,6.8,7.1,4.5,5.9,7.6,4,2.3,7,3.9,98.8,1.7,9.6,11.6,3.8,6,0,7,89.2,5.4,7.1,0,36,19.5,11.1,5.2,7.4,10,25.3,6.6,6.5,0,78.5,6.8,3.9,6.2,2.9,13.1,3.6,3.4,12.9,5.9,31.1,18.5,5.5,190.6,7.5,13.3,6.4
SLC5A7,"CHT1, hCHT",ENSG00000115665,Solute carrier family 5 member 7,Q9GZV3,2,107986523-108013994,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport",NA,"Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,NA,Tissue enriched,Detected in many,9,brain: 45.1,Group enriched,Detected in some,13,Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Club cells: 5.7,Cancer enhanced,Detected in single,NA,testis cancer: 0.8,Group enriched,Detected in some,13,basal ganglia: 13.8;pons and medulla: 45.1,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,19,RT4: 8.9;SCLC-21H: 2.6,Group enriched,Detected in many,4,basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1,Region enhanced,Detected in some,NA,pons and medulla: 26.3,HPA046105,NA,NA,Approved,"Nuclear bodies,Cell Junctions,Intermediate filaments",NA,NA,NA,NA,NA,"Cell Junctions, Intermediate filaments",Nuclear bodies,HPA046105:,unprognostic (2.98e-1),NA,unprognostic (1.01e-1),NA,NA,NA,NA,unprognostic (1.29e-3),NA,NA,unprognostic (7.10e-2),unprognostic (1.66e-1),unprognostic (3.39e-4),unprognostic (1.05e-2),unprognostic (9.78e-3),unprognostic (6.42e-2),unprognostic (1.61e-2),0.3,2.4,0.1,1.6,13.8,0,0.3,0.1,0.4,3.3,5.2,0.1,0.3,2.3,1.6,0.7,1,0.2,0.5,1.2,0.2,2.2,0.9,0.2,0.9,0,0.3,0.5,0.8,0.5,0,0.1,0,45.1,0.8,2.5,1,0.9,4.2,0.1,0.1,2.5,3.1,10,0.1,1.7,0.3,0.8,0,4,0.3,0.1,4.4,1.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,8.9,2.6,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,13.8,0.1,0.4,0.2,2.2,0.3,0.5,45.1,0.8,3,0,0,0,0,0,0.3,0,2.7,5.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0.1,0,0,0,0,0.3
SLC5A9,SGLT4,ENSG00000117834,Solute carrier family 5 member 9,Q2M3M2,1,48222685-48248644,"Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,11,intestine: 77.3,Cell type enhanced,Detected in some,18,Alveolar cells type 1: 20.8;Early spermatids: 5.8;granulocytes: 4.6;Late spermatids: 7.9,Cancer enhanced,Detected in many,NA,liver cancer: 4.1,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in some,8,Hep G2: 18.3,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,HPA050263,NA,NA,Approved,"Actin filaments,Cytosol",NA,NA,NA,NA,NA,Actin filaments,Cytosol,HPA050263:,unprognostic (3.09e-3),unprognostic (1.89e-1),unprognostic (6.75e-2),unprognostic (5.66e-2),unprognostic (2.36e-1),unprognostic (1.35e-3),unprognostic (3.64e-2),unprognostic (4.59e-2),unprognostic (3.60e-2),unprognostic (1.59e-1),unprognostic (7.42e-2),unprognostic (1.97e-1),prognostic unfavorable (1.84e-5),unprognostic (4.56e-1),unprognostic (2.11e-1),unprognostic (4.30e-3),unprognostic (1.06e-2),0,0.1,0,0.2,0,0,0,0.1,0,0.1,33,0.1,0.8,26,0.1,7.2,0.1,0.2,2.2,0.1,0,0,3.1,4.9,2,0,0,0,0,2.3,0,0,0,0,0.1,0.2,0,0.1,0.4,0,1,77.3,0,0,0,0.4,0.5,0,0,0.1,0,0,0,0.1,0,0.4,0.5,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.1,0,0,0,0,0,0,0,0,0,0,0.1,0,0,18.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0.1,0,0,0.5,0,0,0,0,0,0,0.4,0,0,0,0.1,0,0.2,0,0,0,0,0,0.1,0,0,0,0,0,0,0,20.8,1,0,0,0.1,0,0.4,2.5,0,0,0,0,0,1.7,0.4,5.8,0,0.7,0,0.2,0,0,0.1,4.6,4.5,0.1,0,0,0,1.2,7.9,0.3,0,0,0,0.6,0,0.1,1.1,0.4,3.4,0,0,0,0.1,0.2,0,0,0,0.2,0
RSC1A1,RS1,ENSG00000215695,Regulator of solute carriers 1,Q92681,1,15659869-15661722,Predicted intracellular proteins,"Transcription, Transcription regulation",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,NA,NA,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in many,NA,NA,NA,NA,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA027813, HPA028676",Approved,NA,Supported,"Nucleoplasm,Cell Junctions",NA,NA,NA,NA,NA,Nucleoplasm,Cell Junctions,"HPA027813: AB_10600308, HPA028676: AB_10600895",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,0.9,0.3,1.7,0.4,2.8,2.6,0.1,0.6,2.2,0.6,NA,NA,0,1.2,0,3.5,1.2,1.1,2.9,0.3,0.5,4,7.7,2.7,2,0.4,NA,4.6,0.2,2.1,1.3,2.3,NA,3.9,1.3,NA,0.1,0.8,0.6,2.1,0.6,3,0.8,0.1,0.6,4.7,NA,NA,1.7,NA,3.2,1.1,2.2,1.1,2.8,0.5,3.5,1.7,2.3,1.5,3.3,3.9,4.8,3.2,6,4.2,6.4,2.8,4.7,7.9,7.4,6.4,5.5,7.4,2.8,6.3,3.9,2.3,12.5,4,9.7,4.9,3.1,6.9,7.7,6.8,1.3,10.1,3.5,3.3,0,13.6,7.5,1.8,4.9,5,19,7,5.7,3.3,5.3,0,5.2,1.9,2.2,4.5,6.8,3.1,1.8,6.2,3.9,1.6,5.3,2.4,4.6,4.3,3.4,0.9,4.8,4,7.4,3.6,2.1,2.1,4,12.9,1.6,2.7,2.8,0,1.2,0.5,0.4,3.5,1.4,1.1,0.5,2.3,2.8,0.2,0.6,0.5,0,1.7,0.1,0.7,2.3,1.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
SLC6A2,"NAT1, NET, NET1, SLC6A5",ENSG00000103546,Solute carrier family 6 member 2,P23975,16,55655604-55706192,"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",NA,"Disease mutation, FDA approved drug targets",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,adrenal gland: 20.4;placenta: 41.8,Group enriched,Detected in some,5,Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7,Cancer enhanced,Detected in some,NA,liver cancer: 1.9,Region enriched,Detected in single,27,pons and medulla: 9.7,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in some,30,SH-SY5Y: 107.1,Region enriched,Detected in some,4,pons and medulla: 8.2,Region enriched,Detected in single,32,pons and medulla: 23.1,"HPA004057, HPA076311, CAB078195",Enhanced,Supported,Approved,"Mitochondria,Cytosol",NA,NA,NA,NA,NA,Cytosol,Mitochondria,"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307",unprognostic (9.58e-3),unprognostic (5.48e-2),NA,unprognostic (1.26e-4),unprognostic (4.07e-1),unprognostic (4.16e-1),unprognostic (8.38e-2),unprognostic (2.97e-2),unprognostic (3.29e-1),unprognostic (2.31e-1),unprognostic (3.27e-1),unprognostic (2.12e-2),unprognostic (2.95e-2),unprognostic (1.72e-1),unprognostic (6.02e-2),unprognostic (8.48e-2),unprognostic (1.43e-2),2.4,20.4,0.3,0.1,0.1,0,1.8,0.1,0.3,3.2,0.3,0.3,0.1,0,4.5,7.2,0.8,0.4,0.4,0.1,0.1,0,0.4,1,0.5,0.1,0.1,0.1,0.2,0.1,0,0.1,41.8,9.7,0.5,0.1,0.1,1.6,1.7,0.1,11.4,0.4,1,0.2,0.1,0.2,8.3,0.2,0.1,0.2,0.9,0.5,0.5,1.7,0,0.2,0.1,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.6,0,0,0,0,0,0,0,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,1.1,0.8,107.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0.1,0.2,0,0,0,0,0,0,0,0,0,0.3,0.1,0.1,0.3,0.1,0,0.1,0.1,9.7,0.2,0,0,0,0.1,1.3,0,0.8,0,0,0,0,0,0.1,0,0,3.2,0,0,0,0,6.9,0.4,0.1,0,0,0.2,0,0,0,0,3.7,0.6,0,0,0,0,0,0,0,0,0,0,0,0,10.4,0.1,0.4,4.7,0,0,0
SLC6A16,NTT5,ENSG00000063127,Solute carrier family 6 member 16,Q9GZN6,19,49289638-49325225,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,13,testis: 102.2,Cell type enhanced,Detected in many,16,Early spermatids: 81.2;Late spermatids: 36.5;Spermatocytes: 90.2,Low cancer specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in many,NA,AF22: 17.3;SuSa: 10.0,NA,NA,NA,NA,NA,NA,NA,NA,HPA076812,NA,NA,Supported,Golgi apparatus,NA,NA,NA,NA,NA,Golgi apparatus,NA,HPA076812: AB_2686816,unprognostic (1.98e-1),unprognostic (7.15e-3),unprognostic (6.39e-3),unprognostic (1.36e-1),unprognostic (1.29e-1),unprognostic (6.83e-3),unprognostic (7.89e-2),unprognostic (7.92e-2),unprognostic (1.77e-2),unprognostic (1.21e-1),unprognostic (2.55e-3),unprognostic (1.63e-1),unprognostic (3.23e-2),unprognostic (3.31e-1),unprognostic (2.10e-1),unprognostic (8.93e-2),unprognostic (4.18e-2),1.5,0.4,0.8,1.1,0.9,1.9,1,0.8,0.8,1.3,1.1,0.8,0.8,0.3,1.5,1,0.8,2,1,0.8,0.8,0.3,2,3.6,1.6,3.1,0.8,0.8,2.9,2.6,0.7,0.8,1.3,0.8,1.8,0.3,0.9,0.8,1.2,0.8,0.7,1.2,0.8,0.8,1.7,1,102.2,0.8,0.8,1.1,0.8,2.4,0.8,1.2,7.8,2.1,4.8,3.7,3.8,3.1,2.2,0,6.8,17.3,6.2,0.3,2.8,3.1,0.9,1.4,0.6,1.9,0.4,0.5,8,1.1,0.7,0.3,0.2,1.9,0.3,2.1,1.3,2,0.7,0.7,1.5,1.3,0.5,2.9,2.7,1.1,1.3,0.9,5.1,1.5,1.4,1.5,1.1,2.2,1.5,0.4,0.5,6.1,0.3,0.9,0.3,4.2,1.5,0.9,0,0.2,0.3,2.7,0.1,0.6,10,2.8,0.2,8.6,1.4,6.6,4,0,3.8,4,7.2,0.1,1.9,0.4,0.4,0.8,4.8,3.1,2.2,3,7.8,1.1,3.1,0.8,4.5,2.7,1.8,4,3.8,3.7,2.1,1.7,2.2,0.8,0.9,0.8,0.8,0.8,0.3,0.8,0.8,0.8,0.8,0,0.6,3.7,0.8,1.3,6.3,1.2,2.5,17.4,0,1.8,2,0,10,0.6,81.2,3.9,0,0,0.5,0,1.6,0.4,1.1,4.9,0.7,0,0,1.3,0.3,36.5,3.4,0.8,5,0,0,0.5,0.3,0,3.2,0,1.3,0,7.2,90.2,2.1,1.1,0,0.5,0,0.2
SLC6A17,NA,ENSG00000197106,Solute carrier family 6 member 17,Q9H1V8,1,110150486-110202202,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",NA,"Disease mutation, Mental retardation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,4,brain: 53.5,Cell type enhanced,Detected in some,22,Bipolar cells: 2.1;Melanocytes: 10.1;Rod photoreceptor cells: 3.6,Cancer enriched,Detected in some,9,melanoma: 17.0,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in some,5,SK-MEL-30: 28.3,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA008043, HPA008044",Enhanced,NA,Approved,Mitochondria,NA,NA,NA,NA,NA,Mitochondria,NA,"HPA008043: , HPA008044: AB_1857192",unprognostic (1.13e-1),unprognostic (1.37e-3),unprognostic (5.52e-3),unprognostic (3.00e-2),unprognostic (1.17e-1),unprognostic (4.88e-2),unprognostic (6.11e-3),unprognostic (3.87e-3),unprognostic (1.70e-2),unprognostic (1.80e-1),unprognostic (1.68e-2),unprognostic (2.94e-1),unprognostic (1.89e-2),unprognostic (1.73e-2),unprognostic (9.76e-2),unprognostic (1.38e-3),unprognostic (1.68e-3),1.4,7.8,9.3,1.2,18.3,1.1,1.3,21.8,53.5,1,1.1,2.3,0,1,1,2.1,1.3,1,1.1,1,11.2,14.9,2.1,0.9,1,0.9,6,16.2,1,2.6,1,12.4,1.8,19.5,1,1,2.6,1.2,1,1,7.6,1.1,1.1,1.8,1,1.8,2.4,0.7,0,1.3,0,0.9,1,0.1,0.3,0,0.8,0,0,0.3,0,0,1.1,0,0,0,0,0,4.3,0.4,1.7,0.2,0,0,0,0.2,0.2,0,0.1,0,0,1.5,0,0,0,0.1,0,0,0,0,0,0,0,0,0.5,0,0,0,0.1,0.8,0.1,0,0,0.1,0,0,0,0,0,0.1,0,2.3,0.6,4.8,1.5,28.3,0.8,0.7,0,0,0,0.5,0,0,0.1,0,0,5.7,0,2.5,0,0,0.5,0.3,0,0,0,0,0,0,0.3,0,0,0.8,0,0,0,0,0,9.3,18.3,21.8,37.3,11.2,14.9,6,16.2,19.5,0.7,0,0,0,0,0.5,2.1,0.8,0,0,0,0,0,0,1.7,0,0.9,0,0,0,0,0.3,0.2,0,0,0,0.1,0,0,0,0,0.4,0,0,10.1,0,0,0.5,0.3,0,0,0,3.6,0,0.4,0,1.1,0.4,0.1,0,0,0
SLC6A18,"FLJ31236, Xtrp2",ENSG00000164363,Solute carrier family 6 member 18,Q96N87,5,1225355-1246189,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Amino-acid transport, Neurotransmitter transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enriched,Detected in single,32,kidney: 14.1,Group enriched,Detected in some,71,Distal tubular cells: 6.6;Proximal tubular cells: 21.3,Cancer enriched,Detected in single,44,renal cancer: 4.2,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in single,NA,MCF7: 1.3,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,HPA011885,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA011885: AB_1857198,NA,NA,unprognostic (2.02e-1),NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (5.69e-3),unprognostic (2.90e-1),NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0.2,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0.2,0.1,0,0,1.3,0,0.4,0.6,0,0,0,0.6,0.3,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,6.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,21.3,0,0,0,0,0,0,0,0,0,0
SLC6A5,"GLYT2, NET1",ENSG00000165970,Solute carrier family 6 member 5,Q9Y345,11,20599400-20659285,"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,4,brain: 21.3,Group enriched,Detected in some,27,Early spermatids: 20.8;Late spermatids: 40.6,Not detected,Not detected,NA,NA,Region enriched,Detected in some,6,pons and medulla: 21.3,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enriched,Detected in single,5,SCLC-21H: 2.6,Region enriched,Detected in some,9,pons and medulla: 51.6,Region enriched,Detected in some,9,pons and medulla: 33.2,CAB079052,NA,Supported,NA,NA,NA,NA,NA,NA,NA,NA,NA,CAB079052:,NA,NA,NA,NA,unprognostic (6.94e-2),unprognostic (2.28e-1),NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (4.75e-2),NA,NA,0,0.1,0.1,0.1,0,0,0,3.3,0.4,0.1,0,0,0,0,0,0,0,0,0,0.2,0.3,0.1,0,0,5.1,0.1,0.1,0,0,0,0,2.2,0,21.3,0,0,0,0.1,0,0,0,0.1,0.1,6,0,0,1.8,0,0.2,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.6,0.1,0,0,0,0.2,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,3.3,0.4,0.3,0.1,0.1,0,21.3,0,0,0,0,0,0,0,1.1,0,0,0,0,0,0,0,0,20.8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40.6,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0.2,0,0,0,0,0
SLC6A1,"GABATHG, GABATR, GAT1",ENSG00000157103,Solute carrier family 6 member 1,P30531,3,10992186-11039249,"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",NA,"Disease mutation, Epilepsy, FDA approved drug targets",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in many,7,brain: 56.2;liver: 75.6,Cell type enhanced,Detected in some,16,Cholangiocytes: 17.8;Hepatocytes: 24.5;Muller glia cells: 41.9;Sertoli cells: 12.9,Group enriched,Detected in some,16,glioma: 16.1;liver cancer: 24.4,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in some,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,HeLa: 4.6,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA013341, CAB022293",Enhanced,NA,Uncertain,Mitochondria,NA,No,NA,NA,NA,Mitochondria,NA,"CAB022293: , HPA013341: AB_1849509",unprognostic (1.66e-3),unprognostic (1.30e-3),unprognostic (4.12e-3),unprognostic (1.70e-1),unprognostic (2.53e-1),unprognostic (2.53e-1),prognostic favorable (3.20e-4),unprognostic (1.05e-1),unprognostic (4.27e-2),unprognostic (8.26e-2),unprognostic (2.90e-1),unprognostic (2.69e-1),prognostic unfavorable (5.05e-6),unprognostic (7.32e-3),unprognostic (2.36e-1),unprognostic (1.35e-1),unprognostic (5.34e-2),1.8,2.1,32.2,1.6,31,3,1.8,15.1,56.2,2,1.7,25.4,0,1.7,1.9,3.9,4.3,2.4,2.3,3.3,22.2,16.6,2.1,75.6,2.5,1.7,22.7,25.3,2.4,1.4,9.3,1,2,17,2.1,1.8,1.7,1.6,5,3.3,1.7,1.7,1.8,13.7,1.9,1.7,4.4,14.3,0.5,1.9,0,1.7,1.9,0.9,1,0.8,1.2,0.3,0.2,0.8,0.2,0.8,0.6,1.9,1.3,1.5,0.4,1.1,0.7,0.2,0.8,1.1,1.5,1,1.6,0.3,0.4,1.8,1.3,2.3,0.9,0.7,0.2,1.8,1.3,4.6,2.8,0.7,2.2,2.3,1.1,0.2,0.2,1.3,0.5,0.3,1.7,1.1,3.7,0.2,1.1,0.7,1.8,0.8,1.2,1.4,1.2,0.2,0.1,0.6,1.8,0.8,0.3,1,0.7,0.2,1.1,1,1,0.3,0.8,0.5,0.7,0.7,1.1,0.3,1.2,0.9,1.7,0.4,0.3,0.3,1.1,0.5,0.1,0.8,0.9,0.6,0.5,0.3,1,0.3,0.5,1.2,0.2,0.3,0.8,0.3,0.2,32.2,31,15.1,41.5,22.2,16.6,22.7,25.3,17,14.3,0,0.3,0,0,0.2,1.8,1.4,17.8,0,1.2,0,0,0,0,0,1.4,0.3,0,0,0,0,0,0,2.3,24.5,0,0,0,0,1,0.2,5.2,0,0,0,0,41.9,0,0,9.6,0.1,3.3,12.9,2.1,5,0,0,0,0,0,0
SLC6A11,GAT3,ENSG00000132164,Solute carrier family 6 member 11,P48066,3,10816200-10940733,"Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in many,6,brain: 37.0;esophagus: 10.5;skin 1: 11.5,Cell type enhanced,Detected in some,19,Bipolar cells: 7.9;Extravillous trophoblasts: 6.2;Muller glia cells: 21.8;Peritubular cells: 6.3,Cancer enhanced,Detected in many,NA,glioma: 7.8,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in single,NA,NA,Low lineage specificity,Detected in single,NA,NA,Cell line enhanced,Detected in some,NA,A-431: 4.7;HaCaT: 12.7;Hep G2: 14.6;hTCEpi: 11.5;NTERA-2: 6.4;SH-SY5Y: 4.4;T-47d: 4.8,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA037981,Supported,Supported,Uncertain,"Nucleoplasm,Vesicles",NA,NA,NA,NA,NA,Nucleoplasm,Vesicles,HPA037981: AB_10671383,unprognostic (6.04e-2),unprognostic (8.01e-2),NA,unprognostic (1.21e-7),unprognostic (8.60e-2),unprognostic (8.68e-2),unprognostic (9.72e-3),unprognostic (6.39e-3),unprognostic (9.77e-2),unprognostic (2.35e-1),unprognostic (3.92e-2),unprognostic (8.78e-2),unprognostic (1.51e-3),unprognostic (6.06e-2),unprognostic (4.44e-2),unprognostic (9.83e-2),unprognostic (2.31e-2),0.8,0.8,11.5,0.7,14.1,0.8,2.9,3.1,23,0.9,0.8,5,0,0.7,1.7,1.1,10.5,1.8,0.7,0.8,8.4,24.5,0.7,0.9,0.8,0.7,37,5.9,0.8,1,0.7,0.2,1.6,35.4,2.3,0.8,0.4,1.1,0.7,1,11.5,0.8,1,10.4,1.5,0.7,3.4,9.2,0,0.8,0.2,1.1,1.3,0.7,0.5,0.3,1.2,0.4,0.2,0.3,0,4.7,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0.7,12.7,0,2.1,0,0,0.2,0.2,0,14.6,0,0,0,0,11.5,0,0,0,0,0,0,0,0,0,0,0,6.4,0,0,0,0,0,0,2.9,1.8,4.4,3.7,0.1,0,0.1,4.8,0.1,0,0,1.5,0,0,0,0,0,0,0.1,0.2,0.5,0.3,0.2,0.1,0.2,0.1,0.2,0.2,0.1,0,0.5,0.2,0.2,1.2,0.2,0.4,0.3,0.3,0,11.5,14.1,3.1,14.7,8.4,24.5,37,5.9,35.4,9.2,0,0,0,0.2,1.1,7.9,0.8,0,0,0,0,0,0.6,0,0,0.4,0,0,0,0,6.2,0.2,0.4,0,0,0.4,0,0,0,0,0.4,3.1,0,0,0,0,21.8,0.3,0,6.3,0,1.3,0,0,0.2,1.5,3.1,0.8,0,0,1.5
SLC6A12,BGT-1,ENSG00000111181,Solute carrier family 6 member 12,P48065,12,190077-214570,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,kidney: 22.1;liver: 59.3,Cell type enhanced,Detected in some,18,Collecting duct cells: 43.6;Hepatocytes: 17.4;monocytes: 17.2,Cancer enhanced,Detected in many,NA,renal cancer: 11.9,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in some,57,classical monocyte: 6.6;intermediate monocyte: 6.4;myeloid DC: 2.9;neutrophil: 3.7;non-classical monocyte: 8.6,Group enriched,Detected in many,51,dendritic cells: 2.9;granulocytes: 3.7;monocytes: 8.6,Cell line enhanced,Detected in some,NA,Hep G2: 8.4;RPTEC TERT1: 17.0;SuSa: 3.7,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,HPA034973,Approved,NA,Approved,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,HPA034973: AB_10610427,unprognostic (3.48e-1),unprognostic (4.73e-2),unprognostic (8.69e-2),prognostic unfavorable (1.59e-4),unprognostic (1.70e-1),unprognostic (1.09e-1),unprognostic (1.88e-2),unprognostic (8.30e-2),unprognostic (6.96e-3),unprognostic (2.70e-2),unprognostic (1.85e-2),unprognostic (3.68e-1),prognostic favorable (2.70e-6),unprognostic (2.30e-1),unprognostic (4.92e-4),unprognostic (3.35e-1),unprognostic (4.31e-4),0.6,0.8,6.3,1.3,12.9,0.6,0.8,6.6,14.7,0.9,1,4.3,0,3.7,1.3,5.6,0.5,3,1.2,0.7,7.2,4.6,22.1,59.3,2.2,0.8,8.1,4.9,0.7,1.3,0.6,0.3,0.9,9.4,0.6,1.8,0.2,0.6,0.5,0.5,0.7,1.1,1.2,3.1,0.8,2.3,1.6,8.8,0,4.5,0,0.7,0.9,0.2,0,2.9,3.7,8.6,0,0,1.9,0,0.3,0,0,0,0,0,0,0,0,0,1,0.1,0,1,0,0.9,0,0.1,0,0,0,0.3,0,0,8.4,0,0.1,0,0,0,0,0,0,0,0,0,0.5,0,0,0,0,0.2,0.1,0,0,0,0,17,0.1,0,0.5,0,0,0.1,3.7,0.3,0.5,0,0,0.6,0,0.1,0.1,0,0,0,1,0,0,6.6,0,0,6.4,0,0,0,0,2.9,0,0,0,3.7,0,8.6,0,0,1.9,6.3,12.9,6.6,14.7,7.2,4.6,8.1,4.9,9.4,8.8,0,0.3,0.9,0,0.1,0,0.4,0,0,0,43.6,0,0,1.7,0,3.6,0,0,0,0.3,0,0.6,0,0,17.4,2.4,0,0,1.3,0.3,3.4,0.6,1.8,0,17.2,1.2,6.3,0,0,0,6.8,0.2,6.5,0,0.5,1.7,0.4,0.7,0,0.8,0
SLC6A13,GAT2,ENSG00000010379,Solute carrier family 6 member 13,Q9NSD5,12,220621-262873,"Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in some,7,kidney: 77.6;retina: 95.9,Cell type enriched,Detected in some,6,Proximal tubular cells: 261.2,Cancer enriched,Detected in some,18,renal cancer: 32.1,Low region specificity,Detected in all,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,5,RPTEC TERT1: 10.0;SuSa: 3.7,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA036449, HPA052726",NA,NA,Supported,"Nucleoplasm,Nucleoli,Mitochondria,Cytosol",NA,NA,NA,NA,NA,Mitochondria,"Nucleoplasm, Nucleoli, Cytosol","HPA036449: AB_2675130, HPA052726: AB_2681927",unprognostic (8.45e-3),unprognostic (4.20e-1),unprognostic (5.44e-2),unprognostic (1.64e-5),unprognostic (1.13e-1),unprognostic (8.02e-2),unprognostic (1.32e-2),unprognostic (1.30e-1),unprognostic (1.75e-1),unprognostic (2.15e-1),unprognostic (7.21e-4),unprognostic (2.93e-1),unprognostic (1.25e-3),unprognostic (3.79e-2),unprognostic (2.62e-1),unprognostic (6.23e-2),unprognostic (1.91e-1),0.6,0.5,3,0.4,5.8,0.5,0.5,2.1,5.8,0.5,0.5,2.5,0,1.8,0.5,0.9,0.4,4.2,0.5,1,3.1,2.4,77.6,13.2,0.9,0.5,3.4,4.1,0.5,0.4,0.4,1,0.5,4.8,0.5,0.5,95.9,0.5,0.5,0.6,0.6,0.8,0.4,5.7,0.5,0.5,1.1,2.1,0,4.9,0,0.5,0.5,0,0.4,0,0,0,0.6,0.9,0.3,0,0,0.1,0.3,0.1,0.2,0.2,0.2,0,0,0,0.5,0,0,0.5,0.1,0,0.1,0,0,0,0.4,0.1,0,0.6,0,0,0,1.3,0.2,0.1,0,0,0.3,0,0.5,0.4,0.4,0.5,0,0,0.2,0.1,0,0,0.2,0,0.1,10,0.1,0.1,0,0.1,0,0.9,3.7,0,0,0.3,0.2,1,0,0.4,1.4,0.9,0,0,0,0.2,0,0,0,0.3,0,0,0,0,0,0,0.4,0.9,0,0,0.6,0,0,0,0.3,3,5.8,2.1,5.8,3.1,2.4,3.4,4.1,4.8,2.1,0,1.1,0.5,0,0,0.2,1.3,0,1.4,0,17.4,2,0,41.4,0,1.1,0,0,0,0,0,0.2,0,0,19.7,0,0,0,0.6,0.6,0.4,0.3,0,0,0,0,0,0,0,0,261.2,0.8,0,0,0.5,0.5,0,0.2,0,0,0
SLC6A14,NA,ENSG00000268104,Solute carrier family 6 member 14,Q9UN76,X,116436622-116461458,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Amino-acid transport, Symport, Transport",NA,Obesity,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5,Cell type enhanced,Detected in some,15,Alveolar cells type 2: 100.3;Club cells: 33.0;Exocrine glandular cells: 28.5;Pancreatic endocrine cells: 101.5,Low cancer specificity,Detected in many,NA,NA,NA,NA,NA,NA,Low cell type specificity,Detected in single,NA,NA,Low lineage specificity,Detected in single,NA,NA,Cell line enhanced,Detected in some,NA,HeLa: 3.8;Hep G2: 8.2;OE19: 3.0,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,HPA003193,Uncertain,NA,Approved,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,HPA003193: AB_2190122,unprognostic (3.06e-2),unprognostic (3.55e-2),unprognostic (8.49e-2),unprognostic (1.00e-3),unprognostic (1.30e-3),unprognostic (1.49e-2),unprognostic (7.41e-3),unprognostic (3.67e-3),unprognostic (2.66e-1),unprognostic (1.83e-2),prognostic unfavorable (9.74e-4),unprognostic (1.34e-2),NA,unprognostic (3.89e-2),unprognostic (2.08e-2),unprognostic (1.71e-1),unprognostic (1.59e-1),0,0,0,1.5,0,0,5.9,0,0,6.3,0.8,0,11.8,0.4,0.1,0,1.8,0,1,0,0,NA,0,0,17.8,0,0,0,0,0,0,14.4,0,0.2,0.5,0.3,0,26.3,5.8,0,1.1,0.2,0,0,0,3,0,0,0,0,23.5,1.2,1,1,0.4,0.2,1.1,0.4,0.3,0.4,0,0,0.1,0,0.1,0,0,0,0,0,0,0,0.1,0.1,0.1,0.1,0,0,0.8,0,0.1,0,0.1,0,0,3.8,8.2,0,0.1,0.2,0,0.3,0,0,0,0,0,0,0.1,0,0.1,0,0.1,0,3,0,0.2,0,0.5,0,0.5,0.1,0.1,0,0.1,0,0,0.1,0,0,0.1,0.3,0.2,0,1.4,0.5,0,0,0.1,0,1.1,0.4,0.5,0.4,0.1,0.3,0.4,0.2,0.2,0.1,0.4,0.3,0.3,0.4,0.3,0.2,0.2,0.1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20.8,100.3,0,0.1,0.1,0,0.2,0,10.7,33,0,0,0,0,12.9,0,0,0.2,0,28.5,0,0,5.2,3.5,0,0,0,2.4,0,0,0,0,0,15.1,0,0.1,0,101.5,0.9,0,0,0,0,0.1,0,0,0.4,0,0,1,3.2
SLC6A15,"FLJ10316, hv7-3, NTT73, SBAT1, V7-3",ENSG00000072041,Solute carrier family 6 member 15,Q9H2J7,12,84859488-84913615,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 31.0,Cell type enhanced,Detected in some,18,Bipolar cells: 18.0;Horizontal cells: 11.1;Melanocytes: 30.4;Rod photoreceptor cells: 10.2,Cancer enhanced,Detected in some,NA,melanoma: 7.6,Low region specificity,Detected in all,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in many,NA,ASC diff: 31.1;ASC TERT1: 19.2;hTERT-HME1: 43.9;SCLC-21H: 30.0;SK-MEL-30: 22.1,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA008609,Uncertain,NA,Approved,"Nucleoli,Vesicles",NA,NA,NA,NA,NA,Nucleoli,Vesicles,HPA008609: AB_1857190,unprognostic (1.01e-4),unprognostic (9.02e-2),unprognostic (1.27e-1),unprognostic (6.65e-6),unprognostic (1.25e-2),unprognostic (2.92e-1),NA,unprognostic (7.65e-3),unprognostic (1.13e-1),unprognostic (1.97e-1),unprognostic (1.51e-1),unprognostic (4.05e-2),unprognostic (7.69e-4),unprognostic (2.57e-2),unprognostic (3.80e-1),unprognostic (1.23e-2),unprognostic (2.63e-3),1.4,4.5,18,2.2,16.2,1,2.3,17.8,31,1.7,2.2,5.4,0,1.4,2.8,1.1,6.7,1.2,1.3,1,10.9,18.2,1.5,1,1.3,1.1,10.3,16.9,2.1,1,1,5.6,8.9,14.7,1.8,1.8,9.2,1.4,1.5,1,4.9,2.1,1.6,4.9,1.1,1.3,3.6,12.8,0,2,1.8,1.8,1.1,1.5,0.9,0,0,0,0,0,0.1,0,0.5,3.6,0,31.1,19.2,0,0,6.5,0.5,0.3,0,0,0,0,0.2,4.1,0.4,0,8.3,0,0,9.5,0,1.5,0,11.5,0,0.2,10.7,16,4.2,43.9,8.5,0.1,0,0,0,7.9,0,0,0,10.2,0,0,0,0,0,0,0,30,7.8,0,9.9,22.1,0.1,0,0,0,4.7,2.5,0,0,0,0,0,8.2,0,8.9,0,0,0,0,0,0,0,0,0,0,0.9,0,0,0,0,0,0,0,0.1,18,16.2,17.8,18.6,10.9,18.2,10.3,16.9,14.7,12.8,0,0,0,0,2.4,18,0.4,0,0,0,0,5.9,0.3,0,0,0.8,0,0,0,0,0.3,1.3,0.1,0,0,0.1,11.1,0,0,0,0.2,0,0,30.4,0,0,1,0,0,0,0,10.2,0,0.2,0.1,0.4,0.5,0.2,0,0,0
SLC6A19,NA,ENSG00000174358,Solute carrier family 6 member 19,Q695T7,5,1201595-1225117,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Amino-acid transport, Symport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,6,intestine: 167.3,Group enriched,Detected in some,6,Cholangiocytes: 63.7;Enterocytes: 25.3;Proximal tubular cells: 65.4,Cancer enhanced,Detected in many,NA,renal cancer: 7.9;stomach cancer: 5.6,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,5,BEWO: 14.4;HEL: 17.6;OE19: 4.8,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,"HPA037415, HPA043207",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA037415: AB_10672346, HPA043207: AB_2678363",NA,NA,unprognostic (1.26e-1),NA,NA,NA,unprognostic (1.01e-3),NA,NA,NA,unprognostic (6.04e-2),unprognostic (3.64e-1),prognostic favorable (4.14e-6),unprognostic (1.37e-1),unprognostic (7.36e-2),NA,NA,0.1,0.1,0.1,0,0.1,0,0.1,0.1,0.1,0.1,55.3,0,0,44.6,0.1,0,0.1,0.1,30,0.1,0.1,0.1,28.7,0.5,0.1,0,0.1,0,0.1,0.4,0,0.1,0,0,0.5,1.7,0,0.1,0,0.1,0.1,167.3,0,0.1,0.1,0.3,0.1,0,0,0.1,0,0,0.1,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,14.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17.6,0,0.2,0,0,0,0,0,0,0,0,0,0,2.5,0,0,0,0,0.4,0,4.8,0,0,0,0.9,0,0,0,0.2,0,0,0,1.4,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0,0,0,0,0,0.5,0,0,0,0.8,63.7,0,1.2,1.8,0,0,1.7,0,0.1,0,25.3,0,0,8.5,0,0,0,0,0.2,0,4.6,0,0,0,0,0,0,0,2.8,0,0,5.8,0,65.4,0,0,0,0,0,0,0.2,0,1.8,0
SLC6A20,"XT3, Xtrp3",ENSG00000163817,Solute carrier family 6 member 20,Q9NP91,3,45755450-45796535,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Amino-acid transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in many,5,gallbladder: 14.3;intestine: 25.5;retina: 51.3,Cell type enhanced,Detected in some,13,Alveolar cells type 2: 5.3;Cholangiocytes: 12.7;Ductal cells: 10.1;Pancreatic endocrine cells: 6.2,Low cancer specificity,Detected in many,NA,NA,Region enhanced,Detected in many,NA,pons and medulla: 6.1,Cell type enhanced,Detected in some,NA,neutrophil: 2.6,Low lineage specificity,Detected in single,NA,NA,Group enriched,Detected in some,4,HaCaT: 3.1;OE19: 7.1;SuSa: 10.3,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,HPA029873,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA029873: AB_10602403,unprognostic (1.57e-1),unprognostic (5.26e-2),unprognostic (1.10e-1),unprognostic (2.70e-2),unprognostic (1.48e-1),unprognostic (9.43e-3),unprognostic (3.26e-2),unprognostic (4.33e-3),unprognostic (2.76e-1),unprognostic (1.34e-1),unprognostic (1.68e-3),unprognostic (1.46e-1),prognostic favorable (1.55e-5),unprognostic (2.87e-1),unprognostic (1.23e-1),unprognostic (7.55e-2),unprognostic (2.09e-2),0.3,0.1,0.3,0.6,0.8,0.5,0.7,1.5,2.2,2.4,11.2,3,0.4,22.3,1.3,1.7,0.1,0.4,14.3,0.1,0.5,0.4,3.3,0.2,1.9,0.2,1,1.7,0.1,5.1,0,2,0.1,6.1,1,0.2,51.3,1.3,0.1,0.9,0.6,25.5,0.3,1.5,0.1,4.7,0.4,0.3,0,0.1,0.4,0.1,0.2,0.3,0.8,0.7,2.6,0.2,0.5,0.4,0.1,0.2,0.4,0.4,0.4,0.1,0,0.5,0.1,0,0,0,1.6,1.4,0.2,1.1,0,0.3,3.1,0.1,0,0.2,0.1,0.2,1.3,1.2,0.2,0,0,0.2,0.1,0.7,0,0.1,0.2,0,0.5,0.2,0.5,0,0.3,0.5,0.3,1.4,7.1,0.3,0.5,0.1,0.4,0.2,0.3,0.4,0.4,1.5,0.2,0,10.3,0.3,0.1,0.1,0.5,0.4,0.4,0.3,0.8,0.3,0.1,0.2,0.3,0.1,1,0.2,0.2,0.3,0.1,0.3,0.2,0.2,0.2,0.1,0.8,0.4,0.3,2.6,0.5,0.1,0.7,0.1,0.1,0.3,0.8,1.5,2.2,0.5,0.4,1,1.7,6.1,0.3,0,5.3,0,0.4,0.5,0,0.8,12.7,0,2.3,0,0,0,0,10.1,0.5,0,2.6,0,0.2,0.1,0.2,1.1,0,0,0,0,0,0.6,0,0.9,0,0,0,0,0.3,0,6.2,0,1.1,1.4,0,0,0.2,0.2,0.1,0.3,0,0,0.4,0.4
SLC6A3,"DAT, DAT1",ENSG00000142319,Solute carrier family 6 member 3,Q01959,5,1392790-1445430,"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",NA,"Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,14,brain: 48.4,Cell type enriched,Detected in single,5,Alveolar cells type 2: 2.9,Cancer enriched,Detected in some,18,renal cancer: 25.7,Region enriched,Detected in some,47,midbrain: 48.4,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,5,NTERA-2: 1.2;RPMI-8226: 2.1;SCLC-21H: 3.8,Group enriched,Detected in some,8,midbrain: 96.4;thalamus: 31.8,Region enriched,Detected in single,138,midbrain: 362.2,"HPA012763, HPA013602, CAB016249, CAB078172",Enhanced,Supported,Approved,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,"CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484",unprognostic (2.25e-4),unprognostic (2.22e-1),unprognostic (8.45e-2),unprognostic (5.24e-2),unprognostic (7.75e-2),unprognostic (1.41e-2),unprognostic (4.64e-5),unprognostic (9.31e-2),unprognostic (7.89e-2),unprognostic (4.81e-2),unprognostic (1.30e-1),unprognostic (2.12e-2),prognostic unfavorable (3.40e-7),unprognostic (6.98e-2),unprognostic (1.64e-1),unprognostic (2.22e-2),unprognostic (4.74e-2),0.2,0.1,0,0,0.7,0,0.1,0,0.3,0.7,0,0,0,0.3,1.1,0.8,0.1,0.8,0.6,0.1,0,0.6,0.3,0,3.4,0,48.4,0,1.5,0,0,0,0.1,1,0.7,0,1.7,0,0.1,0,0,0,1.3,0,0.1,0,0.8,0,2.4,2.2,0,0.3,0.2,0,0.2,0,0,0,0,0.4,0,0,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2,0,0,1.2,0,0,0,0,2.1,0,0.1,3.8,0,0,0.1,0,0.4,0,0.1,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0.4,0,0,0,0,0,0,0.2,0.1,0.4,0,0,0,0,0,0,0,0.7,0,0.3,0,0.6,48.4,0,1,0,0,2.9,0,0,0,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.5,0,0,0,0,0
SLC6A4,"5-HTT, HTT, OCD1, SERT1",ENSG00000108576,Solute carrier family 6 member 4,P31645,17,30194319-30236002,"FDA approved drug targets, Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",NA,FDA approved drug targets,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in some,NA,intestine: 25.0;lung: 50.5,Group enriched,Detected in some,6,Cytotrophoblasts: 90.5;Syncytiotrophoblasts: 89.0,Cancer enhanced,Detected in some,NA,breast cancer: 2.3,Region enriched,Detected in single,36,pons and medulla: 11.2,Cell type enhanced,Detected in single,NA,neutrophil: 1.0,Low lineage specificity,Detected in single,NA,NA,Cell line enhanced,Detected in some,NA,BEWO: 2.9;CACO-2: 5.5;Hep G2: 14.7,Region enriched,Detected in some,5,midbrain: 69.9,Low region specificity,Detected in all,NA,NA,"HPA054723, HPA071354, HPA074728",Supported,Supported,Supported,"Golgi apparatus,Vesicles",NA,NA,NA,NA,NA,"Golgi apparatus, Vesicles",NA,"HPA054723: , HPA071354: , HPA074728: AB_2686708",unprognostic (7.45e-2),unprognostic (7.13e-2),unprognostic (2.26e-1),unprognostic (3.72e-4),unprognostic (2.07e-1),unprognostic (8.42e-3),unprognostic (2.73e-2),unprognostic (3.39e-2),unprognostic (3.37e-3),unprognostic (1.17e-3),unprognostic (2.70e-3),unprognostic (1.16e-1),unprognostic (8.78e-2),unprognostic (4.98e-2),unprognostic (1.76e-1),unprognostic (4.05e-2),unprognostic (7.18e-2),0.2,0.1,0.1,0.1,0.1,0,0.2,0.2,0.3,0.2,0.2,0.1,0.1,6.3,0.1,0.3,1.6,0.9,0.1,0.7,0.1,0.1,0.3,0.1,50.5,0.1,0.1,0.1,0.1,0.6,0,0.1,11.3,11.2,0.1,0,0.2,0.7,0.1,0.1,0.4,25,0.4,0.1,0.1,0.5,0.3,0.1,0.1,0.2,0.1,0.3,0.1,0.3,0,0.1,1,0.2,0.4,0.3,2.3,0,0,0,0.1,0,0,2.9,0,0,0,0,5.5,0,0.1,0,0,0,0,0,0,0,0.1,0.1,0,0.1,14.7,1.5,0,0.2,0,0.1,0,0,0,0.1,0.1,0.1,0.1,0,0,0.1,0.2,0,0,0,0.1,0,0.1,0,0.4,0.1,0.1,0,1,0,0.7,0.8,0,0,0.1,0.2,0.2,0,0.1,0.1,0,0.1,0,0,0.3,0.1,0.1,0.3,0,0.1,0,0.1,0.1,0,0,0.2,0.1,1,0.4,0.2,0.1,0,2.3,0.1,0.1,0.2,0.3,0.1,0.1,0.1,0.1,11.2,0.1,14.9,5.3,0,0.4,0.1,0.2,0.8,0,1.4,3.4,1.8,0,90.5,0,0,2.3,0.5,1,0,0,7,1.6,0.3,2.3,0,8.4,0,0,2.5,0.6,1,0.3,0.4,0,0,0,0.5,0.5,0,0.4,0.3,0.9,0,1.4,0,0.4,0.3,89,0,0,0.3
SLC6A6,TAUT,ENSG00000131389,Solute carrier family 6 member 6,P31641,3,14402576-14489349,"Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,retina: 76.4,Group enriched,Detected in many,4,Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 502.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enriched,Detected in many,5,neutrophil: 33.2,Lineage enriched,Detected in many,5,granulocytes: 33.2,Cell line enhanced,Detected in many,NA,RPTEC TERT1: 45.5,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA015028, HPA016488",Enhanced,NA,Approved,"Cell Junctions,Cytosol",NA,NA,NA,NA,NA,"Cell Junctions, Cytosol",NA,"HPA015028: AB_1857200, HPA016488: AB_1857202",unprognostic (8.25e-2),unprognostic (7.29e-3),unprognostic (2.63e-2),prognostic favorable (5.22e-5),prognostic unfavorable (5.75e-8),unprognostic (4.14e-2),prognostic unfavorable (8.78e-4),unprognostic (2.58e-1),unprognostic (2.56e-1),unprognostic (3.81e-1),unprognostic (6.96e-2),unprognostic (2.38e-1),unprognostic (2.78e-3),unprognostic (1.11e-1),unprognostic (1.01e-2),unprognostic (9.65e-2),unprognostic (1.90e-1),10.2,25.9,5.7,18,16.5,46.4,8.1,11.1,12.2,11.3,9.5,8.7,3.6,8.5,14.5,4.4,7,7,14.5,23.2,5.6,4.6,16.6,2.3,18.6,12.9,18,7.6,31.3,2.8,3.8,9.6,18,13.3,5,4.1,76.4,15.7,7.7,26.6,16.8,22.2,8.2,11.1,20.3,14,4,12.6,6.2,10.4,11.3,11.2,8.8,6.1,1.6,1.9,33.2,6.9,0.7,3.9,2.3,4.6,17.3,6.2,4.7,8.1,2.5,12.8,7,27.8,8.3,6.1,6.3,8,13.5,6.4,11,12,3.7,4.2,5.7,7.4,1.5,5.2,12.8,22.7,9.4,0.2,3.5,27.8,1.3,1.7,7.6,2,7.2,9,6.3,7.1,2.7,7.3,4.9,9.8,6.8,9.6,6.5,5,7,7.4,21.1,45.5,9.7,11.5,4.1,5.2,2.8,1.5,24.4,10.7,1.9,22.7,10.6,5.7,2.6,5,3,3.4,5,24.7,6.9,32.4,2.5,5.1,5,1.3,4.2,0.7,1.6,1.4,1.7,1.9,0.9,0.2,0.3,33.2,0.7,6.9,0.7,3.9,2.3,5.7,16.5,11.1,12.2,5.6,4.6,18,7.6,13.3,12.6,6,22.1,4.7,11.2,43.8,102.1,3.6,2.5,12,12.5,19.2,538,2.2,0,9.6,17,16.1,0.7,0,7.1,12.8,16.4,5.5,12.7,0.4,26.7,9.5,13.8,11.6,62.5,13.3,16.1,47.4,16.9,129,2.9,28.2,21.5,2.9,16.3,26.3,502.9,0,8.2,0.5,1.5,20.8,4.2,22.4,1.2,10.6
SLC6A7,PROT,ENSG00000011083,Solute carrier family 6 member 7,Q99884,5,150189957-150222788,"Predicted membrane proteins, Transporters","Amino-acid transport, Neurotransmitter transport, Symport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,5,brain: 40.2,Cell type enhanced,Detected in some,18,Enterocytes: 2.1;Intestinal endocrine cells: 3.5;Mucus-secreting cells: 4.8;Paneth cells: 8.6;Undifferentiated cells: 3.4,Cancer enhanced,Detected in single,NA,colorectal cancer: 0.8,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,GAMG: 1.6;HeLa: 1.8;SK-BR-3: 1.4;U-87 MG: 1.1,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in many,NA,NA,HPA028907,Uncertain,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA028907: AB_10602404,unprognostic (3.01e-1),unprognostic (1.97e-2),unprognostic (3.70e-2),unprognostic (1.42e-3),unprognostic (1.09e-2),unprognostic (1.82e-4),unprognostic (6.42e-2),unprognostic (1.35e-1),unprognostic (1.59e-1),unprognostic (1.33e-1),unprognostic (2.55e-1),unprognostic (3.50e-1),unprognostic (3.73e-4),unprognostic (8.11e-2),unprognostic (5.46e-2),unprognostic (2.73e-1),unprognostic (3.70e-3),0.5,0.4,3.9,1,9.7,0.4,0.5,40.2,22.4,0.6,5.7,0.3,0,2.6,0.5,0.6,0.4,0.4,0.5,0.5,6.5,4.5,0.4,0.4,0.5,0.7,1.3,14.5,0.4,0.5,0.4,0.2,0.4,1.6,0.4,7.7,0,0.8,0.4,0.5,0.5,4.9,0.7,1.4,0.4,0.4,0.5,0,0,0.4,0,0.7,0.4,0.2,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0.2,0,0.2,0.1,0,0.2,0.3,0,0,0,1.6,0.1,0,0.1,0.1,0,0,0,1.8,0,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0,0,0.2,0.1,0.5,0,0,0,0,0,0,0,0.1,0,1.4,0,0,0,0,0,0.6,0,0.7,0,0,0,0,1.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.9,9.7,40.2,22.4,6.5,4.5,1.3,14.5,1.6,0,0,0,0,0,0.2,0.1,0.5,0,0,0,0,0,0,0,0.1,0,0,2.1,0,0,0,0,0.1,0,0,0.4,0,3.5,0,0,0,0.3,0,0,0,4.8,0,0.1,8.6,0,0,0.1,0,0.3,0,0,0.1,0,0,3.4,0.1
SLC6A8,"CRTR, CT1",ENSG00000130821,Solute carrier family 6 member 8,P48029,X,153688099-153696593,"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Ion transport, Sodium transport, Symport, Transport",NA,"Disease mutation, FDA approved drug targets, Mental retardation",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,8,Bipolar cells: 127.1;Enterocytes: 208.5;Horizontal cells: 112.8,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enriched,Detected in single,4,neutrophil: 2.6,Lineage enriched,Detected in single,4,granulocytes: 2.6,Cell line enhanced,Detected in many,NA,AN3-CA: 42.8;SK-BR-3: 44.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (5.80e-2),unprognostic (1.24e-1),unprognostic (2.39e-2),unprognostic (9.98e-2),unprognostic (1.47e-1),unprognostic (7.16e-2),unprognostic (1.59e-2),unprognostic (1.59e-2),unprognostic (2.08e-1),unprognostic (2.10e-1),unprognostic (1.21e-1),unprognostic (1.43e-1),prognostic unfavorable (1.53e-4),unprognostic (1.41e-1),unprognostic (1.06e-1),prognostic unfavorable (7.39e-4),unprognostic (2.87e-1),17.6,19.5,26.3,5.8,39,19.3,7.3,23.9,31.9,6.1,26.8,36.6,7.6,32.4,11.2,9.1,20,10.6,20.2,53.1,29.3,16.1,27.3,1.9,3.1,1.9,55.6,22,5.1,8.3,17,7.2,22.6,25.8,12.8,20.2,20.9,31.8,24.9,76.4,28,48.3,13.5,28.2,5.1,11,16.7,38.9,4.6,2.8,11,5,40.4,10.1,0.5,0,2.6,0.2,0,0,0.1,40.6,1.7,12.5,42.8,4,2.8,2.9,6.1,10.1,7.9,9.8,5.2,0.5,0,4.7,7.3,9.3,15.1,25,21,4.9,0.7,23.8,0.1,14.1,15.5,13.9,0.3,2.8,5.9,4.5,7.9,28.7,15,3.9,0.2,9.9,0.6,4.4,2.4,0.2,0.9,12.8,8.1,17.9,1.9,1.4,0.5,8.6,7.9,16.1,18,8.9,44.4,28.8,3,8.6,6.2,3.9,13.1,20.9,16.8,18,1.5,0.7,0.4,29.3,1.2,13,0,0.2,0,0,0,0,0,0,0,0,0.5,0,0,2.6,0,0,0,0,0.1,26.3,39,23.9,30.4,29.3,16.1,55.6,22,25.8,38.9,0,3.4,2.7,10.6,20.6,127.1,89,25.5,8.1,0,5.2,104.1,11,3.3,3.6,0.6,5.6,208.5,23.3,18.9,27.8,11.2,21.2,4.6,0.8,4.3,112.8,24.9,4.9,1.3,2.2,8.3,1.6,23.6,5.4,32.8,17.4,55.3,41.8,7.8,49.9,48.6,32.3,15.3,2.9,2.8,13.7,76,0,15.7,17.6
SLC6A9,GLYT1,ENSG00000196517,Solute carrier family 6 member 9,P48067,1,43991500-44031467,"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Neurotransmitter transport, Symport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,brain: 42.2;skin 1: 38.2,Cell type enhanced,Detected in many,16,Bipolar cells: 26.6;Erythroid cells: 70.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enhanced,Detected in single,NA,naive CD4 T-cell: 1.4,Lineage enriched,Detected in single,5,T-cells: 1.4,Cell line enhanced,Detected in many,NA,HaCaT: 23.9;hTCEpi: 41.9,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA013977,Uncertain,NA,Approved,"Nucleoplasm,Golgi apparatus",NA,NA,NA,NA,NA,Golgi apparatus,Nucleoplasm,HPA013977: AB_1849835,unprognostic (2.73e-2),unprognostic (1.92e-2),unprognostic (1.63e-1),prognostic unfavorable (9.50e-4),unprognostic (5.98e-2),unprognostic (6.83e-3),unprognostic (3.06e-2),unprognostic (9.72e-2),unprognostic (1.85e-2),unprognostic (3.52e-2),unprognostic (1.41e-1),unprognostic (5.72e-2),prognostic unfavorable (5.93e-4),unprognostic (5.36e-3),unprognostic (1.59e-1),unprognostic (2.53e-1),unprognostic (1.20e-2),2.9,22.8,8.8,4.6,18.3,8.6,5.4,5.5,14.3,6,7.9,38.1,2.6,2.5,6.2,1.5,16.5,9.6,4.9,1.3,9.9,10,2,4.9,5.6,1.4,29.5,4.5,4,7.8,2.1,1,1.7,26.8,2.6,6.2,24,7.9,6.1,1.3,38.2,5.6,8.9,42.2,1.1,3.5,1.2,26.3,0,4.9,7.2,4.3,6.6,10.9,0.2,0,0.2,0.1,0,1.4,0.2,7.3,5.5,2.7,7,4.4,1.5,6.2,5.9,15.9,9.6,11.9,1.8,2.9,0.1,0.6,16.3,0,23.9,4.2,4.7,1.9,0,0.7,6.5,13.1,2.1,20.2,1.4,0.3,4.5,41.9,4.7,11.2,6,0.2,4.7,5,18.8,0.4,4,1,0,2.1,2.8,7.4,0.8,0,8.4,0.9,0.8,1.7,1.6,3,13.7,2.7,0.7,3.6,3.9,0.1,1.1,4.5,0.9,3,20.8,14.3,1.6,3.6,0,1.4,0,0,0.2,0.4,0.1,0.2,0.2,0.4,0,0,0,1.4,0.3,0.2,0,0,0,0,0.2,8.8,18.3,5.5,9.4,9.9,10,29.5,4.5,26.8,26.3,0,1.3,0.9,0.7,6.6,26.6,0.6,5.1,8.1,0,1.8,15.7,0.4,0,3.2,5.8,0.4,9.8,70,7.9,0.7,0.9,1,0,0,0.3,1.6,0,0,0,0.4,1.4,0,3.3,1.8,2.9,1.2,4.2,2,1.4,1,10.2,6.5,6.3,0,0.4,11.3,0.5,0,1.3,2.5
SLC7A10,asc-1,ENSG00000130876,Solute carrier family 7 member 10,Q9NS82,19,33208664-33225850,"Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,adipose tissue: 40.9;brain: 13.6;breast: 15.6,Group enriched,Detected in some,5,Muller glia cells: 1.8;Spermatogonia: 1.1,Low cancer specificity,Detected in some,NA,NA,Low region specificity,Detected in all,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,5,BEWO: 4.3;HHSteC: 2.6;HSkMC: 3.7;THP-1: 8.4;U-2 OS: 2.5,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA041884, HPA057036",Uncertain,NA,Uncertain,"Nucleoplasm,Nucleoli",NA,NA,NA,NA,NA,"Nucleoplasm, Nucleoli",NA,"HPA041884: AB_10794494, HPA057036: AB_2683317",unprognostic (1.85e-2),unprognostic (1.69e-3),unprognostic (2.79e-2),unprognostic (1.79e-6),unprognostic (1.16e-1),unprognostic (2.08e-1),unprognostic (1.31e-1),unprognostic (4.98e-3),unprognostic (4.64e-2),unprognostic (1.96e-1),unprognostic (3.28e-3),unprognostic (1.10e-1),unprognostic (2.22e-2),unprognostic (1.34e-3),unprognostic (8.91e-2),unprognostic (3.47e-1),unprognostic (2.18e-2),40.9,1,9.8,1.9,13.6,1,15.6,2.4,12.1,1,2.2,0.8,0,1,1,1,1,1,1,1.1,4.7,6.2,1.3,1,1,1.2,7.6,5,1,1.2,1,0,1.2,9,1,1,8.4,2.3,1,1,1.1,1,1.1,0.8,1,1,1.4,1.8,0,1.4,0,1.4,1,1.3,0,0,0.7,0,0,0,0,0,0,0.1,0,0,0,4.3,0,0,0,0,0,0,0,0.3,0,0,0,0.8,0,0,0,0,0,0,0,2.6,0,0,3.7,0,0,0,0,0,0,0,0,0,0,0,0,0.5,0,0,0,0,0,0,0,0,0.2,0.6,0,0,0,0.2,8.4,0,0,2.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.7,0,0,0,0,0,9.8,13.6,2.4,12.1,4.7,6.2,7.6,5,9,1.8,0,0,0,0,0,0.2,0.3,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0.1,0.2,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,1.8,0.1,0,0,0,0,0,0,0,1.1,0.1,0.1,0,0,0
SLC7A6OS,FLJ13291,ENSG00000103061,Solute carrier family 7 member 6 opposite strand,Q96CW6,16,68284503-68310946,Predicted intracellular proteins,"Protein transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA041533,Approved,NA,Approved,"Nucleoplasm,Cytosol",NA,NA,NA,NA,NA,Nucleoplasm,Cytosol,HPA041533: AB_10794298,unprognostic (1.43e-1),unprognostic (2.02e-2),unprognostic (7.59e-2),unprognostic (3.09e-1),unprognostic (5.51e-2),unprognostic (4.62e-4),unprognostic (2.44e-4),unprognostic (2.05e-1),unprognostic (3.41e-1),unprognostic (2.38e-1),unprognostic (2.61e-2),unprognostic (3.03e-2),prognostic favorable (2.35e-4),unprognostic (1.84e-1),unprognostic (3.93e-2),unprognostic (2.11e-1),unprognostic (1.68e-1),19.8,14.1,15.7,16.1,20,20.1,17.4,29.1,18.2,13.2,13.1,20.2,10.9,13.9,15.5,18,12.4,13.4,10.7,16.5,14.6,11.7,13.4,9.3,13.8,24.7,19.8,14.2,17,14.7,18.8,13.1,15.9,18.1,13.4,13.4,14.2,14.1,15,24.5,15.5,16.3,12.3,17.4,20.3,13.7,12.2,24.5,17,15.7,8.7,19.8,14,21.6,13.3,11.2,21.8,13.3,12.7,14.9,10.6,8.1,8.4,12.3,9.2,7.2,9.9,14.1,10.3,6,12.3,10.9,21.2,11.8,14.3,9.5,6.9,7.8,14.8,11.5,8.8,11.2,5.3,7,9.5,13.3,17.4,9.3,13.4,10.4,7.6,9.8,10.1,16.4,11,9.2,12.4,14.6,6.4,11.2,12.2,17.3,13.6,8.8,9.4,7.2,20.5,7.6,17.5,7.8,10.8,13,9.5,19.8,4.6,11.6,10,12.4,12.4,13.5,9.9,8.5,9.6,8.2,15.9,12.8,21.3,10.2,16.2,10.1,21.5,11.4,21.8,13.4,13.3,14.9,13.1,13.4,12,8.7,13.3,14.5,11.4,10.3,12.7,10.8,11.2,13.3,10.6,15.7,20,29.1,18.2,14.6,11.7,19.8,14.2,18.1,24.5,8.9,4.6,16.6,10.7,8.1,22,0.8,12.7,14.7,6.8,12.2,33.4,19.6,14.9,11,2.5,10.8,7.4,0,9.8,9.6,8.7,9.1,13.9,5.8,18.3,15.9,13.3,11.6,16.3,1.3,14.7,10.8,11.8,21.6,7.5,26.5,13.1,7,15.2,6.9,22.8,0,9.5,12.5,18.9,5.8,18.4,20.2,8.8,12.3
SLC7A1,"ATRC1, CAT-1, ERR, HCAT1, REC1L",ENSG00000139514,Solute carrier family 7 member 1,P30825,13,29509410-29595688,"Predicted membrane proteins, Transporters","Amino-acid transport, Transport",Receptor,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,esophagus: 42.8,Cell type enhanced,Detected in many,4,Collecting duct cells: 68.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA039721, HPA077838",Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"HPA039721: AB_10672893, HPA077838:",unprognostic (1.85e-1),unprognostic (1.04e-3),unprognostic (1.26e-1),unprognostic (1.96e-1),unprognostic (3.95e-3),unprognostic (2.43e-2),unprognostic (1.36e-3),unprognostic (2.02e-3),unprognostic (4.98e-2),unprognostic (1.23e-2),unprognostic (7.45e-2),unprognostic (9.14e-2),prognostic unfavorable (1.32e-5),unprognostic (3.20e-2),unprognostic (3.02e-1),unprognostic (1.19e-1),unprognostic (7.37e-3),5.7,4.5,8.5,9,11.7,8.6,7,8.7,19.6,8.1,8.7,10.7,7.5,9,7.3,9.6,42.8,6.9,4.8,6.2,12.2,10.4,4.3,2.4,4.4,7.1,11.4,7.7,5.3,26.6,2.9,6.4,12.9,20,7.2,6.8,6.1,16.2,12.6,2.1,14.8,12.9,8.1,11.9,5.7,10,8.8,6.9,5.3,8.6,27.7,16.2,6.4,8.3,2,3.7,0.5,2.8,0.8,3.3,1.7,12.2,9.9,8.7,17.5,4.5,9,9.9,26.2,17.5,22.7,16.9,20,21.6,24.3,7.1,39.9,25.4,56.3,15.1,18.5,30,22.8,9,18.2,10.8,10.8,23.4,26.4,12,11.4,39.6,25.2,29.9,5.3,11.1,27.8,11.6,11.4,9.5,16.5,19.2,7.1,8.3,21.8,6.6,13.3,18,13.9,14.4,8.2,29.7,14.1,14.9,14.6,23.7,5.7,6.4,22.5,10.4,17.9,12.5,15.7,18.7,12.8,9.2,27.7,14.3,10.7,18,0,1.1,0.5,3.3,1.2,2.7,2,2.4,2.7,1.8,1.4,1.9,3.1,0,0.8,2.8,3.7,1.9,1.7,8.5,11.7,8.7,15.9,12.2,10.4,11.4,7.7,20,6.9,0,5.3,14.9,42.8,44.3,15.1,6.7,10.2,5.3,12.5,68,15.7,0.4,1.7,19.5,0.2,14.3,16.1,23.3,49.3,31.4,9.3,41.6,6.9,0.8,6.1,23.8,29.9,3.7,4.3,0.4,5.8,5.2,8.5,4.6,28,3.4,45.4,24.5,3.5,0,17.8,6.5,9.9,0.5,2.1,30.6,3.3,4.9,24.5,38.1
SLC7A11,xCT,ENSG00000151012,Solute carrier family 7 member 11,Q9UPY5,4,138164097-138242349,"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,FDA approved drug targets,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,brain: 27.2,Cell type enhanced,Detected in many,13,Glandular cells: 37.7;monocytes: 90.2;Muller glia cells: 48.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enriched,Detected in single,8,plasmacytoid DC: 3.8,Lineage enriched,Detected in single,8,dendritic cells: 3.8,Cell line enhanced,Detected in many,NA,hTCEpi: 28.6;TIME: 31.4;WM-115: 46.1,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA064215,NA,NA,Approved,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,HPA064215: AB_2685213,unprognostic (3.55e-3),unprognostic (4.64e-3),unprognostic (2.43e-2),unprognostic (7.18e-3),unprognostic (2.59e-1),unprognostic (8.80e-3),unprognostic (2.07e-8),unprognostic (1.98e-2),unprognostic (1.09e-2),prognostic favorable (1.77e-4),unprognostic (1.90e-2),unprognostic (4.07e-2),unprognostic (2.22e-8),unprognostic (3.81e-2),unprognostic (3.76e-2),unprognostic (2.29e-2),unprognostic (1.54e-2),1.1,0.9,16.3,4.7,15.8,2.2,1.5,8.2,26,2.4,2,17.9,0,1.5,1.3,13.4,3.3,8.9,3.8,2.5,17.4,6.9,0.9,0.9,2.3,1.5,12.6,16.8,1.7,5.4,1,1.2,2.1,17.2,2,2.8,0.3,1.6,1,0.8,1.9,1.4,1,27.2,1.4,9.2,2.2,14,0,8.9,6,2.2,4,0.8,0.1,3.8,0.4,0,0.1,0,0,1.6,13.8,6.2,4.8,1.3,1.7,1.7,7.6,5.3,1.7,4,1.5,5.8,3.1,10,26.5,9.4,2.2,3.3,6.5,7.4,5.9,0.7,2.2,13.1,3.4,20.6,5.8,2.1,4.1,28.6,4.9,22.1,2.6,21.6,3.2,3,8.2,9.1,1.2,0.8,0.5,1.2,8.1,3.9,0.9,2,3.6,1,6.6,2.5,0.5,3.3,0.9,11.7,1.4,1.5,12.4,31.4,2.3,6.5,3.4,6,6.9,3.1,3.2,3.9,3.2,46.1,0.3,0,0.1,0,0,0,0.1,0,0,0,0.1,0,0,0.4,0.1,0,3.8,0,0,16.3,15.8,8.2,15.9,17.4,6.9,12.6,16.8,17.2,14,0,5.9,3.7,7,4,4,3.6,2.5,1.4,3.4,0,2,2.2,0,3.6,2.1,1.6,1.1,0,21.4,0.5,1,37.7,4.6,0.4,0.5,1.6,25.9,3.7,0,0.4,2.3,9,5,90.2,5.4,48.4,27.4,1.1,2.1,0,1.9,0,1,0.7,0.7,2.8,0.9,0,1.3,11.1
SLC7A13,"AGT-1, XAT2",ENSG00000164893,Solute carrier family 7 member 13,Q8TCU3,8,86214052-86321146,"Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,NA,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,NA,Tissue enriched,Detected in some,12,kidney: 31.7,Cell type enhanced,Detected in some,31,Collecting duct cells: 1.8;Distal tubular cells: 3.3;Proximal tubular cells: 8.6,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell type enhanced,Detected in single,NA,neutrophil: 1.6,Lineage enriched,Detected in single,5,granulocytes: 1.6,Cell line enhanced,Detected in single,NA,RPMI-8226: 2.5,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (3.34e-1),NA,NA,NA,NA,NA,unprognostic (2.62e-1),NA,NA,NA,NA,unprognostic (1.12e-1),unprognostic (2.96e-5),NA,NA,NA,NA,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,2.5,0,0,0,31.7,0.1,0,0,0,0,0,0,0,0,0,0,0.2,0,0,0,0,0,0.1,0,0,0,0,0,0.6,0,0,0,0,0,0,0,0.2,0.1,1.6,0.1,0.3,0.1,0,0.1,0,0,0,0,0,0,0,0,0,0,0.4,0.2,0,0.1,0,0,0.3,0,0,0,0.2,0,0.3,0.2,0,0,0,0.1,0,0,0,0,0,0,0.1,0,0.4,0,0,0.1,0,0,0,0,0,0,2.5,0,0.2,0,0.1,0,0,0,0,0,0,0.7,0.2,0,0,0,0,0,0,0,0.1,0.2,0.5,0.1,0.1,0.1,0,0.1,0.2,0.1,0.1,0,0.2,0.1,0,1.6,0.3,0,0.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.8,0,0,3.3,0,0,0,0,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.6,0,0,0,0,0,0,0,0,0,0
SLC7A14,"KIAA1613, PPP1R142",ENSG00000013293,Solute carrier family 7 member 14,Q8TBB6,3,170459584-170586074,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,Retinitis pigmentosa,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in many,4,brain: 33.4;pituitary gland: 14.5,Group enriched,Detected in some,5,Bipolar cells: 31.5;Horizontal cells: 27.0,Group enriched,Detected in some,11,glioma: 0.8;pancreatic cancer: 0.6,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in some,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in some,NA,LHCN-M2: 7.2;SCLC-21H: 7.2;SH-SY5Y: 2.1,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA045929,Approved,NA,Approved,"Nucleoplasm,Vesicles,Plasma membrane,Cytosol",NA,NA,NA,NA,NA,"Vesicles, Cytosol","Nucleoplasm, Plasma membrane",HPA045929: AB_2679501,unprognostic (1.00e-1),NA,unprognostic (9.56e-2),unprognostic (1.03e-1),unprognostic (4.15e-2),unprognostic (1.43e-2),unprognostic (7.46e-2),unprognostic (9.16e-2),unprognostic (1.13e-1),unprognostic (1.29e-1),unprognostic (6.68e-3),unprognostic (6.36e-2),unprognostic (3.03e-6),unprognostic (1.54e-2),unprognostic (8.05e-2),unprognostic (1.71e-2),unprognostic (3.24e-3),1.1,5.8,12.1,1.9,17.7,1.4,1.1,14.9,33.4,1,1.8,8,0,1.6,1.1,1.2,1.1,1.1,1.3,1.1,11.5,12.1,1.3,1.2,1.1,1.1,6.7,12.8,1.3,2.4,1.1,14.5,1.1,11.8,1.2,1.9,0.1,1.1,1.1,1.2,1.3,1.7,1.3,9,1.1,1.5,1.3,6.3,0,1.1,0,1.1,1.1,0.3,1,0.6,2.1,0.5,0.7,0.6,0.1,0,0,0.4,0.1,1.3,2,0.1,0.6,0.2,0.8,0.8,0.1,0.1,0.1,0,0.8,0.1,0.1,0,0,0.5,0,0,0,0.1,0.1,0.2,0.1,0.1,1.8,0,0.1,1.3,0.8,0.2,0.1,0,0.2,7.2,0,0,0.2,1,0,0.1,0.1,0,0.1,0,0.1,7.2,2.1,0,0.1,0,0.3,0.1,0.1,1.1,0.1,0.1,0.1,0,0.1,0,0,0.2,0,0.1,2.1,0.5,0.5,0.4,0.3,0.3,0.8,0.3,0.3,0.1,1,0.6,0.5,1.2,0.7,0.3,0.6,0.3,0.1,12.1,17.7,14.9,16.9,11.5,12.1,6.7,12.8,11.8,6.3,3,2.1,0,0.3,0.3,31.5,0.8,0,5.3,4.5,0,2,0,0,0,0.5,0.3,0,0,0,0.1,0.5,0.2,2.3,1,0,27,1.7,0,0,0.4,2,0.9,3.3,0,0,1.8,0.1,0,2.5,0,3.9,0,0.2,0,0.1,0.5,0,0,0,0.1
SLC7A2,"ATRC2, CAT-2, HCAT2",ENSG00000003989,Solute carrier family 7 member 2,P52569,8,17497088-17570573,"Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8,Cell type enhanced,Detected in many,11,Hepatocytes: 230.6,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in many,NA,HHSteC: 67.7;RT4: 17.4,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA009277,NA,NA,Supported,"Plasma membrane,Cell Junctions",NA,NA,NA,NA,NA,Plasma membrane,Cell Junctions,HPA009277: AB_2668229,unprognostic (1.31e-1),unprognostic (2.28e-1),unprognostic (1.07e-1),unprognostic (1.13e-2),unprognostic (1.06e-1),unprognostic (5.20e-2),unprognostic (7.24e-3),unprognostic (3.11e-1),unprognostic (1.76e-1),unprognostic (4.49e-1),unprognostic (1.34e-2),unprognostic (1.11e-2),prognostic unfavorable (2.65e-7),prognostic unfavorable (3.08e-4),unprognostic (1.46e-2),unprognostic (8.98e-2),unprognostic (1.79e-1),10.6,3.8,8.6,1.4,3.4,0.1,18,2.5,8.3,11.5,2.5,2.4,2.9,0.8,6.4,11.8,3.7,13.6,5.1,9.7,6.8,0.9,3.8,68.1,3.3,2.8,4.4,3.5,35.1,32.2,78.2,3,29,9.1,4.9,1.5,13,2.4,3.3,57.8,3.3,2,4.3,10.9,1.8,3.3,7.7,3.5,0,14.3,10.4,1.2,3.4,6.4,0,0,0.8,0,0.3,0,0,0,0.9,0.3,10.4,0,0.1,11.3,0,7,0.5,0.6,3.3,0,0,2.4,0,1.5,0,7.5,1.7,2.4,0,3.9,0,8.1,7.2,67.7,3.1,0,9.1,1.4,8.8,8.4,0,3.2,0,0,0,7.9,11,0.4,3.6,3.8,2.3,0.9,0,5.2,5.4,0.8,17.4,0.1,1.4,0.5,0.2,3.1,8,0,0.3,7.2,0,3.8,0,0,0,0,0,0,0,0.6,0.8,0,0,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,0,8.6,3.4,2.5,8.3,6.8,0.9,4.4,3.5,9.1,3.5,11.9,63.8,0,6.1,7.3,1.8,14.3,33.1,84.3,27.3,7,33.4,17,0,4.5,10.8,5.2,0.1,0,79.6,13.8,18.2,28.5,2.3,230.6,4.7,0,84.5,6.7,6.9,17.4,35.1,1.5,3.3,1,2.2,15,29.6,0,26.2,1.8,38.5,58.2,52.8,0.4,0.4,3.3,21.7,2.5,2.6,1.8
SLC7A3,"ATRC3, CAT-3, FLJ14541",ENSG00000165349,Solute carrier family 7 member 3,Q8WY07,X,70925582-70931125,"FDA approved drug targets, Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,FDA approved drug targets,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,4,lymphoid tissue: 45.5,Group enriched,Detected in some,6,Early spermatids: 5.3;Late spermatids: 1.9,Cancer enriched,Detected in some,12,testis cancer: 43.0,Region enhanced,Detected in many,NA,hypothalamus: 6.7,Cell type enriched,Detected in single,16,naive CD8 T-cell: 1.5,Lineage enriched,Detected in single,16,T-cells: 1.5,Group enriched,Detected in some,4,HAP1: 20.7;NTERA-2: 42.6;SuSa: 53.1,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (1.42e-4),unprognostic (4.30e-4),unprognostic (3.59e-3),unprognostic (1.81e-2),unprognostic (6.45e-2),NA,NA,unprognostic (1.45e-2),NA,unprognostic (3.66e-1),unprognostic (9.18e-3),unprognostic (1.89e-1),NA,unprognostic (7.99e-5),unprognostic (1.31e-2),unprognostic (5.42e-4),unprognostic (3.57e-2),0.1,0,1,0.1,1,1.3,1.4,0.1,2.1,2,0.1,1.1,0.8,0.1,9.1,6.2,0.7,2.7,0.1,0,1.2,6.7,0.2,0,0.1,0.5,0.5,0.5,1.7,0,0,0.6,0,1.2,10.4,0,0.5,0.2,9.4,0,0,0.3,4.6,0.2,0.1,5.6,2.4,0.4,45.5,0,0.2,0.5,4,1.4,0,0,0,0,0,1.5,0.3,0,0,1.4,0,0,0,0,0,0,0,0,0,0,7.5,0.1,0,0,0,20.7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.1,0,42.6,0,0,8.9,3.1,0,0,0,0,0,0,0,0,53.1,0,0,0,0,0.3,0,0,0,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.5,0,0,0,0,0,0.3,1,1,0.1,2.1,1.2,6.7,0.5,0.5,1.2,0.4,0,0,0,0.4,0,0,0.2,0,0,0,0,0,0,0,0,5.3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.9,0.6,0,0,0,0,0.5,0,0,0,0,0,0,0,0.1,0.5,0,0,0,0,0
SLC7A4,"CAT-4, HCAT3, VH",ENSG00000099960,Solute carrier family 7 member 4,O43246,22,21028718-21032840,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,placenta: 19.6;testis: 29.1,Cell type enhanced,Detected in some,8,Alveolar cells type 1: 6.0;Cytotrophoblasts: 9.1;granulocytes: 4.6;Mucus-secreting cells: 7.9;Syncytiotrophoblasts: 8.5,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in many,NA,NA,Cell type enhanced,Detected in some,NA,MAIT T-cell: 2.4;naive CD8 T-cell: 2.4,Group enriched,Detected in many,18,NK-cells: 1.0;T-cells: 2.4,Cell line enriched,Detected in some,21,BEWO: 57.3,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in many,NA,NA,HPA031023,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA031023: AB_10669669,unprognostic (1.02e-3),unprognostic (4.34e-2),unprognostic (6.75e-2),unprognostic (1.27e-1),unprognostic (3.82e-2),unprognostic (1.04e-2),unprognostic (1.58e-1),unprognostic (3.91e-2),unprognostic (3.68e-2),unprognostic (2.51e-2),unprognostic (2.58e-2),unprognostic (1.21e-3),unprognostic (9.69e-2),unprognostic (2.87e-1),unprognostic (1.62e-1),unprognostic (1.32e-2),unprognostic (4.00e-3),2.7,3.5,2.2,0.4,3.8,0.1,2.6,6,5.9,2.8,1.8,0.4,1.4,1.7,1.5,0.7,8.5,1.6,4.1,1.2,2.7,7.1,0.2,0.3,1.4,1.2,2.4,4.3,0.3,0.4,0.1,5.1,19.6,2.4,4.1,1.4,3.3,4.3,5.3,0.6,1.9,2,0.6,0.6,0.9,2.4,29.1,0.4,0.2,0.1,1.3,2.1,2.4,0.7,0,0,0,0,1,2.4,0.8,0,0,0,0,0,0,57.3,0,0,0.1,0,0.4,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,2.7,0,0,0,0,0.2,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0.6,0,0,0,0.5,0.2,0.1,0,0,0.2,0,0,0,0.1,0,0,0,0,0,0,0.5,0,0,0,0,0,0.5,0,2.4,0,0.2,1.2,0,0,0.1,2.4,0,1,0,0,0,0.8,2.2,3.8,6,5.9,2.7,7.1,2.4,4.3,2.4,0.4,6,3.4,0,0.2,0,0.4,0.3,0,0,0,0,0,9.1,0,0,0.1,0,0.1,0,0.4,2.8,0.1,0.4,4.6,0,1.2,0,1.2,1.8,0,1.3,1.7,0,0,0,7.9,1.8,0.6,0,0.7,0,0,0,0,0.2,0.2,0,8.5,0,0.6,0.1
SLC7A5,"CD98, D16S469E, E16, LAT1, MPE16",ENSG00000103257,Solute carrier family 7 member 5,Q01650,16,87830023-87869488,"Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,bone marrow: 71.2,Cell type enhanced,Detected in many,5,Erythroid cells: 70.0;granulocytes: 68.9;Intestinal endocrine cells: 82.6;Smooth muscle cells: 85.8;Syncytiotrophoblasts: 89.8,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Cell type enriched,Detected in some,11,plasmacytoid DC: 15.9,Lineage enriched,Detected in many,11,dendritic cells: 15.9,Cell line enhanced,Detected in many,NA,HBEC3-KT: 108.7;hTCEpi: 186.8;MCF7: 101.2;SiHa: 153.4,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA052673, HPA056077",Approved,NA,Supported,"Vesicles,Plasma membrane,Cytosol",NA,NA,NA,NA,NA,"Plasma membrane, Cytosol",Vesicles,"HPA052673: AB_2681909, HPA056077: AB_2683031",unprognostic (2.71e-3),unprognostic (1.10e-2),unprognostic (1.02e-1),unprognostic (2.64e-1),unprognostic (3.22e-2),unprognostic (2.99e-3),unprognostic (1.64e-1),prognostic unfavorable (2.43e-4),unprognostic (6.86e-2),unprognostic (4.46e-2),unprognostic (1.27e-1),unprognostic (3.17e-1),prognostic unfavorable (0.00e+0),unprognostic (5.93e-2),unprognostic (5.52e-3),unprognostic (1.64e-2),unprognostic (7.19e-3),8.2,3.2,18.3,14.7,24.5,71.2,4.3,15.9,45.8,7.9,4.6,16.7,8.9,6.2,5.3,30.4,38.7,3.3,6.4,8.2,19.8,22.1,3.6,9.7,3.8,11.1,23.9,9.6,5.1,12.1,1.5,9,28.4,23.4,4.3,3.4,34.9,11.5,15.4,11.2,10.7,5.7,4.8,17.7,6.4,12.7,34.9,19.8,3.7,4.2,16.7,15,11.5,7.7,0.5,15.9,0.6,0,0.2,1.4,0.4,14.9,56.6,1.1,15.9,0.4,0.9,40.8,12,4.3,7.3,4.7,36.9,21.4,13.7,10.6,15.2,2.5,67.4,11.7,108.7,5.1,14.3,5.9,11.2,53.1,26.4,17.1,10.4,20.7,3,186.8,9,66.8,2.4,1.4,48.5,16.7,15.3,5.8,101.2,12.5,15.3,5.2,9.4,13.8,12.2,4.3,20.9,8.1,1.2,9.1,3.6,153.4,30.7,32.9,10.8,14.1,13.8,1.1,2.6,17.1,10.6,9.3,20,16.3,59.1,10.1,25.9,24.4,0.6,0,0,1,0,1.2,0.5,0.5,0.8,0.3,0,0.1,0.4,0.1,0.2,0,15.9,1.4,0.4,18.3,24.5,15.9,28.1,19.8,22.1,23.9,9.6,23.4,19.8,0,1.1,16.4,11.1,65.1,12.7,2.8,2.5,0,0,1.8,15.7,12.4,0,16.8,0.8,4.3,1.7,70,8,28.4,10.4,13.9,68.9,14.5,8.2,9.5,82.6,2.5,3.5,4,1.7,6.6,37.1,2.8,2.8,13.3,19.5,0.2,1.4,0.5,50.1,0,85.8,1.7,2.5,32.9,89.8,8.6,1.6,26.1
SLC7A6,"KIAA0245, LAT-2, LAT3, y+LAT-2",ENSG00000103064,Solute carrier family 7 member 6,Q92536,16,68264516-68301823,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Antiport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,skeletal muscle: 58.8,Cell type enhanced,Detected in many,4,Alveolar cells type 1: 38.7;Syncytiotrophoblasts: 40.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA050713,Uncertain,NA,Approved,"Vesicles,Plasma membrane",NA,NA,NA,NA,NA,Plasma membrane,Vesicles,HPA050713: AB_2681218,unprognostic (6.35e-2),unprognostic (4.63e-2),unprognostic (1.41e-1),unprognostic (1.40e-2),unprognostic (2.41e-1),unprognostic (5.02e-2),unprognostic (1.24e-3),unprognostic (1.16e-1),unprognostic (1.48e-1),unprognostic (5.16e-2),unprognostic (1.11e-1),unprognostic (2.76e-2),unprognostic (1.89e-3),unprognostic (7.82e-2),unprognostic (2.66e-1),unprognostic (4.79e-3),prognostic unfavorable (1.84e-4),25.9,7.6,5.4,12.9,6.7,6.9,18.7,9,8,5.3,7.1,3.4,6.7,3.6,5.5,14,4,7.1,4.7,13.1,5.3,3.3,5.4,2.3,9.8,16.3,3.3,4.6,3,3.2,2.5,11.1,16.3,5.4,6.6,10.8,9,5.8,5.1,58.8,8.4,9.4,8.3,3.4,9.4,5.3,5.2,3.7,31.8,15,8,19.6,5.7,8,7.2,16.2,5.9,3.6,6.7,12.6,1.7,9.4,9.7,7.2,7.7,21.4,12.8,20.3,11.1,8.1,16.6,13.9,41.3,7.2,18.8,8.8,14.2,4.8,14.5,14,13.9,18.1,3.8,10,10,19.1,13.1,3.9,11.8,9.1,8.6,12.2,12.9,6.5,5.3,11.1,9.8,14.7,3.4,9,5.1,15.3,8.2,5.4,6.4,3.5,19.5,4.5,15.8,5.8,8.3,10.6,5.8,32.1,9,3.8,6.3,13.5,6.4,16.3,11,8.4,9.2,13.9,7.2,13.5,21.5,7,8.7,7.4,2.5,3.6,3,4.9,1.7,6.1,6.6,7.3,4.6,3.4,7.2,12.6,7.4,5.9,6.7,1.4,16.2,3.1,1.7,5.4,6.7,9,8,5.3,3.3,3.3,4.6,5.4,3.7,38.7,16.8,11.1,8,17.4,3.7,17.3,0,8.1,3.4,17.4,35.3,20.4,0,3,4,9,4.2,0,3.4,1.6,10.5,3,4.6,1.3,12,9.5,2.4,7.4,6.7,14.6,5.5,7.5,10.1,3.6,8.9,2.1,4.1,6.2,3.5,0.3,2.6,0,7.3,14.2,9.4,19.2,40,17.5,6.9,2.3
SLC7A7,"LPI, y+LAT-1",ENSG00000155465,Solute carrier family 7 member 7,Q9UM01,14,22773222-22829820,"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,"Disease mutation, FDA approved drug targets",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,blood: 63.8;intestine: 93.5;kidney: 67.3,Cell type enhanced,Detected in many,13,Hofbauer cells: 200.4;Kupffer cells: 312.3;Macrophages: 142.1;Proximal tubular cells: 254.4,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in many,NA,NA,Cell type enhanced,Detected in many,NA,intermediate monocyte: 59.5;non-classical monocyte: 63.8,Lineage enriched,Detected in many,4,monocytes: 63.8,Cell line enhanced,Detected in some,NA,BEWO: 44.5;CACO-2: 72.0;EFO-21: 15.6;OE19: 63.3,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in many,NA,NA,HPA036227,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA036227: AB_10696653,unprognostic (1.34e-1),unprognostic (7.65e-2),unprognostic (4.25e-2),unprognostic (2.52e-1),unprognostic (6.12e-2),unprognostic (3.69e-2),unprognostic (7.84e-3),unprognostic (1.47e-1),unprognostic (2.88e-2),unprognostic (1.73e-2),unprognostic (2.60e-3),unprognostic (7.15e-2),prognostic unfavorable (6.28e-6),unprognostic (2.68e-3),unprognostic (1.86e-2),unprognostic (2.61e-1),unprognostic (1.12e-1),10.4,2.8,1.9,8.3,3.1,3.6,3.2,0.7,2.7,2.6,48,4.1,0.2,24.1,2.7,2.3,2.1,4.6,7.6,3,2.2,1.6,67.3,6.5,15.3,20.5,3.7,1,2.6,2.7,26.3,1,6.5,3.2,2.7,3.4,2.1,3.3,0.9,1.6,1.8,93.5,3.5,4.5,32.4,3,13.4,2.7,2.1,2.8,0.8,5.7,4.1,3.6,3,14.6,5.4,63.8,0,0.1,17.8,0,2.4,0.2,0.1,0.4,0.8,44.5,0.5,3.6,0.1,0.3,72,7.3,3.5,15.6,0.3,0.2,2.7,0,0,0.1,0.1,0,0.2,0,0.7,2.1,0.3,0.3,1.6,0.2,0.2,0.1,0.3,5.5,0.2,0,2.8,0.5,0.1,0,0.3,0.7,63.3,0,0.6,7.8,2.1,0.1,0.2,0,0.1,0.1,0.1,0.5,2.1,0.1,1.7,0.3,0.1,0.3,0.1,0.1,0.6,0.1,1.8,0.2,0.1,0,0,41.2,0.1,0,59.5,0,3,0,0,14.6,2.3,0.1,0,5.4,0,63.8,0.5,0.1,17.8,1.9,3.1,0.7,2.7,2.2,1.6,3.7,1,3.2,2.7,11.9,10.3,23.7,0.1,0.9,0,0.8,58.6,9.4,4.5,3.5,0,1,10,6.7,40.8,4.5,8.6,0,5.8,4.5,4.8,0.2,1.1,1.3,200.4,0,1.2,22.1,312.3,7.5,3.4,142.1,5,34.3,0.4,0.5,7.3,0,0,254.4,1.2,6.5,2.8,12.2,1.7,0.4,1.5,5,0.3,0
SLC7A8,"LAT2, LPI-PC1",ENSG00000092068,Solute carrier family 7 member 8,Q9UHI5,14,23125295-23183674,"Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in all,4,parathyroid gland: 204.0,Cell type enhanced,Detected in many,6,Ito cells: 97.0;Kupffer cells: 71.7;Proximal tubular cells: 98.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in some,7,basophil: 7.6;eosinophil: 13.2;naive CD8 T-cell: 3.5,Group enriched,Detected in many,46,granulocytes: 13.2;T-cells: 3.5,Cell line enhanced,Detected in many,NA,AF22: 21.2;ASC diff: 22.3;BEWO: 38.9;CACO-2: 21.5;K-562: 40.6;NTERA-2: 21.2;SuSa: 25.5,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"CAB046015, HPA051950, HPA060672",Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CAB046015: AB_2239464, HPA051950: AB_2681670, HPA060672: AB_2684340",unprognostic (1.50e-1),unprognostic (1.52e-1),unprognostic (2.88e-1),unprognostic (1.03e-2),unprognostic (1.12e-2),unprognostic (3.03e-2),prognostic unfavorable (1.97e-4),prognostic favorable (3.15e-4),unprognostic (1.24e-1),unprognostic (2.37e-1),unprognostic (1.39e-3),unprognostic (9.44e-2),unprognostic (7.00e-2),unprognostic (2.96e-2),unprognostic (8.56e-3),unprognostic (1.64e-1),prognostic unfavorable (1.52e-4),10.5,5.9,4.6,3,6.6,1.3,11,10.9,10.7,12.7,5.9,2.5,28.2,11.7,23,7.2,13.2,21.7,6.2,3.1,7.8,3,37.6,3,6.2,5.8,2.4,5.6,33.7,9.1,204,16.7,19.8,6.9,13,5.1,31.2,9.5,50.9,23.6,11.2,8.8,7.5,1.9,10,19.3,10.5,4.7,0.3,12.8,5.2,4.9,15.2,14.5,0.1,0,13.2,0.1,0,3.5,1.7,0.4,0,21.2,0,22.3,2.7,38.9,2.1,8.5,0,0.6,21.5,1.1,0.1,0.3,4.6,2.2,3.6,2.8,1.1,0.1,0,2,0.1,0,0,8.7,0,12.1,19.2,10.7,0.3,0.2,5,1.7,1.9,40.6,0,0.4,0.3,0,0.2,21.2,4,15.8,0,0.2,4,0.2,7.9,2.6,0.1,0,3.7,10,25.5,13.5,0.1,0.1,0.7,0.5,0.2,0,0.1,4.6,0,2.4,0,0.1,7.6,0.1,13.2,0,0.1,1.1,0.1,0.9,0.1,0,0,0.9,3.5,0.4,0,0,0,0.5,1.7,4.6,6.6,10.9,10.7,7.8,3,2.4,5.6,6.9,4.7,14.9,16.7,2.9,22.2,2.7,28,5.1,0,0,13.6,15.7,0,14.7,5,1.3,1.8,1.3,12.9,0,2.1,2.2,8.7,34.8,4.7,0.4,47.4,25.4,31.8,97,71.7,1.7,8.9,9.7,18.6,0,30.8,48.5,3.9,3.5,7.4,98.9,4.2,0,3.1,0.3,0.6,2.6,34.6,1.3,18.9,31.8
SLC7A9,CSNU3,ENSG00000021488,Solute carrier family 7 member 9,P82251,19,32830509-32869766,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Amino-acid transport, Transport",NA,"Cystinuria, Disease mutation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,NA,Group enriched,Detected in some,4,intestine: 63.3;kidney: 26.4,Cell type enriched,Detected in some,5,Proximal tubular cells: 55.5,Group enriched,Detected in some,7,liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Group enriched,Detected in some,17,BEWO: 4.9;CACO-2: 11.3;Hep G2: 11.0,Not detected,Not detected,NA,NA,Low region specificity,Detected in all,NA,NA,HPA042591,Enhanced,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HPA042591: AB_10962500,unprognostic (4.12e-2),unprognostic (5.40e-2),unprognostic (6.19e-2),unprognostic (3.37e-3),unprognostic (1.69e-1),unprognostic (1.54e-1),unprognostic (4.17e-2),unprognostic (3.87e-2),unprognostic (1.49e-1),unprognostic (1.78e-1),unprognostic (1.24e-1),unprognostic (2.39e-1),unprognostic (9.69e-2),unprognostic (5.97e-2),unprognostic (3.20e-1),unprognostic (4.94e-3),unprognostic (5.10e-5),0.1,0,0.1,0.3,0.2,0,0.1,0.3,0.2,0.2,20.1,0.1,0.1,30.5,0.1,1.1,0.1,0.2,0.1,0.1,0.1,0.1,26.4,11,0.1,0.1,0.1,0.1,0.2,0.1,0,0.3,0.2,0.1,0.3,0,0.1,0.1,0.1,0.1,0.1,63.3,0.1,0.1,0.1,0,0.1,0.1,0.1,0.3,0.1,0.1,0.1,0.2,0,0,0,0,0,0,0,0,0.2,0,0,0.1,0.1,4.9,0,0,0,0,11.3,0,0,0,0,0,0,0,0,0,0.3,0,0,0,11,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0.3,0,0,0.1,0,0,0.5,0,0.1,0,0.1,0,0,0,0.1,0,0,0,0,0.1,0.2,0,0,0.2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0.2,0.3,0.2,0.1,0.1,0.1,0.1,0.1,0.1,0,0,0,0.1,0,0.8,0.3,0,2.7,0,5.2,3.9,0.1,1.7,0,0.7,0,0,0,6.6,6.5,0,0,0,10.5,0.2,0,0,0,0,0,0.6,0,0,0,0,0.5,0.5,0,0,55.5,1.3,0,0,0,0.2,0,0,0,0,0
SLC9A3R1,"EBP50, NHERF, NHERF1",ENSG00000109062,SLC9A3 regulator 1,O14745,17,74748652-74769353,"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters",Wnt signaling pathway,NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,7,Enterocytes: 372.3;Proximal tubular cells: 352.2,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Cell line enhanced,Detected in all,NA,MCF7: 78.7;SK-BR-3: 64.2;T-47d: 124.2,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"CAB001962, HPA009672, HPA027247",Enhanced,NA,Approved,"Vesicles,Plasma membrane,Centriolar satellite",NA,NA,Yes,NA,9600000,Plasma membrane,"Vesicles, Centriolar satellite","CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162",unprognostic (1.29e-1),unprognostic (4.58e-2),unprognostic (1.73e-2),unprognostic (5.51e-2),unprognostic (5.83e-2),unprognostic (1.73e-1),prognostic unfavorable (9.83e-5),unprognostic (7.41e-2),unprognostic (5.61e-2),unprognostic (5.38e-2),unprognostic (7.53e-2),unprognostic (4.49e-2),unprognostic (1.56e-3),unprognostic (7.81e-3),unprognostic (5.53e-2),unprognostic (3.84e-2),unprognostic (2.08e-2),5.4,33.3,19.8,9.9,23.3,22.6,15.2,21.9,15.1,12.5,30.6,15.2,35.9,57.6,5.4,12,74.3,20.5,30.8,5.6,14.2,8.8,36.1,64.9,8.6,13.5,14.3,14,5,26.5,12.5,4.9,8.3,12.8,10.1,13.4,22.9,41.8,23.3,1.5,11.2,73.3,3.1,12.1,13.8,14.8,5.4,14.1,18.4,5.6,24.3,30.3,7.1,20.3,9.8,14.3,72.7,24.8,45.1,70.4,44.3,13.9,11.5,5.7,5.9,3.5,2.5,25.9,3.3,3.1,8.6,8.4,36,8.4,3,3.4,7.1,4.6,20.1,9.8,6.5,4.1,3.7,9.4,23,31.1,47.9,7.1,15,15.6,2.1,3.6,6.8,2.9,18,7.1,9.2,7.3,16.5,13.2,78.7,35.3,33.7,5.1,39.5,6.8,3.8,6.5,13.9,11.9,10,4.9,6.5,3.5,64.2,7.2,16.6,124.2,12,2.3,2.7,7.8,6.3,5.5,28.6,12.9,5.6,4.3,20,1.5,72.7,14.1,65.3,70.4,20.6,46.6,9.8,43.2,59.3,13.7,8.6,25.5,45.2,50.3,45.1,24.8,14.3,47,44.3,19.8,23.3,21.9,15.1,14.2,8.8,14.3,14,12.8,14.1,6,18.8,36.3,18.8,41,1.9,14.9,206.4,41.5,14.8,29.6,3.9,67.4,56.3,154.8,9.9,11.7,372.3,0,86,43,16.6,31.5,24.3,159.6,66.7,4.8,18,4.9,23.7,8.2,8.1,24.4,27,7.2,41.8,82,78.1,101.7,39.3,352.2,4.7,6.5,14.4,6,20.7,50.2,93.3,101.5,27.5,31.5
SLC9A3R2,"E3KARP, NHERF-2, SIP-1, TKA-1",ENSG00000065054,SLC9A3 regulator 2,Q15599,16,2025356-2039026,"Predicted intracellular proteins, Transporters",NA,NA,NA,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,9,Endothelial cells: 275.4;Hepatocytes: 196.4;Ito cells: 306.3;Pancreatic endocrine cells: 190.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Group enriched,Detected in some,5,classical monocyte: 3.6;intermediate monocyte: 2.7;myeloid DC: 6.8;plasmacytoid DC: 5.0,Group enriched,Detected in many,5,dendritic cells: 6.8;monocytes: 3.6,Cell line enhanced,Detected in many,NA,A549: 38.1;MCF7: 60.8;PC-3: 57.3;SK-BR-3: 38.5;U-251 MG: 38.3;WM-115: 41.1,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA001672, HPA066520",Enhanced,NA,Supported,Plasma membrane,NA,NA,NA,NA,120000,Plasma membrane,NA,"HPA001672: AB_1080017, HPA066520: AB_2732748",unprognostic (6.99e-2),unprognostic (4.56e-2),unprognostic (2.06e-2),prognostic favorable (1.03e-4),unprognostic (1.41e-2),unprognostic (1.54e-1),unprognostic (2.94e-3),unprognostic (9.17e-2),unprognostic (1.68e-2),unprognostic (1.56e-2),unprognostic (2.17e-2),unprognostic (1.70e-2),unprognostic (2.20e-2),unprognostic (6.20e-3),unprognostic (9.10e-2),unprognostic (2.40e-1),unprognostic (2.80e-2),51.5,19.4,20,10,25.4,1.1,41,15.5,26.6,29.7,13.1,15.2,13.5,13.5,28.7,10.3,16.1,20.9,30.4,65.1,18.4,15.7,40.7,80.9,51.2,11.1,21,15.9,18.3,14,5.3,17.4,25.1,17.8,25.5,6.5,37.5,76.3,22.9,60.9,7.1,15.7,9.9,12.2,39,35,8.8,13.5,2.5,32.7,21.5,12.3,13.3,25,0.1,6.8,0,3.6,0.1,0.9,1,6.3,38.1,1,7.9,1.3,1.8,1.1,27.8,16.8,14,4.6,5,8.5,0,13.2,11.9,1.8,6.2,3,2.7,1.5,0,9.1,0.6,16.4,12.1,9.3,0.1,2.8,1.9,2.8,4.1,1.2,6.6,13.9,2.9,4.6,0.5,0.9,60.8,0.1,7,1.5,15.2,57.3,5.4,1.6,10,3.1,0.6,7.3,6.8,1.9,38.5,2.5,1,31.2,3.3,35.5,4.4,6.4,0.4,38.3,1,0.8,0.1,0.5,0.7,41.1,0,3.6,0,0.9,2.7,0.3,0,0.2,0.2,6.8,0.1,0.9,0.9,0,0.1,0.9,5,0.2,1,20,25.4,15.5,26.6,18.4,15.7,21,15.9,17.8,13.5,3,13.8,20.1,19.8,13.5,1.5,21,66.2,6.7,5.7,12.2,0,0.8,5,30.7,12.9,275.4,5.7,0,7.5,0.7,37.7,42,0,196.4,2.2,3.2,20.6,306.3,28.2,22.9,75.9,9.5,32.1,1.8,66.3,11.2,190.9,5.8,41.8,12.2,4.4,25.8,53.1,1.7,7.7,9.9,0.8,6.9,14.3,41.9
SLC9A8,"KIAA0939, NHE8",ENSG00000197818,Solute carrier family 9 member A8,Q9Y2E8,20,49812713-49892242,"Plasma proteins, Predicted membrane proteins, Transporters","Antiport, Ion transport, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in all,NA,SK-BR-3: 27.8,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,CAB033682,Approved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CAB033682: AB_2270441,unprognostic (1.90e-1),unprognostic (1.90e-1),unprognostic (6.11e-2),unprognostic (2.73e-2),unprognostic (2.58e-1),unprognostic (1.29e-2),unprognostic (4.49e-2),unprognostic (3.22e-1),unprognostic (3.96e-2),unprognostic (5.89e-2),unprognostic (1.60e-2),unprognostic (2.32e-1),unprognostic (2.19e-2),unprognostic (1.96e-2),unprognostic (1.10e-1),unprognostic (1.48e-2),unprognostic (5.28e-2),9,14,7.6,11.4,13.9,29.8,8.9,10.3,15.1,8.4,9.1,14,7.7,9.7,12.2,10.6,16,8.6,9.4,6.8,7.3,7.8,8.4,16.2,9.5,10.6,6.6,8,7.2,13.5,11.7,12.4,7.2,11.9,9.1,9,15.4,13.7,7.9,19.5,7.3,9.8,9,8.1,13.9,12.8,19.6,5.8,13.6,11.9,8.4,18.6,11.4,7.6,2.2,1.4,7.1,1.7,0.8,2.5,1.4,4.3,7.9,3.5,3.5,4.5,2.9,9,4.5,6.1,8.6,4.1,5.6,9.8,5.2,5.8,6.4,7,9.7,3.7,4.5,4.4,4.5,2,2.5,5,2.8,6.3,4.5,6.3,5.4,5.2,4.5,9.2,4.5,3.6,6.9,4.9,5.4,5.2,4.7,4.1,3.1,2.9,6.5,3.7,3.1,4.2,3.7,5.1,4.7,3.6,3.1,7.4,27.8,5.6,2.5,9,7.5,5.5,11.7,6.5,5.7,4.3,8.3,3.6,3.8,16,6.1,4.8,2.8,1.4,3.6,2.3,1.1,2.5,1.6,1.7,2,1.4,2.2,1.8,1.1,7.1,0.8,1.7,0.7,1.2,1.4,7.6,13.9,10.3,15.1,7.3,7.8,6.6,8,11.9,5.8,11.9,9.1,3,3.8,2.3,5.5,4.4,2.5,12,11.4,3.5,13.7,4.9,1.7,5.1,2.1,4.3,10.5,0,5.5,3.3,3.3,6.3,21.9,13.9,4.4,6.4,6.4,6.2,10,5.3,3.4,4.1,1.7,4.6,7.1,5.2,7.7,6,4.6,3.5,9.5,0,3.4,6.5,6.5,1.6,2.9,6.9,6.6,6.7
SLC9A1,"APNH, NHE1, PPP1R143",ENSG00000090020,Solute carrier family 9 member A1,P19634,1,27098815-27166981,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Antiport, Ion transport, Sodium transport, Transport",Calmodulin-binding,"Deafness, Disease mutation, Neurodegeneration",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,salivary gland: 60.7,Cell type enhanced,Detected in many,4,Enterocytes: 52.0,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"CAB022371, HPA048532, HPA052891",Enhanced,NA,Supported,Plasma membrane,NA,NA,NA,NA,NA,Plasma membrane,NA,"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981",unprognostic (6.18e-2),unprognostic (1.59e-1),unprognostic (2.21e-1),unprognostic (8.48e-2),prognostic unfavorable (7.47e-4),unprognostic (2.70e-2),unprognostic (4.33e-3),unprognostic (3.18e-2),unprognostic (9.74e-2),prognostic unfavorable (7.10e-4),unprognostic (3.44e-2),unprognostic (6.95e-2),unprognostic (2.05e-2),unprognostic (1.27e-2),unprognostic (1.60e-1),unprognostic (3.34e-1),unprognostic (1.16e-2),7.1,11.3,7.5,9.9,10.1,7.3,8.4,11.7,18.9,8.7,14,5,26.9,20.7,10.6,6.8,10.3,7.1,24.4,13.4,4.6,5.3,7.3,2.4,11.2,5.8,5,6.7,6.9,6.4,13.4,8,42.5,14.8,8.5,10.2,10.1,60.7,55.4,3.8,9.2,24.7,8.1,3.9,10.5,45.6,8.3,4.9,6,8,6.5,9,18.8,8.4,0.9,0.6,5.5,1.5,0.4,4.2,1.8,13.7,4.7,4.5,4.5,10.2,7.4,27.6,11.3,17.3,9.9,10.8,5.7,9,6.2,9.7,14.7,4.8,17.2,4.4,28,6.2,7.4,4.1,9.5,3.1,2.4,31.1,5.5,7.2,9.2,13.6,16.7,23.3,7.2,16.4,4.4,2.6,6.1,14.5,8.2,2.8,2.9,6.2,17,9.8,5.1,4,2.9,5.2,20.8,5.2,1.6,9.5,13,5.7,4.8,6,3.5,17.6,10.6,4.2,9.8,6.2,5.5,3.5,1.8,11.3,6.2,6.1,0.1,1.5,1.5,1.9,0.9,4.2,0.2,2.2,2,0.6,0.9,1.4,1.7,5.5,0.4,1.5,0.1,0.8,1.8,7.5,10.1,11.7,18.9,4.6,5.3,5,6.7,14.8,4.9,6,17.9,5.2,16.2,27.7,6.3,11.3,10.2,0,3.4,10.4,0,30,0,8.5,26.9,7.1,52,0,10.9,16.2,11,8.8,26.5,1,11.5,19.1,12,8,4.9,9.7,8.6,6.6,6.8,1.8,12.3,10.8,19.4,22,12.4,1.3,3.6,6.5,8.7,1.4,3.4,22,44.3,6.7,14.3,16.3
SLC9A2,NHE2,ENSG00000115616,Solute carrier family 9 member A2,Q9UBY0,2,102619707-102711318,"Plasma proteins, Predicted membrane proteins, Transporters","Antiport, Ion transport, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,gallbladder: 16.8;intestine: 16.1;stomach 1: 19.8,Cell type enhanced,Detected in some,10,Early spermatids: 19.1;Enterocytes: 23.6;Late spermatids: 22.4;Mucus-secreting cells: 26.9;Paneth cells: 40.3;Undifferentiated cells: 31.4,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in many,NA,NA,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell line enhanced,Detected in some,NA,A-431: 6.8;OE19: 25.9;RT4: 11.9;SK-BR-3: 10.5;T-47d: 13.2,Low region specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA035121, HPA035122",Approved,NA,Supported,Cell Junctions,NA,NA,NA,NA,NA,Cell Junctions,NA,"HPA035121: AB_10602894, HPA035122: AB_2674477",unprognostic (1.53e-2),unprognostic (8.05e-3),unprognostic (6.00e-2),unprognostic (3.00e-3),unprognostic (3.12e-1),unprognostic (1.09e-1),unprognostic (2.12e-1),unprognostic (1.86e-1),unprognostic (1.55e-1),unprognostic (1.23e-1),unprognostic (2.37e-2),unprognostic (1.97e-1),unprognostic (1.40e-3),unprognostic (1.60e-1),unprognostic (7.51e-2),unprognostic (1.39e-2),unprognostic (1.70e-1),0.2,0.4,0.9,10.8,1.4,0,1,0.5,1.9,1,15,0.6,8.4,4.6,0.2,5.8,0.5,0.2,16.8,0.2,1.5,1,4.6,0.2,0.2,0,0.9,0.7,0.2,0.2,0.1,1.7,0,1.8,4.5,16.1,0.9,3.7,11.7,4.4,1.3,9.5,0.4,1.3,0.2,19.8,5.3,0.6,1,0.6,1.8,3.1,2.8,0.2,0,0,0.3,0,0.3,0.1,0,6.8,4.3,0,1.3,0,0,0.1,0,0,0,0,4.7,0.1,0,2.5,0,0.4,0,0,0,0,0,0.2,2.3,2.1,0,0,0.3,0.5,0,0,0,0,0,0,0,0.6,0,0,5.3,0,0,0.1,25.9,3.6,0,0,0,0.8,11.9,0,0,0,10.5,0,0,13.2,0,0,0,0.5,0,1,0.4,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0.3,0.3,0,0,0,0,0.9,1.4,0.5,1.9,1.5,1,0.9,0.7,1.8,0.6,0,0,0,0.2,0.3,0,0.4,0,0,0,8.7,0,0.4,0,0.2,19.1,0,23.6,0,0,0,0,4.3,0,0,0.1,0,9.4,0,0,22.4,0.6,0,0,0,26.9,0.5,4.9,40.3,0,1,0,0,0.3,0.7,0.1,0.5,0.2,0,31.4,0.7
SLC9A3,NHE3,ENSG00000066230,Solute carrier family 9 member A3,P48764,5,470458-524332,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Antiport, Ion transport, Sodium transport, Transport",NA,Disease mutation,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,NA,gallbladder: 65.8;intestine: 85.1;kidney: 43.6,Cell type enhanced,Detected in some,15,Alveolar cells type 1: 14.9;Club cells: 10.3;Collecting duct cells: 15.7;Proximal tubular cells: 38.9,Low cancer specificity,Detected in many,NA,NA,Low region specificity,Detected in some,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in all,NA,HDLM-2: 28.2,Region enriched,Detected in single,14,cerebellum: 4.6,Not detected,Not detected,NA,NA,"HPA036493, HPA036669",Enhanced,NA,Supported,Plasma membrane,NA,NA,NA,NA,NA,Plasma membrane,NA,"HPA036493: AB_10673353, HPA036669: AB_10670843",unprognostic (1.27e-1),unprognostic (4.88e-1),unprognostic (9.35e-3),unprognostic (1.11e-1),unprognostic (2.37e-1),unprognostic (3.35e-1),unprognostic (2.51e-1),unprognostic (9.40e-2),prognostic unfavorable (8.49e-4),unprognostic (5.18e-2),unprognostic (1.29e-1),unprognostic (3.69e-2),unprognostic (3.84e-1),unprognostic (1.30e-1),unprognostic (1.04e-1),unprognostic (1.24e-2),unprognostic (1.32e-1),0.6,0.6,0.5,16.2,1,0,0.6,4.2,0.9,0.9,27.5,0.7,1.1,12.7,0.9,3.4,2.4,0.8,65.8,0.6,0.6,0.6,43.6,0.5,0.5,0.9,0.9,0.7,0.8,1.1,0.6,0.9,0.5,1.2,1.4,2.3,1.2,2.1,0.8,0.7,4.2,85.1,1.1,0.6,0.5,22.7,1.1,0.5,0.6,0.7,2.4,2.7,0.8,2,1.9,2,0.2,1.2,3.5,6.8,2.9,4.2,3.8,7,7.4,1.7,2,5.5,4.2,2.5,5.2,3.3,9.3,4.9,10.2,5.5,1.9,3.8,7,3.9,2.5,2.5,28.2,7.3,4.6,16.5,3.4,2.6,3.4,5.9,2.7,5.2,2.3,3.5,2.6,1.5,4.2,6.1,5.4,1.8,6.6,3.7,16.7,2.6,12.2,6.3,5.6,6.6,5.3,1.8,3.6,7.9,3.3,12.6,3.5,2.6,3.2,8,2.7,1.9,6,5.3,4.1,2.7,9.1,3.6,5.8,3.8,15.3,3.8,0,1.2,0.1,4.3,0.5,3.8,1.6,5.6,4.1,1.4,1.9,6.8,5.2,0.2,3.5,0.4,2,4.2,2.9,0.5,1,4.2,0.9,0.6,0.6,0.9,0.7,1.2,0.5,14.9,4.3,0,0,0,0,0.6,0,5.3,10.3,15.7,0,0,5,7.5,0,0,1,0,7.7,0,0,0,2.3,0,0,0,0,0,0,0,0,0.7,0,8.2,0,0,6.5,0,0,38.9,0,0,0,0,0,0,0,0,0,0
SLC9A4,NHE4,ENSG00000180251,Solute carrier family 9 member A4,Q6AI14,2,102473303-102533972,"Predicted membrane proteins, Transporters","Antiport, Ion transport, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,NA,Group enriched,Detected in some,6,gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9,Cell type enriched,Detected in some,8,Collecting duct cells: 24.4,Low cancer specificity,Detected in some,NA,NA,Not detected,Not detected,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in some,NA,HDLM-2: 3.9;OE19: 11.4;RT4: 7.1,Group enriched,Detected in some,18,hippocampal formation: 11.6;olfactory region: 8.3,Not detected,Not detected,NA,NA,HPA036096,Supported,NA,Approved,"Nucleoplasm,Plasma membrane",NA,NA,NA,NA,NA,"Nucleoplasm, Plasma membrane",NA,HPA036096: AB_2674939,unprognostic (1.41e-1),unprognostic (3.76e-2),unprognostic (9.31e-2),unprognostic (3.09e-3),unprognostic (7.58e-2),unprognostic (1.46e-1),NA,unprognostic (7.17e-2),unprognostic (5.35e-1),unprognostic (9.44e-3),unprognostic (3.26e-2),unprognostic (1.30e-1),unprognostic (2.46e-2),unprognostic (3.12e-1),unprognostic (5.04e-1),unprognostic (2.50e-1),unprognostic (1.98e-2),0,0.1,0.1,0,0.1,0.4,0.1,0.1,0.1,0.2,0.1,0.3,0,1.1,0.1,0,1.3,0.1,23.2,0.2,0.1,0.1,12.3,0.1,0.1,0.2,0.1,0,0.1,0.1,0,0.1,0,0.1,0.7,0,0,3.7,2.4,0.7,0.2,0.2,0,0.1,0.1,33.9,0.3,0,0.2,0.1,0.5,0.4,0.6,0.2,1.5,0.9,1.8,0.8,1.2,1.2,0.1,0.2,0.2,0.2,0.6,0,0,0.1,0.2,0,0,0,1.1,0.4,0.1,2.4,0,0.3,0.3,0,0,0,3.9,0.1,0.2,0.4,0.1,0,0.1,0.3,0,0,0,0,0.3,0,0.1,0.2,0.9,0,0.4,0.1,0.1,1.1,11.4,0.4,0.2,0.5,0.3,0,7.1,0.2,0.2,0.1,0.4,0,0.3,0.2,0.1,0.5,0.4,1.1,0.7,0.2,0.2,0.2,0,0.5,0.1,0.1,1.6,0.7,1.1,1.2,0.6,0.8,0.8,0.9,0.9,0.5,1.5,1,1.2,1.8,1.2,0.8,0.9,0.6,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0,0.1,0,3,2.7,0,0,0,0,0.2,0,2.7,1.2,24.4,0,0,0,0,1.4,0,0,0,0,0,0,0,1.1,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0.1,0.1,0,0.1,0,0,0.3
SLC9A5,NHE5,ENSG00000135740,Solute carrier family 9 member A5,Q14940,16,67237683-67272190,"Predicted intracellular proteins, Predicted membrane proteins, Transporters","Antiport, Ion transport, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,NA,Tissue enhanced,Detected in many,NA,brain: 13.5;lymphoid tissue: 14.5,Cell type enriched,Detected in some,5,Horizontal cells: 15.9,Low cancer specificity,Detected in some,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in some,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in many,NA,U-138 MG: 8.8,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA041004, HPA041329",Uncertain,NA,Uncertain,"Plasma membrane,Cytosol",NA,NA,NA,NA,NA,Cytosol,Plasma membrane,"HPA041004: AB_10794433, HPA041329: AB_10794373",unprognostic (8.90e-2),unprognostic (9.70e-2),unprognostic (3.39e-3),unprognostic (1.37e-1),unprognostic (1.44e-1),unprognostic (1.43e-1),unprognostic (2.24e-2),unprognostic (5.17e-2),unprognostic (1.50e-1),unprognostic (1.12e-1),unprognostic (2.50e-3),unprognostic (4.84e-2),unprognostic (9.85e-11),unprognostic (9.21e-2),unprognostic (1.95e-1),unprognostic (8.12e-3),unprognostic (9.07e-2),1.7,1.7,2.9,1.1,8.8,0.5,1.1,13.5,8.6,0.9,1.4,0.5,3.6,1.3,1.1,3.2,0.6,0.6,1.9,2.3,2.9,3.6,1.1,0.6,2.9,2.1,2.1,2.3,1.4,1.5,0.5,0.6,1.7,4.3,1,1.1,0.5,1,2.5,1.7,4.2,0.9,0.6,2.7,14.5,0.8,3.3,1.2,0,1,0,1.3,1.6,0.4,1.5,0.8,1,0.5,0.6,0.9,0.1,0.5,4.1,3.7,1.2,6.8,4.7,0.4,1.3,5.8,3.4,3.1,0.2,2.9,0,0.8,1.6,1.7,0.2,1,0.7,1.3,1.2,1.2,3.2,0.3,0.9,0.8,1.4,6.7,5.3,1.4,1.9,0.4,6.3,0.7,1.2,0.7,1.9,2.2,2.3,0.1,0.3,2.5,0.2,0.4,0,0.8,0.9,0.6,0.7,2.1,0.9,3.5,0.2,1.8,0.9,1.4,0.3,1,8.8,1.4,1.6,0.6,3.6,0.9,1.8,6.3,0.7,2.2,0,0.4,0,0,0,0.6,1.5,0.4,0.9,0.1,0,0.4,0.4,1,0.6,0.5,0.8,0,0.1,2.9,8.8,13.5,8.6,2.9,3.6,2.1,2.3,4.3,1.2,3,3.2,0,0.1,0.6,1.9,1.2,2.5,0,0,0,0,0.2,0,0.3,0.6,0.7,0,0,0.2,0.1,0.6,0.4,0,0,0.1,15.9,1.2,2.5,0,0,0.3,0,0,1,0,0.3,0.4,0,2.1,0,0.6,0,0.7,1.7,1.1,0.6,0,0,0.2,0.1
SLC9A6,"KIAA0267, NHE6",ENSG00000198689,Solute carrier family 9 member A6,Q92581,X,135973841-136047269,"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Antiport, Ion transport, Sodium transport, Transport",NA,"Disease mutation, Epilepsy, Mental retardation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,brain: 35.1,Cell type enhanced,Detected in many,7,Horizontal cells: 46.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA059445, HPA059590",Enhanced,NA,Supported,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,"HPA059445: AB_2684021, HPA059590: AB_2684075",unprognostic (1.35e-1),unprognostic (8.28e-3),unprognostic (4.36e-1),unprognostic (4.93e-2),unprognostic (1.84e-1),unprognostic (1.19e-1),unprognostic (2.60e-2),unprognostic (1.57e-1),unprognostic (1.15e-1),unprognostic (2.72e-2),unprognostic (7.43e-2),unprognostic (1.29e-1),unprognostic (7.07e-2),unprognostic (5.30e-2),unprognostic (1.75e-1),unprognostic (4.49e-2),unprognostic (5.06e-2),4.3,5.7,16.4,4.7,27.6,4,3.1,15.3,35.1,5.2,5.2,7.8,1.6,7.5,5.7,3.2,5.6,5.2,4.8,7.2,19.1,24.3,6.2,3.9,5.7,4.7,15,15.6,7.4,3.3,9.3,8.6,4,22.3,3.6,5.5,4.6,3.3,4.6,5.5,4.1,6.5,6.5,9.5,4.8,5.2,5.1,4,3.6,5.9,1.7,5.8,4.7,3.2,5.3,6.8,3.2,8.4,5.9,13.9,6,13.2,7,7.4,2.7,10.5,10.2,13.3,10.7,11.5,9.2,19.5,6.1,10.6,9.9,24.4,12.3,13.7,7.9,9.6,9.6,13.4,7.7,8.7,2.7,11.2,3.6,5.5,7.7,9.4,5.6,8.5,15.2,7.5,6.6,7.8,9.7,4.9,14.1,10.1,5.8,10.2,2.2,4.2,4.9,9.5,6.9,11,10,6.6,6.6,6.6,5,7.7,0.8,6.2,6.6,3.2,6,11.1,11.5,8.2,17,13.7,6.8,15.1,8.7,7,13.2,6.4,2.2,6,3.2,8.1,8.4,13.9,5.3,9.5,7.9,6.8,4,10.6,7.9,2.6,5.9,6.6,4.3,8,6,16.4,27.6,15.3,25.9,19.1,24.3,15,15.6,22.3,4,3,4.8,4.2,1.3,6.6,13.4,8.1,17.8,0,1.2,12.2,7.9,2.2,0,4,0.6,4.6,8,0,5.1,2.1,4.7,2.1,1.1,7.8,8.9,46.1,10.3,8.6,12.9,0.9,5.2,8.8,8.5,2.8,3.4,13.2,4.6,5.8,4.2,4.9,7,0,4.9,5,12.3,5.9,2.4,7.7,5,2.2
SLC9A7,NHE7,ENSG00000065923,Solute carrier family 9 member A7,Q96T83,X,46599252-46759172,"Plasma proteins, Predicted membrane proteins, Transporters","Antiport, Ion transport, Potassium transport, Sodium transport, Transport",NA,"Disease mutation, Mental retardation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in all,NA,brain: 42.0,Low cell type specificity,Detected in many,NA,NA,Low cancer specificity,Detected in all,NA,NA,Region enhanced,Detected in all,NA,basal ganglia: 42.0,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Low cell line specificity,Detected in many,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA048938, HPA075385",Approved,NA,Supported,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,"HPA048938: AB_2680565, HPA075385: AB_2686747",unprognostic (2.77e-1),unprognostic (4.68e-2),unprognostic (1.37e-1),prognostic unfavorable (8.58e-4),prognostic unfavorable (8.14e-4),unprognostic (2.16e-2),unprognostic (2.73e-3),unprognostic (5.26e-3),unprognostic (1.28e-2),unprognostic (9.25e-2),unprognostic (5.30e-2),unprognostic (1.11e-1),unprognostic (2.08e-1),unprognostic (7.20e-2),unprognostic (2.62e-1),unprognostic (1.57e-1),unprognostic (1.13e-1),1.7,7.2,4.4,3.8,42,4.4,7.9,7,12.4,1.8,1.2,1.8,1.2,1.7,1.2,3.8,3.2,2.5,2.2,2.3,3.3,7.1,3.3,4.1,1.8,7.8,3.6,4.3,6.3,4.6,11.5,13.6,1.4,12.7,6.5,1.3,2.3,7.3,2.9,10,2.9,2.7,1,2.7,4.7,8.2,1.3,8.2,2.8,6.9,1.7,8.2,2.3,2.2,4.3,6,2.1,0.6,1.4,0.7,0.5,7,5.4,0.8,2.4,0.9,5.4,3.1,6.7,8.4,4,3.3,5.5,7.7,15.5,2.1,10.7,7.9,3.3,5.2,7.6,7.4,8.1,2.8,1.6,2.1,2.2,3.3,0.7,12.8,3.4,1,11.4,7.6,19.2,5.7,5.4,0.1,0.3,5.5,10.6,1.7,0.8,3.7,3.4,6.5,6.9,0.3,0.2,3.1,7.9,5.8,0.7,3.4,5.2,1.5,6.8,6.9,0.3,0.3,8.7,2.9,1.3,3.9,1.6,0.4,7.8,12.3,0.1,2.8,1,0.6,0.3,0.6,0.6,0.4,3.4,0.7,0.3,2.4,4.3,0.4,0.5,2.1,1.4,0.6,6,0.7,0.5,4.4,42,7,8.3,3.3,7.1,3.6,4.3,12.7,8.2,3,8,17.9,7.5,0.6,10.1,4.5,2.5,0,3.4,15.7,3.9,5.5,0,15.3,0,0.5,0,0,12.2,0.3,0.4,18.2,0,4.9,6.6,12.7,2.4,0.6,4.7,0.4,0.9,9.1,1.7,9,1,6.6,12.5,0,0.4,1.7,3.4,6.5,0.8,0,0.9,0.9,6.1,0.5,0.8,11.2
SLC9A9,"FLJ35613, NHE9",ENSG00000181804,Solute carrier family 9 member A9,Q8IVB4,3,143265222-143848531,"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Antiport, Ion transport, Sodium transport, Transport",NA,"Autism, Autism spectrum disorder",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in many,8,Erythroid cells: 23.3;Hofbauer cells: 42.3;Ito cells: 25.2;Kupffer cells: 24.1,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in many,NA,NA,Low lineage specificity,Detected in many,NA,NA,Cell line enhanced,Detected in some,NA,ASC diff: 10.6;ASC TERT1: 13.8;HSkMC: 9.6;Karpas-707: 33.4;RPMI-8226: 15.5;U-266/70: 15.6,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA058234,Approved,NA,NA,NA,NA,NA,NA,NA,41000,NA,NA,HPA058234: AB_2683648,unprognostic (8.22e-2),unprognostic (6.88e-2),unprognostic (7.23e-3),unprognostic (1.65e-1),unprognostic (3.65e-2),unprognostic (7.05e-2),unprognostic (1.24e-1),prognostic favorable (8.18e-4),unprognostic (2.66e-1),unprognostic (1.35e-3),unprognostic (7.73e-2),unprognostic (4.51e-2),prognostic unfavorable (5.57e-7),unprognostic (5.01e-2),unprognostic (4.69e-2),unprognostic (1.56e-1),unprognostic (4.28e-2),17.4,8.4,16.8,11.4,25.9,2.7,7.7,4.5,17.2,10.6,9.6,17.2,2,4.5,6.2,5.7,18,9.2,13.4,8.2,14.7,11.7,3.7,9.9,8.3,17.5,23,7.4,11.8,2.2,1.9,6.5,21.3,18.3,12.9,8.6,4.6,7.1,12.8,3.5,10.3,9.3,12.1,27.5,16.9,7.3,2.9,24.1,10.7,5.7,7.1,17.8,17.3,10.8,4.4,8.7,0.7,10.8,3.9,9.3,4.7,0.3,0.3,0.4,0.5,10.6,13.8,0.1,0.5,3.5,0.2,1.7,0,0.1,1.6,0.1,1.6,0.9,0.4,0.5,1,0.4,6.8,0.1,0.9,0.2,0,1.2,0.4,0.7,9.6,2.8,0.3,0.5,0.6,0.1,1.2,0,33.4,2.2,0,0.8,0,0.1,0,0.2,1.3,0.1,15.5,0,0.2,0.2,0,0.8,0,0,0.2,0.1,0.3,0,1.3,0.3,1.5,0.7,15.6,0,0,2.3,0.2,0.6,0.1,6.6,0.7,5.2,10.8,4.5,3.7,5.5,8.1,8.7,4.4,3.1,4.6,0.5,3.9,9.2,0.6,9.3,4.7,16.8,25.9,4.5,17.2,14.7,11.7,23,7.4,18.3,24.1,0,1.4,3.7,9.4,3.3,0.1,1.1,0,1.4,2.3,3.5,2,0.4,0,0.8,3.9,2.8,0,23.3,0.2,0.3,9.4,12.5,0,0,42.3,0,0,25.2,24.1,2.7,8.6,9.6,6.8,19.8,0,3.7,1,0,6.7,0.4,0,0,3.1,0.2,0.2,4.4,0.9,10.2,0,4.8
SLC9C1,"NHE, SLC9A10",ENSG00000172139,Solute carrier family 9 member C1,Q4G0N8,3,112140887-112294258,"Predicted membrane proteins, Transporters","Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport",Developmental protein,NA,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,6,testis: 25.5,Cell type enriched,Detected in some,6,Spermatocytes: 12.7,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,Cell type enhanced,Detected in single,NA,naive B-cell: 1.2,Lineage enriched,Detected in single,12,B-cells: 1.2,Cell line enhanced,Detected in some,NA,AF22: 1.0;HaCaT: 1.5;Karpas-707: 1.0;REH: 1.3,Not detected,Not detected,NA,NA,Not detected,Not detected,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,unprognostic (1.21e-2),unprognostic (3.63e-1),unprognostic (4.79e-2),unprognostic (2.92e-1),unprognostic (1.57e-3),unprognostic (9.56e-2),unprognostic (3.92e-2),unprognostic (1.24e-1),unprognostic (4.40e-2),unprognostic (2.41e-1),unprognostic (1.85e-1),unprognostic (1.98e-2),unprognostic (1.65e-2),unprognostic (8.32e-2),unprognostic (5.89e-2),unprognostic (9.62e-3),unprognostic (3.25e-1),0.3,0.1,0.1,1.4,0.2,0.1,0.1,0.1,0.1,0.3,0.2,0,0.4,0,0.2,0.1,0.1,0.3,1.7,0.5,0.1,0.1,0.2,0.1,0.2,0,0.1,0.1,0.3,1.2,0,0.8,0.7,0.4,0.1,0.1,0.3,0.2,1.1,0.1,4,1,0.2,0.3,0.4,0.3,25.5,0,1,0.5,0.5,0.4,0.3,0.8,1.2,0,0,0,0,0,0,0.2,0,1,0,0,0,0,0.3,0,0,0,0,0,0,0,0,0.2,1.5,0,0,0,0,0,0,0.1,0,0,0,0,0,0.7,0,0,0.6,0,0,0,1,0,0,0,0.3,0,0.5,0.3,1.3,0,0,0,0.2,0,0,0.1,0,0,0.1,0.5,0.1,0,0,0.4,0,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0.3,0,0,0,1.2,0,0,0,0,0,0,0,0,0.1,0.2,0.1,0.1,0.1,0.1,0.1,0.1,0.4,0,0,0,0,0.1,0,0,0.4,0,0,0,0,0,0.1,0,0,2.3,0,0,0,0,0.2,0,0.1,0,0,0,0,0,0,0,1.6,0,0,0,0,0,0,0.1,0,0,0,0,0,0,12.7,0.4,0,0.3,0,0,0
CHP1,"CHP, p22, p24, Sid470p, SLC9A1BP",ENSG00000187446,Calcineurin like EF-hand protein 1,Q99653,15,41230839-41281890,"Plasma proteins, Predicted intracellular proteins, Transporters","Protein transport, Transport",Protein kinase inhibitor,"Disease mutation, Neurodegeneration",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in all,NA,NA,Cell type enhanced,Detected in all,4,Distal tubular cells: 330.0;Enterocytes: 365.9,Low cancer specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low cell type specificity,Detected in all,NA,NA,Low lineage specificity,Detected in all,NA,NA,Low cell line specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,Low region specificity,Detected in all,NA,NA,HPA006616,Approved,NA,Approved,Vesicles,NA,NA,NA,NA,NA,Vesicles,NA,HPA006616: AB_1857461,unprognostic (2.06e-2),unprognostic (3.26e-1),unprognostic (2.84e-1),prognostic favorable (9.63e-4),unprognostic (7.29e-2),unprognostic (3.74e-1),prognostic favorable (4.07e-6),unprognostic (2.20e-1),unprognostic (7.46e-2),unprognostic (3.26e-2),unprognostic (1.26e-3),unprognostic (2.79e-1),prognostic favorable (2.79e-6),unprognostic (1.06e-1),unprognostic (1.49e-1),unprognostic (4.62e-3),unprognostic (2.04e-1),39.4,32.5,21.2,17,21.5,25.7,32.3,13.5,34.1,17,51,19,18.9,41,13.4,16.4,39.1,11.2,38.8,27.3,22.7,23.8,35.6,82.3,31.6,14.4,22.4,15.6,13.6,31.1,27.1,13.9,12.2,32.1,16.8,37.6,15.2,28.7,23.1,42.2,24.2,55.6,15.8,19,12.6,52.5,7.5,11.3,10.3,23.6,34.2,24.7,21.7,22.5,8.6,30.5,52.5,47.4,11,11.8,19.4,21.7,21.3,8.2,31.5,34.9,33.2,12.8,16.9,21.3,13.3,14.3,18.8,42,3.7,19,22.2,14.1,26.7,15.9,25.7,14.7,15.3,6,14.6,17.6,29.1,27.3,19.2,23.1,34,28,15.2,15.3,19.4,23.8,11.5,23.6,24,14.6,12,8,19.7,8.9,32.5,11.4,11.5,13.4,10.5,26,39.8,5.6,13.9,28.8,53.1,14,14.8,31.4,18.2,34.1,15,16.2,23.5,11,14.1,37.3,17.8,26.8,11.8,13.5,42.9,47.4,52.5,10.7,40,11,8.6,10.1,10.7,30.5,6.8,6.5,9.3,35.6,11,38.5,19.2,11.8,19.4,21.2,21.5,13.5,34.1,22.7,23.8,22.4,15.6,32.1,11.3,41.7,95.4,37.9,53.7,64.2,9.4,73.8,193.6,22.7,38.7,97.7,9.8,29.7,330,84.2,45,25.3,365.9,23.3,131.3,51.6,41.6,79.7,36.9,304.1,61.4,11.1,53.4,75.5,170.6,81.7,27.3,82.7,123.2,54.1,120.3,19,140.2,153.1,27.6,162.5,9.3,25.8,42.4,12.5,19,94.9,56,55.4,104.3,95.4
SLC9C2,"MGC43026, SLC9A11",ENSG00000162753,Solute carrier family 9 member C2 (putative),Q5TAH2,1,173500464-173603094,"Predicted membrane proteins, Transporters","Antiport, Ion transport, Sodium transport, Transport",NA,NA,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,9,testis: 24.9,Cell type enhanced,Detected in some,13,Club cells: 2.3;Cone photoreceptor cells: 5.9;Early spermatids: 4.2;Late spermatids: 2.3;Spermatocytes: 4.2,Not detected,Not detected,NA,NA,Low region specificity,Detected in some,NA,NA,Cell type enriched,Detected in single,17,plasmacytoid DC: 1.7,Lineage enriched,Detected in single,17,dendritic cells: 1.7,Group enriched,Detected in some,4,BEWO: 1.8;THP-1: 3.7,NA,NA,NA,NA,Low region specificity,Detected in all,NA,NA,"HPA059122, HPA079529",Enhanced,NA,Approved,"Nuclear speckles,Plasma membrane",NA,NA,NA,NA,NA,Plasma membrane,Nuclear speckles,"HPA059122: , HPA079529:",unprognostic (2.10e-1),unprognostic (2.69e-1),NA,unprognostic (8.52e-2),unprognostic (5.88e-3),unprognostic (3.24e-2),unprognostic (2.21e-1),unprognostic (1.29e-3),unprognostic (1.19e-1),unprognostic (4.21e-2),unprognostic (4.92e-1),unprognostic (1.88e-1),unprognostic (1.18e-6),unprognostic (1.66e-1),unprognostic (1.01e-2),unprognostic (2.98e-1),unprognostic (1.81e-1),0.4,0.1,0.3,0,1.3,0,0,0,1.6,0.1,0,0,0.5,0,0.1,0.4,0,1.7,0,0.1,0.5,0.3,0.2,0,0.4,0.1,0,0.4,0.8,0.3,0.1,0.4,0.5,0.5,0.1,0,0.1,0,2.7,0,0,0,0.1,0.3,1,0.3,24.9,0.4,0,0,0,0.1,0,0,0,1.7,0,0,0,0,0,0,0,0.5,0,0.1,0,1.8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0.1,0,0,0,0,0,0,0,0,0,0,0,3.7,0,0,0,0,0,0,0,0,0,0.6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.7,0,0,0.3,1.3,0,1.6,0.5,0.3,0,0.4,0.5,0.4,0,0,0,0,0,0,1.4,0,0,2.3,0,5.9,0.1,0,0,4.2,0.3,0,0,0,0.3,0,0,0,0.8,0,0,0,0,0,2.3,0,0,0,0,0,1,0.2,0,0,0,0,0,0,4.2,0.4,0,0.1,0,0,0